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ABSTRACT 
ARYNES AND HETEROARYNES IN THE SYNTHESIS OF DIBENZOCINNOLINES, 
DIAZAXANTHYLEDENES, AND TRIPTYCENES 
 
Sung-Eun Suh 
David M. Chenoweth 
 
Arynes are known as useful synthons in organic synthesis. In particular, reactions 
accompanying multiple arynes have been employed for the construction of arenes and 
heteroarenes of complex molecules. Employing known reactivity modes of arynes such as 
cycloadditions, nucleophilic addition, bond insertion, Alder-ene, annulation, desaturation, and 
polymerization, a wide variety of transformation of reactive starting materials led to the 
development of novel fluorophores and energy materials, as well as the synthesis of natural 
products.  
Harnessing the highly reactive arynes, the triple aryne-tetrazine (TAT) reaction was 
disclosed as a novel metal-free synthetic method for the preparation of dibenzo[de,g]cinnoline 
derivatives in a single operation. Dibenzo[de,g]cinnolines have been shown as potential 
fluorescent probes in cells. For the mechanism, multiple mechanistic steps of the TAT reaction 
were scrutinized by isolation of intermediates and byproducts as well as a computational study 
on the transition states and the competitive reactions pathways.  
A facile two-step synthesis of the reported structure of xylopyridine A was developed from 
a pyridyne precursor and 2-fluorobenzoic acid utilizing a pyridyne insertion reaction followed by 
reductive coupling. Simple transformation of the reported xylopyridine A structure have given 
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photoactivatable dyes and specific organelle staining probes in either live or fixed cells and 
tissues, exhibiting high quantum yields, photostability, cell permeability and low toxicity. On the 
basis of these results, the synthesis of multistage photoactivatable dyes was designed and studied. 
Utilization of arynes allowed access to the synthesis of 9-substituted triptycene derivatives 
which have been recognized as three-way junction binders. Accompanying solid-phase peptide 
synthesis, the rapid diversification of the triptycene scaffold was achieved for screening in a 
nucleic acid junction binding assay.  
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1.1 Introduction 
1.1.1 Prologue 
For more than 70 years, aryne-engaged reactions have been highly praised as one of the 
most rapid ring-constructing methodologies.1 Along with providing brisk reaction speed, arynes 
possess diverse reactivity modes, participating in [2+2], [3+2], [4+2], [5+2], and [2+2+2] 
cycloadditions1a as well as nucleophilic addition,1l σ-bond insertion,1g Alder-ene reactions,2 
annulation,3 desaturation,4 and polymerization.5 To accompany other substrates, 
multicomponent or domino aryne reactions have been developed.1f,n Furthermore, 
intermolecular reactions of more than two arynes and substrates have shortened the number of 
reaction steps toward target molecules, constructed polycyclic compounds, and led to the 
discovery of new synthetic methodologies. 
 
1.1.2 History of Benzyne Generation Methods 
The first preliminary evidence for the existence of arynes was reported in 1902.6 
Stoermer and Kahlert demonstrated that 3-bromobenzofuran with KOH/EtOH affords the 
unexpected 2-ethoxybenzofuran not 3-ethoxybenzofuran. To explain the result, they proposed a 
triple bond on the furan ring of the intermediate; however, the mechanism was unclear. In 1953, 
Roberts and co-workers proposed benzyne formation and provided evidence based on their 
observations.7 
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Figure 1.1. Timeline of representative benzyne generation methods. 
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Twenty-six years before the term “benzyne” was coined by Roberts, Bachman and 
Clarke reported the [2+2+2] cycloaddition of three equivalents of benzyne, which is called “free 
phenylene” in the report (Figure 1.1).8 Two equivalents of free phenyl radicals, which are 
generated from the Wurtz-Fittig reaction of chlorobenzenes, react with sodium metal to 
generate benzene and benzyne. The authors observed triphenylene as the cycloaddition 
product. In 1939, Lüttringhaus and Sääf disclosed that benzyne generation from the reaction of 
diphenylether and phenylsodium might explain the unforeseen rearrangements.9 In the early 
1940s, Wittig and co-workers proposed the possible generation of a triple bond on the benzene 
ring from the reaction of fluorobenzyne and phenyl lithium even though the authors were 
unsure about the formation of benzyne.10 In 1945, Gilman and Avakian reported the unexpected 
synthesis of aniline.11 In this report, addition of sodium amide to 1-chloro-2-methoxybenzene 
did not yield the desired ortho-substitution product, and only meta-amination was observed. 
After 8 years, Benkeser and Schroll explained that the addition of the amide to the meta position 
of 1-chloro-2-methoxybenzene followed by a 1,2-hydride shift and elimination may lead to the 
formation of the meta-substituted product.12 However, this mechanism was improbable because 
the formation of benzyne from the addition of sodium amide to 1-chloro-2-methoxybenzene 
was proven by Roberts in the same year.7 In 1955, Wittig and Pohmer excluded strong base for 
the formation of benzyne and employed 1-bromo-2-fluorobenzene as a benzyne precursor.13 
The addition of lithium amalgam generated benzyne, which reacted with furan to afford 
epoxynaphthalene. After 4 years, in place of lithium amalgam, magnesium was used to make 
benzyne, which undergoes a Diels-Alder reaction with anthracene to afford triptycene.14 
The first metal-free benzyne generation method was introduced by Stiles and Miller in 
1960.15 Phenyldiazonium-2-carboxylate was formed by the reaction of anthranilic acid and 
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isoamylnitrite with the release of N2 and CO2 gas. Two years later, Wittig and Hoffmann 
developed benzo[d][1,2,3]thiadiazole 1,1-dioxide, which released SO2 and N2 gas to form 
benzyne.16 In 1965, Fields and Meyerson reported the thermal decomposition of phthalic 
anhydride to generate benzyne with CO and CO2 gas.17 Three years later, Stevens reported 2-
azoxybenzoic acid as a benzyne precursor, which was decomposed into benzyne with CO2 gas 
and diimide as the byproducts.18  
A hypervalent iodine-benzyne precursor (i.e., diphenyliodonium-2-carboxylate) was 
reported by Beringer and Huang in 1964.19 Although the phenyliodonio group is a good leaving 
group, the generation of benzyne still required a high reaction temperature (i.e., approximately 
200 oC). In the 1990s, phenyl[o-(trimethylsilyl)phenyl]iodonium triflate was developed by 
Kitamura and co-workers.20 Replacing the carboxylic group of diphenyliodonium-2-carboxylate, 
Beringer’s hypervalent iodine-benzyne precursor containing a silyl group enabled a lower 
reaction temperature (n-BuLi at –78 oC or TBAF at room temperature). In 1974, Kawanisi and 
co-workers also proposed the diaryliodonium benzyne precursor, which does not have any ortho 
substituent.21 Benzyne was generated by adding sodium 5-phenyltetrazolide to diaryliodonium 
halides. Recently, Wang and Huang utilized diaryliodonium triflate as the benzyne precursor 
and potassium t-butoxide as the base for N-arylation of secondary amides.22  
In 1964, Rees and Campbell reported the first oxidative method for benzyne generation 
in their short communication.23 1-Aminobenzotriazole goes through oxidation with lead(IV) 
acetate, evolving two equivalents of N2 gas. After 29 years, Knight and Berkett succeeded in 
excluding the toxic lead oxidant and used NBS for the generation of benzyne.24 
In 1960, Horner and Brüggemann reported the first photolytic method for benzyne 
generation.25 Upon exposure to UV irradiation, phthaloyl peroxide releases CO2 to form 
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benzyne at room temperature. In 1973, the report by Chapman and co-workers disclosed that 
irradiation of benzocyclobutenedione generated benzyne with two equivalents of CO2 gas.26 
After two years, Maki and co-workers designed a novel photolytic benzyne precursor.27 o-(N-
acetyl-N-alky1triazeno)benzoic acids can be photochemically degraded into benzyne and side 
products, such as N-methylacetamide, N2, and CO2. In 2014, Schnarr and co-workers revisited 
this method and successfully performed the click reaction involving azides and Maki’s benzyne 
precursor.28 
Since Kobayashi developed silylaryl triflate aryne precursors in 1983, the scope of aryne 
derivatives has been broadened, and the synthetic utilization of arynes has become more 
accessible due to its mild reaction conditions.29 Exploiting the strength of the Si-F bond, 
benzyne can be generated upon addition of a fluoride source at room temperature. The Suzuki,30 
Hosoya,31 Akai,32 and Greaney33 groups have explored replacing the silyl group in Kobayashi’s 
benzyne precursor with a halogen or bolyl group to enrich the application of aryne. 
Furthermore, in place of the triflate group, the Knochel,34 Novak,35 Xu, Jiang, Wang,36 and 
Daugulis37 groups installed halo or other sulfonate groups to broaden the scope of aryne 
reactions.  
The method for generating benzyne by addition of a strong base to a benzyne precursor 
has been modified and is still used today. Scott, Wickham, and co-workers employed phenyl 
trifluoromethanesulfonate,38 and Tilley and co-workers attached inductively electron-
withdrawing group on meta position of phenyl halides.39 Beyond the harsh conditions, the 
Greaney group recently developed novel benzyne generation methods. In 2010, the authors 
reported that benzoic acid undergoes palladium- or copper-catalyzed tandem C-H activation 
and decarboxylation to afford benzyne.40 Akai and co-workers used perfluorobutanesulfonyl 
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fluoride (NfF) and cesium carbonate for the in situ formation of nonaflate followed by 
generation of benzyne from 2-(trimethylsilyl)phenol in 2011.41 Recently, they modified 2-
(trimethylsilyl)phenol to prepare a more stable precursor. NfF and TBAT have been employed 
to generate benzyne from 2-(trimethylsilyl)phenyl trimethylsilyl ethers.42 
A hexadehydro-Diels–Alder (HDDA) reaction was independently reported by both the 
Ueda43 and Johnson44 groups in 1997. Johnson and Bradley employed nona-1,3,8-triyne with 
vacuum pyrolysis at 580 oC to afford indane and indene in 86% and 14% yield, respectively. The 
authors also performed the reaction with nona-1,3,8-triyne-1,9-d2 to support the mechanism of 
benzyne formation. More strained acyclic tetraynes for the HDDA reactions were used by Ueda 
and co-workers. In their first report, the HDDA reaction was finished at room temperature 
within two to three days. By 2008, they had reported HDDA of various tetrayne derivatives as 
well as mechanistic studies.45 In 2012, Hoye and co-workers reestablished the HDDA of tetra- 
and triyne with a broad substrate scope, experimental mechanistic evidence, computational 
studies, aryne-trapping reactions, and substitution effects.46 Since this report, numerous 
applications of HDDA have been reported by several groups including the Hoye group. 
 
1.1.3 Scope 
This review addresses each type of reaction that yields products bearing more than two 
aryne synthons. Here, the reported reactions encompass both intramolecular and intermolecular 
mechanisms and include both multistep and one-pot addition of arynes. Very detailed reviews 
have been previously published on multicomponent aryne reactions,1b,f,k,n aryne reactions in 
natural product synthesis,1c,e transition metal-catalyzed aryne reactions,1p utilities of aryne in the 
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synthesis of heterocycles,1d,f,g polycyclic aromatic compounds,1h,j biaryls,1o and general 
information1a,i,l,m on aryne reactions. 
We focus on introducing the general reaction schemes, mechanisms, and notable 
information in the references. In the absence of proposed mechanisms, we carefully refer to 
other reports to visualize a plausible mechanism. Some structures, such as phenylenes, were 
impossible to include in this review due to their numerous examples. In this case, some 
representative structures have been selected for discussion. For unclear mechanisms in 
references, the original authors’ explanation has been followed. For example, the aryne insertion 
reaction would look identical to a [2+2] cycloaddition followed by a ring opening reaction if the 
detailed mechanistic study was not included in the report. Transition-metal catalyzed 
cycloadditions are categorized as formal cycloadditions in the cycloaddition section. For 
sections 2 to 9, the categories are named after the first aryne reaction in the mechanism. All 
aryne synthons in the intermediates, transition states, and products are colored blue. 
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1.2 [2+2] Cycloadditions 
1.2.1 Biphenylene Synthesis 
 
Figure 1.2. Representative biphenylenes. 
The synthesis of biphenylenes (called “diphenylenes” in the report) from benzynes was 
introduced by Heaney, Mann, and Millar in 1957.47 (2-Bromophenyl)magnesium iodide was 
used for the generation of benzynes and in situ [2+2] cycloaddition of two equivalent of 
benzynes afforded biphenylenes. Several syntheses with various substituted arynes were 
subsequently reported.48 The representative biphenylenes are depicted in Figure 1.2. 2,3-
Dibromo-1,4,5,6,7,8-hexamethylnaphthalene was used with n-BuLi to synthesize 
dodecamethylbinaphthylene 1 by Hart and Teuerstein.49 Komatsu and co-workers synthesized 
biphenylene 2 bearing four bicyclo[2.2.2]octane units.50 Interestingly, 2 was prepared from o-
dibromobenzyne with n-BuLi but aryl diazonium carboxylate did not work. Pascal and co-
workers found that 3% of 1,2,3,4,5,6,7,8-octaphenylbiphenylene 3 was obtained from aryl 
diazonium carboxylate.51 Müllen and co-workers used 1,4,5,8-tetraiodo-2,3,6,7-
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tetraalkoxybiphenylenes and 1,4,5,8-tetra(trimethylsilyl)-2,3,6,7-tetraalkoxybiphenylenes to 
synthesize nanographenes 4 and 5, respectively.52 
 
1.2.2 [2+2]/[2+2] Cycloadditions 
Scheme 1.1. Aly’s Bis-acridine Synthesis via double [2+2] cycloadditions. 
 
In 1999, Aly and co-workers reported double formal [2+2] cycloadditions of N,N’-bis-
(aryl)-benzene-1,4-diyldimethylidene-diamines 7, and two equivalents of benzyne were 
generated from benzenediazonium carboxylate 6 (Scheme 1.1).53 The reactions afforded double 
[2+2] cycloadducts (1,4-bis(2’-substituted-acridine-10-yl)benzenes 12) with two other 
products including 10-(4′-formylphenyl)-2-substituted-acridines 16 and N-phenyl-arylamines 
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17. [2+2] cycloaddition between imines 7 and benzyne first forms azetidine ring (10 or 13), 
which is then opened by retro-[2+2] cycloaddition followed by electrocyclization to yield 12 
(for double cyclization) and both 16 and 17 (for mono cyclization) in the proposed mechanism. 
 
Scheme 1.2. Caubere’s Benzocyclobutabiphenylenes Synthesis via Stepwise [2+2]/[2+2] 
Cycloadditions. 
 
Consecutive [2+2] cycloadditions of enolates (19 and 24) and benzyne were performed 
by Caubere and co-workers in 1991 (Scheme 1.2).54 Enolate 19 undergoes the first [2+2] 
cycloaddition with benzyne to afford hexahydrobiphenylene 20. The new enolate formed after 
acetylation and deacetoxylation reacted with another benzyne to afford 
hexahydrobenzocyclobutabiphenylene 23. The enolate 24 after THP protection of 
hexahydrobiphenylene was reacted with benzyne to yield the corresponding 
hexahydrobenzocyclobutabiphenylene 26. 
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Scheme 1.3. Yu and Liu’s Double [2+2] Cycloaddition Reactions of Norbornadiene with 
Benzynes. 
 
Norbornadienes have been used as [2+2] and [4+2] cycloaddition partners due to their 
strain (Scheme 1.3). Double [2+2] cycloadditions of norbornadiene 28 and two equivalent of 
benzynes were employed by Yu, Lin, and co-workers.2b When one equivalent of benzyne was 
used, 73% of the mono-cycloadduct 29 was obtained. 
  
1.2.3 [2+2]/[2+2]/[2+2] Cycloadditions 
As discussed in section 2.1, biphenylenes were obtained from [2+2] cycloaddition of 
two benzynes. Friedman reported that two biphenylenes 30 underwent ring opening followed  
Scheme 1.4. Tetra- and Hexaphenylene Synthesis. 
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by dimerization at 400 °C to afford tetraphenylene 32 in 96% yield (Scheme 1.4).48a 
Subsequently, several transition metal-catalyzed reactions with substituents has been developed 
for this conversion. In 2001, Jones and co-workers found two isomers of hexaphenylene (37 and 
38) from the reaction of biphenylenes 30 and platinum complex 33.55 
 
1.2.4 [2+2]/[2+2]/[4+2] Cycloadditions 
Scheme 1.5. Shindo’s One-Pot Triptycene Synthesis via Triple Cycloadditions. 
 
As shown in Scheme 1.2, enolates can be [2+2] cycloaddition partners for aryne. 
Recently, Shindo and co-workers used benzyne and lithium ynolates 40 generated from the 
reaction of precursor 39 and t-BuLi to synthesize triptycenes 44 in one pot (Scheme 1.5).56 In 
the plausible mechanism, ynolates 40 reacted with benzyne via formal [2+2] cycloaddition, and 
the resulting enolates further reacted with a second benzyne in a [2+2] cycloaddition reaction to 
afford 42. Retro-[2+2] cycloaddition of the strained Dewar anthracene 42 leads to anthracene 
43 followed by [4+2] cycloaddition with the third benzyne to afford triptycenes 44. This 
approach is a rapid method for synthesizing tri ortho-substituted C3-symmetrical triptycenes. 
The computational study explained the regioselectivity of this triple aryne reaction. 
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1.2.5 [2+2]/[4+2] Cycloadditions 
Scheme 1.6. Fleming’s Anthracene Synthesis. 
 
In 1975, Fleming and Mah reported the anthracene synthesis using THF and 
bromophenols 45 with LiTMP (Scheme 1.6).57 THF was degraded into ethylene gas and 
enolates 47 by LiTMP. The resulting enolates 47 react with benzyne to form ortho-
quinodimethane intermediates 49. Intermediates 49 undergo a [4+2] cycloadditions with the 
second benzyne followed by oxidation to afford anthracenes (51-54b). 
9-Arylxanthenes 59 were synthesized by Yoshida, Kunai, and co-workers utilizing two 
equivalents of benzynes and 9-arylaldehydes 55 (Scheme 1.7).58 The [2+2] cycloaddition of 
aldehydes 55 and benzyne yields quinone methide intermediates 58 bearing a fixed cis-diene. 
Then, the diene reacts with another benzyne via [4+2] cycloaddition followed by oxidation to 
afford the desired 9-arylxanthenes 59 in the proposed mechanism. 
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Scheme 1.7. Yoshida and Kunai’s 9-Arylxanthene Synthesis. 
 
  
1.2.6 [2+2] Cycloaddition/Nucleophilic Addition 
Scheme 1.8. Gogoi’s Conversion from Coumarins to Isocoumarins. 
 
The synthesis of isocoumarins 66 from coumarins 60 was demonstrated by Gogoi and 
co-workers in 2017 (Scheme 1.8).59 [2+2] Cycloaddition of benzyne and 4-hydroxycoumarins 
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60 affords the four-membered intermediate 61 followed by ring opening of coumarin 61 and 
nucleophilic addition to another benzyne. The resulting cyclobutanone intermediates 63 
undergo retro-[2+2] cycloaddition to ketene intermediates 64. Then, a pericyclic reaction closes 
the ring to form isocoumarins 66. When coumarin 68 and two different aryne precursors 27 and 
67 are employed, three component reaction adduct 69 was obtained as four different products 
due to their crossover reactions between two competitive arynes. 
 
Scheme 1.9. Biehl’s Arylindane Synthesis. 
 
Biehl and co-workers have reported the synthesis of arylindane 77 from crotonamide 71 
and benzyne (Scheme 1.9).60 Lithiation of crotonamide 71 leads to dianion intermediate 72, 
which reacts with benzyne via the formal [2+2] cycloaddition to yield benzocyclobutane 
intermediates 74. Intermediate 74 undergoes ring opening followed by either five-membered 
ring formation or quenching with a proton source to afford indane intermediate 76 or 
cinnamamide 79. Indane dianion 76 was added to an additional benzyne to afford arylindane 
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compound 77. Unlike 3,6-dimethylbenzyne, 3,4,5,6-tetramethylbenzyne only yielded 81 with no 
double benzyne adducts. 
 
Scheme 1.10. Studer’s Carbazole Synthesis Cotrolled by Fluoride Sources. 
 
 Studer and co-workers developed the synthesis of carbazoles (87a and 87b) from 
nitrobenzenes 82 and arynes (Scheme 1.10).61 In the proposed mechanism, [2+2] cycloaddition 
of aryne and nitrobenzenes 82 forms four-membered ring intermediates 83, and the subsequent 
ring opening of 83 yield hydroxylcarbazole intermediates 85. Elimination and hydrolysis of 86 
affords carbazoles 87a when CsF is used. However, in the presence of tetrabutylammonium 
difluorotriphenylsilicate (TBAT), consecutive elimination of 85 and nucleophilic addition to 
the second aryne result in the formation of N-arylcarbazole 87b. 
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1.3 [3+2] Cycloadditions 
1.3.1 [3+2]/[3+2] Cycloadditions 
Scheme 1.11. Nakayama’s Synthesis of Dibenzotetrathiafulvalene and Related Compounds. 
 
In 1970, Meyerson and Fields described the generation of benzo-1,3-dithiolium carbene 
88 via [3+2] cycloaddition of benzyne and carbon disulfide (Scheme 1.11).62 To harness the 
reactivity of 88, several salt forms of 88 were reported.63 In 1974, the formation of fluoroborate 
salt 90 from carbene 88 was developed by Nakayama and co-workers. In their report in 1976, 
Nakayama revisited the previous synthetic application of carbene 88 to modify or reproduce the 
result with fluoroborate salt 90.64 This salt (90) was used to modify the previous synthetic 
applications of the other salt forms of 88. Hydrolysis of 90 afforded trimer 91. Another trimer 
structure (92) was obtained from ammonium acetate or ammonium chloride and 90 under basic 
conditions. Insertion of a sulfur atom between two equivalents of 90 was observed by adding 
sodium sulfide. Using pyridine, a primary amine or malononitrile group was inserted between 
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two equivalents of 90, yielding both 94a and 94b or 95. Dimerization of 90 occurred when only 
trimethyl amine or DMF was employed in the reaction. 
 
Scheme 1.12. Cariou and Dodd’s Double [3+2] Cycloadditions of Azides and Arynes. 
 
 
Scheme 1.13. Nakayama’s Synthesis of Tetracyclic Sulfonium Salts and Dibenzo-1,3,6,-
trithiocin Derivatives. 
 
Click reactions of azides and alkyne are well-known [3+2] cycloadditions. The first 
aryne click reaction (i.e., a cycloaddition of azides and arynes) was reported by Larock and co-
workers in 2008.65 Subsequently, several aryne click reaction have been reported. Dodd, Cariou, 
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and co-workers reported double click reactions of diazido adduct 97 and benzyne to yield 98 
(Scheme 1.12).66 
 Nakayama and co-workers employed trithiocarbonate 100 for [3+2] cycloaddition with 
benzyne to afford 1,3-benzodithiole-2-thione 101 followed by a second [3+2] cycloaddition 
with benzyne to form the tetracyclic intermediate 102 (Scheme 1.13).67 After work-up with HCl, 
tetracyclic sulfonium chloride 104 was prepared. This core structure was transformed to 
dibenzo[d,g][1,3,6]trithiocin 107 by addition of hydride to 104 or two-step 
hydrolysis/reduction of 104. Dimer product 109 was successfully prepared from deprotonation 
of 104 using a strong base at -18 oC. 
 
Scheme 1.14. Larock’s Conversion from Bishydrazonobenzene to Dibenzoylbenzene. 
 
Larock and Dubrovskiy reported the synthesis of dibenzoylbenzene 116 from 
bishydrazonobenzene 110 (Scheme 1.14).68 [3+2] Cycloaddition of hydrazone 110 and 
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benzyne leads to the five-membered intermediate 112 followed by rearrangement of 112 and 
hydrolysis of 114 to yield dibenzoylbenzene 116. 
 
1.3.2 [3+2] Cycloaddition/Nucleophilic Addition 
Scheme 1.15. Larock’s Pyridoindole Synthesis. 
 
Less than a year earlier, a report by Larock and co-workers presented the unusual 
pyridoindole synthesis from N-pyridin-2-yl-methanimines 117 and arynes (Scheme 1.15).3b The 
formal [3+2] cycloaddition was initiated by the addition of nitrogen from pyridines 117 to 
benzyne. The resulting carbanion attacks the imine intramolecularly to form a five-membered 
ring 118, which is rearranged by α-deprotonation to yield pyridoindoles 119. The next 
mechanistic step is proposed to be nucleophilic addition of secondary amines 119 to another 
benzyne to afford 120. In place of the pyridyl group, a thiazolyl group was employed to yield 
thiazolo[3,2-a]indole 122. When diimine was used as the starting material, double annulation 
product 121 was formed. 
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Scheme 1.16. Synthesis of 1-Arylindazoles. 
 
The 1-arylindazole synthesis has been demonstrated by Yamamoto and Jin (Scheme 
1.16).69 Similar to Huisgen cycloaddition, diazomethanes 123, an isostere of azides, undergoes 
1,3-dipolar cycloaddition with benzyne and subsequent proton transfer. The corresponding 1H-
indazoles 124 further reacted with a second benzyne via N-arylation to yield 126 when two 
equivalents of benzyne were added. In the same year, Larock and co-workers also reported the 
same reactions to prepare 128 with a different substrate scope.70 
Without the catalyst, the reaction between diazomethanes and benzynes afforded 1-
arylindazoles. Using a silver catalyst, Liu and Wang successfully achieved 2-arylindazoles 134 in 
2012 (Scheme 1.17).71 According to their proposed mechanism, the mechanistic pathway 
differed from the non-catalytic pathway in Scheme 1.16 due to the coordination of Ag(I) to the 
1-position of indazole 131. This trapping inhibits the addition to the second benzyne at the 1-
position of 131. In lieu of the addition to the 1-position, N-arylation becomes more accessible at 
the 2-position of 132, yielding 134. 
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Scheme 1.17. Liu’s 2-Phenyl-3-carbonylindazoles Synthesis. 
 
 
Scheme 1.18. Xia’s Tandem [3+2] Cycloaddition/Nucleophilic Addition. 
 
 
Scheme 1.19. Studer’s Synthesis of Fully Substituted Alkenes. 
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As shown in Scheme 1.12, the click reactions of azido compounds and benzynes yield 
benzotriazoles. In addition, double aryne click reactions of azido derivatives and other multiple 
aryne reactions including a click reaction have been reported. Tandem Huisgen cycloaddition of 
azide adduct 135 and nucleophilic addition to benzyne was introduced in the end of the report 
by Xia and co-workers (Scheme 1.18).72 
Studer and co-workers reported that vinyl sulfide derivatives 137 undergo [3+2] 
cycloaddition with benzyne, affording ylide intermediates 139 (Scheme 1.19).73 The following 
1,4-proton transfer of 140 and β-elimination of 141 afford the desired alkene products 142. In 
the report, when 1,2 equivalents of benzyne and 5 equivalents of water were employed, the 
second arylation of 139 was blocked. 
The first example of a tandem [3+2] cycloaddition and N-O bond insertion reaction 
was reported by Okuma and co-workers (Scheme 1.20).74 Quinoline N-oxides 143 were used for 
the synthesis of oxazepino[4,5-a]quinolones 145 and 2-(2-hydroxyphenyl)quinolones 146. 
Initial [3+2] cycloaddition of nitrones 143 and benzyne forms the five-membered intermediates  
 
Scheme 1.20. Okuma’s Oxazepino[4,5-a]quinolone Synthesis. 
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144, which is allowed to go through either benzyne insertion or rearrangement to 7-membered 
heterocyclic products 145 and ring-opened products 146. 
1.4 [4+2] Cycloadditions 
1.4.1 [4+2]/[2+2] Cycloadditions 
Scheme 1.21. He and Wang’s [4+2]/[2+2] Cycloadditions. 
 
He, Wang, and co-workers developed tandem aza-[4+2] and [2+2] cycloadditions of 
benzyne and 1-sulfonyl-1-azadienes 147 (Scheme 1.21).75 Depending on the amount of 
benzyne, the reaction was tunable to afford aza-[4+2] adducts 148 and aza-[4+2]/[2+2] 
adducts 150. 
In 1984, Wege and Anthony demonstrated tandem [2+2]/[4+2] cycloadditions of 
benzofuran 151 and benzyne (Scheme 1.22).48e A [2+2] cycloadduct 152 and a [2+2]/[4+2] 
cycloadduct 153 were isolated. After thirty years, Liu and Yu reported their results for the 
tandem [4+2]/[2+2] or [2+2]/4+2] cycloadditions of indene 154 and benzyne to afford 155.2b 
Simultaneously, Biju and co-workers disclosed the scope of the reactions of benzofurans and 
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indenes (156) in the synthesis of 158 and proposed a mechanism involving a [4+2] 
cycloaddition that is preceded by a [2+2] cycloaddition.76 However, the mechanistic pathway 
remains unclear due to non-isolable [2+2] intermediates 157 from 156. 
 
Scheme 1.22. [4+2]/[2+2] or [2+2]/4+2] Cycloadditions of Indene or Benzofurans with 
Arynes. 
 
Mead and co-workers discovered the reactivity of 1-azadiene 159 with benzynes 
(Scheme 1.23).77 The azadiene 159 reacts with benzyne via either [2+2] or [4+2] cycloaddition 
to yield benzoazetidine 160 or quinolone 161. For the [4+2] adduct 161, one more [2+2] 
cycloaddition was observed by isolation of benzoquinoline 162. Interestingly, no benzoazetidine 
160 was observed at 130 °C. 
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Scheme 1.23. Mead’s Synthesis of Benzoazetidine, Quinolines, and Benzoquinolines. 
 
 
Scheme 1.24. Sugihara and Nakayama’s [4+2]/[2+2] Cycloadditions of 
Adamantylidenecyclopentadiene with Aryne. 
 
The aryne reaction of adamantylfulvene 164 was reported by Sugihara, Kobiki, and 
Nakayama (Scheme 1.24).78 When 1.5 equivalents of benzyne was employed, the [4+2] adduct 
165 was the major product, and the tandem [4+2]/[2+2] adduct 166 was the minor product. 
 
1.4.2 [4+2]/[4+2] Cycloadditions 
Barrett and co-workers reported the synthesis of binapthyl 170 and either dinaphthyl 
ether (173a and 173b) or napthylaryl ether (174a and 174b) (Scheme 1.25).79 The reaction 
goes through double [4+2] cycloaddition reactions of aryne with 2,2'-bifuryl 168 or 2-
methoxyfuran 172 as one of the synthetic efforts to prepare binaphthyl or dinaphthyl ether-
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containing natural products, such as palmarumycin CP1, diepoxin σ, preussomerin G, and 
spiroxin C. 
 
Scheme 1.25. Barrett’s Synthetic Approach to the Synthesis of Binaphthyl or Dinaphthyl Ether-
Containing Natural Products. 
 
 
Scheme 1.26. Ōki’s Synthesis of Bitriptycyl Derivative. 
 
Ōki and co-workers used tetramethoxybianthryl 175 and benzyne to synthesize 
bitriptycenes 176 (Scheme 1.26).80 Two rotational isomers were separated with 176 by HPLC. 
The demethylation of 176 with sodium ethanethiolate at room temperature only yielded the 
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methoxy groups of the 3 and 3’ positions facing outward being converted to hydroxyl groups. 
The 2- and 2’-methoxy groups were intact due to steric hindrance. 
Gold-catalyzed double [4+2] cycloadditions of ortho-alkynyl(oxo)benzenes 177 and 
benzynes were developed by Asao and co-workers (Scheme 1.27).81 In the proposed 
mechanism, the coordination of alkyne to AuCl followed by nucleophilic addition of the oxygen 
atom of the carbonyl group of 178 to the alkyne forms zwitterionic intermediates 179. The 
[4+2] cycloaddition of 179 and benzyne affords the bicyclic intermediates 181, which 
undergoes rearrangement to anthracenes 182. Another benzyne [4+2] cycloaddition of 182 
affords the corresponding triptycenes (183a and 183b). 
 
Scheme 1.27. Asao’s Triptycene Synthesis. 
 
Anthracene synthesis from oxazoles 184 and benzyne was introduced by Bhatt and 
Reddy in 1980 (Scheme 1.28).82 The double [4+2] cycloadditions of benzyne and oxazoles 184 
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yields 9,10-dihydro-9,10-epoxyanthracenes 187, which reduces 187 with zinc and acetic acid to 
afford anthracenes 188. 
 
Scheme 1.28. Bhatt’s Anthracene Synthesis. 
 
 
Scheme 1.29. Coquerel and Rodriguez’s Nornitidine Synthesis. 
 
In 2015, Coquerel, Rodriguez, and co-workers employed two arynes to synthesize the 
alkaloid natural product nornitidine 194 (Scheme 1.29).83 N-Boc-pyrrole 190 reacted with aryne 
189 via [4+2] cycloaddition to yield azabicyclic compound 191. Rhodium-catalyzed ring 
opening of 191 followed by deprotection afforded naphthylamine 192. Amine 192 reacted with 
N,N-dialkylformamide dimethylacetal to yield N,N-dimethylformamidine 193, which further 
reacted with another aryne 67 to afford nornitidine 194.  
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Scheme 1.30. Kuck and Cao’s Synthesis of Bis-tribenzotriquinacene and Monoanthro-
dibenzotriquinacene. 
 
Kuck and Cao reported the synthesis of bis-tribenzotriquinacenes 200, monoanthro-
dibenzotriquinacene 202, and hexadecacycle 203 (Scheme 1.30).84 Tribenzotriquinacene 
(TBTQ)-based aryne 195 reacted with furan via [4+2] cycloaddition to form oxabicycle 196, 
and the subsequent acetylene extrusion by [4+2] cycloaddition of 3,6-di-(2-pyridyl)-1,2,4,5-
tetrazine (DPT) of 196 affords isobenzofuran 198. Further [4+2] cycloaddition of 198 and the 
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second aryne 196 and in situ titanium reduction afford bis-tribenzotriquinacenes (anti- and syn-
199). The addition of benzyne rather than 195 to 198 and deoxygenation of syn- and anti-201 
resulted in the formation of 202. 0.5 equivalents of DPT were added to 4 to achieve 203. 
The synthesis of dihydroethenopentacene 206 from tetramethylidene 204 and benzyne 
was reported by Uno and co-workers in 2005 (Scheme 1.31).85 The double [4+2] 
cycloadditions of 204 and two equivalents of benzynes afforded intermediates 205, which were 
subjected to DDQ oxidation to form dihydroethenopentacene 206. In the same year, Ono and 
co-workers also used this method to prepare the substituted dihydroethenopentacene 
derivatives 207.86 The syntheses of heptacene 208 and hexacene 209 were developed by Neckers 
and co-workers in 200687 and Neckers, Shah, and co-workers in 2007,88 respectively. In 2010, 
Yamada and co-workers used a similar method to prepare tetraaryl-substituted pentacenes 210.89 
 
Scheme 1.31. Synthesis of Dihydroethenopentacene Derivatives. 
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Gribble and Lopshuk employed münchnone 212 as the starting material in double aryne 
[4+2] cycloadditions to prepare dihydroepiminopentacene 214 and dihydroepiminoanthracene 
217 (Scheme 1.32).90 214 was obtained in 89% yield when 0.7 equivalents of naphthyne were 
added. The reaction with 3.0 equivalents of 212 accompanying the subsequent oxidation with 
silica gel and/or in air affords dione 215. The desired dihydroepiminoanthracene 217 was 
obtained, and benzoisoindole 216 were isolated as the intermediates using benzyne and 1.5 
equivalents of 212. 
 
Scheme 1.32. Gribble’s Dihydroepiminopentacene Synthesis. 
 
Sha and Wu reported the synthesis of xanthenes 224a and benzophenones 224b from 3-
vinylchromones 218 and arynes (Scheme 1.33).91 Acid reversibly drives 218 to tautomers 219. 
The [4+2] cycloaddition of 219 affords oxo-bridged tricycles 222, which undergo further [4+2] 
cycloaddition and ring opening of 223 to form xanthenes 224a. In another pathway, 220 reacts 
with benzyne through [4+2] cycloaddition to afford benzophenones 224b. Addition of 1.1 
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equivalents of TfOH led to 224a as the major products and 224b as the minor products but 2.5 
equivalents of TFA only yielded 224b. 
 
Scheme 1.33. Sha and Wu’s Xanthene and Benzophenone Synthesis. 
 
Garcia-Garibay and co-workers synthesized acetone-protected triptycene 226 from 
anthracene 225 in 2002 (Figure 1.3).92 Tandem deprotection of 226 and Sonogashira coupling 
with an aromatic spacer led to bis-triptycene derivatives 227-230. In addition to the Sonogashira 
coupling method, several other approaches to the synthesis of various bridged triptycenes (231 
and 232) have been developed.93 In 2014, the report by Mastalerz and co-workers showed the 
formation of a trace amount of double benzyne adduct rac-237 from the [4+2] cycloaddition 
reaction of ortho--methoxybenzynes and two side rings of 1,8-dimethoxyanthracene 233.94 
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Figure 1.3. Representative iptycene synthesis. 
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Scheme 1.34. Rubin’s Fullerene Synthesis. 
 
 
Scheme 1.35. Fabris’ Dimerization Reaction. 
 
After applying the double benzyne [4+2] cycloaddition strategy to fullerene, Rubin and 
co-workers functionalized the fullerene (Scheme 1.34).95 Bisfurans 238 reacted with benzynes to 
yield 1,4-dihydro-1,4-epoxynaphthalene derivatives 239, which underwent tandem acetylene 
extrusion by dipyridyltetrazine 240 and double [4+2] cycloadditions to yield the corresponding 
fullerenes 241. 
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Figure 1.4. Representative [4+2]/[4+2] cycloaddition adducts. 
Fabris and co-workers described the dimerization of two epiminonaphthalenes 244 that 
were formed by [4+2] cycloadditions of N-tosyl-protected pyrrole 243 and aryne (Scheme 
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1.35).96 Dimerization of 244 was performed by addition of n-BuLi followed by elimination of 
Ts-NLiBr from 246 to yield dimer 247. 
Other double [4+2] cycloadducts are described in Figure 1.4. Znder and Franke 
reported the synthesis of benzo[c]picene 248 from double aryne cycloaddition of 1,5-
divinylnaphthalene.97 Pascal and co-workers employed a fully phenyl-substituted Stiles benzyne 
precursor (i.e., 3,4,5,6-tetraphenylanthranilic acid) to synthesize polycycle 249.51 Using the 
Kitamura hypervalent iodine-benzyne precursor, Nuckolls and co-workers synthesized 
hexaphenyl pentacene and decaphenyl pentacene (250).98 Wudl and co-workers have attempted 
to synthesize heptacenes, and they reported the synthesis of 251 from arynes and 2,5-diaryl-6-
oxo-1,3,4-oxadiazine-6-one with the release of N2 and CO2 gas.99 Dibenzo([f,f’]-4,4’,7,7’-
tetraphenyl)diindeno[1,2,3-cd:1’,2’,3’-Im]perylene (DBP) 252 is a well-known organic field 
effect transistor material. To synthesize DBP 252, several coupling reactions on fissure, bay, 
cove, and fjord regions of the precursors of 252 have been employed.100 Osedach and co-workers 
used benzynes for double [4+2] cycloadditions on two terminal bay regions of 252.101 Hopf and 
co-workers synthesized phenanthrenophanes (253a-253c) using the double [4+2] 
cycloaddition reaction of diethenyl[2.2]paracyclophanes and benzynes.2g Mattson and co-
workers used benzyne for [4+2] cycloaddition of benzoylacetone to prepare 4-phenyl-2-
naphthol.102 The resulting naphthols were coupled to one another to afford BINOL 254. Pérez 
and co-workers designed a highly substituted Kobayashi benzyne (i.e., 5,6,7,8-tetraphenyl-4-
(trimethylsilyl)phenanthrene-3-yl triflate) and synthesized 255 but the mechanism remains 
controversial.103 Müllen and co-workers have focused on the synthesis of perylenes, and we 
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introduce one example.104 They employed double aryne [4+2] cycloaddition for the synthesis of 
perylene imides 256. 
  
1.4.3 [4+2]/[4+2]/[4+2] Cycloadditions 
Scheme 1.36. Seitz’s Triple [4+2] Aryne Cycloaddition for the Synthesis of Triptycene. 
 
Seitz and Laue obtained 3,6-bis(trifluoromethyl)phthalazine 258 from the reaction of 
3,6-bis(trifluoromethyl)tetrazine 257 and benzyne in 1987 (Scheme 1.36).105 After 9 years, they 
reported the synthesis of 9,10-bis(trifluoromethyl)triptycene 260 from two equivalents of 
 
Scheme 1.37. Fabris’ Triple [4+2] Aryne Cycloaddition Reaction. 
 
40 
 
Scheme 1.38. Mislow’s Tris(9-triptycyl) Derivative Synthesis. 
 
benzynes and 258.106 A total of three equivalents of benzynes reacted with 257 to afford 260 in 
31% yield over two reaction steps. 
Epiminonaphthalenes 244 that were developed by Fabris and co-workers (Scheme 
1.35) were used for the synthesis of benzocyclotrimers (syn- and anti-247) (Scheme 1.37).96 
After transmetalation and stannylation of 244, the cyclotrimerization of stannane 245 with 
copper(I) 2-thiophenecarboxylate 246 affords syn- and anti-247. The total yield of 247 (68%) 
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was calculated based on the sum of the syn- and anti-isomer yields (i.e., 21% and 47%, 
respectively). 
Mislow and co-workers reported the synthesis of tris(9-triptycyl) scaffolds bearing 
cyclopropenium, germanium, or stannum as the center component (Scheme 1.38).93k To 
prepare bis(9-triptycyl)cyclpropenone 249, bis(9-anthryl)cyclopropenone 248 reacted with 
benzynes via double [4+2] cycloadditions. After transmetalation of 9-bromotriptycenes (251a 
and 251b) generated from 9-bromoanthracene 250, lithiated triptycene intermediates were 
added to 249 to yield tris(9-triptycyl)cyclopropeniums. Cyclopropenium perchlorates (252 and 
255) were isolated by treating the cyclopropeniums with perchloric acid. Furthermore, the 
addition of lithiated triptycene to GeCl4 or SnCl4 led to tris(9-triptycyl)germanium chloride 
253, tris(9-triptycyl)germanium chloride and bromide 254. 
 
1.4.4 [4+2]/[4+2]/[4+2]/[4+2] Cycloadditions 
Scheme 1.39. Müllen’s Synthesis of Nonacene Precursor. 
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Scheme 1.40. Müllen and Li’s Synthesis of Tetranaphthoterrylene Tetracarboxdiimide. 
 
As shown in Scheme 1.31, tetramethylidene 204 has been used for the synthesis of linear 
acenes. Müllen and Herwig employed one equivalent of benzyne to trap dimethylidene 
intermediate 257, which underwent double [4+2] cycloaddition with bisaryne followed by 
oxidation to afford nonacene precursor 260 (Scheme 1.39).107 
As discussed in Figure 1.4, the synthesis of dibenzocoronenebis(dicarboximide)s 256 
from two equivalents of benzynes and 1,7-dibromoperylenebis(dicarboximide) has been 
reported by Müllen and co-workers (Scheme 1.40).108 After four years, Müllen, Li, and co-
workers reported formal quadruple benzyne [4+2] cycloadditions with 
tetrabromoterrylenebis(dicarboximide) 261 to yield tetranaphthoterrylene tetracarboxdiimides 
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(262, 263a, and 263b) as three isomers. The prominent review for perylene synthesis was 
reported by Müllen and co-workers in 2010.109 
 
1.4.5 [4+2]/[4+2] Cycloadditions/ Nucleophilic Addition 
Scheme 1.41. Zhang’s N-Phenylanthracenamine Synthesis. 
 
In 2007, Zhang and Xie reported one-pot double benzyne [4+2] cycloaddition and 
nucleophilic addition of imidazoles 264 (Scheme 1.41).110 The first [4+2] cycloaddition of 
benzyne and 264 affords bicyclic intermediates 265, which undergo expulsion of R3CN to afford 
isoindole intermediates 266. The corresponding intermediates 266 reacts with another benzyne 
via [4+2] cycloaddition and subsequent nucleophilic addition to the third benzyne to yield N-
phenylanthracenamines 268. 
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1.4.6 [4+2] Cycloaddition/Nucleophilic Addition 
Scheme 1.42. Rickborn’s Benzyne-Oxazole Reaction. 
 
In 1990, Rickborn and co-workers utilized Rees’ method to generate benzyne from the 
oxidation of 1-aminobenzotriazole 269 to study the reactivity between oxazole 272 and benzyne 
(Scheme 1.42).111 The [2+2] cycloadduct 30 and benzyne-oxazole-NMM adduct 273 were 
obtained. Additionally, dione 274 was formed at 0 oC, and both the benzyne-oxazole-OAc 
adduct 276 and double benzyne adduct 275 were obtained at –78 oC. 
 
Scheme 1.43. Zhu’s One-Pot [4+2] Cycloaddition and Nucleophilic Addition. 
 
Zhu and co-workers synthesized cyclohexanone-fused furan 277 from alkynone using a 
gold catalyst (Scheme 1.43).112 Further transformation of 277 afforded bis(benzyne) adduct 
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278. The mechanism was not studied but is assumed to involve tandem [4+2] cycloaddition and 
nucleophilic addition or these reactions in the reverse order. 
 
1.4.7 [4+2] Cycloaddition/Nucleophilic Addition/[4+2] Cycloaddition 
Scheme 1.44. Chenoweth’s Triple Aryne-Tetrazine Reaction. 
 
In 2015, we reported the triple aryne-tetrazine (TAT) reaction affording 
dibenzo[de,g]cinnolines 280 (Scheme 1.44).113 Tetrazines 279 reacted with three equivalent of 
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aynes to yield 280. Then, we observed solvent adducts that were formed via a multicomponent 
reaction (MCR) of solvent, benzyne, and phthalazine 282.114 Dichloromethane- and acetonitrile 
adducts (283 and 284) were isolated, and the reaction mechanism was confirmed by hydrogen–
deuterium exchange experiments. Recently, we scrutinized the reaction mechanism, isolated the 
intermediates and byproducts, and conducted a crossover experiment and computational study 
with Houk and Chen.115 For the proposed mechanism, [4+2] and retro-[4+2] cycloaddition of 
tetrazine 281 and benzyne affords the corresponding phthalazine 282, and the subsequent 
nucleophilic addition of 282 to benzyne yields zwitterionic intermediate 283. The 
intermolecular water-mediated proton transfer of 283 led to (E/Z)-284, which undergoes both 
[2+2] and [4+2] cycloaddition to afford a [2+2] adduct rac-286 and intermediate rac-287. 285 
was obtained after work-up. The intermediate rac-287 is diversified into rearranged product rac-
289, ene-product rac-290, and 288. 
Coquerel, Rodriguez, and co-workers employed N-aryl aldimines 291 for pseudo MCR 
with arynes (Scheme 1.45).116 [4+2] cycloaddition of aryne and aldimine 291 followed by 
nucleophilic addition to aryne yield N-arylated 1,2-dihydroisoquinolines 294. For the specific 
substituent, one more [4+2] cycloaddition of 294 affords the 5,6-
dihydrobenzo[c]phenanthridine 296. Addition of benzyne to N-pyrazolyl ketamine 297 affords 
spirooxindole scaffold 299 bearing two aryne synthons. The reaction performed in THF 
produced etherated spirooxindole 298. N-pyrazolyl cyclopentanoneimine 300 did not proceed 
through a [4+2] cycloaddition but triple N-arylation to afford 301. 
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Scheme 1.45. Coquerel and Rodriguez's Pesudo MCR between Imines and Arynes. 
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1.4.8 [4+2] Cycloaddition/Ene Reaction 
Scheme 1.46. Liu and Yu’s Diphenyldihydrophenanthrene Synthesis. 
 
Scheme 1.47. Li and Jia’s Tandem [4+2] Cycloaddition/Formal Ene Reaction of Oxindoles and 
Arynes. 
 
In the synthesis of 9,10-diphenyl-9,10-dihydrophenanthrene 304 from trans-stilbene 
302 and benzyne by Liu, Yu, and co-workers, the reaction of benzyne with the diene of stilbene 
302 via [4+2] cycloaddition followed by an ene reaction affords desired product 304 (Scheme 
1.46).2b The possibility of [2+2+2] cycloaddition of two benzynes and stilbene was not 
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mentioned in the literature. However, this reaction pathway does not appear to be plausible 
because their control experiment disclosed that cis-stilbene 305 did not react with benzynes. 
Li, Jia, and co-workers reported the synthesis of arylidenoxindole derivatives 310 by 
employing two equivalents of benzynes and oxindole 306 (Scheme 1.47).117 [4+2] cycloaddition 
of benzyne affords intermediate 307. The proposed mechanism of the transformation from 308 
to 310 involves a [1,3]-H shift of 308 and subsequent deprotonation/nucleophilic addition to 
benzyne to yield 310. Another possible pathway for this transformation involves a direct ene 
reaction of 307 to afford 310. 
 
Scheme 1.48. Liu’s Tandem [4+2] Cycloaddition/Formal Ene Reaction of 
Benzylidenephthalans and Arynes. 
 
The synthesis of phenanthro[10,1-bc]furans 315 from benzylidenephthalans 311 and 
arynes was developed by Liu and co-workers (Scheme 1.48).118 In comparison to Scheme 1.47, 
benzylidenephthalans 311 resembles oxindoles 306 and thus, the proposed mechanisms are also 
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similar to one another. After [4+2] cycloaddition of 311 and benzyne, deprotonation and 
rearomatization of 302 led to intermediate 313, which afforded 315 via nucleophilic addition to 
another benzyne. As shown in the previous scheme, a direct ene reaction of 312 should yield 
315. 
 
Scheme 1.49. Biju’s Aryldihydrophenanthrene Synthesis. 
 
Biju and co-workers reported the synthesis of aryldihydrophenanthrenes 318 via tandem 
[4+2] cycloaddition and ene reaction of styrenes 316 and arynes (Scheme 1.49).119 In general, 
aryne-engaged synthetic approaches to the synthesis of phenanthrenes or 
dihydrophenanthrenes involve [2+2+2] cycloaddition of two equivalent of arynes with one 
equivalent of alkynes or alkenes. However, [4+2] cycloaddition with 316 and benzyne followed 
by either an ene reaction or stepwise deprotonation/nucleophilic addition of 317 afford 318 in 
this study. A [2+2+2] cycloaddition method for the preparation of phenanthrene derivatives will 
be discussed in Section 6.2. 
 
 
 
51 
 
1.5 [5+2] Cycloadditions 
1.5.1 [5+2]/[2+2] Cycloadditions 
Scheme 1.50. Yoo’s 1,4-Benzodiazepines Derivatives Synthesis. 
 
Recently, Yoo and co-workers reported tandem [5+2]/[2+2] cycloadditions for the 
synthesis of 1,4-benzodiazepines derivatives 321 (Scheme 1.50).120 Higher-order cycloaddition 
is very rare in aryne chemistry, and [5+2] cycloaddition has not been described prior to this 
published study. Zwitterion pyridinium 319 reacted with benzyne via [5+2] cycloaddition, and 
the corresponding 1,4-benzodiazepine 320 goes through [2+2] cycloaddition with another 
benzyne to yield 1,4-benzodiazepines 321. Polycycle 323 was obtained when dimethoxy aryne 
precursor 67 and 322 were employed. The [5+2] cycloaddition is most likely the rate-
determining step based on their mechanistic study. 
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1.6 [2+2+2] Cycloadditions 
1.6.1 Triphenylene Synthesis 
 
Figure 1.5. Representative triphenylenes. 
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As shown in Figure 1.1, Bachman and Clarke introduced the generation of benzyne 
from chlorobenzene and sodium metal in 1927.8 In the report, they reported the formation of 
triphenylene via [2+2+2] cycloaddition. Subsequently, several highly strained and gigantic 
triphenylenes have been synthesized (Figure 1.5).121 Triphenylene synthesis3a,d,33,40,47,48f,122 was 
not discussed in this review but a valuable review on the synthesis of triphenylenes and other 
polycyclic aromatic compounds was recently reported by Pérez, Peña, and Guitián in 2013.1h 
 
1.6.2 Phenanthrene, Phenanthridine, and Related Compounds Synthesis 
The synthesis of phenanthrenes/dihydrophenanthrene via [2+2+2] cycloaddition of 
two equivalents of arynes with one equivalent of alkynes or alkenes has been 
reported.2b,41,119,121h,j,122w,123 Utilizing nitriles as the partner of arynes, the limited scope of 
phenanthridine synthesis from various arynes has been developed.3e,124 Representative structures 
of phenanthrenes, dihydrophenanthrene, and phenanthridine are shown in Figure 
1.6.3e,121h,j,123c,i,n,124 
Gold/copper-catalyzed formal [2+2+2] cycloaddition of arynes and acetylenes 335 was 
employed for the synthesis of alkynylated biphenyl derivatives 339 by Zhang and co-workers in 
2008 (Scheme 1.51).123l Only diphenylacetylene was isolated in good yield when the gold 
catalyst was excluded from the reaction. Subsequently, Yoshida and co-workers observed 
suppression of diphenylacetylene formation when CuCl rather than CuI was employed.125 In the 
reaction, the desired alkynylated biphenyl products 340 were obtained in good yield. They 
obtained fluorenylidene 346 from ethyl propiolate 341 and benzynes in their effort to synthesize  
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Figure 1.6. Representative phenanthrene, phenanthridine, and related compounds. 
 
alkynylbiphenyl. This result supports the presence of intermediate 344 in the mechanism. In 
2010, they extended the scope of acetylenes for the reaction and succeeded in synthesizing 
bromoalkynylation products 347 from bromoacetyelenes with CuBr2.126 
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Scheme 1.51. Synthesis of Alkynylbiphenyl Derivatives. 
 
Using Pd(OAc)2 and a bicyclic phosphite ligand (i.e., 4-ethyl-2,6,7-trioxa-1-
phosphabicyclo[2.2.2]octane (ETPO)), Kunai, Yoshida, and co-workers conducted formal 
[2+2+2] cycloaddition of hexamethylditin 348 and two equivalents of arynes (Scheme 1.52).127 
After formation of palladabenzocyclopropene 349, another aryne was inserted into the 
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cyclopropene ring. Ditin 348 was added to cyclopropene 349 and biphenyl ring 350 to afford 
distannylarene 351 and distannylbiaryl 352, respectively. 
 
Scheme 1.52. Kunai and Yoshida’s Synthesis of Distannylbiaryls and Distannylarenes. 
 
 
1.7 Nucleophilic Additions 
1.7.1 Nucleophilic Addition/[3+2] Cycloaddition 
Yao and co-workers accomplished the synthesis of dihydrobenzo[d]isoxazoles 356 and 
dihydrobenzo[d]oxazoles 360 from nitrones and arynes (Scheme 1.53).128 The nitrogen of 
nitrones 353 were added to aryne to generate zwitterionic intermediate 354, which underwent 
proton transfer and ring closure to yield dihydrobenzo[d]isoxazole 356. The N-O bond can be 
cleaved via a radical pathway or an ionic pathway. The addition of TEMPO to the reaction still 
led to 360 but the TEMPO adduct was not observed. Therefore, this experiment may indicate 
that the ionic pathway is more favorable. The resulting spirocyclic intermediate 358 is opened 
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and rearranged to form dihydrobenzo[d]oxazole 360. The ratio of 356 and 360 was controlled 
by temperature. 356 was a major product at 10 or 40 oC, and 360 was formed as a major product 
at 80 oC. 
 
Scheme 1.53. Yao’s Synthesis of Dihydrobenzo[d]isoxazoles and Dihydrobenzo[d]oxazoles. 
 
 
1.7.2 Nucleophilic Addition/[4+2] Cycloaddition 
Scheme 1.54. Aly’s Phenylisoindolophenathridine Synthesis. 
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Phenylisoindolophenathridines 363 were synthesized by Aly and co-workers (Scheme 
1.54).129 In the proposed mechanism, arylisoindoline 361 was oxidized to isoindole 362 followed 
by nucleophilic addition to benzyne to afford diarylisoindole intermediate 362. [4+2] 
cycloaddition of 362 followed by oxidation led to phenylisoindolophenathridine 363. 
Interestingly, N-phenylanthracenamine was not observed. A shown in Scheme 1.41, the 
arylisoindole intermediate 266 reacted with two equivalents of benzynes to form N-
phenylanthracenamine 268. The mechanism was not studied but the first oxidation step most 
likely plays a key role in inhibiting the pathway to N-phenylanthracenamine. 
 
Scheme 1.55. Biehl’s Anthrone Imine Synthesis. 
 
Biehl and co-workers used two equivalents of 3,6-dimethylbenzyne for the annulation of 
nitriles 364 to produce anthrone imines 370 (Scheme 1.55).130 Lithiation of nitrile 365 followed 
by nucleophilic addition of 365 to benzyne led to intermediate 366. Intramolecular addition and 
subsequent ring opening yield intermediate 368, which undergoes [4+2] cycloaddition with 
another aryne to afford desired anthrone imines 370. 
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Scheme 1.56. Huang and Wu’s Isoquinolines Synthesis. 
 
 In 2009, Huang and Sha discovered the multicomponent reaction of isocyanides 371, 
alkynes 372, and benzynes (Scheme 1.56).131 After the addition of 371 to aryne, the alkynyl 
anion  
 
Scheme 1.57. Katritzky’s One-Pot Nucleophilic Addition/[4+2] Cycloaddition. 
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attacks the resulting intermediate 373, yielding 1-alkynyl imine 374. Isomerization of 374 
affords aza-diene 375, which undergoes [4+2] cycloaddition of aryne and oxidation to afford 
isoquinolines 376. Subsequently, Wu, Huang, and Sha extended the reaction scope and 
introduced a plausible mechanism based on their studies.132 
In 1972, Katritzky and co-workers embarked on the formation of tricyclic compounds 
using hydroxypyridine and two equivalents of benzynes (Scheme 1.57).133 Then, they have 
reported the synthesis of several tricyclic compounds and proposed the representative 
mechanism of one of the reactions in 1975.134 According to the report, the nitrogen of 
phthalazin-l(2H)-one 377 was added to benzyne, and the following [4+2] cycloaddition yielded 
the desired cycloadduct 382. In another possible pathway, 377 undergoes [4+2] cycloaddition 
of benzyne followed by nucleophilic addition to benzyne to afford 382. The synthesis of other 
double benzyne adducts (383-387) has been reported by Katiritzky.134-135 
 
1.7.3 Nucleophilic Addition/[4+2] Cycloaddition/Nucleophilic Addition 
Scheme 1.58. Larock’s Conversion from Pyrrole to Diphenylaminonaphthalene. 
 
One year prior to Zhang’s N-phenylanthracenamine synthesis, Larock and Liu reported 
the synthesis of diphenylaminonaphthalene 391 from pyrrole 388 (Scheme 1.58).136 N-arylation 
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of pyrrole 388 occurs along with a simultaneous [4+2] cycloaddition followed by one more N-
arylation to afford diphenylaminonaphthalene 391. 
 
1.7.4 Nucleophilic Addition/[4+2]/[4+2] Cycloadditions/Nucleophilic Addition 
Scheme 1.59. Okuma’s Synthesis of Diphenylaminoanthracene, Xanthene, Xanthone, and 
Quaternary Ammonium Salts. 
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In 2011, Okuma and co-workers reported the synthesis of quadruple benzyne adducts 
from acetylimidazole 392 or formaides 399 (Scheme 1.59).48b As shown in Schemes 1.41 and 
1.58, once the N-substituted furans 266 or benzofuran ring 389 is formed, consecutive [4+2] 
cycloaddition of benzyne and N-arylation yield N-phenylanthracenamines 268 or N,N-
diphenylnaphthalenamine 391. Similarly, N-phenylbenzofuran 396 was formed as an 
intermediate via N-arylation of 392, deprotection of acetyl-protected imidazole 393, and [4+2] 
cycloaddition of 394. N-phenylbenzofuran 396 reacted with two more benzynes to afford N,N-
diphenylanthracenamine 398.  
In the same report, the synthesis of xanthene 402, xanthone 403, and quaternary 
ammonium salts 404 from formaides 399 as a single starting material was demonstrated. After 
formal [2+2] cycloaddition of benzyne with 399 and the subsequent ring opening of 400, 
intermediate 401 reacted with benzyne via [4+2] cycloaddition or hydrolysis, which resulted in 
the formation of xanthene 402, xanthone 403, and quaternary ammonium salts 404. 
 
1.7.5 Nucleophilic Addition/Nucleophilic Addition 
Di- or triarylamines 410 were synthesized from isocyanates 405 and arynes by Hsieh and 
co-workers (Scheme 1.60).137 The addition of lutidine to 405 generates zwitterion 406, which 
attacks aryne to form intermediate 407. Hydrolysis of 407 affords carbamic acid 408, and the 
subsequent decarboxylation of 408 and nucleophilic addition of 409 to aryne afford di- or 
triarylamines 410. The mechanism of the reaction with lutidine or pyridine catalyst is not 
conclusive. However, isocyanate typically requires a pre-nucleophile to be an active nucleophile. 
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Water is the crucial factor for this reaction because the yield of the desired product 410 
decreases in the absence of water. 
 
Scheme 1.60. Hsieh’s Conversion from Isocyanate to Tertiaryamines. 
 
 In 1998, Biehl and co-workers conducted the aryne reaction by employing o-
chlorophenylmethanol 411 and 2-phenylacetonitrile 412 for the synthesis of 6-benzyl-2-
hydroxymethylbenzonitriles 419, 3-arylmethyl-4-methylphthalimides 420, and 1-
hydroxymethyl-6-aryl-2H-anthra[9,1-bc]furans 421 (Scheme 1.61).138 After lithiation of 411 
and 412, arylcyanomethyl lithium 414 is added to aryne 413 to yield intermediate 415. 
Intermediate 415 also undergoes cyclization and ring opening to afford intermediate 417. 
Hydrolysis of 417 affords 419 but cyclization of 417 followed by hydrolysis of 421 produces 421. 
In addition, intermediate 417 undergoes another aryne addition and annulation to form a new 6-
membered ring in 419. Then, one of the lithiated methanol groups attacks imine, and thus, the 
following hydrolysis forms 420. 420 was the major product, and 422 was only observed when 2-
(4-methoxyphenyl)acetonitrile was used. 
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Scheme 1.61. Biehl’s Mono and Double [4+2] Cycloaddition Reactions. 
 
 
Scheme 1.62. Chandrasekhar’s Solvent-Dependent Tunable Multiaryne Reaction. 
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The tunable synthesis of dibenzo[b,e]azepin-6-imines 426 and highly substituted 
indoles 427 was reported by Chandrasekhar and co-workers (Scheme 1.62).139 2-
Sulfonyliminoindoline 423 reacted with benzyne via either [2+2] cycloaddition toward 426 or 
double nucleophilic additions to benzynes to yield 427. Interestingly, the reaction was tunable 
using acetonitrile or THF as the solvent. Acetonitrile and THF conditions afforded 426 and 427 
as major products, respectively. When the reaction was performed in deuterated acetonitrile, 
solvent-assisted protonation was proposed as one of the mechanistic steps in the synthesis of 
427. 
Knochel’s benzyne precursor 428 was used for the one-pot synthesis of 2,2’-bis-
substituted biphenyls 431 by Studer and co-workers in 2015 (Scheme 1.63).140 Benzyne and 
ArMgCl 430 are generated from 428 and 429 and coupled in situ using a Grignard reagent. 
Intermediate 430 was dimerized using Li2CuCl4 and oxygen gas. The addition of DMF rather 
than Li2CuCl4 and oxygen gas led to intermediate 430 not to the dimer but to benzaldehyde. 
 
Scheme 1.63. Studer’s Biaryl Synthesis. 
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Scheme 1.64. Larock’s Phenylcarbazole Synthesis. 
 
The synthesis of carbazole and dibenzofuran was reported by Larock and Liu (Scheme 
1.64).141 In the report, the reaction between 2-iodoaniline 432 and more than two equivalents of 
benzyne produces N-phenylcarbazole 434. This one-pot reaction involves double N-arylation of 
432 and Pd-catalyzed annulation of the resulting triaryl amine intermediate 433 to afford 434. 
 
Scheme 1.65. Kunai and Yoshida’s Multicomponent Reaction. 
 
1,3- and 1,4-Phenylene-bis(dihydroisobenzofuranimine)s (439a and 439b) were 
synthesized from benzynes, isocyanides, and benzaldehydes 435 by Kunai, Yoshida, and co-
workers (Scheme 1.65).142 In this mechanism, the addition of isocyanide to benzyne followed by 
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addition of anion of zwitterion 436 to iso- or terephthalaldehyde 435 yield intermediate 437. 
Annulation of 437 affords 439a or 439b. 
 
Scheme 1.66. Castedo’s N-Phenylation of Alkaloid Natural Products. 
 
In 1993, Castedo and co-workers modified alkaloid natural products by employing 
benzynes (Scheme 1.66).2c Diphenylamines were obtained from nuciferine 440a, glaucine 440b, 
cularine, and laudanosine. In the proposed mechanism for double arylation of 440a or 440b, N-
phenylation followed by β-elimination of 441a or 441b affords ring-opened intermediate 442a 
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or 442b. Further N-phenylation of 443a or 443b and subsequent α-elimination affords 
diphenylamine derivatives 444a and 444b. Similarly, 445 and 446 were individually obtained 
from cularine and laudanosine. 
 
Figure 1.7. Double nucleophilic addition products. 
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Double nucleophilic additions of arynes are one of the most plentiful multiple aryne 
reactions in the literature. Representative products of double nucleophilic additions are shown 
in Figure 1.7. Sha, Wu, and co-workers reported the synthesis of spiro-products 447 from the 
reaction of benzynes and aziridines.143 Double α-arylations of malonamide esters, 
bis(phenylsulfonyl)methanes, and 1,3-diones to 448,144 449,145 and 450,146 respectively, have 
been independently reported by the Mihaske, Hu, and Wang groups. Larock and Rogness 
introduced the synthesis of 1,10-(1,3-Phenylene)bis-(indoline-2,3-dione) 451.147 In the report, 
double annulation of bis(N-substituted methyl oxamates) was initiated by nucleophilic addition 
of arynes. Freixa and co-workers conducted double N-arylation of rac-4,4,4’,4’,6,6’-
hexamethylspiro-2,2’-bi(chroman) diamine with two equivalents of benzyne to afford 452 and 
453.148 Biehl successfully synthesized areneselenol using arylation of selenourea and elimination 
of cyanamide. 1,2-Diaryldiselane 454 was obtained by oxidative homocoupling of two 
areneselenols.149 The effort of Argade and Vaidya to synthesize the natural product cruciferane 
revealed the formation of aryne adducts 455 and 456.150 455 was formed by consecutive 
insertion-type nucleophilic additions and C-arylation, and 466 was obtained via double C-
arylation. In the multiple reports from the Larock group, double N-arylations and double O-
arylation are reported with aryne adducts 457-460.136,151 Hydroboration of arynes with double 
and triple B-arylated compounds (461 and 462) were reported in the study by Curran and 
Taniguchi.152 Due to the efforts of the Kunai/Yoshida and Knochel groups, the syntheses of 
biaryl compounds (463153 and 464154) containing dithiols, diselenols, and diamines have been 
developed. Beller reported domino Grignard-double-coupling fluorination for the synthesis of 
2-(4-methylbiphenyl)-fluorobenzene using two equivalents of benzynes and 4-tolylmagnesium 
bromide.155 
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1.7.6 Nucleophilic Addition/Nucleophilic Addition/Nucleophilic Addition 
Scheme 1.67. Yoshida’s Triarylation of Chlorotriazines. 
 
In 2009, Yoshida and co-workers reported the synthesis of chlorotriazines 470 from 
cyanuric chloride 466 and arynes (Scheme 1.67).156 Nucleophilic aromatic substitution of 466 
with fluoride yields cyanuric intermediate 467 and chloride. The chloride was added to aryne, 
and 467 or 468 undergoes nucleophilic aromatic substitution with chlorobezenoid to yield 469. 
Repeating the process affords chlorotriazines 470. 
Mehta, Srihari, and co-workers used indolin-2-ones 471 and benzynes to synthesize 
triarylated oxindoles 478 and dibenzo[b,e]azepin-6-ones 480 (Scheme 1.68).157 N-arylation of 
471 and the subsequent deprotonation of 472 yield 1-phenylindolin-2-ones 473, which undergo 
diarylation on the alpha carbon. The corresponding benzenide intermediates 477 go through 
protonation to afford 478. The addition of the benzenide 477 to the carbonyl group leads to 
four-membered ring intermediate 479. Ring opening of 479 results in expansion of the ring to 
afford 480. At room temperature, only 478 was formed but 480 was the major product at 90 oC. 
The related products (481-489) are shown at the bottom of Scheme 1.68. 
71 
 
Scheme 1.68. Mehta and Srihari’s Oxindole and Dibenzo[b,e]azepin-6-one Synthesis. 
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1.7.7 Nucleophilic Addition/Ene Reaction 
Scheme 1.69. Biju’s Synthesis of Indoles and Arylindoles. 
 
Biju and co-workers conducted the reaction of azirines 490 and arynes to synthesize 
indoles 493 and arylindoles 494 (Scheme 1.69).158 The nitrogen atom of azirine 490 attacks 
aryne, and the resulting aryl anion 491 is added to iminium to form 3H-indole intermediate 492. 
A 1,3-hydrogen shift of 492 affords indole 493, and an aryne ene reaction of 492 yields 
arylindole 494. The addition of three equivalents of aryne at –10 oC produced 494 as the major 
product. Interestingly, indole 493 was obtained as the major product with 1.8 equivalents of 
aryne at 60 oC. 
 
1.8 Insertion Reactions 
1.8.1 Insertion Reaction/[4+2] Cycloaddition 
Using diarylcyclopropenones 496 and arynes, Werz and co-workers reported the 
formation of spiroxanthenes 502 (Scheme 1.70).159 Insertion of aryne to the cyclopropenones 
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496 yields spirobenzoxete intermediates 497, which undergo rearrangement and a subsequent 
aryne insertion reaction of 499 to afford the desired spirocyclic xanthenes 502. The process was 
expected to follow either a biradical or ionic mechanism. The biradical pathway is described 
with red arrows in Scheme 1.70. 
 
Scheme 1.70. Werz’s Spriocyclic Xanthene Synthesis. 
 
 
Scheme 1.71. Okuma’s Selenoxanthene Synthesis. 
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Okuma and co-workers reported the reactivity of selones with benzynes (Scheme 
1.71).160 In the report, the double benzyne reaction of selenofenchone 503 was observed. After 
insertion of 503 to benzyne, intermediate 505 reacts with another benzyne via [4+2] 
cycloaddition to afford spiro(fenchone-9,9’-selenoxanthene) 506 in 25% yield. The structure of 
506 was confirmed by X-ray crystallographic analysis. 
 
1.8.2 Insertion Reaction/Nucleophilic Addition 
Scheme 1.72. Shi, Wu, and Wu’s Tandem Aryne Insertion/Nucleophilic Reaction with 
Carbodiimides. 
 
Carbodiimides 507 were used to synthesize 2-arylaminobenzimidates 511 by Shi, Wu, 
and Wu (Scheme 1.72).161 Insertion of aryne to 507 occurs through a four-membered 
intermediate (508) to afford aza-o-quinomethide 509. Intermediate 509 reacts with water or 
alcohol to yield 2-aminobenzimidate 510, which undergoes N-arylation to afford 511. 
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Scheme 1.73. Alajarin, López-Ortiz, and Lopez-Leonardo’s Tandem P=N and P=S Bond 
Insertion/Nucleophilic Addition. 
 
 
Scheme 1.74. Larock’s Xanthene Synthesis. 
 
 
The benzyne insertion reaction worked for P=N and P=S bonds. In 2014, insertion of 
iminophosphoranes or phosphane sulfides 512 was disclosed by Alajarin, López-Ortiz, Lopez-
Leonardo, and co-workers (Scheme 1.73).162 Benzyne was inserted into the P=N or P=S bond of 
512, and the resulting intermediate 514 underwent nucleophilic addition to benzyne to afford 
516 from iminophosphoranes or 517 from phosphane sulfides.  
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Scheme 1.75. Greaney’s Insertion/Nucleophilic Addition of Thioureas. 
 
The report by Larock and Dubrovskiy described the synthesis of 9-propylidene-9H-
xanthene 523 from butyric acid 518 and benzynes (Scheme 1.74).163 After insertion of benzyne 
to 518, the resulting phenoxide 521 was added to benzyne for annulation to afford intermediate 
522. The loss of water produces 523. 
In 2011, Greaney and Biswas reported the synthesis of phenyl carbamimidothioates 526 
and 2-(phenylthio)benzimidamides 529 from thiourea 524 and benzynes (Scheme 1.75).164 
Insertion of benzyne to 524 and subsequent nucleophilic addition of 528 to benzyne afford 3, 
and S-arylation of 524 followed by quenching zwitterionic intermediate 525 with acetonitrile 
afford 526. Interestingly, for some substituents, only 530a-530c were isolated from the crude 
mixture. The aryne insertion reaction of cyclic thiourea 531 proceeded to afford 532 and 533 in 
75% and 18%, respectively. 
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Figure 1.8. Insertion reaction/nucleophilic addition products. 
Other tandem insertion reactions and nucleophilic additions have been reported 
(Figure 1.8). Wang and co-workers reported aryne insertion to sulfoxides and the subsequent O-
arylation to afford 534.165 The Peng group broadened the scope of the sulfoxides for this reaction 
with 535 and 536.166 Tandem insertion of phosphinic acid to aryne and O-arylation was reported 
with products 537 by He, Guo and co-workers.167 Greaney and co-workers disclosed new biaryl 
synthetic methods with 538, employing a benzyne Truce–Smiles rearrangement of 
sulfonamides.168 The synthesis of o-keto benzyl sulfones 539 from aryne insertion of β-keto 
sulfones and in situ C-arylation was developed by the Huang group.169 
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1.8.3 Insertion Reaction/Nucleophilic Addition/Nucleophilic Addition 
Scheme 1.76. Conversion from β–Lactam to Acridone and Dihydroquinolinone. 
 
In 2012, Stoltz and Kim reported the synthesis of 10-phenylacridin-9(10H)-one 549 
and dihydroquinolinone 550 from β-lactams 540 and benzynes (Scheme 1.76).170 The initial 
insertion of 540 to benzyne led to azeidinium intermediates 542, which undergo nucleophilic 
addition of 544 to afford zwitterionic intermediate 545. Proton abstraction of 545 affords 
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dihydroquinolinone 550, and then, benzenide attacks the carbonyl group to form bicyclic 
intermediate 546. After extrusion of ethylene gas, the resulting acridone reacts with the third 
benzyne followed by proton abstraction to yield 10-phenylacridin-9(10H)-one 549. In addition, 
1-phenylazetidin-2-one 551 was obtained from the reaction of non-substituted lactam with 
benzyne. Just prior to this report, Shi, Larock, and co-workers reported the same synthesis that 
afforded four different kinds of aryne adducts (552-555).171 
 
1.8.4 Insertion Reaction/Insertion Reaction 
The synthesis of macrocycles was developed by Vincente, Saura-Llamas, and co-workers 
(Scheme 1.77).172 Double aryne insertion reaction into dimeric cyclopalladated complex 557 
leads to the formation of dimer 558 of the ten-membered palladacycle, which is diversified into  
Scheme 1.77. Vicente and Saura-Llamas’s Macrocycle Synthesis. 
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Scheme 1.78. Chenoweth’s Two-Step Synthesis of the Reported Xylopyridine A Structure. 
 
ten-membered C,N-palladacycle 559 by ligand exchange, ten-membered tribenzazecine 560 by 
CO insertion, and eleven-membered palladacycle 561 by addition of 2,6-dimethylphenyl 
isocyanide (XyNC). Employing TlTfO and heating 561 results in the isolation of ten-membered 
amidinium salt 562. 
In 2013, we reported the five-step synthesis of the reported structure of xylopyridine A 
(E-571 and Z-571) in Scheme 1.78, which exists in both the E and Z forms.173 After four years, 
we recently significantly shortened the number of steps by employing a pyridyne insertion 
reaction.174 Deprotonation of 2-fluorobenzoic acid 563 yields carboxylate intermediate 565, 
which was inserted into pyridyne to afford intermediates 586a and 586b. Intramolecular 
nucleophilic aromatic substitution of 568 results in the formation of 569a. We observed 569b as 
the isomer of 569a. Dimerization of 569a was performed via Woollins’ coupling to (E/Z)-571. 
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Scheme 1.79. Yamazaki’s Bis-Perfluoroalkanamide Synthesis. 
 
Yamazaki and co-workers demonstrated double aryne insertions to the C-N bonds of 
amides 572 (Scheme 1.79).175 A mechanism was not proposed in the report but it presumably 
follows the typical C-N bond insertion pathway. The nitrogen atom of 572 attacks benzyne, and 
the resulting anions 573 on the phenyl group are added to the carbonyl group to form four-
membered ring intermediates 574. Ring opening of 574 affords the desired products 575. 
Repeating the process may afford double aryne-inserted products 576. 
Representative double or triple insertion reaction products are shown in Figure 1.9. 
Murai, Chatani, and co-workers revealed the cobalt-catalyzed double aryne insertion to one 
equivalent or two equivalents of carbon monoxide to afford 577 and 578.176 Glorius and Biju 
reported carbene-catalyzed formal double aryne insertion to terephthalaldehyde to yield 1,4-
dibenzoylbenzene 579.177 Using benzynes, Zeng and co-workers developed the ring expansion 
strategy.178 In their report, the cyclohexanone ring was expanded with single or double aryne 
insertion reactions. For double aryne insertion, nine-membered ring-containing compound 580 
was obtained and confirmed by X-ray crystallographic analysis. Okuma observed double aryne 
insertion adducts 581 (open-ring form) and 582 (closed-ring form) from the reaction of 4,4,4-
trifluorobutane-1,3-dione and benzynes.179 
82 
 
 
Figure 1.9. Double or triple insertion reaction. 
 
1.8.5 Insertion Reaction/Ene Reaction 
Scheme 1.80. He’s Quinolone Synthesis. 
 
He and co-workers discovered the synthesis of 4-quinolones 588 from aza-
Morita−Baylis−Hillman (AMBH) adducts 583 and arynes (Scheme 1.80).2a The nitrogen of the 
AMBH adducts 583 are added to aryne, and the resulting anions 585 undergo 1,2-addition to 
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the carbonyl group for annulation. The corresponding enones 587 undergo an ene reaction with 
aryne to afford 4-quinolones 588. Intermediate 587 was isolated by addition of only 1.2 
equivalents of aryne. When isolated 587 was resubjected to aryne, 588 was obtained in good 
yield. 
 
1.8.6 Miscellaneous 
Scheme 1.81. Ramtohul’s Acridone Synthesis. 
 
The synthesis of acridones 547 and 592 from ethyl pyrrole-2-carboxylate 589 and aryne 
precursors (27 and 189) was reported by Ramtohul and Giacometti (Scheme 1.81).3f 
Deprotonation of 589 and the subsequent insertion reaction afford pyrroloindolone 591, which 
was isolated with 547. When 591 was resubjected to the reaction with 189, unsymmetric 
acridone 592 was obtained. The mechanism remains unclear for the second aryne addition in 
the report. 
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1.9 Ene Reactions 
1.9.1 Ene Reaction/Nucleophilic Addition 
As shown in Scheme 1.66, Castedo and co-workers studied the reactivity between 
alkaloids and benzynes (Scheme 1.82).2c In the report, they found that dehydronoraporphine 
593 reacts with benzyne via an aza-ene reaction to yield arylated intermediate 594. Restoring the 
aromaticity of 594 and subsequent nucleophilic addition of 595 to benzyne afforded diarylated 
product 596. 
 
Scheme 1.82. Castedo’s Ene Reaction and Nucleophilic Addition of Dehydronoraporphine. 
 
 
1.9.2 Ene Reaction/Ene Reaction 
Liu, Yin, and co-workers reported the aryne-ene reaction of aryne and various olefins 
(Scheme 1.83).2d In the report, double arylation of 1,5-cyclooctadiene 597 was demonstrated. 
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The proposed mechanism involved the double aryne-ene reaction of 1,5-cyclooctadiene 597 to 
afford 3,7-diphenylcycloocta-1,5-diene 598. 
 
Scheme 1.83. Liu and Yin’s Double Ene reactions. 
 
Other double ene products are shown in Figure 1.10. In 1972, Friedman and Brinkley 
reported that toluene undergoes an ene reaction with aryne twice to yield 599.2h As shown in 
Figure 1.4, the Hopf group reported double [4+2] cycloaddition of 
diethenyl[2.2]paracyclophanes and benzynes. In this report, they observed that 4-
vinyl[2.2]paracyclophanes undergo double aryne ene reactions to afford 600. In 2012, Greneay 
and co-workers obtained the double ene-products 601a and 601b (regioisomer of 601a) from 
the reaction of ditritylbenzene-1,4-diamine and benzynes.2f 
 
Figure 1.10. Double ene reaction products. 
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1.10 Polymerization 
Scheme 1.84. Inoue & Ihara’s Copolymerization of Benzyne and Pyridine. 
 
 
Scheme 1.85. Swager’s Synthesis of Dihydroindenofluorene Polymer by Using Bisaryne-
Engaged Monomer. 
 
In 2005, Ihara and co-workers reported the synthesis of copolymers 603 from arynes and 
pyridines 602 (Scheme 1.84).5d To synthesize poly(o-phenylene), Kobayashi benzyne precursor 
27 and CsF were used with several nucleophiles, transition metals, and radical initiators but the 
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reaction did not proceed. However, they employed pyridine and successfully synthesized 
copolymer 603 containing ortho-phenylene and 2,3-dihydropyridine. 
Swager and Amara used bisaryne precursor 604 for the synthesis of polymers 609 bearing 
indenofluorene and fluorene in 2006 (Scheme 1.85).5e The generation of bisaryne from 1,4-
dibromo-2,5-diodobenzene 604 with PhMgBr was performed, and this Grignard reagent was 
also accompanied by hexafluoroacetone and bisaryne for an in situ three-component reaction to 
yield 605. After the intramolecular Friedel–Crafts reaction of 605, the corresponding 
indenofluorene 606 was iodinated to afford monomer 607. Pd-catalyzed polymerization of 607 
and diiodofluorine 608 afforded polymers 609. 
 
Scheme 1.86. Nozaki and Ito’s Formal Aryne Polymerization. 
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In 2014 and 2015, Nozaki, Ito, and co-workers employed [2.2.1]oxabicyclic alkenes 610 
as aryne equivalents for the synthesis of polymers 612 or 614 bearing o-arylene or both o-arylene 
and ethylene (Scheme 1.86).5b,f Pd-catalyzed polymerization of 610 affords polymer 611, which 
undergoes dehydration to yield poly(o-arylene)s 612. When ethylene was added for 
polymerization, formal aryne-ethylene copolymer 614 was obtained. 
 
Scheme 1.87. Garg and Maynard’s Synthesis of Benzonorbornadiene Polymers by Using Aryne-
Engaged Monomer. 
 
 
Scheme 1.88. Uchiyama and Mikami’s Aryne Polymerization. 
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In 2015, benzyne precursor 27 was used for the formation of polymer 617 bearing 1,4-
epoxynaphthalene or benzonorbornadiene by Garg, Maynard, and co-workers (Scheme 1.87).5c 
Benzyne [4+2] cycloaddition of cyclopenta-1,3-diene or furan (615) yields monomer 616. Ring-
opening metathesis of 616 with Grubbs I or III catalyst affords poly(benzonorbornadiene)s or 
poly(1,4-epoxynaphthalene)s (617). 
In 2015, Uchiyama, Mikami, and Mizukoshi reported the first direct aryne 
polymerization using Kobayashi benzyne precursors 27 and copper catalysts (Scheme 1.88).5a 
Based on DFT calculations of the polymerization mechanism, benzyne and CuCN form 
triangular complex 619, and then, the triple bond of benzyne inserts into the Cu-CN bond to 
afford intermediate 621. The addition of another benzyne to 621 follows the same mechanistic 
pathway to afford biaryl intermediate 624. 
 
1.11 Conclusion 
In this review, we attempted to cover all existing multiple aryne-engaged reactions and 
provide the reaction scopes and mechanisms. Arynes are very powerful tools for the rapid 
construction of cyclic and heterocyclic molecules. The reaction scope is also notably broad from 
pericyclic reactions to polar reactions. In particular, combinations of more than two aryne 
reactions have become efficient methods for building complex molecules. Despite the potential 
of aryne reactions, many questions remain to be studied and explored in the area of multiaryne 
reactions. We hope that this review stimulates the interest of the audience outside the area of 
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aryne chemistry as well as helps chemists conducting research in this area by providing insight 
and ideas. 
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Chapter 2 
Triple Aryne-Tetrazine Reaction Enabling Rapid 
Access to a New Class of Polyaromatic Heterocycles 
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2.1 Introduction 
 
Figure 2.1. Triple aryne-retrazine reaction. Red bold lines represent new bonds formed during 
the course of the reaction. 
New polyaromatic heterocycles are important for the discovery and development of lead 
bioactive molecules. Our interest in developing new chemical probes and selective nucleic acid 
modulators motivated us to explore direct methods for rapidly accessing novel polyaromatic 
systems.1,2 Recent advances in benzyne/aryne chemistry have paved the way for use of these 
reactive intermediates in new synthetic methods,3–12 complex natural product synthesis,13–20 and 
aryne polymerizations (Figure 2.1).21 In principal, multiple-consecutive aryne additions to a 
central core molecule could provide a novel and efficient approach for rapid access to new 
polyaromatic systems. Metal catalyzed methods have been reported for cyclotrimerization22 and 
polymerization21 of arynes. However, harnessing the reactivity of arynes for controlled multiple-
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consecutive intermolecular reaction processes still remains a significant challenge. An alternative 
strategy for directly accessing higher order polyaromatic systems could be envisioned using 
arynes, such as benzyne, in combination with a reactive core molecule, such as a tetrazine, acting 
as a scaffold for iterative additions. 
The reaction between benzyne and tetrazine 1 was reported approximately 50 years ago 
(Figure 2.1).23 Tetrazine 1 proceeds through a Diels-Alder/retro-Diels-Alder process, producing 
phthalazine 2  as the terminal product. However, if phthalazine is thought of as an intermediate, 
one could envision further aryne additions, producing polyaromatic products. Here, we show 
that a simple change in the functionality on tetrazine (3a, Figure 2.1) can unveil latent reactivity 
in the presence of arynes, providing rapid and direct access to a new class of 
dibenzo[de,g]cinnoline polyaromatic heterocycles 5a. This new class of dibenzo[de,g]cinnoline 
exhibits pH responsiveness resulting in dramatic shifts in photophysical properties upon 
protonation enabling tenability of these properties. These molecules have several potential 
applications as a new class of small molecule cellular imaging agents. 
 
2.2 Results and Discussion 
The reaction transforming tetrazines into dibenzocinnolines is operationally simple and 
requires less than 5 minutes from start to finish. Recently, important new methods have paved 
the way for the efficient synthesis of tetrazines, providing easy access to many substitution 
patterns.24 A source of fluoride anion serves as a mild reagent to rapidly initiate the reaction via  
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Figure 2.2. (A) Proposed mechanism of the reaction. DA, Diels-Alder; DAinv, inverse electron 
demand Diels-Alder. (B) Reaction conditions trapping intermediate 6 (C) Resubjection of 
isolated intermediate 6 to the original reaction conditions. (D) Reaction of benzyne with 
diphenyltetrazine 1 to produce 9,10-diphenylanthracene 7. 
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desilylation of a masked benzyne precursor,25,26 obviating the necessity for a metal catalyst, 
external heat source, or inert gas. The reaction was performed in a vial, under air, charged with 
tetrazine and the benzyne precursor. After dropwise addition of a 1.0 M solution of 
tetrabutylammonium fluoride (TBAF) in THF at 24 ºC, dibenzo[de,g]cinnoline 5a was 
produced (Figure 2.1). The structure of dibenzocinnoline 5a was confirmed using X-ray 
crystallography (Table 2.2 and SI). Dibenzo[de,g]cinnolines, which have not been previously 
reported, share significant structural homology to several natural products.27,28 
A plausible mechanism for the reaction proceeding through six elementary steps is 
shown in Figure 2.2A. Aryne formation commences after addition of TBAF followed by 
formation of the initial [4+2] bicyclo intermediate I from 3a. Cycloreversion with concomitant 
loss of nitrogen gas produces intermediate phthalazine heterocycle 6.23 Next, phthalazine 6 
undergoes nucleophilic addition to benzyne, affording key intermediate II followed by proton 
transfer to produce s-cis diene intermediate III. A third aryne engages the newly formed diene 
through one of two possible mechanisms. This first possibility is a second [4+2] cycloaddition 
reaction, resulting in dihydrophenanthrene-like intermediate V. The alternate possibility is a 
non-concerted pathway where a third equivalent of benzyne is attacked by the nucleophilic 
enamine like intermediate III to produce iminium IV, followed by intramolecular conjugated 
addition to afford V.29 Two mechanistic possibilities are envisioned for the final oxidation, where 
the first mechanism involves a direct 1,4-oxidation to yield 5a. Although this mechanism is 
plausible, we favor a second possible pathway in which a base, such as fluoride, hydroxide, or 
water,11 facilitates an initial 1,4- to 1,2-dihydro rearrangement of cross-conjugated intermediate 
V to restore aromaticity in the [de] ring leading to intermediate VI. This step is then followed by 
either direct oxidation or aryne promoted desaturation leading to the fully aromatized 
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dibenzocinnoline 5a. The feasibility of the aryne promoted desaturation process was recently 
demonstrated in seminal studies by Hoye and coworkers.12 To test the aryne desaturation 
pathway, we conducted the tandem reaction in the absence of air. The heterocyclic product was 
formed, providing support for the desaturation pathway. 
   
Table 2.1. Selected Optimization Experiments of the Reaction. 
 
Entry Solvent Conc. (M) Yield (%)[a] 
1 THF 1 22 
2 Et2O 1 25 
3 hexanes 1 14 
4 xylenes 1 14 
5 DMF 1 1 
6 CH3CN 1 25 
7 CH2Cl2 1 26 
8 CH2Cl2 0.1 6 
9 CH2Cl2 0.5 7 
10 CH2Cl2 1.5 10 
11 CH2Cl2 2.0 13 
12 - - 19 
[a] HPLC yield. 9.10-diphenylanthracene was used as an internal standard. 
 
To trap intermediate pthalazine 6, 2 equivalents of 3a were used since 6 was not 
observed in the optimized condition shown in Table 2.1, entry 7. Using these conditions, 6 was 
obtained in 7% yield and was resubjected to the optimized reaction conditions (Figure 2.2B and 
2C). The desired product 5a was produced in 27% yield. Furthermore, we assumed that further 
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inverse Diels-Alder reaction between intermediate 6 and a benzyne might occur but no 9,10-
dimethylanthracene was observed. However, when diphenyltetrazine 1 reacted with benzyne 
precursor 4a and TBAF in THF at 50 oC for 2 hours, 9,10-diphenylanthracene 7 and 1,4-
diphenylphthalazine 2 was obtained. This result was consistent with our hypothesis that a 
benzylic proton unveils masked reactivity at phthalazines and detoured to 
dibenzo[de,g]cinnolines to avoid anthracenes as further inverse Diels-Alder product. 
Reaction optimization studies were conducted using nonvolatile tetrazine 3d (Table 2.1). 
Among the several desilylating reagents used (see Table 2.5 in Section 2.4), TBAF afforded 5d 
in 26% yield (Table 2.5, entry 1), while other fluoride anion sources, such as 
tetrabutylammonium difluorotriphenylsilicate (TBAT), CsF, HF, and KF, resulted in no 
reaction (Table 2.5, entries 2-12). In the presence of 18-crown-6, KF resulted in a low yield of 
product 5d (Table 2.5, entry 13). As expected, the reaction did not occur when other additives 
including tetrabutylammonium chloride or tetrabutylammonium bromide were added in the 
absence of a fluoride source (Table 2.6 in Section 2.4). 
 The highest yields were obtained using CH2Cl2 as the solvent. However, several 
alternative solvents such as THF, Et2O, xylene, hexane, and CH3CN resulted in a reasonable 
yield of product 5d (Table 2.1, entries 1-7). The reaction was sensitive to the concentration with 
the highest conversion to product achieved at a final concentration of 1.0 M (Table 2.1, entries 
7-12). In addition, excess benzyne precursor and TBAF reagents were required to achieve 
optimal yields (Table 2.7 in Section 2.4). A decrease in the temperature and an increase in the 
reaction time resulted in decreased product yields (Table 2.8 in Section 2.4). The addition of 
TBAF to the reaction mixture over the course of 60 seconds resulted in the best yields. During  
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Table 2.2. Substrate Scope for the Synthesis of Dibenzo[de,g]cinnolines and X-Ray Crystal 
Structure of 5a. 
 
the TBAF addition, a steady increase in the internal temperature of the reaction mixture to a 
maximum of 51 ºC after 70 seconds followed by a decrease to 24 ºC was observed. After a total 
time of 300 seconds, the reaction was complete (see Figure 2.6 in Section 2.4). 
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 Interestingly, 5d was isolated in 27 % yield when 4a was used as a limiting reagent,  
TBAF was added to 3d over a period of 4 hours at 0 oC, and the solution was stirred for an 
additional 20 hours (entry 7, Table 2.8 in Section 2.4). Reduction in the amount of benzyne 
precursor used resulted in longer reaction times with unreacted tetrazine and required lower 
temperatures. Further optimization is currently underway in our group. 
Using the optimized conditions described here, several dibenzocinnolines 5a-5j were 
synthesized. Given that the reaction forms four new C-C bonds and one new C-N bond during 
the course of 6-8 steps, yields from 10-52% are quite reasonable. Alkyl, aryl, and heteroaryl 
substituents are tolerated in position R1. Differentially dialkylated tetrazines show selectivity for 
reaction at the least sterically hindered position. For example, 3-methyl-6-nonyl-1,2,4,5-
tetrazine 3b has two benzylic positions; however,  only product 5b (Table 2.2) was observed, 
consistent with nonyl group sterics dictating addition of the second benzyne to the least 
sterically hindered nitrogen atom (see intermediate II in Figure 2.2), which is much bulkier than 
the methyl group. In addition, isolated 5a or 5b did not react further with excess benzyne in 
CH2Cl2 or THF under refluxing conditions. This result is consistent with the nitrogen-benzyne 
adduct creating a sterically congested environment that precludes addition to the adjacent 
nitrogen atom, as seen from the crystal structure of 5a in Table 2.2. To further test the infuence 
of steric hindrance, the bulky adamantyl tetrazine 3c was used. The bulky adamantyl group was 
expected to shut down the Diels–Alder reaction, preventing appropriate alignment of the aryne 
with the central tetrazine carbon atoms. To our surprise, product 5c was produced in 10% yield. 
 To broaden the scope of the reaction, difunctionalized tetrazines were explored. We 
found that the reaction is not limited to substitution at the R1 position. Difunctionalized 
tetrazines with substitution at R2 resulted in reasonable yields of dibenzocinnoline products 5k-
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5m (Table 2.3). Encouraged by these results, alternate benzyne precursors were tested with a set 
of tetrazines (Table 2.4). We found that addition of 4,5-dimethyl-o-benzyne to tetrazines 
afforded 5n-5p in reasonable yields (24-31%; Table 2.4). 
 
Table 2.3. Scope of Tetrazines for the Synthesis of Dibenzo[de,g]cinnolines. 
 
Depending on the tetrazine used, we found that TBAF not only initiates the reaction but 
also decomposes the tetrazine starting materials in a competing but slower background reaction. 
For mono-substituted tetrazines, such as 3-methyl-1,2,4,5-tetrazine, decomposition was faster 
than the initial Diels-Alder reaction, resulting in neither the desired product nor the phthalazine 
intermediate. Additionally, 3-benzyl-6-methyl-1,2,4,5-tetrazine decomposed faster due to the 
increased acidity of the methylene accelerating the tetrazine decomposition. Also, the addition 
of dinaphthyne precursor to 3-methyl-6-phenyl-1,2,4,5-tetrazine 3d led to dinaphthocinnoline 
5q. 
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Table 2.4. Addition of 4,5-Dimethyl-o-Benzyne. 
 
 
 
Figure 2.3. Structure of 5q. Solutions of 5q in CH2Cl2 (left) and in CH2Cl2/TFA (right) 
irradiated at 365 nm with a UV lamp (left). 
 
 Dibenzo[de,g]cinnolines exhibit interesting photophysical properties (Figure A1.77-
90). Dibenzo[de,g]cinnolines 5b, 5d, and 5i are emissive in the solid state and solution state 
under 365nm UV radiation. Additionally they exhibited hypsochromic emission response in the 
presence of acid. In contrast, dinaphthocinnoline 5q exhibited a bathochromic emission shift in 
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the presence of acid unlike 5b, 5d, and 5i (Figure 2.3). Taken together, these results show that 
the photophysical properties are tunable across a large window of the visible spectrum (Figure 
2.4) 
 
Figure 2.4. Emission spectra for the neutral and protonated forms of compounds 5b, 5d, 5i, and 
5q. 
and we expect even more interesting photophysical phenomena as we explore new derivatives 
for applications in materials, sensing, and imaging. Preliminary cellular imaging with 5e shows 
that upon excitation of the acidic form at 405 nm, intracellular vesicles can be selectively stained 
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(Figure 2.5a). When paired with commonly used dyes, such as Hoechst and MitoTracker, we 
have the ability to differentiate different intracellular compartments (Figure 2.5b). The ability to 
tune the spectral properties of the dibenzocinnolines for selective imaging of subcellular 
structures makes this a promising new class of fluorescent probes for live cell imaging. 
 
Figure 2.5. Live-cell imaging of HeLa cells in the presence of 5e. (A) Cultured HeLa cells were 
incubated with 5e for 2 hours and imaged using confocal microscopy. (B) Cells were incubated 
with 5e for 2 hours, then counterstained with Hoechst 33342 and MitoTracker Red FM. 
Extranuclear cyan corresponds to compound 5e. Using an excitation of 405 nm and emission 
from 450 to 500 nm allows for simultaneous visualization of 5e, nuclear localized Hoechst 
33342, and mitochondrial localized MitoTracker Red FM. 
 
2.3 Conclusions 
In summary, we have developed a new synthetic approach to rapidly access a structurally 
novel class of dibenzo[de,g]cinnolines using tetrazine and aryne precursors. The starting 
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materials are easily prepared, and the reaction is facile and simple, proceeding in less than 5 
minutes. The photophysical properties of this new class of fluorophore are tunable and 
compatible with live-cell imaging. Efforts are currently underway to further probe the biological 
activity and to expand access to different structures via regioselective asymmetric aryne 
addition.30 
 
2.4 Experimental Section 
General information 
Materials.  
All commercial reagents and solvents were used as received. Zinc 
trifluoromethanesulfonate, hydrazine anhydrous, propionitrile, decanenitrile, 2-
thiophenecarbonitrile, 2-pyridinecarbonitrile, 2-fluorobenzonitrile, adamantane-1-carbonitrile, 
4-(aminomethyl)benzonitrile hydrochloride, di-tert-butyl dicarbonate and 1.0M 
tetrabutylammonium fluoride in THF were purchased from Aldrich. Acetonitrile and 
benzonitrile were purchased from Fisher Scientific, 4-bromobenzonitrile from Oakwood 
Products Inc, 3-(Trimethylsilyl)-2-naphthyl trifluoromethanesulfonate from TCI and 
methylene chloride-d2 and chloroform-d from Cambridge Isotope Laboratories Inc. Flash 
column chromatography was performed using Silicycle silica gel (55−65 Å pore diameter). 
Thin-layer chromatography was performed on Sorbent Technologies silica plates (250 μm 
thickness). Dulbecco’s Modified Eagle Medium (DMEM) and Alamar Blue were purchased 
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from Invitrogen. Fetal bovine serum (FBS) was purchased from Gibco, Life Technologies. L-
glutamine and penicillin/streptomycin were purchased from Corning Cellgro. 
 
General spectroscopic methods.  
Proton nuclear magnetic resonance spectroscopy (1H NMR) and Carbon nuclear 
magnetic resonance spectroscopy (13C NMR) spectra were recorded on a Bruker UNI 500 
NMR. Fluorine nuclear magnetic resonance spectroscopy (19F NMR) was recorded on a Bruker 
DMX 360 NMR. High-resolution mass spectra were obtained by Dr. Rakesh Kohli at the 
University of Pennsylvania’s Mass Spectrometry Service Center on a Micromass AutoSpec 
electrospray/chemical ionization spectrometer. X-ray diffraction data obtained and solved by 
Dr. Patrick Carroll at the University of Pennsylvania. Ultraviolet absorption spectrophotometry 
was performed on a JASCO V-650 spectrophotometer with a PAC-743R multichannel Peltier 
using quartz cells with a 1 cm cell path length. High performance liquid chromatography analysis 
was performed using a Jasco HPLC instrument equipped with a Phenomenex column (Luna 5u 
C18(2) 100A; 250 × 4.60 mm, 5 μm). Graph of time versus temperature was obtained using a 
Vernier Go-Link and temperature probe. 
 
Cell culture and imaging.  
HeLa cells were maintained in a humidified incubator at 37 °C in 5% CO2. HeLa cells 
were cultured in DMEM supplemented with 10% fetal bovine serum (Giboc, Life 
Technologies) and penicillin and streptomycin (Corning Cellgro). For live cell imaging, cells 
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were plated in glass-bottom 35-mm dishes (MatTEK) 24 hours before experiments. 24 hours 
after plating, 1 μL of compounds (stock solution 10 mM) was added to 2 mL of media. Cells 
were incubated for 2 hours with compounds at 37 °C followed by washing with fresh media 2 
times. During imaging, cells were maintained in DMEM without phenol red supplemented with 
10% FBS. 
A  Leica  TCS  SP8  confocal  microscope  equipped  with  a  63x/1.4  NA  oil  immersion  objecti
ve  lens was  used.  Compound 5e was excited with 405 nm and emission was observed from 
450-500 nm. To observe MitoTracker Red FM, an excitation of 552 nm and emission from 575-
640 nm were used. Hoechst 33342 was observed by excitation with 405 nm and emission from 
408-450 nm. Images were processed using Fiji ImageJ. 
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Additional optimization information.  
The yield was determined by HPLC and 9,10-dipbhenylanthracene was used as an 
internal standard. 
 
Table 2.5. Effect of Fluoride Anion Source and Combination with Additive. 
Entry F- Eq of F- Eq of Benz. Additiveb Temp 
(oC) 
Time Yield (%)c 
1 TBAFa 10 11 - 24 1 h - 
2 TBAFa 10 11 TFA 24 1 h - 
3 TBAFa 10 11 NEt3 24 1 h - 
4 TBAF 11 10 - 24 5 min 26 (23 d) 
5 TBAT 11 10 - 24 1 h - 
6 TBAT 11 10 TFA 24 1 h - 
7 TBAT 11 10 NEt3 24 1 h - 
8 CsF 11 10 - 24 1 h - 
9 CsF 11 10 TFA 24 1 h - 
10 CsF 11 10 NEt3 24 1 h - 
11 HF 11 10 - 24 1 h - 
12 KF 11 10 - 24 1 h - 
13 KF 11 10 18-crown-6 24 5 min 3 
a 1 eq of TBAF was added to 1.1 eq of benzyne precursor and then 10 eq of stock solution from those mixture was added 
to tetrazine. 
b 10 eq of additive was added. 
c HPLC yield. 
d Isolated yield. 
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Table 2.6. Effect of Additive without Fluoride Anion Source. 
Entry F- Eq of F- Eq of Benz. Additivea Temp 
(oC) 
Time Yield (%)b 
1 - - 10 Indole 24 1 h - 
2 - - 10 Imidazole 24 1 h - 
3 - - 10 TMG 24 1 h - 
4 - - 10 DBU 24 1 h - 
5 - - 10 t-BuOK/THF 24 1 h - 
6 - - 10 2,6-lutidine 24 1 h - 
7 - - 10 Pyridine 24 1 h - 
8 - - 10 t-BuNH2 24 1 h - 
9 - - 10 TBAOH 24 1 h - 
10 - - 10 TBABr 24 1 h - 
11 - - 10 TBACl 24 1 h - 
a 10 eq of additive was added. 
b HPLC yield. 
 
 
Table 2.7. Effect of Equivalence of Benzyne Precursor and TBAF. 
Entry F- Eq of F- Eq of Benz. Additive Temp 
(oC) 
Time Yield (%)a 
1 TBAF 11 10 - 24 5 min 26 
2 TBAF 11 11 - 24 5 min 25 
3 TBAF 8.8 8 - 24 5 min 19 
4 TBAF 6.6 6 - 24 5 min 11 
5 TBAF 4.4 4 - 24 5 min 6 
6 TBAF 2.2 2 - 24 5 min 3 
7 TBAF 1.1 1 - 24 5 min 1 
8 TBAF 9 10 - 24 5 min 22 
9 TBAF 7 10 - 24 5 min 14 
10 TBAF 11 22 - 24 5 min 23 
a HPLC yield. 
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Table 2.8. Effect of Temperature and Reaction Time. 
Entry F- Eq of F- Eq of Benz. Additive Temp (oC) Time Yield (%)a 
1 TBAF 11 10 - 24 5 min 26 
2 TBAF 11 10 - 0 5 min 6 
3 TBAF 11 10 - 0 to 24
b 35 min 7 
4 TBAF 11 10 - 0 to 24b 65 min 10 
5 
6 
7 
TBAF 
TBAF 
TBAF 
11 
3.3 
3.3 
10 
3 
3 
- 
- 
- 
24 
0 
24 
65 min 
24 hc 
4 he 
13 
27d 
5d 
a HPLC yield except entry 6. 
b TBAF was added dropwise for 5 min at 0 oC and then the reaction mixture was warmed to 24 oC for additional time. 
C TBAF was added in period of 4 h at 0 oC and then was stirred for additional 20 h. 
d Isolated yield based on the benzyne precursor as the starting material. 
e TBAF was added in period of 4 h at 24 oC. 
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Real-time temperature study 
 
A vial was charged with 14.8 mg (0.086 mmol) of 3d and 300 mg (0.86 mmol) of 3-
(trimethylsilyl)-2-naphthyl trifluoromethanesulfonate in 0.09 mL of dichloromethane at 24˚C, 
and 1 M TBAF in THF (0.95 mL, 0.95 mmol) was slowly added to the solution over the course 
of 1 min (0 to 60 sec in Supplementary Figure 2.1). The highest temperature was 52 ˚C at 73 
sec. 
 
 
Figure 2.6. Graph of time vs. temperature of the reaction. 
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Experimental procedures 
 
3,6-dimethyl-1,2,4,5-tetrazine (3a): 3a was prepared according to the previously published 
procedure24 from commercially available acetonitrile. The product was purified by flash column 
chromatography (ethyl acetate/hexane 1:4) to afford 3a. The data for this compound was 
previously reported in the literature.31-33 
Physical Property: Red crystal. 
Isolated Yield: 30% 
TLC: Rf = 0.29 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 2.96 (s, 6H). 
13C NMR (125 MHz, CDCl3) δ 167.2, 21.0 
IR (neat): 1636, 1412, 1350, 1292, 1270, 913, 873, and 734 cm-1. 
HRMS (ESI) calculated for C4H7N4 [M+H]+ 111.0660, no peak matched the calculated exact 
mass.34 
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3-methyl-6-nonyl-1,2,4,5-tetrazine (3b): 3b was prepared according to the previously published 
procedure24 from commercially available acetonitrile and decanenitrile. The product was 
purified by flash column chromatography (ethyl acetate/hexane 1:16) to afford 3b. 
Physical Property: Purple crystal, m.p. = 33-34 ˚C. 
Isolated Yield: 19% 
TLC: Rf = 0.50 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 3.27 (t, 2H, J = 7.7 Hz), 3.02 (s, 3H), 1.96-1.88 (m, 2H), 1.46-
1.19 (m, 12H), 0.90-0.84 (m, 3H). 
13C NMR (125 MHz, CDCl3) δ 170.3, 167.4, 34.9, 32.0, 29.5, 29.39, 29.37, 29.27, 28.5, 22.8, 
21.2, 14.2. 
IR (neat): 2953, 2914, 2848, 2870, 1718, 1653, 1469, 1407, 1338, 1317, 1274, 1200, 891, 774, 
and 720 cm-1. 
HRMS (ESI) calculated for C12H23N4 [M+H]+ 223.1918, found 223.1922. 
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3-((3r,5r,7r)-adamantan-1-yl)-6-methyl-1,2,4,5-tetrazine (3c): 3c was prepared according to 
the previously published procedure24 from commercially available acetonitrile and adamantane-
1-carbonitrile. The product was purified by flash column chromatography (ethyl acetate/hexane 
1:12) to afford 3c. 
Physical Property: Red solid, m.p. = 55-56 ˚C.  
Isolated Yield: 22% 
TLC: Rf = 0.37 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 2.90 (s, 3H), 2.10-2.00 (m, 9H), 1.71 (bs, 6H). 
13C NMR (125 MHz, CDCl3) δ 174.3, 166.6, 40.5, 39.2, 36.3, 28.2, 21.0. 
IR (neat): 2905, 2850, 1453, 1398, 1353, 1312, 1088, 1046, 890, 736 cm-1. 
HRMS (ESI) calculated for C13H19N4 [M+H]+ 231.1605, found 231.1600. 
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3-methyl-6-phenyl-1,2,4,5-tetrazine (3d): 3d was prepared according to the previously 
published procedure1 from commercially available acetonitrile and benzonitrile. The product 
was purified by flash column chromatography (ethyl acetate/hexane 1:10) to afford 3d. The 
data for this compound was previously reported in the literature.33,35 
Physical Property: Purple crystal.  
Isolated Yield: 58% 
TLC: Rf = 0.42 (silica gel, 25% ethyl acetate/hexane). 
1H NMR (500 MHz, CDCl3) δ 8.51-8.45 (m, 2H), 7.56-7.46 (m, 3H), 3.01 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 167.1, 163.9, 132.4, 131.8, 129.1, 127.8, 21.1. 
IR (neat): 1473, 1401, 1362, 1176, 1089, 1022, 890, 760, 722, 692, and 675 cm-1. 
HRMS (ESI) calculated for C9H9N4 [M+H]+ 173.0822, found 173.0819. 
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3-(4-bromophenyl)-6-methyl-1,2,4,5-tetrazine (3e): 3e was prepared according to the 
previously published procedure24 from commercially available acetonitrile and 4-
bromobenzonitrile. The product was purified by flash column chromatography (ethyl 
acetate/hexane 1:10) to afford 3e. 
Physical Property: Purple crystal, m.p. = 151-152 ˚C. 
Isolated Yield: 16% 
TLC: Rf = 0.53 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.43-8.38 (m, 2H), 7.70-7.66 (m, 2H), 3.07 (s, 3H) 
13C NMR (125 MHz, CDCl3) δ 167.5, 163.6, 132.6, 130.8, 129.4, 127.7, 21.3. 
IR (neat): 1588, 1402, 1366, 1174, 1091, 1072, 1008, 890, 847, 798, and 633 cm-1. 
HRMS (ESI) calculated for C9H8BrN4 [M+H]+ 250.9922, no peak matched the calculated exact 
mass. 
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3-(2-fluorophenyl)-6-methyl-1,2,4,5-tetrazine (3f): 3f was prepared according to the previously 
published procedure24 from commercially available acetonitrile and 2-fluorobenzonitrile. The 
product was purified by flash column chromatography (ethyl acetate/hexane 1:8) to afford 3f. 
Physical Property: Red solid, m.p. = 50-51 ˚C. 
Isolated Yield: 26% 
TLC: Rf = 0.44 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.18 (td, 1H, J = 7.6, 1.8 Hz), 7.59-7.53 (m, 1H), 7.33 (td, 1H, J 
= 7.6, 1.0 Hz), 7.26 (dd, 1H, J = 10.8, 1.0 Hz), 3.08 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 166.8, 163.9, 162.3, 160.2, 133.9, 133.8, 131.3, 124.74, 124.71, 
120.7, 120.6, 117.32, 117.15, 21.2. 
19F NMR (338 MHz, CDCl3) δ -112.8 to -112.9 (m, 1F). 
IR (neat): 2129, 1614, 1586, 1497, 1466, 1400, 1364, 1253, 1216, 1114, 1087, 1028, 888, 821, 
763, 736 cm-1. 
HRMS (ESI) calculated for C9H8FN4 [M+H]+ 191.0729, no peak matched the calculated exact 
mass. 
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3-(2-(methoxymethoxy)phenyl)-6-methyl-1,2,4,5-tetrazine (3g): A vial was charged with 80 mg 
(0.43 mmol) of 3n and 0.44 mL (2.55 mmol) of N,N-diisopropylethylamine (DIPEA) in 1.00 
mL of dichloromethane at 0 ˚C, and the solution was stirred for 20 min. To the resulting 
solution was added 0.01 mL (1.28 mmol) of chloromethylmethyl ether (MOMCl). After 20 min 
at 0 ˚C, the solution was warmed to 24 ˚C and stirred for another 12 h. The solution was 
quenched with saturated NH4Cl solution, extracted with dichloromethane, and purified by 
column chromatography (ethyl acetate/hexane 1:4) to afford 3g (54.1 mg). 
Physical Property: Red oil.  
Isolated Yield: 55% 
TLC: Rf = 0.30 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 7.89 (dd, 1H, J = 7.7, 0.9 Hz), 7.53 (ddd, 1H, J = 8.4, 7.5, 1.7 
Hz), 7.32 (d, 1H, J = 8.4 Hz), 7.20 (td, 1H, 7.5, 0.9 Hz), 5.23 (s, 2H), 3.47 (s, 3H), 3.10 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 166.3, 165.9, 155.9, 132.9, 131.6, 123.3, 122.3, 116.1, 95.1, 56.4, 
21.2. 
IR (neat): 2923, 1603, 1496, 1461, 1399, 1154, 1080, 982, 756, 736 cm-1. 
HRMS (ESI) calculated for C11H13N4O2 [M+H]+ 233.1034, found 233.1048. 
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tert-butyl (4-(6-methyl-1,2,4,5-tetrazin-3-yl)benzyl)carbamate (3h): 3h was obtained 
according to the literature procedures and 1H NMR was matched with the literature.24 
1H NMR (500 MHz, CDCl3) δ 8.46 (d, 2H, J = 8.2 Hz), 7.44 (d, 2H, J = 8.2 Hz), 5.22 (bs, 1H), 
4.38 (d, 2H, J = 5.7 Hz), 3.04 (s, 3H), 1.44 (s, 9H). 
 
 
3-methyl-6-(thiophen-2-yl)-1,2,4,5-tetrazine (3i): 3i was prepared according to the previously 
published procedure24 from commercially available acetonitrile and thiophene-2-carbonitrile. 
The product was purified by flash column chromatography (ethyl acetate/hexane 1:10) to 
afford 3i. 
Physical Property: Orange-red crystal, m.p. = 132-133 ˚C. 
Isolated Yield: 27% 
TLC: Rf = 0.46 (silica gel, ethyl acetate/hexane 1:10). 
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1H NMR (500 MHz, CDCl3) δ 8.19 (dd, 1H, J = 3.7, 0.8 Hz), 7.62 (dd, 1H, J = 5.0, 0.8 Hz), 
7.21-7.18 (m, 1H), 3.00 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 166.7, 162.0, 135.8, 132.3, 131.0, 128.9, 21.2. 
IR (neat): 1535, 1437, 1394, 1370, 1346, 1294, 1216, 1082, 1054, 991, 897, 854, 732, and 670 
cm-1. 
HRMS (ESI) calculated for C7H7N4S [M+H]+ 179.0386, found 179.0393. 
 
 
3-methyl-6-(pyridin-2-yl)-1,2,4,5-tetrazine (3j): 3j was prepared according to the previously 
published procedure24 from commercially available acetonitrile and 2-cyanopyridine. The 
product was purified by flash column chromatography (ethyl acetate/hexane 1:1) to afford 3j. 
Physical Property: Purple crystal, m.p. = 104-105 ˚C.  
Isolated Yield: 11% 
TLC: Rf = 0.06 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.70 (dd, 1H, J = 4.7, 0.7 Hz), 8.38 (d, 1H, J = 7.9 Hz), 7.76 (td, 
1H, J = 7.8, 1.7 Hz), 7.34 (ddd, 1H, J = 7.6, 4.7, 1.0 Hz), 2.93 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 167.7, 163.2, 150.5, 149.9, 137.1, 126.0, 123.5, 21.0. 
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IR (neat): 1641, 1584, 1567, 1400, 1364,1103, 1040, 992, 902, 778, 745, 736 cm-1. 
HRMS (ESI) calculated for C8H8N5 [M+H]+ 174.0775, found 174.0783. 
 
3,6-diethyl-1,2,4,5-tetrazine (3k): 3k was prepared according to the previously published 
procedure24 from commercially available propionitrile. The product was purified by flash 
column chromatography (ethyl acetate/hexane 1:20) to afford 3k. 
Physical Property: Red oil.  
Isolated Yield: 38% 
TLC: Rf = 0.60 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 3.22 (q, 4H, J = 7.6 Hz), 1.40 (t, 6H, J = 7.6 Hz). 
13C NMR (125 MHz, CDCl3) δ 170.8, 28.2, 12.2. 
IR (neat): 2983, 2942, 2884, 1688, 1464, 1399, 1266, 1056, 888, 737, 701, 652 cm-1. 
HRMS (ESI) calculated for C6H11N4 [M+H]+ 139.0973, no peak matched the calculated exact 
mass. 
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3,6-dinonyl-1,2,4,5-tetrazine (3l): 3l was prepared according to the previously published 
procedure24 from commercially available decanenitrile. The product was purified by flash 
column chromatography (ethyl acetate/hexane 1:20) to afford 3l. 
Physical Property: Red crystal, m.p. = 32-33 ˚C.  
Isolated Yield: 40% 
TLC: Rf = 0.75 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 3.27 (t, 4H, J = 7.7 Hz), 1.97-1.88 (m, 4H), 1.46-1.19 (m, 24H), 
0.90-0.83 (m, 6H). 
13C NMR (125 MHz, CDCl3) δ 170.2, 34.8, 31.9, 29.4, 29.3, 29.3, 29.2, 28.3, 22.7, 14.1. 
IR (neat): 2928, 2856, 1458, 1395, 906, 731, 668 cm-1. 
HRMS (ESI) calculated for C20H39N4 [M+H]+ 335.3170, found 335.3180. 
 
 
 
 
 
134 
 
 
3-ethyl-6-phenyl-1,2,4,5-tetrazine (3m): 3m was prepared according to the previously published 
procedure24 from commercially available propionitrile and benzonitrile. The product was 
purified by flash column chromatography (ethyl acetate/hexane 1:12) to afford 3m. 
Physical Property: Red oil.  
Isolated Yield: 69% 
TLC: Rf = 0.57 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.57-8.53 (m, 2H), 7.58-7.52 (m, 3H), 3.36 (q, 2H, J = 7.6 Hz), 
1.53 (t, 3H, J = 7.6 Hz). 
13C NMR (125 MHz, CDCl3) δ 170.8, 164.2, 132.5, 131.9, 129.2, 127.9, 28.3, 12.3. 
IR (neat): 1465, 1396, 1265, 1091, 898, 736, 692 cm-1. 
HRMS (ESI) calculated for C10H11N4 [M+H]+ 187.0980, no peak matched the calculated exact 
mass. 
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2-(6-methyl-1,2,4,5-tetrazin-3-yl)phenol (3n): 3n was prepared according to the previously 
published procedure24 from commercially available acetonitrile and 2-hydroxybenzonitrile. The 
product was purified by flash column chromatography (ethyl acetate/hexane 1:10) to afford 3n. 
Physical Property: Red crystal, m.p. = 63-64 ˚C.  
Isolated Yield: 36% 
TLC: Rf = 0.50 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 11.11 (bs, 1H), 8.64 (dd, 1H, J = 8.1, 1.7 Hz), 7.52 (ddd, 1H, J = 
8.3, 7.2, 1.7 Hz), 7.14-7.05 (m, 2H), 3.12 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 166.6, 164.9, 160.0, 135.1, 128.6, 120.3, 118.7, 114.1, 21.3. 
IR (neat): 3053, 1618, 1585, 1484, 1402, 1265, 1234, 1085, 909, 759, 735 cm-1. 
HRMS (ESI) calculated for C9H9N4O [M+H]+ 189.0772, no peak matched the calculated exact 
mass. 
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4,5-dimethyl-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (4b): 4b was obtained 
according to the literature procedures and 1H NMR was matched with the literature.36 
Isolated Yield: 82%. 
1H NMR (500 MHz, CDCl3) δ 7.25 (s, 1H), 7.10 (s, 1H), 2.29 (s, 3H), 2.27 (s, 3H), 0.36 (s, 
9H). 
 
 
General procedure for the preparation of 4-nonyl-6-phenyl-6H-dibenzo[de,g]cinnoline (5a-
5p): A vial was charged with 0.1 mmol of tetrazine 3a-3m and 1 mmol of 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate 4a (or 4,5-dimethyl-2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate 4b) in 0.1 mL of dichloromethane at 24˚C, and 1 M TBAF in THF 
(1.1 mmol) was slowly added to the solution over the course of 1 min. After the addition, the 
solution was concentrated in vacuo and purified by flash column chromatography to afford 5a-
5p. 
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4-methyl-6-phenyl-6H-dibenzo[de,g]cinnoline (5a): 5a was prepared according to the general 
procedure using 3a and 4a. The product was purified by flash column chromatography (ethyl 
acetate/hexane 1:20) to afford 5a. 
Physical Property: Yellow solid, m.p. = 145-146 ˚C. 
Isolated Yield: 51%. 
TLC: Rf = 0.60 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.39 (d, 1H, J = 8.3 Hz), 8.34 (d, 1H, J = 8.2 Hz), 7.64-7.56 (m, 
5H), 7.46-7.37 (m, 3H), 7.30 (ddd, 1H, J = 8.3, 6.2, 2.1 Hz), 7.26 (dd, 1H, J = 7.4, 0.9 Hz), 6.43 
(s, 1H), 2.29 (s, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 144.4, 142.6, 137.7, 134.3, 131.8, 130.3, 128.7, 127.9, 127.8, 
127.1, 127.1, 126.3, 126.2, 124.3, 123.1, 123.0, 122.8, 118.2, 97.7, 19.1. 
IR (neat): 3057, 2920, 2850, 1618, 1588, 1496, 1441, 1400, 1340, 1305, 1272, 1233, 1207, 1142, 
1024, 807, 756, 744, 735, 699, and 644 cm-1. 
HRMS (ESI) calculated for C22H17N2 [M+H]+ 309.1387, found 309.1406. 
Quantum Yield (Φ):  
(a) 1.5 % of the neutral form. 
(b) 27.7 % in the presence of 1073 equivalents of trifluoroacetic acid. 
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Extinction Coefficient (ε):  
(a) 7362 ± 164 (417 nm), 16847 ± 348 (349 nm), 18285 ± 419 (269 nm), 34084 ± 214 (231 
nm) for the neutral form. 
(b) 7378 ± 181 (411 nm), 46894 ± 370 (230 nm) in the presence of of 1073 equivalents of 
trifluoroacetic acid. 
 
4-nonyl-6-phenyl-6H-dibenzo[de,g]cinnoline (5b): 3b was prepared according to the general 
procedure using 3b and 4a. The product was purified by flash column chromatography (ethyl 
acetate/hexane 1:25) to afford 5b. 
Physical Property: Yellow solid, m.p. = 99-100 ˚C. 
Isolated Yield: 41%. 
TLC: Rf = 0.74 (silica gel, diethylether/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.38 (d, 1H, J = 8.0 Hz), 8.34 (d, 1H, J = 8.1 Hz), 7.63-7.54 (m, 
5H), 7.44-7.36 (m, 3H), 7.33-7.28 (m, 2H), 6.45 (s, 1H), 2.72-2.60 (m, 2H), 1.79-1.69 (m, 
2H), 1.50-1.42 (m, 2H), 1.41-1.20 (m, 10H), 0.91-0.85 (m, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 145.8, 144.5, 137.7, 134.3, 132.0, 130.3, 128.7, 127.8, 127.1, 
127.0, 126.6, 125.7, 124.4, 123.1, 122.78, 122.76, 118.0, 97.6, 32.7, 32.3, 30.04, 30.01, 29.9, 29.8, 
27.1, 23.1, 14.3. 
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IR (neat): 3050, 2925, 2852, 1616, 1588, 1496, 1461, 1442, 1399, 1338, 1301, 1264, 1232, 1206, 
1142, 815, 738, 704, 668, and 649 cm-1. 
HRMS (ESI) calculated for C30H33N2 [M+H]+ 421.2639, found 421.2630. 
Quantum Yield (Φ):  
(a) 1.2% of the neutral form. 
(b) 6.6% in the presence of 1048 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε):  
(a) 9205 ± 358 (419 nm), 15954 ± 109 (350 nm), 17336 ± 601 (269 nm), 34072 ± 342 (229 
nm) for the neutral form. 
(b) 7103 ± 16 (419 nm), 42445 ± 459 (229 nm) in the presence of 1048 equivalents of 
trifluoroacetic acid. 
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4-((3r,5r,7r)-adamantan-1-yl)-6-phenyl-6H-dibenzo[de,g]cinnoline (5c): 5c was prepared 
according to the general procedure using 1c and 4a. The product was purified by flash column 
chromatography (ethyl acetate/hexane 1:30) to afford 5c. 
Physical Property: Yellow oil. 
Isolated Yield 10%. 
TLC: Rf = 0.79 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.37 (m, 2H), 7.90 (d, 1H, J = 7.5 Hz), 7.66-7.52 (m, 5H), 7.44-
7.36 (m, 3H), 7.31 (ddd, 1H, J = 8.3, 6.2, 1.7 Hz), 6.56 (s, 1H), 2.25-2.19 (m, 6H), 2.14 (bs, 
3H), 1.90-1.80 (m, 6H). 
13C NMR (125 MHz, CDCl3) δ 149.4, 144.3, 136.5, 133.5, 132.0, 129.6, 127.5, 127.30, 127.28, 
126.9, 126.4, 125.7, 124.13, 123.9, 122.7, 122.3, 121.8, 120.1, 96.9, 40.5, 40.0, 37.0, 29.0. 
IR (neat): 2903, 2848, 1612, 1584, 1494, 1440, 1392, 1339, 1288, 1233, 1144, 760, 736 cm-1. 
HRMS (ESI) calculated for C31H28N2 [M+H]+ 429.2326, found 429.2298. 
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4,6-diphenyl-6H-dibenzo[de,g]cinnoline (5d): 5d was prepared according to the general 
procedure using 3d and 4a. The product was purified by flash column chromatography (ethyl 
acetate/hexane 1:20) to afford 5d.  
Physical Property: Yellow solid, m.p. = 135-136 ˚C. 
Isolated Yield 26%. 
TLC: Rf = 0.53 (silica gel, diethylether/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.37 (d, 1H, J = 8.0 Hz), 8.34 (d, 1H, J = 8.1 Hz), 7.65-7.60 (m, 
4H), 7.59-7.54 (m, 2H), 7.53-7.37 (m, 7H), 7.33 (ddd, 1H, J = 8.2, 6.3, 2.1 Hz), 7.20 (dd, 1H, J 
= 7.5, 0.9 Hz), 6.45 (s, 1H). 
13C NMR (125 MHz, CD2Cl2) δ 146.0, 143.7, 137.2, 136.0, 133.8, 131.7, 129.9, 128.6, 128.53, 
128.51, 128.1, 127.6, 127.5, 126.8, 126.4, 125.4, 124.2, 123.0, 122.6, 122.4, 119.4, 97.7. 
IR (neat): 3052, 2918, 2848, 1614, 1586, 1492, 1458, 1441, 1398, 1320, 1237, 1145, 1129, 984, 
816, 761, 735, and 698 cm-1. 
HRMS (ESI) calculated for C27H19N2 [M+H]+ 371.1543, found 371.1547. 
Quantum Yield (Φ):  
(a) 0.7% of the neutral form 
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(b) 8.1% in the presence of 1034 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε): 
(a) 4478 ± 140 (419 nm), 13669 ± 371 (357 nm), 18217 ± 536 (261 nm), 25145 ± 719 (242 
nm) for the neutral form. 
(b) 7346 ± 19 (417 nm), 25976 ± 371 (404 nm) in the presence of 1034 equivalents of 
trifluoroacetic acid. 
 
4-(4-bromophenyl)-6-phenyl-6H-dibenzo[de,g]cinnoline (5e): 5e was prepared according to 
the general procedure using 3e and 4a. The product was purified by flash column 
chromatography (ethyl acetate/hexane 1:20) to afford 5e. 
Physical Property: Yellow solid, m.p. = 188-189 ˚C. 
Isolated Yield 46%. 
TLC: Rf = 0.59 (silica gel, diethylether/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.37 (d, 1H, J = 8.3 Hz), 8.33 (d, 1H, J = 8.2 Hz), 7.65-7.38 (m, 
12H), 7.33 (ddd, 1H, J = 8.1, 5.9, 2.4 Hz), 7.21 (dd, 1H, J = 7.4, 0.5 Hz), 6.45 (s, 1H). 
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13C NMR (125 MHz, CD2Cl2) δ 144.8, 143.6, 137.1, 135.0, 133.7, 131.8, 131.7, 130.2, 129.9, 
128.1, 127.7, 127.5, 126.92, 126.88, 126.5, 125.1, 124.2, 123.2, 122.7, 122.4, 122.4, 119.1, 98.0. 
IR (neat): 3064, 2916, 2848, 2176, 1614, 1588, 1493, 1456, 1441, 1315, 1237, 1144, 1128, 1080, 
1011, 984, 832, 757, 737, and 625 cm-1. 
HRMS (ESI) calculated for C27H18BrN2 [M+H]+ 449.0648, found 449.0643. 
Quantum Yield (Φ):  
(a) 0.5% of the neutral form. 
(b) 6.9% in the presence of 1083 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε): 
(a) 5949 ± 130 (418 nm), 19021 ± 243 (358 nm), 34833 ± 827 (243 nm) for the neutral form. 
(b) 7960 ± 63 (418 nm), 11769 ± 581 (356 nm), 40935 ± 701 (242 nm) in the presence of 
1083 equivalents of trifluoroacetic acid. 
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4-(2-fluorophenyl)-6-phenyl-6H-dibenzo[de,g]cinnoline (5f): 5f was prepared according to the 
general procedure using 3f and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:20) to afford 5f. 
Physical Property: Yellow solid, m.p. = 80-81 ˚C. 
Isolated Yield 19%. 
TLC: Rf = 0.63 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.40-8.33 (m, 2H), 7.66-7.39 (m, 10H), 7.38-7.33 (m, 1H), 7.31 
(td, 1H, J = 7.5, 1.2 Hz), 7.26-7.21 (m, 1H), 6.92 (ddd, 1H, J = 7.4, 2.9, 0.9 Hz). 
13C NMR (125 MHz, CDCl3) δ 161.7, 159.7, 143.5, 141.7, 137.1, 133.7, 131.6, 131.43, 131.40, 
130.73, 130.66, 130.0, 128.3, 127.8, 127.5, 126.9, 126.5, 125.5, 124.70, 124.67, 124.3, 123.7, 
123.6, 123.2, 122.7, 122.4, 119.25, 119.23, 116.0, 115.8, 98.1.  
19F NMR (338 MHz, CD2Cl2) δ -113.3 to -113.4 (m, 1F). 
IR (neat): 1738, 1373, 1238, 1045, 939, 918 cm-1. 
HRMS (ESI) calculated for C27H18FN2 [M+H]+ 389.1449, found 389.1454. 
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4-(2-(methoxymethoxy)phenyl)-6-phenyl-6H-dibenzo[de,g]cinnoline (5g): 5g was prepared 
according to the general procedure using 3g and 4a. The product was purified by flash column 
chromatography (ethyl acetate/hexane 1:15) to afford 5g. 
Physical Property: Yellow oil. 
Isolated Yield 25%. 
TLC: Rf = 0.45 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) δ 8.35 (dd, 2H, J = 8.6, 2.8 Hz), 7.66-7.61 (m, 2H), 7.60-7.54 (m, 
2H), 7.51-7.38 (m, 6H), 7.33 (ddd, 1H, J = 8.3, 6.6, 1.7 Hz), 7.25 (d, 1H, J = 8.0 Hz), 7.14 (td, 
1H, J = 7.6, 1.0 Hz), 6.84 (dd, 1H, J = 7.3, 0.7 Hz), 6.50 (s, 1H), 5.15 (m, 2H), 3.36 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 155.6, 144.5, 143.7, 137.2, 133.8, 131.4, 130.9, 130.1, 129.8, 
128.1, 127.5, 127.4, 126.8, 126.4, 126.3, 125.95, 125.90, 124.2, 123.0, 122.3, 122.2, 119.8, 114.8, 
97.6, 94.7, 56.1. 
IR (neat): 3053, 1587, 1493, 1453, 1440, 1398, 1319, 1264, 1234, 1153, 996, 735, 703 cm-1. 
HRMS (ESI) calculated for C29H23N2O2 [M+H]+ 431.1755, found 431.1760. 
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tert-butyl (4-(6-phenyl-6H-dibenzo[de,g]cinnolin-4-yl)benzyl)carbamate (5h): 5h was 
prepared according to the general procedure using 3h and 4a. The product was purified by flash 
column chromatography (ethyl acetate/hexane 1:4) to afford 5h. 
Physical Property: Yellow solid, m.p. = 177-178 ˚C. 
Isolated Yield: 31%. 
TLC: Rf = 0.21 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.40-8.25 (m, 2H), 7.67-7.56 (m, 5H), 7.55-7.49 (m, 1H), 7.48-
7.38 (m, 5H), 7.34 (ddd, 1H, J = 8.3, 6.1, 2.2 Hz), 7.27 (d, 1H, J = 7.3 Hz), 6.47 (s, 1H), 5.03 
(bs, 1H), 4.37 (d, 1H, J = 5.8 Hz), 1.48 (s, 9H). 
13C NMR (125 MHz, CD2Cl2) δ 155.8, 145.7, 143.7, 140.1, 137.2, 134.9, 133.8, 131.8, 129.9, 
128.7, 128.1, 127.7, 127.5, 127.4, 126.9, 126.8, 126.5, 125.4, 124.2, 123.1, 122.6, 122.4, 119.5, 
97.8, 79.2, 44.3, 28.1. 
IR (neat): 3345, 2976, 1707, 1612, 1586, 1492, 1440, 1397, 1365, 1318, 1288, 1271, 1237, 1167, 
1145, 1129,760, 737, 695 cm-1. 
HRMS (ESI) calculated for C33H30N3O2 [M+H]+ 500.2333, found 500.2332. 
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6-phenyl-4-(thiophen-2-yl)-6H-dibenzo[de,g]cinnoline (5i): 5i was prepared according to the 
general procedure using 3i and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:20) to afford 5i. 
Physical Property: Red solid, m.p. = 139-140 ˚C. 
Isolated Yield 52%. 
TLC: Rf = 0.56 (silica gel, diethylether/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.40 (d, 1H, J = 8.4 Hz), 8.35 (d, 1H, J = 8.1 Hz), 7.66 (dd, 1H, 
J = 7.5, 1.0 Hz), 7.64-7.53 (m, 6H), 7.48-7.38 (m, 4H), 7.34 (ddd, 1H, J = 8.2, 6.0, 2.2 Hz), 7.16 
(dd, 1H, J = 5.1, 3.5 Hz), 6.47 (s, 1H). 
13C NMR (125 MHz, CD2Cl2) δ 143.9, 140.4, 138.8, 137.2, 134.1, 132.3, 130.4, 128.7, 128.3, 
128.0, 127.5, 127.4, 127.3, 127.1, 126.9, 126.1, 125.4, 124.8, 123.8, 123.3, 122.9, 119.5, 98.8. 
IR (neat): 3057, 2922, 2850, 1614, 1586, 1492, 1458, 1443, 1394, 1338, 1293, 1238, 1146, 1128, 
947, 798, 752, 700, 694, and 674 cm-1. 
HRMS (ESI) calculated for C25H17N2S [M+H]+ 377.1107, found 377.1099. 
Quantum Yield (Φ):  
(a) 0.6% of the neutral form. 
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(b) 1.5% in the presence of 1001 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε): 
(a) 4610 ± 20 (418 nm), 14238 ± 20 (362 nm), 27222 ± 192 (244 nm) for the neutral form. 
(b) 6395 ± 318 (419 nm), 9607 ± 879 (360 nm), 31340 ± 27 (242 nm), 38234 ± 959 (228 nm) 
in the presence of 1001 equivalents of trifluoroacetic acid. 
 
6-phenyl-4-(pyridin-2-yl)-6H-dibenzo[de,g]cinnoline (5j): 5j was prepared according to the 
general procedure using 3j and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:4) to afford 5j. 
Physical Property: Orange solid, m.p. = 139-140 ˚C. 
Isolated Yield 15%. 
TLC: Rf = 0.12 (silica gel, diethylether/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.70 (d, 1H, J = 4.5 Hz), 8.40 (d, 1H, J = 8.3 Hz), 8.37 (d, 1H, J 
= 8.2 Hz), 8.04 (d, 1H, J = 7.6 Hz), 7.81 (td, 1H, J = 7.7, 1.8 Hz), 7.76 (d, 1H, J = 7.9 Hz), 7.68-
7.55 (m, 5H), 7.51-7.33 (m, 5H), 6.45 (s, 1H). 
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13C NMR (125 MHz, CD2Cl2) δ 156.0, 148.8, 144.1, 143.8, 137.6, 137.3, 134.0, 132.1, 130.5, 
128.6, 128.3, 127.9, 127.7, 127.3, 127.1, 125.01, 124.99, 123.74, 123.73, 123.6, 123.0, 122.8, 
121.0, 98.7. 
IR (neat): 3052, 2922, 1614, 1586, 1494, 1472, 1458, 1443, 1429, 1398, 1338, 1322, 1264, 1150, 
1055, 997, 819, 736, 708, 698, and 645 cm-1. 
HRMS (ESI) calculated for C26H18N3 [M+H]+ 372.1496, found 372.1498. 
Quantum Yield (Φ):  
(a) 0.6% of the neutral form  
(b) 0.0% in the presence of 1048 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε): 
(a) 1641 ± 46 (413 nm), 5306 ± 80 (361 nm), 17336 ± 601 (271 nm) for the neutral form. 
(b) 1749 ± 100 (560 nm), 3857 ± 118 (365 nm), 26933 ± 133 (228 nm) in the presence of 
1048 equivalents of trifluoroacetic acid. 
 
4-ethyl-7-methyl-6-phenyl-6H-dibenzo[de,g]cinnoline (5k): 5k was prepared according to the 
general procedure using 3k and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:30) to afford 5k. 
Physical Property: Yellow solid, m.p. = 60-61 ˚C. 
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Isolated Yield: 44%. 
TLC: Rf = 0.80 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.53-8.48 (m, 2H), 7.87 (dd, 1H, J = 8.4, 0.6 Hz), 7.64-7.56 (m, 
2H) 7.48 (ddd, 1H, J = 8.2, 7.0, 1.2 Hz), 7.40 (dd, 1H, J = 7.4, 0.8 Hz), 7.40-7.33 (m, 4H), 7.10 
(tt, 1H, 6.8, 1.7 Hz), 2.82 (q, 2H, 7.4 Hz), 2.01 (s, 3H), 1.37 (t, 3H, 7.5 Hz) 
13C NMR (125 MHz, CD2Cl2) δ 149.7, 148.2, 134.3, 132.1, 129.6, 128.8, 127.3, 127.2, 126.9, 
125.6, 123.5, 123.4, 122.9, 122.6, 121.2, 118.4, 109.2, 25.4, 16.9, 10.8. 
IR (neat): 2916, 2849, 2360, 2342, 1587, 1485, 1446, 1388, 1372, 1335, 1283, 1265, 1231, 1212, 
1138, 1032, 1012, 752, 737, 691, 668 cm-1. 
HRMS (ESI) calculated for C24H20N2 [M]+ 336.1621, found 336.1630. 
 
4-nonyl-7-octyl-6-phenyl-6H-dibenzo[de,g]cinnoline (5l): 5l was prepared according to the 
general procedure using 3l and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:30) to afford 5l. 
Physical Property: Yellow oil. 
Isolated Yield: 24%. 
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TLC: Rf = 0.80 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.51 (d, 1H, J = 8.6 Hz), 8.48 (d, 1H, J = 8.2 Hz), 7.89 (d, 1H, J 
= 8.4 Hz), 7.63-7.58 (m, 1H), 7.55 (ddd, 1H, J = 8.5, 6.9, 1.3 Hz), 7.46 (ddd, 1H, J = 8.1, 6.9, 1.1 
Hz), 7.43-7.38 (m, 3H), 7.36-7.30 (m, 2H), 7.10 (tt, 1H, J = 7.3, 1.1 Hz), 2.76 (t, 2H, J = 7.7 
Hz), 2.59 (t, 2H, J = 7.6 Hz), 1.83-1.75 (m, 2H), 1.52-1.44 (m, 2H), 1.42-1.22 (m, 14H), 1.22-
1.04 (m, 8H), 0.94-0.82 (m, 6H). 
13C NMR (125 MHz, CD2Cl2) δ 149.1, 148.9, 133.5, 132.1, 129.6, 129.0, 127.4, 127.0, 126.8, 
126.2, 124.1, 123.89, 123.86, 123.4, 122.9, 122.8, 121.3, 118.5, 115.5, 32.2, 31.8, 31.8, 29.5, 29.5, 
29.4, 29.32, 29.28, 29.19, 29.1, 28.2, 26.7, 22.67, 22.60, 13.84, 13.82. 
IR (neat): 2954, 2924, 2853, 2361, 2340, 1586, 1490, 1438, 1386, 1332, 1281, 1264, 1228, 1211, 
1136, 818, 755, 694, 612 cm-1. 
HRMS (ESI) calculated for C38H48N2 [M]+ 532.3812, found 532.3821. 
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7-methyl-4,6-diphenyl-6H-dibenzo[de,g]cinnoline (5m): 5m was prepared according to the 
general procedure using 3m and 4a. The product was purified by flash column chromatography 
(ethyl acetate/hexane 1:20) to afford 5m. 
Physical Property: Yellow oil. 
Isolated Yield: 11%. 
TLC: Rf = 0.61 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.53-8.48 (m, 2H), 7.88 (dd, 1H, J = 8.3, 0.9 Hz), 7.68-7.63 (m, 
2H), 7.59 (ddd, 1H, J = 8.3, 6.9, 1.3 Hz), 7.55-7.45 (m, 5H), 7.43-7.33 (m, 4H), 7.30 (dd, 1H, J 
= 7.5, 0.9 Hz), 7.13 (tt, 1H, 7.1, 1.5 Hz), 2.02 (s, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 149.1, 148.1, 135.9, 134.5, 132.1, 129.8, 128.9, 128.82, 128.80, 
128.5, 128.1, 127.5, 126.7, 125.7, 123.88, 123.86, 123.81, 123.6, 123.1, 122.7, 121.3, 120.6, 
109.4, 16.8 
IR (neat): 2916, 2849, 2348, 1594, 1489, 1460, 1445, 1372, 1138, 1031, 755, 696, 655, 644 cm-1. 
HRMS (ESI) calculated for C28H20N2 [M]+ 384.1621, found 384.1612. 
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6-(3,4-dimethylphenyl)-1,2,4,9,10-pentamethyl-6H-dibenzo[de,g]cinnoline (5n): 5n was 
prepared according to the general procedure using 1a and 4b. The product was purified by flash 
column chromatography (ethyl acetate/hexane 1:20) to afford 5n. 
Physical Property: Yellow oil. 
Isolated Yield: 24%. 
TLC: Rf = 0.54 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.20 (s, 1H), 7.33-7.25 (m, 2H), 7.25-7.20 (m, 1H), 7.16 (s, 
1H), 7.12 (s, 1H), 6.21 (s, 1H), 2.85 (s, 3H), 2.54 (s, 3H), 2.41 (s, 3H), 2.36 (s, 3H), 2.34 (s, 
3H), 2.33 (s, 3H), 2.27 (s, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 142.0, 141.3, 138.5, 137.9, 137.0, 136.0, 135.8, 134.2, 133.7, 
131.3, 130.7, 129.7, 128.2, 127.9, 126.3, 125.0, 124.0, 123.3, 123.0, 119.5, 96.7, 21.7, 21.6, 20.1, 
19.6, 19.5, 19.22, 18.7. 
IR (neat): 2916, 2857, 1606, 1502, 1449, 1372, 1300, 1235, 1194, 1170, 1086, 1014, 871, 803, 
736 cm-1. 
HRMS (ESI) calculated for C28H28N2 [M]+ 392.2247, found 392.2252. 
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6-(3,4-dimethylphenyl)-1,2,9,10-tetramethyl-4-phenyl-6H-dibenzo[de,g]cinnoline (5o): 5o 
was prepared according to the general procedure using 3d and 4b. The product was purified by 
flash column chromatography (ethyl acetate/hexane 1:20) to afford 5o. 
Physical Property: Yellow oil. 
Isolated Yield: 31%. 
TLC: Rf = 0.59 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.18 (s, 1H), 7.63-7.60 (m, 2H), 7.50-7.40 (m, 3H), 7.35-7.25 
(m, 3H), 7.17 (s, 1H), 7.09 (s, 1H), 6.25 (s, 1H), 2.83 (s, 3H), 2.423 (s, 3H), 2.416 (s, 3H), 
2.36 (s, 3H), 2.34 (s, 3H), 2.35-2.32 (m, 6H). 
13C NMR (125 MHz, CD2Cl2) δ 145.3, 141.8, 138.6, 137.9, 136.9, 136.4, 136.2, 136.0, 134.1, 
133.9, 131.7, 130.7, 130.7, 130.1, 128.6, 128.5, 128.4, 128.2, 127.6, 126.4, 126.2, 123.8, 123.6, 
122.4, 121.1, 29.7, 21.5, 20.1, 19.6, 19.4, 19.2. 
IR (neat): 2921, 1603, 1500, 1418, 1300, 1264, 1227, 1141, 1068, 1005, 878, 831, 738, 687 cm-1. 
HRMS (ESI) calculated for C33H30N2 [M]+ 454.2404, found 454.2403. 
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6-(3,4-dimethylphenyl)-4-ethyl-1,2,7,9,10-pentamethyl-6H-dibenzo[de,g]cinnoline (5p): 5p 
was prepared according to the general procedure using 3k and 4b. The product was purified by 
flash column chromatography (ethyl acetate/hexane 1:20) to afford 5p. 
Physical Property: Yellow oil. 
Isolated Yield: 30%. 
TLC: Rf = 0.69 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.22 (s, 1H), 7.55 (s, 1H), 7.27 (s, 1H), 7.11 (d, 1H, J = 2.3 
Hz), 7.04 (d, 1H, J = 8.2 Hz), 6.92 (dd, 1H, J = 8.2, 2.3 Hz), 2.85 (s, 3H), 2.79 (q, 2H, J = 7.4 
Hz), 2.55 (s, 3H), 2.48 (s, 3H), 2.46 (s, 3H), 2.242 (s, 3H), 2.237 (s, 3H), 1.91 (s, 3H), 1.33 
(3H, t, 7.4 Hz). 
13C NMR (125 MHz, CD2Cl2) δ 148.6, 146.6, 137.2, 136.7, 135.8, 134.9, 133.9, 131.8, 131.6, 
130.4, 129.7, 129.5, 128.9, 126.8, 124.7, 123.0, 122.7, 120.7, 120.5, 118.7, 108.2, 25.5, 21.7, 21.6, 
20.1, 20.0, 19.9, 19.0, 16.8, 11.3. 
IR (neat): 2968, 2917, 1607, 1594, 1499, 1488, 1453, 1357, 1264, 1195, 1166, 1002, 865, 820, 
737 cm-1. 
HRMS (ESI) calculated for C30H32N2 [M]+ 420.2560, found 420.2550. 
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8-(naphthalen-2-yl)-6-phenyl-8H-dinaphtho[3,2,1-de:2',3'-g]cinnoline (5q): A vial was 
charged with 14.8 mg (0.086 mmol) of 3d and 300 mg (0.86 mmol) of 3-(trimethylsilyl)-2-
naphthyl trifluoromethanesulfonate in 0.09 mL of dichloromethane at 24˚C, and 1 M TBAF in 
THF (0.95 mL, 0.95 mmol) was slowly added to the solution over the course of 1 min. After the 
addition, the solution was concentrated in vacuo, and fiterated on the silica gel, and purified by 
preparative TLC using ethyl acetate/hexane (1:10) as the eluent to give 0.61 mg of 5q. 
Physical Property: Red solid. 
Isolated Yield: 1 %. 
TLC: Rf = 0.50 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 9.43 (s, 1H), 9.18 (d, 1H, J = 8.6 Hz), 8.21 (s, 1H), 8.15-7.94 
(m, 6H), 7.90 (d, 1H, J = 8.0 Hz), 7.88-7.44 (m, 13H), 7.01 (s, 1H). 
13C NMR (125 MHz, CD2Cl2) δ 146.3, 141.9, 136.78, 136.73, 134.7, 134.6, 133.5, 133.1, 132.9, 
131.3, 130.9, 130.2, 129.7, 129.4, 129.3, 129.2, 129.1, 128.7, 128.5, 128.31, 128.26, 128.0, 127.8, 
127.4, 127.3, 127.1, 126.9, 126.8, 125.8, 125.5, 125.4, 124.8, 124.2, 124.0, 122.8, 122.0, 101.2. 
HRMS (ESI) calculated for C38H48N2 [M]+ 520.1934, found 520.1930. 
Quantum Yield (Φ):  
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(a) 6.7% of the neutral form. 
(b) 2.0% in the presence of 1001 equivalents of trifluoroacetic acid. 
Extinction Coefficient (ε): 
(a) 2061 ± 339 (532 nm), 1850 ± 355 (501 nm), 9469 ± 57 (362 nm), 8663 ± 100 (340 nm), 
23217 ± 698 (266 nm), 23141 ± 720 (257 nm) for the neutral form. 
(b) 2290 ± 519 (524 nm), 15500 ± 793 (279 nm) in the presence of 1001 equivalents of 
trifluoroacetic acid. 
 
1,4-dimethylphthalazine (6): A vial was charged with 400 mg (4 mmol) of 1a and 0.48 mL (2 
mmol) of 2 in 2.0 mL of dichloromethane at 24 ˚C, and 1 M TBAF in THF (2.2 mmol, 1.1 mL) 
was slowly added to the solution over the course of 1 min. After the addition, the solution was 
concentrated in vacuo, and filtered on the silica gel, and purified by flash column 
chromatography (ethyl acetate = 100%) to afford 23 mg of 4. The data for this compound was 
previously reported in the literature.37 
Physical Property: White solid. 
Isolated Yield: 7 %. 
TLC: Rf = 0.10 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, CDCl3) 
δ 8.03 (dd, 2H, J = 6.3, 3.3 Hz), 7.86 (dd, 2H, J = 6.3, 3.3 Hz), 2.93 (s, 6H). 
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13C NMR (125 MHz, CDCl3) 
δ 156.26, 131.80, 125.85, 124.79, 19.76. 
 
 
9,10-diphenylanthracene (7) and 1,4-diphenylphthalazine (2): A vial was charged with 23.4 mg 
(0.1 mmol) of 1 and 298.4 mg (1 mmol) of 4a in 0.1 mL of THF at 24 ˚C, and 1 M TBAF in 
THF (1.1 mmol, 1.1 mL) was added to the solution. After the addition, the solution was heated 
to 50 oC for 2 hours and athen was concentrated in vacuo, and filtered on the silica gel, and 
purified by flash column chromatography (ethyl acetate/hexane 1:4) to afford 10 mg of 7 and 8 
mg of 2. The data for these compounds were previously reported in the literature.38,39 
9,10-diphenylanthracene (7) 
Physical Property: White solid. 
Isolated Yield: 30 %. 
TLC: Rf = 0.79 (silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 7.72-7.68 (m, 4H), 7.63-7.53 (m, 6H), 7.51-7.47 (m, 4H), 7.35-7.31 (m, 4H). 
1,4-diphenylphthalazine (2) 
Physical Property: White solid. 
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Isolated Yield: 28 %. 
TLC: Rf = 0.11 (silica gel, silica gel, ethyl acetate/hexane 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 8.17-8.12 (m, 4H), 7.87-7.79 (m, 6H), 7.62-7.54 (m, 6H). 
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Figure A1.1. 1H NMR spectrum of 2 in CDCl3 (500 MHz). 
 
 
164 
 
Figure A1.2. 1H NMR spectrum of 3a in CDCl3 (500 MHz). 
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Figure A1.3. 13C NMR spectrum of 3a in CDCl3 (125 MHz). 
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Figure A1.4. 1H NMR spectrum of 3b in CDCl3 (500 MHz).  
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 Figure A1.5. 13C NMR spectrum of 3b in CDCl3 (125 MHz). 
 
 
168 
 
Figure A1.6. 1H NMR spectrum of 3c in CDCl3 (500 MHz).  
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Figure A1.7. 13C NMR spectrum of 3c in CDCl3 (125 MHz). 
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Figure A1.8. 1H NMR spectrum of 3d in CDCl3 (500 MHz).  
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Figure A1.9. 13C NMR spectrum of 3d in CDCl3 (125 MHz). 
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Figure A1.10. 1H NMR spectrum of 3e in CDCl3 (500 MHz).  
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Figure A1.11. 13C NMR spectrum of 3e in CDCl3 (125 MHz). 
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Figure A1.12. 1H NMR spectrum of 3f in CDCl3 (500 MHz).  
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Figure A1.13. 13C NMR spectrum of 3f in CDCl3 (125 MHz).  
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Figure A1.14. 19F NMR spectrum of 3f in CDCl3 (338 MHz). 
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Figure A1.15. 1H NMR spectrum of 3g in CDCl3 (500 MHz).  
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Figure A1.16. 13C NMR spectrum of 3g in CDCl3 (125 MHz). 
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Figure A1.17. 1H NMR spectrum of 3h in CDCl3 (500 MHz).  
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Figure A1.18. 1H NMR spectrum of 3i in CDCl3 (500 MHz).  
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Figure A1.19. 13C NMR spectrum of 3i in CDCl3 (125 MHz).  
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Figure A1.20. 1H NMR spectrum of 3j in CDCl3 (500 MHz).  
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Figure A1.21. 13C NMR spectrum of 3j in CDCl3 (125 MHz). 
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Figure A1.22. 1H NMR spectrum of 3k in CDCl3 (500 MHz).  
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Figure A1.23. 13C NMR spectrum of 3k in CDCl3 (125 MHz). 
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Figure A1.24. 1H NMR spectrum of 3l in CDCl3 (500 MHz).  
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Figure A1.25. 13C NMR spectrum of 3l in CDCl3 (125 MHz). 
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Figure A1.26. 1H NMR spectrum of 3m in CDCl3 (500 MHz).  
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Figure A1.27. 13C NMR spectrum of 3m in CDCl3 (125 MHz). 
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Figure A1.28. 1H NMR spectrum of 3n in CDCl3 (500 MHz).  
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Figure A1.29. 13C NMR spectrum of 3n in CDCl3 (125 MHz). 
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Figure A1.30. 1H NMR spectrum of 4b in CDCl3 (500 MHz).  
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Figure A1.31. 1H NMR spectrum of 5a in CD2Cl2 (500 MHz).  
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Figure A1.32. 13C NMR spectrum of 5a in CD2Cl2 (125 MHz). 
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Figure A1.33. 1H NMR spectrum of 5b in CD2Cl2 (500 MHz).  
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Figure A1.34. 13C NMR spectrum of 5b in CD2Cl2 (125 MHz). 
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Figure A1.35. 1H NMR spectrum of 5c in CD2Cl2 (500 MHz).  
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Figure A1.36. 13C NMR spectrum of 5c in CD2Cl2 (125 MHz). 
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Figure A1.37. 1H NMR spectrum of 5d in CD2Cl2 (500 MHz).  
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Figure A1.38. 13C NMR spectrum of 5d in CD2Cl2 (125 MHz). 
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Figure A1.39. 1H NMR spectrum of 5e in CD2Cl2 (500 MHz).  
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Figure A1.40. 13C NMR spectrum of 5e in CD2Cl2 (125 MHz). 
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Figure A1.41. 1H NMR spectrum of 5f in CD2Cl2 (500 MHz). 
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Figure A1.42. 13C NMR spectrum of 5f in CD2Cl2 (125 MHz). 
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Figure A1.43. 19F NMR spectrum of 5f in CD2Cl2 (338 MHz). 
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Figure A1.44. 1H NMR spectrum of 5g in CD2Cl2 (500 MHz).  
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Figure A1.45. 13C NMR spectrum of 5g in CD2Cl2 (125 MHz). 
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Figure A1.46. 1H NMR spectrum of 5h in CD2Cl2 (500 MHz).  
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Figure A1.47. 13C NMR spectrum of 5h in CD2Cl2 (125 MHz). 
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Figure A1.48. 1H NMR spectrum of 5i in CD2Cl2 (500 MHz).  
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Figure A1.49. 13C NMR spectrum of 5i in CD2Cl2 (125 MHz). 
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Figure A1.50. 1H NMR spectrum of 5j in CD2Cl2 (500 MHz).  
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Figure A1.51. 13C NMR spectrum of 5j in CD2Cl2 (125 MHz). 
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Figure A1.52. 1H NMR spectrum of 5k in CD2Cl2 (500 MHz).  
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Figure A1.53. 13C NMR spectrum of 5k in CD2Cl2 (125 MHz). 
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Figure A1.54. 1H NMR spectrum of 5l in CD2Cl2 (500 MHz).  
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Figure A1.55. 13C NMR spectrum of 5l in CD2Cl2 (125 MHz). 
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Figure A1.56. 1H NMR spectrum of 5m in CD2Cl2 (500 MHz).  
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Figure A1.57. 13C NMR spectrum of 5m in CD2Cl2 (125 MHz). 
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Figure A1.58. 1H NMR spectrum of 5n in CD2Cl2 (500 MHz).  
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Figure A1.59. 13C NMR spectrum of 5n in CD2Cl2 (125 MHz). 
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Figure A1.60. 1H NMR spectrum of 5o in CD2Cl2 (500 MHz).  
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Figure A1.61. 13C NMR spectrum of 5o in CD2Cl2 (125 MHz). 
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Figure A1.62. 1H NMR spectrum of 5p in CD2Cl2 (500 MHz).  
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Figure A1.63. 13C NMR spectrum of 5p in CD2Cl2 (125 MHz). 
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Figure A1.64. 1H NMR spectrum of 5q in CD2Cl2 (500 MHz).  
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Figure A1.65. 13C NMR spectrum of 5q in CD2Cl2 (125 MHz). 
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Figure A1.66. HSQC spectrum of 5q in CD2Cl2. 
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Figure A1.67. Expanded partial HSQC spectrum of 5q in CD2Cl2. 
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Figure A1.68. HMBC spectrum of 5q in CD2Cl2. 
 
 
 
231 
 
Figure A1.69. Expanded partial HMBC spectrum of 5q in CD2Cl2. 
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Figure A1.70. TOCSY spectrum of 5q in CD2Cl2. 
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Figure A1.71. 1st Expanded partial TOCSY spectrum of 3m in CD2Cl2. 
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Figure A1.72. 2nd Expanded partial TOCSY spectrum of 3m in CD2Cl2. 
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Figure A1.73. COSY spectrum of 3m in CD2Cl2. 
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Figure A1.74. 1H NMR spectrum of 6 in CDCl3 (500 MHz).  
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Figure A1.75. 13C NMR spectrum of 6 in CDCl3 (125 MHz). 
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Figure A1.76. 1H NMR spectrum of 7 in CDCl3 (500 MHz). 
 
 
239 
 
Figure A1.77. Absorption, emission, and exitation spectra of 5a at 24 ˚C in CH2Cl2. 
 
 
Figure A1.78. Absorption, emission, and excitation spectra of 5a at 24 ˚C in CH2Cl2/TFA. 
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Figure A1.79. Absorption, emission, and excitation spectra of 5b at 24 ˚C in CH2Cl2. 
 
 
Figure A1.80. Absorption, emission, and excitation spectra of 5b at 24 ˚C in CH2Cl2/TFA.  
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Figure A1.81. Absorption, emission, and excitation spectra of 5d at 24 ˚C in CH2Cl2. 
 
 
Figure A1.82. Absorption, emission, and excitation spectra of 5d at 24 ˚C in CH2Cl2/TFA.  
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Figure A1.83. Absorption, emission, and excitation spectra of 5e at 24 ˚C in CH2Cl2.  
 
 
Figure A1.84. Absorption, emission, and excitation spectra of 5e at 24 ˚C in CH2Cl2/TFA.  
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Figure A1.85. Absorption, emission, and excitation spectra of 5i at 24 ˚C in CH2Cl2. 
 
 
Figure A1.86. Absorption, emission, and excitation spectra of 5i at 24 ˚C in CH2Cl2/TFA.  
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Figure A1.87. Absorption, emission, and excitation spectra of 5j at 24 ˚C in CH2Cl2. 
 
 
Figure A1.88. Absorption spectrum of 5j at 24 ˚C in CH2Cl2/TFA. 
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Figure A1.89. Absorption, emission, and excitation spectra of 5q at 24 ˚C in CH2Cl2. 
 
 
Figure A1.90. Absorption, emission, and excitation spectrum of 5q at 24 ˚C in CH2Cl2/TFA. 
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Table A1.1. Crystal Data and Structure Refinement for 5a. 
Empirical formula  C22H16N2 
Formula weight  308.37 
Temperature  100(1) K 
Wavelength  0.71073 Å  
Crystal system  monoclinic 
Space group  P21/c      
Cell constants:   
a  11.9993(9) Å  
b  4.2453(3) Å  
c  29.803(2) Å  
b 100.261(4)° 
Volume 1493.90(18) Å 3 
Z 4 
Density (calculated) 1.371 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 648 
Crystal size 0.48 x 0.12 x 0.04 mm3 
Theta range for data collection 1.39 to 25.38° 
Index ranges -14 ≤ h ≤ 14, -5 ≤ k ≤ 5, -35 ≤ l ≤ 35 
Reflections collected 32407 
Independent reflections 2740 [R(int) = 0.0637] 
Completeness to theta = 25.38° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.4717 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2740 / 0 / 219 
Goodness-of-fit on F2 1.104 
Final R indices [I>2sigma(I)] R1 = 0.0541, wR2 = 0.1464 
R indices (all data) R1 = 0.0664, wR2 = 0.1579 
Largest diff. peak and hole 0.308 and -0.270 e.Å -3 
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Chapter 3 
Aryne Compatible Solvents are not Always Innocent 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted with permission from Suh, S.-E.; Chenoweth, D. M. Org. Lett. 2016, 18, 4080-4083. 
Copyright 2016 American Chemical Society. 
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3.1 Introduction 
 
Figure 3.1. General Scheme of the TAT reaction and proposed mechanistic steps. Red bold lines 
represent newly formed bonds. Red bold fonts denote aryne-engaged steps. 
 
Arynes have been utilized in a wide variety of transformations for the formation of 
multiple carbon-carbon, carbon-nitrogen, carbon-oxygen, and/or carbon-hydrogen bonds.1–7 In 
comparison to an unstrained alkyne, arynes primarily exhibit high electrophilic reactivity due to 
LUMO lowering.8 Several aryne-based reactions have been developed including sigma-bond 
insertions,9–12 nucleophilic additions,13-15 ene reactions,1,16–18 desaturations,19 cycloadditions, such 
as [4+2],20–23 [3+2],24–26 [2+2],27,28 and [2+2+2]29–31 modes. Our laboratory is interested in new 
chemical tools and rapid access to new fluorescent probes.32 Recently, we reported a new 
multistep aryne addition reaction referred to as the triple aryne-tetrazine (TAT) reaction.32 The 
TAT reaction enables rapid access to a new class of polyaromatic heterocycles by coupling 
diverse reactivity modes between simple aryne and tetrazine33 starting materials into a single 
multistep process (Figure 3.1). The TAT reaction provides a rapid route to several substituted 
dibenzo[de,g]cinnolines with unique fluorescent properties. 
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Aryne-based reactions are commonly performed in acetonitrile, dichloromethane or 
combinations of both.34-38 A few notable studies by Hoye19,39 and Coe40 have described solvent 
effects on aryne-based reactions. However, reports describing the reactivity of common solvents 
used in aryne chemistry are limited to tetrahydrofuran,41,42 acetonitrile,43 and other alkylnitriles.44 
During recent investigtions into the TAT reaction we found that dichloromethane, as well as 
acetonitrile, are not innocent solvents and can result in byproduct formation when deprotonated 
by the resulting intermediate aryl anion formed after an initial aryne addition reaction. We 
discovered that these common aryne compatible solvents can contribute to low yields by 
reacting with key intermediates along the TAT reaction pathway to produce solvent adducts. 
Herein, we describe the formation of these solvent adducts in the context of the TAT reaction, 
providing insight into the reactivity of commonly used organic solvents in aryne-based reactions. 
 
3.2 Results and Discussion 
Scheme 3.1. Isolation of Phthalazine Intermediate 4. 
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During analysis of the TAT reaction, a phthalazine is the first isolable intermediate in 
the TAT reaction, following an initial Diels-Alder/retro-Diels-Alder reaction of benzyne with a 
tetrazine. Benzyne precursor 245 was used as the limiting reagent in a reaction with tetrazine 1 to 
prepare phthalazine intermediate 4 in 37% yield. Intermediate 4 was isolated and characterized 
(Scheme 3.1) prior to use as the starting material under the TAT reaction conditions (Scheme 
3.2, eq 1). Exposure of 4 to the TAT reaction conditions afforded desired product 3 in low yield 
(7%) (Scheme 3.2, eq 1), which is lower than the yield of 3 using the standard TAT reaction 
conditions (44%) (Scheme 3.1).32 Interestingly, solvent adduct rac-5a was isolated from the 
complex reaction mixture (Scheme 3.2, eq 1). A trace amount of rac-5a was also observed in the 
standard TAT reaction. The crystal structure of 5a (Figure 3.2) revealed that the 
dihydropyridazine ring is puckered with a dihedral angle (C1-N1-N2-C2 angle) of 28.2°. The 
N1-N2-C3-C4 dihedral angle between the dihydropyridazine plane and the N-phenyl plane was 
54.9° due to the sterics imposed by the adjacent fully substituted carbon center. 
A plausible mechanism leading to the formation of rac-5a involves nucleophilic addition 
of phthalazine 4 to benzyne, producing non-isolable zwitterionic intermediate I. The resulting 
zwitterion then deprotonates dichloromethane and the conjugate base attacks the hydrazonium 
species to afford solvent adduct rac-5a. To probe the reaction pathway from 4 to rac-5a, labeling 
experiments were performed using deuterated solvent. The reaction was conducted by addition 
of TBAF to 4b and benzyne precursor 2, using CD2Cl2 as the reaction solvent (Scheme 3.2, eq 
2). The 1H NMR analysis revealed a single deuterium (X1 = D) on the N-phenyl group and a 
missing proton (X2 = D) on the dichloromethyl substituent of rac-[D2]-5a. The result supports  
 
251 
 
Scheme 3.2. Crossover Experiment for the Dichloromethane-Adduct Formation Reactions in 
CH2Cl2, CD2Cl2, 1:1 Mixture of CH2Cl2 and CD2Cl2, and CCl4. 
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Figure 3.2. X-ray crystal structure of dichloromethane solvent adduct 5a. 
 
the idea that the formation of the solvent adduct is indeed initiated by deprotonation by the aryl 
zwitterion I. 
By varying the concentration of deuterated to non-deuterated solvent, a significant 
kinetic isotope effect (KIE) was observed in dichloromethane. The yield of rac-5a reached 13% 
in CH2Cl2 (Scheme 3.2, eq 1) and the reaction in CD2Cl2 afforded the corresponding product 
rac-[D2]-5a in only 3% yield (Scheme 3.2, eq 2). Although the ratio of rac-5a:rac-[D2]-5a was 
4:1, rac-[D2]-5a was not observed when the reaction was conducted in a 1:1 mixture of CH2Cl2 
and CD2Cl2 (Scheme 3.2, eq 3). As the amount of CD2Cl2 was increased, the yield of 3 increased 
and the yield of the solvent adduct (rac-5a or rac-[D2]-5a) decreased (Scheme 3.2, eq 4). 
Solvents such as CH2Cl2 appear to be acidic enough to be deprotonated under the reaction 
conditions and this leads to solvent adduct 5a, as evidenced by the high KIE in CD2Cl2. Based on 
these results, we conducted the reaction in CCl4 (Scheme 3.2, eq 5) and the yield of 3 was 16%. 
This was a higher yield of TAT reaction product than that obtained from the reaction in CH2Cl2, 
CD2Cl2, or a mixture of CH2Cl2/CD2Cl2 (Scheme 3.2, eq 4). 
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Scheme 3.3. Acetonitrile-Adduct Formation Reaction and Competitive Solvent Adduct 
Formation Using Different Ratios of CH2Cl2 and CH3CN. 
 
To determine if a solvent-trapped intermediate could be generated from other common 
organic solvents used in aryne chemistry, experiments were conducted in acetonitrile (Scheme 
3.3, eq 6). This reaction afforded the acetonitrile adduct rac-5b in 8% yield. The zwitterion 
intermediate I also appears to be sufficiently basic enough to deprotonate acetonitrile. Note that 
the pKa of benzene is 43 in H2O48, and the pKa of acetonitrile has been reported to be 31.3 in 
DMSO.49 Similar to the dichloromethane solvent adduct 5a, the X-ray crystal structure of 5b 
254 
 
exhibited a puckered conformation with a dihedral angle (C1-N1-N2-C2 angle) of 36.7° on 
dihydropyridazine ring (Figure 3.3). Consistent with the structure of 5a, the biaryl ring torsional 
angle (N1-N2-C3-C4) between the dihydropyridazine plane and the N-phenyl plane was found 
to be twisted 50.0° away from coplanarity. 
 
Figure 3.3. X-ray crystal structure of acetonitrile solvent adduct 5b. 
 
To gain insight into the relative reactivity of the two different solvents with benzyne, 
crossover experiments were conducted on a 10 µmol scale with several different ratios of CH2Cl2 
and CH3CN (Scheme 3.3, eq 7). Dichlromethane resulted in significant formation of the solvent 
adduct versus acetonitrile. When 1:1 CH2Cl2/CH3CN was used as the solvent for the reaction, 
the yield of rac-5a was more than twice that of rac-5b. 
 
Scheme 3.4. Solvent Adduct rac-7 from Intermediate 6. 
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To probe steric effects on solvent adduct formation, phthalazine 6 was subjected to the 
TAT reaction conditions in dichloromethane and acetonitrile at 24 oC. None of the possible 
solvent adducts were observed and only starting material was recovered. Interestingly, when the 
reaction was conducted in acetonitrile at 80 oC for 24 hours the acetonitrile-adduct rac-7 was 
produced in 1% yield (Scheme 3.4). This result indicates that the reaction is possible but 
strongly biased by the steric demands of the phthalazine substrate. The solvent adduct 
formation appears to be greatly influenced by the solvent pKa and the substrate sterics. 
 
3.3 Conclusions 
Herein, we reported participation of dichloromethane and acetonitrile in aryne 
reactions with phthalazines. Isolation of dichloromethane and acetonitrile solvent adducts (rac-
5a and rac-5b) demonstrates that common solvents thought to be compatible with aryne 
chemistry are not always innocent bystanders. Deuterium labeling experiments not only 
confirmed non-interrupted bimolecular reaction pathways between the zwitterionic 
intermediate I and dichloromethane but also explained solvent-engaged side reaction leading to 
lower yields of desired product 3 in the course of TAT reaction. The crossover experiment of 
dichloromethane and acetonitrile highlighted that dichloromethane is more reactive than 
acetonitrile in the TAT reaction condition. As expected, the experiment with sterically bulky 
phthalazine 6 demonstrated that solvent adduct formation is affected by steric hinderance of the 
electrophile as well as pKa. The discovery of solvent participation in TAT reaction side product 
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formation provides insight into the reactivity of benzyne with two commonly used solvents. 
Similar side reactions may contribute to low yields in other aryne-based reactions. Additionally, 
these results could inspire new reactions for the construction of fully substituted carbon centers 
based on aryne addition/solvent capture reactions, as demonstrated in this report. 
 
3.4 Experimental Section 
General information 
All commercial reagents and solvents were used as received. Flash column 
chromatography was performed using Silicycle silica gel (55−65 Å pore diameter). Thin-layer 
chromatography was performed on Sorbent Technologies silica plates (250 μm thickness). 
Proton nuclear magnetic resonance spectroscopy (1H NMR) and Carbon nuclear magnetic 
resonance spectroscopy (13C NMR) spectra were recorded on a Bruker DMX 500 1H NMR. 
High-resolution mass spectra were obtained by Dr. Rakesh Kohli at the University of 
Pennsylvania’s Mass Spectrometry Service Center on a on a Waters LC-TOF mass spectrometer 
(model LCT-XE Premier) using electrospray ionization. X-ray diffraction data obtained and 
solved by Dr. Patrick Carroll at the University of Pennsylvania. High performance liquid 
chromatography analysis was performed using a Jasco HPLC instrument equipped with a 
Phenomenex column (Luna 5u C18(2) 100A; 250 × 4.60 mm, 5 μm). 
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Experimental procedures  
 
3,6-diethyl-1,2,4,5-tetrazine (1): Synthetic method and characterization data of 1 have been 
reported in our previous publication.32a 
 
2-(trimethylsilyl)phenyl trifluoromethanesulfonate (2): 2 was prepared according to the 
literature procedure.48 
1H NMR (500 MHz, CDCl3) δ 7.56-7.52 (m, 1H), 7.47-7.41 (m, 1H), 7.37-7.32 (m, 2H), 0.37 
(s, 9H). 
 
4-ethyl-7-methyl-6-phenyl-6H-dibenzo[de,g]cinnoline (3): Synthetic method and 
characterization data of 3 have been reported in our previous publication.32a 
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1,4-diethylphthalazine (4): A vial was charged with 8.0 mmol of 1 (1.10 g) and 4.0 mmol of 2 
(0.97 mL) in 4.0 mL of dichloromethane at 24 ˚C, and 1 M TBAF in THF (4.4 mmol, 4.4 mL) 
was slowly added to the solution over the course of 20 minutes. After the addition, the solution 
was concentrated in vacuo, and filtered on the silica gel, and purified by flash column 
chromatography (hexanes/ethyl acetate 1:3) to afford 4 (0.27 g). The data for this compound 
was previously reported in the literature.49,50 
Isolated Yield: 37 %. 
Physical Property: White solid. 
TLC: Rf = 0.17 (silica gel, 25% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) 
δ 8.05 (dd, 2H, J = 6.3, 3.3 Hz), 7.80 (dd, 2H, J = 6.3, 3.3 Hz), 3.30 (q, 4H, 7.5 Hz), 1.44 (t, 6H, 
7.5 Hz). 
13C NMR (125 MHz, CDCl3) 
δ 159.9, 131.5, 125.3, 124.5, 26.3, 13.1. 
HRMS (ESI) calculated for C12H14N2Na+ [M+Na]+ 209.1049, found 209.1064. 
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(R)- and (S)-1-(dichloromethyl)-1,4-diethyl-2-phenyl-1,2-dihydrophthalazine (rac-5a): A 4 
mL vial was charged with 48 μmol of 1,4-diethylphthalazine 4 (9.0 mg), 480 μmol of 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (140 mg) in 50 μL of dichloromethane at 24 
oC, 1 M TBAF in THF (530 μmol, 53 μL) was slowly added to the solution over the course of 5 
minutes. After the addition, the solution was concentrated in vacuo, and filtered on the silica gel, 
and purified by flash column chromatography (ethyl acetate/hexanes 1:10) to afford rac-5a (2.2 
mg). 
Isolated Yield: 13 % 
Physical Property: White solid, m.p. = 111-112 ˚C. 
TLC: Rf = 0.70 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CD2Cl2) 
δ 7.59-7.54 (m, 1H), 7.54-7.50 (m, 2H), 7.49-7.46 (m, 3H), 7.43-7.37 (m, 2H), 7.29 (tt, 1H, J = 
7.4, 0.9 Hz), 5.77 (s, 1H), 2.79-2.55 (m, 3H), 2.04-1.95 (m, 1H), 1.22 (t, 3H, J = 7.5 Hz), 1.07 
(t, 3H, J = 7.2 Hz). 
13C NMR (125 MHz, CD2Cl2) 
δ 145.5, 142.4, 129.2, 128.6, 128.5, 127.9, 127.84, 127.80, 127.0, 126.3, 123.6, 122.7, 77.3, 69.8, 
28.2, 25.4, 11.6, 9.9. 
IR (neat): 2973, 2929, 2869, 1596, 1492, 1446, 1093, 1034, 753, 699 cm-1. 
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HRMS (ESI) calculated for C19H21N2Cl2+ [M+H]+ 347.1076, found 347.1083. 
 
(R)- and (S)-1-(dichloromethyl-d)-1,4-diethyl-2-(phenyl-2-d)-1,2-dihydrophthalazine (rac-
[D2]-5a): A vial was charged with 19 mg (0.10 mmol) of 4 and 300 mg (1.0 mmol) of 2 in 100 
μL of dichloromethane at 24 ˚C, and 1 M TBAF in THF (1.1 mmol, 1.1 mL) was slowly added 
to the solution over the course of 5 minutes. After the addition, the solution was concentrated in 
vacuo, and filtered on the silica gel, and purified by flash column chromatography (ethyl 
acetate/hexanes 1:10) to afford rac-[D2]-5a (1.2 mg). 
Isolated Yield: 3 %. 
Physical Property: White solid, m.p. = 112-113 ˚C. 
TLC: Rf = 0.70 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CD2Cl2) 
δ 7.59-7.54 (m, 1H), 7.54-7.50 (m, 1H), 7.49-7.46 (m, 3H), 7.43-7.37 (m, 2H), 7.29 (tt, 1H, J = 
7.4, 0.9 Hz), 2.79-2.55 (m, 3H), 2.04-1.95 (m, 1H), 1.22 (t, 3H, J = 7.5 Hz), 1.07 (t, 3H, J = 7.2 
Hz). 
HRMS (ESI) calculated for C19H18D2N2Cl2+ [M+H]+ 349.1202, found 349.1204. 
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(R)- and (S)-2-(1,4-diethyl-2-phenyl-1,2-dihydrophthalazin-1-yl)acetonitrile (rac-5b), 
Procedure I (Scheme 3.2, eq 6): A 4 mL vial was charged with 48 μmol of 1,4-diethylphthalazine 
4 (9.0 mg), 480 μmol of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (140 mg) in 50 μL 
of dichloromethane at 24 oC, 1 M TBAF in THF (530 μmol, 530 μL) was slowly added to the 
solution over the course of 5 minutes. After the addition, the solution was concentrated in 
vacuo, and filtered on the silica gel, and purified by flash column chromatography (ethyl 
acetate/hexanes 1:10) to afford rac-5b (1.2 mg). 
(R)- and (S)-2-(1,4-diethyl-2-phenyl-1,2-dihydrophthalazin-1-yl)acetonitrile (rac-5b), 
Procedure II: A 4.0 mL vial was charged with 48 μmol of 1,4-diethylphthalazine 4 (9.0 mg), 480 
μmol of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (140 mg), 530 μmol of anhydrous 
CsF (81 mg) in 50 μL of acetonitrile was heated to 80 oC. After 2 hours, the solution was cooled 
down, concentrated in vacuo and purified by flash column chromatography (ethyl 
acetate/hexanes 1:10) to afford rac-5b (3.6 mg). 
Isolated Yield: 8% (Procedure I), 25 % (Procedure II). 
Physical Property: Pale yellow solid, m.p. = 135-136 ˚C. 
TLC: Rf = 0.38 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CD2Cl2) 
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δ 7.54-7.40 (m, 7H), 7.39-7.36 (m, 1H), 7.34-7.30 (m, 1H), 2.83-2.68 (m, 4H), 2.10-1.95 (m, 
2H), 1.26 (t, 3H, J = 7.6 Hz), 0.97 (t, 3H, J = 7.3 Hz). 
13C NMR (125 MHz, CD2Cl2) 
δ 146.1, 146.0, 132.9, 130.1, 128.6, 128.4, 128.2, 126.6, 125.2, 123.3, 117.6, 63.4, 27.7, 25.8, 
25.4, 11.6, 8.9. 
IR (neat): 2973, 2032, 2877, 1594, 1492, 1472, 1446, 1210, 1119, 756, 702 cm-1. 
HRMS (ESI) calculated for C20H22N3+ [M+H]+ 304.1808, found 304.1808. 
 
3,6-diisopropyl-1,2,4,5-tetrazine: 3,6-diisopropyl-1,2,4,5-tetrazine was prepared according to 
the literature procedure from commercially available isobutyronitrile.33 The product was 
purified by flash column chromatography (ethyl acetate/hexanes = 6.25%). 
Isolated Yield: 56 %. 
Physical Property: Red oil. 
TLC: Rf = 0.46 (silica gel, 25% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) δ 3.36 (sep, 2H, J = 7.0 Hz), 1.25 (d, 12H, J = 7.0 Hz). 
13C NMR (125 MHz, CDCl3) δ 173.4, 33.9, 21.0. 
IR (neat): 2973, 2934, 2877, 1472, 1461, 1383, 1365, 1336, 1286, 1250, 1072, 899, 883 cm-1. 
HRMS (ESI) calculated for C8H14N4+ [M]+ 166.1213, found 166.1222. 
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1,4-diisopropylphthalazine (6): A vial was charged with 0.117 mmol of 3,6-diisopropyl-1,2,4,5-
tetrazine (19.5 mg) and 1.17 mmol of 2 (350 mg) in 0.1 mL of dichloromethane at 24 ˚C, and 1 
M TBAF in THF (1.30 mmol, 1.30 mL) was slowly added to the solution over the course of 5 
minutes. After the addition, the solution was concentrated in vacuo, and filtered on the silica gel, 
and purified by flash column chromatography (hexanes/ethyl acetate 1:3) to afford 6 (18.6 mg). 
Isolated Yield: 74 %. 
Physical Property: White solid, m.p. = 85-86 ˚C. 
TLC: Rf = 0.19 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 8.18 (dd, 2H, J = 6.3, 3.3 Hz), 7.86 (dd, 2H, J = 6.3, 3.3 Hz), 3.86 (sep, 2H, 6.8 Hz), 1.53 (d, 
12H, 6.8 Hz). 
13C NMR (125 MHz, CDCl3) 
δ 162.5, 131.3, 125.0, 124.3, 30.2, 22.0. 
IR (neat): 2968, 2930, 2873, 1540, 1566, 1472, 1457, 1386, 1264, 1087, 1035, 991, 774, 735, 
703, 668 cm-1. 
HRMS (ESI) calculated for C22H16N2+ [M+H]+ 215.1543, found 215.1554. 
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(R)- and (S)-2-(1,4-diisopropyl-2-phenyl-1,2-dihydrophthalazin-1-yl)acetonitrile (rac-7): A 4 
mL vial was charged with 0.13 mmol of 1,4-diisopropylphthalazine 6 (28 mg), 1.3 mmol of 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (390 mg), 1 M TBAF in THF (1.4 mmol, 
1.4 mL)  in 50 μL of dichloromethane was heated to 80 oC. After 2 hours, the solution was 
cooled down, concentrated in vacuo and purified by flash column chromatography (ethyl 
acetate/hexanes 1:10) to afford rac-7 (0.60 mg). 
Isolated Yield: 1 %. 
Physical Property: White solid, m.p. = 140-141 ˚C. 
TLC: Rf = 0.38 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CD2Cl2) 
δ 7.60-7.40 (m, 7H), 7.35-7.28 (m, 1H), 7.24-7.18 (m, 1H), 3.37 (d, 1H, J = 17.6 Hz), 3.28-3.18 
(m, 1H), 2.85 (d, 1H, J = 17.6 Hz), 2.19-2.09 (m, 1H), 1.25-1.21 (m, 6H), 0.90 (d, 3H, J = 6.8 
Hz), 0.74 (d, 3H, J = 6.8 Hz). 
13C NMR (125 MHz, CD2Cl2) 
δ 146.5, 146.2, 130.2, 129.4, 128.7, 128.5, 128.1, 126.4, 126.0, 125.7, 122.8, 118.1, 66.6, 37.0, 
29.1, 27.6, 21.3, 19.7, 19.2, 17.6. 
IR (neat): 2960, 2921, 2849, 1262, 1096, 1028, 803 cm-1. 
HRMS (ESI) calculated for C22H26N3+ [M+H]+ 332.2121, found 332.2121. 
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Crossover Experiment in Scheme 3.2. 
 
Each vial was charged with 0.10 mmol of phthalazine 4 (19 mg) and 1.0 mmol of 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (300 mg) in 100 μL of CH2Cl2, CD2Cl2, 
CH2Cl2/CD2Cl2 (1:1), and CCl4 at 24 ˚C, and 1 M TBAF in THF (1.1 mmol, 1.1 mL) was 
slowly added to the solution over the course of 5 minutes. After the addition, the solution was 
concentrated in vacuo, and filtered on the silica gel, and purified by flash column 
chromatography (ethyl acetate/hexanes 1:10 to straight ethyl acetate) to afford 3, 4, and rac-5a 
(or rac-[D2]-5a). 
 
Crossover Experiment in Scheme 3.3 (eq 7). 
 
Each vial was charged with 10 μmol of phthalazine 4 (1.9 mg) and 100 μmol of 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate 2 (30 mg) in CH3CN and CH2Cl2 in different 
molar ratios (total 5.0 mmol) at 24˚C, and 1 M TBAF in THF (110 μmol, 110 μL) was slowly 
added to each solution over the course of 5 minutes. After the addition, the solutions and 9,10-
diphenylanthracene as an internal standard were directly subjected to HPLC for analysis. 
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Appendix 2 
NMR Spectra and X-Ray Structure Data  
Relevant to Chapter 3 
 
 
 
 
 
 
 
 
 
Adapted with permission from Suh, S.-E.; Chenoweth, D. M. Org. Lett. 2016, 18, 4080-4083.  
Copyright 2016 American Chemical Society. 
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Figure A2.1. 1H NMR spectrum of 2 in CDCl3 (500 MHz).  
 
272 
 
Figure A2.2. 1H NMR spectrum of 4 in CDCl3 (500 MHz).  
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Figure A2.3. 13C NMR spectrum of 4 in CDCl3 (125 MHz). 
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Figure A2.4. 1H NMR spectrum of rac-5a in CD2Cl2 (500 MHz).  
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Figure A2.5. 13C NMR spectrum of rac-5a in CD2Cl2 (125 MHz).  
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Figure A2.6. HSQC spectrum of rac-5a in CD2Cl2. 
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Figure A2.7. HMBC spectrum of rac-5a in CD2Cl2. 
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Figure A2.8. 1H NMR spectrum of rac-[D2]-5a in CD2Cl2 (500 MHz).  
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Figure A2.9. 1H NMR spectrum of rac-5b in CD2Cl2 (500 MHz).  
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Figure A2.10. 13C NMR spectrum of rac-5b in CD2Cl2 (125 MHz).  
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Figure A2.11. HMBC spectrum of rac-5b in CD2Cl2. 
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Figure A2.12. 1H NMR spectrum of 3,6-diisopropyl-1,2,4,5-tetrazine in CDCl3 (500 MHz).  
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Figure A2.13. 13C NMR spectrum of 3,6-diisopropyl-1,2,4,5-tetrazine in CDCl3 (125 MHz). 
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Figure A2.14. 1H NMR spectrum of 6 in CDCl3 (500 MHz). 
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Figure A2.15. 13C NMR spectrum of 6 in CDCl3 (125 MHz). 
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Figure A2.16. 1H NMR spectrum of rac-7 in CD2Cl2 (500 MHz).  
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Figure A2.17. 13C NMR spectrum of rac-7 in CD2Cl2 (125 MHz). 
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Table A2.1. Crystal Data and Structure Refinement for 5a. 
Empirical formula  C19H20N2Cl2 
Formula weight  347.27 
Temperature  100(1) K 
Wavelength  0.71073 Å  
Crystal system  orthorhombic 
Space group  P212121  
Cell constants:   
a  8.5618(10) Å  
b  8.6657(9) Å  
c  22.783(3) Å  
Volume 1690.4(3) Å 3 
Z 4 
Density (calculated) 1.365 Mg/m3 
Absorption coefficient 0.385 mm-1 
F(000) 728 
Crystal size 0.32 x 0.22 x 0.12 mm3 
Theta range for data collection 2.51 to 25.39° 
Index ranges -10  h  10, -10  k  10, -27  l  27 
Reflections collected 22569 
Independent reflections 3110 [R(int) = 0.0433] 
Completeness to theta = 25.39° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.4705 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3110 / 67 / 275 
Goodness-of-fit on F2 1.237 
Final R indices [I>2sigma(I)] R1 = 0.0764, wR2 = 0.1911 
R indices (all data) R1 = 0.0769, wR2 = 0.1913 
Absolute structure parameter 0.49(19) 
Largest diff. peak and hole 0.600 and -0.640 e.Å -3 
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Table A2.2. Crystal Data and Structure Refinement for 5b. 
Empirical formula  C20H21N3 
Formula weight  303.40 
Temperature  100(1) K 
Wavelength  0.71073 Å  
Crystal system  monoclinic 
Space group  P21      
Cell constants:   
a  7.1149(3) Å  
b  26.5631(11) Å  
c  8.5150(4) Å  
 90.955(3)° 
Volume 1609.06(12) Å 3 
Z 4 
Density (calculated) 1.252 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 648 
Crystal size 0.12 x 0.12 x 0.05 mm3 
Theta range for data collection 1.53 to 25.48° 
Index ranges -8  h  8, -31  k  32, -10  l  10 
Reflections collected 29916 
Independent reflections 5858 [R(int) = 0.0402] 
Completeness to theta = 25.48° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6245 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5858 / 1 / 420 
Goodness-of-fit on F2 1.080 
Final R indices [I>2sigma(I)] R1 = 0.0632, wR2 = 0.1647 
R indices (all data) R1 = 0.0748, wR2 = 0.1719 
Absolute structure parameter 2(3) 
Largest diff. peak and hole 0.485 and -0.238 e.Å -3 
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Chapter 4 
Mechanistic Study of the Triple Aryne–Tetrazine 
Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with Dr. Kendall N. Houk and Dr. Shuming Chen at 
the University of California, Los Angeles. 
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4.1 Introduction 
 
Figure 4.1. Reactivity modes of 1,2,4,5-tetrazine and arynes. 
 
Recently, we reported a new multistep process termed the triple aryne-tetrazine (TAT) 
reaction.1 The reaction coupled diverse reactivity modes between simple 1,2,4,5-tetrazine 1 
(henceforth referred to as “tetrazine”) starting materials2 and aryne 2 into a single multistep 
process, resulting in the addition of three aryne equivalents to a tetrazine core. In the TAT 
reaction, dibenzocinnoline 3 and cycloaddition intermediate 4 were isolated. In addition, we 
reported solvent participation in aryne reactions with two solvent-trapped intermediates 5a and 
5b (Scheme 4.1).3 Detailed investigation of these side reactions can yield valuable insight into 
aryne chemistry4 and provide access to new heterocyclic scaffolds.5 Here we report new 
mechanistic aspects of the reaction between a tetrazines and arynes, elucidating unique 
divergent pathways to alternative products that arise during the reaction course. The reaction 
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mechanism consists of six consecutive elementary steps. As many as five steps can directly 
engage the aryne.6 Using a combination of experimental and computational methods, we 
elucidate the unique competing pathways that are operational throughout the course of the 
reaction to yield products 6, rac-7, rac-8, and rac-9a.   
 
4.2 Results and Discussion 
In the TAT reaction, it was observed that 1 undergoes [4+2] cycloaddition with 2 to 
afford phthalazine intermediate 47 followed by several further mechanistic steps to give 
dibenzocinnoline 3 (Figure 4.2A). In the TAT reaction, anthracene 10 was not observed,8 
indicating that the phthalazine intermediate 4 does not undergo a further [4+2] cycloaddition. 
Instead, 4 is observed to undergo a nucleophilic addition to another equivalent of 2. To compare 
the energy profiles of the competing [4+2] versus nucleophilic addition reaction pathways, 
density functional theory (DFT) calculations were performed on analogous structures with the 
ethyl substituents on phthalazine 4 simplified into methyl groups (Figure 4.2B). The optimized 
transition state and product structures for the nucleophilic addition of phthalazine 11 to aryne is 
shown in Figure 4.2C, with a Gibbs free energy of activation of 9.4 kcal/mol.9 A very small C–
N–C–C dihedral angle of approach (0.7°) indicate little distortion of planarity in the forming 
conjugated π system in the transition state. In contrast, the zwitterionic product I exhibits a C–
N–C–C dihedral angle of 36.0°, indicating compromised planarity of the conjugated π system 
due to the alkyl substituent on the phthalazine fragment. The reaction is overall slightly  
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Figure 4.2. Two Possible Reaction Pathways. (a) The reported TAT reaction and isolated 
phthalazine intermediate 4. (b) Nucleophilic addition reaction vs. Diels-Alder reaction. (c) 
Transition states and product structures for the nucleophilic addition and Diels-Alder/retro-
Diels-Alder reaction pathway (B3LYP/6-31G(d)//B3LYP/6-311+G(d,p)/CPCM (CH2Cl2)). 
The Gibbs free energies of activation (ΔG‡) are reported in kcal/mol. (d) Optimized 
geometries of intermediates and transition states in the pathway 1 and 2. 
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endergonic. The Diels-Alder reaction between phthalazine 11 and aryne was calculated to have a 
Gibbs free energy of activation of 18.5 kcal/mol (TS2), 9.1 kcal/mol higher than the 
nucleophilic addition pathway (TS1). Although the Diels-Alder reaction is overall strongly 
exergonic, the significantly higher kinetic activation barrier renders it unfavorable compared to 
the nucleophilic addition pathway. Structures and energies were also calculated for the possible 
retro-Diels Alder reaction of adduct II. The retro-Diels Alder reaction was found to have a low 
activation barrier (0.4 kcal/mol, TS3), indicating facile extrusion of dinitrogen to give the 
dimethylanthracene 12.11 
The standard TAT reaction is conducted with 1, tetrabutylammonium fluoride (TBAF) 
in THF, and benzyne precursor 13 in CH2Cl2 at 24 oC, to produce product 3 within 5 minutes. 
The intermediate 4 is isolable from the TAT reaction when conducted with an excess of 
tetrazine 1. The reaction between 13 and intermediate 4 under standard TAT reaction 
conditions afforded the desired product 3 in 7% yield. Here, using anhydrous CsF instead of 
TBAF, which has a low concentration of water and is considered a wet fluoride source, we 
conducted the reaction in CH3CN under reflux. Higher conversion and higher yield of the 
dibenzo[de,g]cinnoline 3 was observed (Figure 4.3A). To discriminate between an intra- versus 
intermolecular proton transfer pathway, the reaction was performed in CD3CN and D2O under 
reflux (Figure 4.3B). Only deuterated dibenzo[de,g]cinnoline [D]-3 was isolated (11% yield), 
as analyzed by 1H NMR. The result indicates that intermediate III most likely did not proceed 
through an intramolecular pathway but instead through an intermolecular proton transfer 
pathway, assisted by a fluoride, a hydroxide, conjugate base of CH3CN, or a phenyl anion of 
another benzyne adduct. To further probe solvent participation in the proton transfer step,  
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Figure 4.3. Crossover experiment to determine intra-, acetonitrile-assisted inter-, or water-
assisted intermolecular proton transfer. (a) The reaction was conducted in the mixture of 1:1 
ratio of CH3CN/H2O. (b) The mixture of 1:1 ratio of CD3CN/D2O. (c) The mixture of 1:1 
ratio of CD3CN/H2O. (d) Importance of water in the previous crossover experiment.3 
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Figure 4.3. Continued. 
 
experiments were conducted in CD3CN and H2O (Figure 4.3C). According to the result shown 
in Figure 4.3B, the intramolecular pathway is unlikely to be favored. Two possibilities arise for 
the intermolecular pathway, a water-mediated or CH3CN-mediated proton transfer, assuming 
H2O can only serve as the proton source and CD3CN can only provide deuterium during the 
proton transfer step. After this reaction, only non-deuterated 3 was observed in 14% yield, which 
ruled out proton transfer with the conjugate base of CH3CN, supporting a  water-mediated 
proton transfer pathway. These results account for why only 3 and rac-[D2]-5a were found and 
[D]-3 was not observed in our previous crossover experiments performed in CD2Cl2 (Figure 
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4.3D).3 When it comes to the stepwise mechanism in Figure 4.3D, after deuterium transfer from 
CD2Cl2 to the intermediate III, the deuterated cationic intermediate is formed. According to the 
isolation of 3 and rac-[D2]-5a, the cationic intermediate may only react with dichloromethanide-
d via 1,2-addition to provide rac-[D2]-5a. but may not undergo further deprotonation assisted 
by either dichloromethanide-d or hydroxide to afford (E/Z)-[D]-IV because [D]-3 was not 
detected. A plausible pathway to account for formation of 3 may involve a water-mediated 
proton transfer to give (E/Z)-IV. As shown above, water is an important proton source for the 
TAT reaction, and this result is consistent with the observation that no desired product from the 
TAT reaction is observed with anhydrous tetrabutylammonium difluorotriphenylsilicate 
(TBAT).1 
 The transition state structure (TS8) for a concerted water-assisted proton transfer is 
shown in Figure 4.4. The negative Gibbs free energy of activation indicates strongly favorable 
interactions between the water molecule and the zwitterionic substrate I to yield intermediate 
14. The transition state for the direct intramolecular transfer of proton could not be located. It is 
possible that due to the requirement that the σ C–H bond being broken must be in plane with 
the π system of the N=C bond, only a hydrogen abstraction from the top or bottom face of the 
molecule would have been favorable. Due to the geometrical constraints of the molecule, such a 
top- or bottom-face hydrogen abstraction by the anionic carbon is geometrically precluded. 
 To isolate non-isolable alkylidene intermediate, another starting material, 3-methyl-6-
phenyl-1,2,4,5-tetrazine (15), was employed (Figure 4.5, middle). A phenyl group on 6-position 
was supposed to stabilize a tetrazine ring and a methyl group on 3-position was expected to 
afford a single methylidene intermediate 16 while 3,6-diethyltetrazine (1) may afford (E/Z)-IV 
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Figure 4.4. Optimized geometries of intermediates, product, and transition states for water-
assisted proton transfer pathway (B3LYP/6-31G(d)//B3LYP/6-311+G(d,p)/CPCM 
(CH2Cl2)). The Gibbs free energies of activation (ΔG‡) are reported in kcal/mol. 
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Figure 4.5. Alternative probe 16 to non-isolable intermediate (E/Z)-IV of the TAT reaction. 
   
as two isomers (Figure 4.5, top). However, the aryne reaction of newly employed tetrazine 15 
also didn’t stop at the intermediate 16 but afforded the dibenzo[de,g]cinnoline 17. Even if 16 
was not isolated, we synthesized 16 through another synthetic route (Figure 4.5, bottom).12 
TBAF (1.1 equiv) was subjected to a solution containing 16 (1.0 equiv) and 13 (1.0 equiv) in 
CH2Cl2, which afforded the desired product 17 in 20% yield. This result supports the notion that 
a methylidene intermediate, such as 16 or (E/Z)-IV, might be a key intermediate in the third 
benzyne addition step of the TAT reaction. 
Interestingly, the reaction between 4 and 13 with CsF in THF at 60 oC for 2 hours 
followed by treatment with saturated brine solution afforded the trapped intermediate 6 in 9% 
yield (Figure 4.6A). There are two possibilities that would lead to the formation of 6. One 
possibility is that the intermediate III is simply quenched by an environmental proton source 
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such as solvent. The other possibility is that the intermediate III deprotonates itself through an 
intermolecular process to yield a neutral intermediate (E/Z)-IV, followed by tautomerization to 
hydrazonium salt 6. The intermolecular pathway was ruled out in Figure 4.3B. Under the same 
reaction conditions as those employed in Figure 4.6A, the [2+2] cycloaddition product rac-7 
was observed as a mixture of inseparable diastereomers in 7% yield.13 The relatively smaller 
amounts of the [2+2] cycloaddition product compared to [4+2] product 3 indicate that the 
[4+2] mode is experimentally more favorable than the [2+2] mode. Calculations support the 
idea that intermediate 14 can react with another equivalent of benzyne in either a formal [2+2] 
or [4+2] cucloaddition to give VII and VIII, respectively (Figure 4.6B). We located the common 
diradical intermediate VI expected on stepwise pathways of both the formal [2+2] and [4+2] 
cycloadditions between 14 and benzyne, with a free energy of -14.8 kcal/mol. Transition states 
for concerted [2+2] or [4+2] cycloadditions were not found for this system. 
During the analysis of the standard TAT reaction in Scheme 4.1, 8% of rac-8 was 
isolated and characterized by HMBC NMR experiments, and its relative stereochemistry was 
determined by NOESY NMR experiments (Figure 4.7). We propose two possible mechanisms 
for the synthesis of rac-8 consisting of a concerted ene-reaction or stepwise ene-type reaction of 
rac-IX.14 In both mechanisms, the two possible pathways support the existence of a currently 
non-isolable intermediate rac-IX. 
Further observation of the rearranged intermediate rac-9a indirectly supports that the 
intermediate rac-IX is in the course of the TAT reaction. The structure of rac-9a was 
characterized by 1H NMR and HRMS spectroscopy. The J coupling constant of two vicinal  
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Figure 4.6. (a) Trapped intermediate salt 6 and competitive cycloaddition between [2+2] and 
[4+2]. (b) Optimized geometries of intermediates and product structures for [2+2] and [4+2] 
cycloaddition reaction pathways (B3LYP/6-31G(d)//B3LYP/6-311+G(d,p)/CPCM 
(CH2Cl2)). The Gibbs free energies of activation (ΔG‡) are reported in kcal/mol. 
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protons (JA) was determined to be 5.5 Hz (Figure 4.8). Based on the results from the HF/6-31G 
(d) calculations, cis isomer rac-9a possessed 64 degree dihedral angles and a J coupling of 4.8 Hz 
between the two vicinal protons. This coupling constant differed from that observed for JA by 0.7 
Hz. Larger dihedral angles of 160 degrees for the trans isomer (rac-9b) resulted in a JC of 12.9 
Hz, which is quite different from the observed value. 
 
Scheme 4.1. Ene or Stepwise Ene-Type Reaction and Rearrangement of the Intermediate rac-
IX. 
 
 
 
Figure 4.7. Representative NMR correlation assignments of rac-8. 
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Figure 4.8. Determination of stereochemistry of rac-9a. J coupling constant of A from 1H NMR 
spectrum (left) and calculated J coupling constant and degree between two protons on cis 
intermediate rac-9a and trans intermediate rac-9b (right). 
 
4.3 Conclusions 
Herein, we provide the first mechanistic insight into the reactivity between a tetrazine 
and arynes. During the course of the reaction, three aryne addition steps occur consecutively 
with each step displaying a distinct reactivity mode with benzyne. By isolating and trapping the 
key intermediates, each of these distinct aryne reactivity modes as well as alternative side 
product pathways were elucidated. DFT calculations of transition states of two competitive 
reactions, further [4+2] cycloaddition and nucleophilic addition, support the assertion that 
[4+2] cycloaddition has higher activation energy barrier, thus, the formation of anthracene is 
supposed to be unfavorable. The computational and experimental study for three plausible 
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proton transfer pathways were performed. This anaylsis showed that the water-assisted proton 
transfer is most favorable fashion. The dibenzocinnoline 17 was observed during the reaction of 
an alternative intermediate 16 with an aryne via [4+2] cycloaddition. The intermediate III 
undergoes further formal [2+2] and [4+2] cycloaddition, with both the [2+2] cycloaddition 
product rac-7 and the [4+2] product 3 being observed. In addition, the plausibility of non-
isolable intermediates rac-IX was confirmed by the isolation and characterization of the ene or 
the stepwise ene-type product rac-8 and rearranged product rac-9a. The observed intermediates 
and byproducts are consistent with the overall proposed mechanism for the TAT reaction. We 
anticipate that the study of arynes-tetrazine-engaged reactivity modes will serve as guidance for 
future explorations of aryne chemistry, and especially in the context of intermolecular multiple 
consecutive aryne addition reactions.  
 
4.4 Experimental Section 
General information 
All commercial reagents and solvents were used as received. Flash column 
chromatography was performed using Silicycle silica gel (55−65 Å pore diameter). Thin-layer 
chromatography was performed on Sorbent Technologies silica plates (250 μm thickness). 
Proton nuclear magnetic resonance spectroscopy (1H NMR) and Carbon nuclear magnetic 
resonance spectroscopy (13C NMR) spectra were recorded on a Bruker DMX 500 1H NMR. 
High-resolution mass spectra were obtained by Dr. Rakesh Kohli at the University of 
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Pennsylvania’s Mass Spectrometry Service Center on a on a Waters LC-TOF mass spectrometer 
(model LCT-XE Premier) using electrospray ionization. X-ray diffraction data obtained and 
solved by Dr. Patrick Carroll at the University of Pennsylvania. High performance liquid 
chromatography analysis was performed using a Jasco HPLC instrument equipped with a 
Phenomenex column (Luna 5u C18(2) 100A; 250 × 4.60 mm, 5 μm). 
Computational methods 
For 2, 11, 12, 14, I, II, VI, VII, VIII, TS1, TS2, TS3, and TS8, all quantum chemical 
calculations were performed with Gaussian 09.12 Geometry optimizations and frequencies were 
calculated with the B3LYP density functional with the 6-31G(d) basis set in conjunction with 
the CPCM implicit solvation model. Optimized geometries were verified by frequency 
calculations as minima (zero imaginary frequencies) or transition structures (a single imaginary 
frequency). Structure graphics were generated using CYLView.13 
For rac-9a and rac-9b, all calculations were performed using Gaussian 09.12 All local 
minima were optimized in the gas phase using Hartree-Fock methods with the 6-31G(d) basis 
set; calculation of total nuclear spin-spin coupling J (Hz) constant values were performed with 
the same basis set. Post processing was performed using UCSF Chimera.14 
 
 
 
 
 
 
306 
 
Experimental procedures 
 
3,6-diethyl-1,2,4,5-tetrazine (1): Synthetic method and characterization data of 1 have been 
reported in our previous publication.1 
 
 
 
 
4-ethyl-7-methyl-6-phenyl-6H-dibenzo[de,g]cinnoline (3): Synthetic method and 
characterization data of 3 have been reported in our previous publication.1 
 
1,4-diethylphthalazine (4): Synthetic method and characterization data of 4 have been reported 
in our previous publication.3 
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4-ethyl-7-methyl-6-(phenyl-2-d)-6H-dibenzo[de,g]cinnoline ([D]-3): A 10 mL round-bottom 
flask was charged with 43 μmol of phthalazine 4 (8.0 mg), 430 μmol of 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate 13 (128 mg), 470 μmol of anhydrous CsF (72 mg) in 40 μL of 
CD3CN and 40 μL of D2O and was heated under reflux. After 2 hours, the solution was cooled 
down, concentrated in vacuo and purified by flash column chromatography (ethyl 
acetate/hexane 1:30) to afford [D]-3 (1.6 mg). 
Isolated Yield: 11 %. 
Physical Property: Yellow solid, m.p. = 59-60 ˚C. 
TLC: Rf = 0.81 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CD2Cl2) δ 8.53-8.49 (m, 2H), 7.86 (dd, 1H, J = 8.2, 1.3 Hz), 7.63 (dd, 1H, 
J = 8.2, 7.4 Hz), 7.58 (ddd, 1H, J = 8.2, 6.9 1.3 Hz), 7.48 (ddd, 1H, J = 8.2, 6.9, 1.3 Hz), 7.43 
(dd, 1H, J = 7.4, 1.0 Hz), 7.39-7.33 (m, 3H), 7.12-7.07 (m, 1H), 2.82 (q, 2H, J = 7.3 Hz), 2.00 
(s, 3H), 1.36 (t, 3H, J = 7.3 Hz) 
HRMS (ESI) calculated for C24H19DN2+ [M]+ 337.1684, found 337.1689. 
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(R)- and (S)-1-(dichloromethyl)-1,4-diethyl-2-phenyl-1,2-dihydrophthalazine (rac-5a): 
Synthetic method and characterization data of rac-5a have been reported in our previous 
publication.3 
 
(R)- and (S)-2-(1,4-diethyl-2-phenyl-1,2-dihydrophthalazin-1-yl)acetonitrile (rac-5b): 
Synthetic method and characterization data of rac-5b have been reported in our previous 
publication.3 
 
 
 
 
1,4-diethyl-2-phenylphthalazin-2-ium chloride (6): A 4 mL vial was charged with 48 μmol of 
1,4-diethylphthalazine 4 (9.0 mg), 480 μmol of 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate 13 (144 mg), 530 μmol of anhydrous CsF (81 mg) in 0.05 mL of 
THF was heated to 60 oC. After 2 hours, the solution was cooled down, concentrated in vacuo 
and purified by reversed phase column chromatography using water containing 0.1% 
trifluoroacetic acid. Trifluoroacetate ion was replaced with chloride ion by the addition of a drop 
of brine to the resulting solid followed by co-evaporation under high-vacuum condition. The 
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solid was filtered with HPLC grade dichloromethane and the filtrate was dried in vacuo for 12 
hours to afford 6 (1.3 mg). 
Isolated Yield: 9 %. 
Physical Property: Colorless semi-solid. 
1H NMR (500 MHz, CD2Cl2) 
δ 8.74 (d, 1H, J = 8.3 Hz), 8.55 (d, 1H, J = 8.3 Hz), 8.48 (ddd, 1H, J = 8.3, 7.2, 1.1 Hz), 8.40 
(ddd, 1H, J = 8.3, 7.2, 1.1 Hz), 7.80-7.72 (m, 3H), 7.68-7.63 (m, 2H), 3.56-3.48 (m, 4H), 1.50 
(t, 3H, J = 7.4 Hz), 1.45 (t, 3H, J = 7.7 Hz). 
13C NMR (125 MHz, CD2Cl2) 
δ 165.7, 164.6, 142.6, 139.1, 136.0, 131.5, 130.3, 129.3, 127.5, 127.2, 126.4, 125.1, 26.3, 25.1, 
14.1, 11.5. 
IR (neat): 2917, 2849, 1265, 1154, 1031, 638 cm-1. 
HRMS (ESI) calculated for C18H19N2+ [M] 263.1543, found 263.1544. 
 
(7R,8R)-, (7S,8S)-, (7R,8S)-, and (7S,8R)-4'-ethyl-8-methyl-2'-phenyl-2'H-
spiro[bicyclo[4.2.0]octane-7,1'-phthalazine]-1(6),2,4-triene (rac-7): A 4 mL vial was charged 
with 48 μmol of 1,4-diethylphthalazine 4 (9.0 mg), 480 μmol of 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate 13 (144 mg), 530 μmol of anhydrous CsF (81 mg) in 50 μL of THF 
was heated to 60 oC. After 2 hours, the solution was cooled down, concentrated in vacuo and 
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purified by reversed phase column chromatography using water containing 0.1% trifluoroacetic 
acid to afford 1.1 mg of rac-7. 
Isolated Yield: 7 % (overall). 
Physical Property: White solid. 
TLC: Rf = 0.30 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 7.71-7.67 (m, Major 1H), 7.44-6.96 (m, 10H Major, 11H Minor), 6.84 (td, Major 1H, J = 7.4, 
0.9 Hz), 6.82 (td, Minor 1H, J = 7.4, 0.9 Hz), 6.66 (d, Minor 1H, J = 7.8 Hz), 6.54 (d, Major 1H, 
J = 7.8 Hz), 3.87 (q, Major 1H, J = 7.0 Hz), 3.53 (q, Minor 1H, J = 7.3 Hz), 2.82-2.62 (m, 2H 
Major, 2H Minor), 1.30 (t, 3H Minor, J = 7.4 Hz), 1.24 (t, 3H Major, J = 7.4 Hz), 1.05 (d, 3H 
Minor, J = 7.3 Hz), 0.94 (d, 3H Major, J = 7.0 Hz). 
IR (neat): 2963, 2921, 2851, 1723, 1596, 1495, 1477, 1459, 1093, 1070, 1044, 800, 743, 699 cm-
1. 
HRMS (ESI) calculated for C24H23N2+ [M+H]+ 339.1856, found 339.1864. 
 
(6aS,7R)- and (6aR,7S)-4-ethyl-7-methyl-6,6a-diphenyl-6a,7-dihydro-6H-
dibenzo[de,g]cinnoline (rac-8): A 4 mL vial was charged with 48 μmol of 1,4-diethylphthalazine 
4 (9.0 mg), 0.483 mmol of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 513(144 mg) in 
50 μL of dichloromethane at 24 oC, 1.0 M TBAF in THF (530 μmol, 530 μL) was slowly added 
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to the solution over the course of 5 min. After the addition, the solution was concentrated in 
vacuo, and filtered on the silica gel, and purified by flash column chromatography (ethyl 
acetate/hexanes 1:20) to afford rac-8 (1.6 mg). 
Isolated Yield: 8 %. 
Physical Property: Colorless oil. 
TLC: Rf = 0.62 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 7.80-7.75 (m, 1H), 7.59-7.56 (m, 1H), 7.52-7.49 (m, 2H), 7.26-7.22 (m, 1H), 7.22-7.15 (m, 
4H), 7.14-7.08 (m, 1H), 7.02-6.92 (m, 5H), 6.83-6.79 (m, 2H), 4.01 (q, 1H, J = 6.7 Hz), 2.90-
2.68 (m, 2H), 1.48 (t, 3H, J = 6.7 Hz), 1.30 (t, 3H, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) 
δ 147.2, 142.8, 140.9, 140.6, 132.1, 131.8, 130.6, 128.5, 128.2, 128.1, 127.8, 127.6, 127.1, 127.0, 
126.9, 126.1, 125.8, 125.3, 124.7, 123.7, 122.4, 65.6, 40.7, 25.7, 18.9, 11.8. 
IR (neat): 2963, 2919, 2849, 1259, 1085, 1018, 795, 704 cm-1. 
HRMS (ESI) calculated for C30H27N2+ [M+H]+ 415.2169, found 415.2174. 
 
(6aR,7R)- and (6aS,7S)-4-ethyl-7-methyl-6-phenyl-6a,7-dihydro-6H-dibenzo[de,g]cinnoline 
(rac-9a): A 4 mL vial was charged with 48 μmol of 1,4-diethylphthalazine 4 (9.0 mg), 480 mmol 
of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 13 (144 mg) in 50 μL of dichloromethane 
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at 24 oC, 1.0 M TBAF in THF (530 μmol, 530 μL) was slowly added to the solution over the 
course of 5 min. After the addition, the solution was concentrated in vacuo, and filtered on the 
silica gel, and purified by flash column chromatography (ethyl acetate/hexanes 1:20) to afford 
rac-9a (0.1 mg). The extremely low stability and yield precluded the 13C NMR characterization. 
Isolated Yield: Less than 1 %. 
Physical Property: White semi-solid. 
TLC: Rf = 0.56 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 7.70 (d, 1H, J = 7.9 Hz), 7.50-7.23 (m, 11H), 4.84 (d, 1H, J = 5.5 Hz), 3.54-3.46 (m, 1H), 
2.52-2.41 (m, 2H), 1.35 (d, 3H, J = 7.5 Hz), 0.95 (t, 3H, J = 7.4 Hz). 
IR (neat): 2968, 2926, 2854, 1259, 1096, 1026, 800 cm-1. 
HRMS (ESI) calculated for C24H23N2+ [M+H]+ 339.1856, found 339.1865. 
 
2-(trimethylsilyl)phenyl trifluoromethanesulfonate (13): 13 was prepared according to the 
literature procedure15 and characterization data of 13 has been reported in our previous 
publication.3 
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3-methyl-6-phenyl-1,2,4,5-tetrazine (15): Synthetic method and characterization data of 15 
have been reported in our previous publication.1 
 
1-methylene-2,4-diphenyl-1,2-dihydrophthalazine (16): 3.0 M methylmagnesium bromide 
solution (0.3 mmol, 0.3 mL) in diethyl ether was slowly added to 0.1 mmol of 2,4-diphenyl-
1(2H)-phthalazinone16 (30 mg) in 0.3 mL of benzene at 24 oC. After 10 hours, 1M HCl solution 
was added.9 Then, K2CO3 was added until the pH of the solution became 7. The organic layer 
was extracted with dichloromethane and water, was washed with brine solution, and was purified 
by flash column chromatography (ethyl acetate/hexanes 1:1 to 9:1) to afford 16 (23 mg). 
Isolated Yield: 77 % 
Physical Property: Green oil. 
TLC: Rf = 0.30 (silica gel, ethyl acetate/hexanes 1:4). 
1H NMR (500 MHz, CDCl3) 
δ 7.77 (d, 1H, J = 7.9 Hz), 7.64-7.58 (m, 4H), 7.54-7.44 (m, 6H), 7.427.37 (m, 2H), 7.31 (t, 1H, 
J = 7.4 Hz), 4.52 (s, 1H), 4.17 (s, 1H). 
13C NMR (125 MHz, CDCl3) 
δ 145.3, 144.1, 142.4, 136.1, 131.9, 131.0, 129.3, 129.11, 129.09, 128.4, 128.3, 126.2, 125.8, 
125.5, 124.7, 123.9, 81.6. 
IR (neat): 2965, 2921, 2848, 1661, 1594, 1492, 1443, 1259, 1096, 1021, 797, 696 cm-1. 
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HRMS (ESI) calculated for C21H17N2+ [M+H]+ 297.1386, found 297.1404. 
 
4,6-diphenyl-6H-dibenzo[de,g]cinnoline (19): A vial was charged with 24 μmol of 16 (7.0 mg), 
24 μmol of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 13 (7.2 mg) in 30 μL of 
dichloromethane at 24˚C, and 1.0 M TBAF in THF (26 μmol, 26 μL) was slowly added to the 
solution over the course of 1 min. After the addition, the solution was concentrated in vacuo and 
purified by flash column chromatography (ethyl acetate/hexane 1:30) to afford 19 (1.8 mg) in 
20% yield. Characterization data of 19 have been reported in our previous publication.1 
 
Deuterium Labeling Experiment in Figure 4.3b and 3c. 
 
Each 10 mL round-bottom flask was charged with 43 μmol of phthalazine 4 (8.0 mg), 430 μmol 
of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 13 (128 mg), 470 μmol of anhydrous CsF 
(72 mg) in 40 μL of CD3CN and 40 μL of D2O (or 40 μL of CD3CN and 40 μL of H2O) and was 
heated under reflux. After 2 hours, the solution was cooled down, concentrated in vacuo and 
purified by flash column chromatography (ethyl acetate/hexane 1:30) to afford 3 (or [D]-3). 
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Appendix 3 
NMR Spectra and Computational Results  
Relevant to Chapter 4 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with Dr. Kendall N. Houk and Dr. Shuming Chen at 
the University of California, Los Angeles. 
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Figure A3.1. 1H NMR spectrum of rac-[D1]-3b in CD2Cl2 (500 MHz).  
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Figure A3.2. 1H NMR spectrum of 6 in CD2Cl2 (500 MHz).  
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Figure A3.3. 13C NMR spectrum of 6 in CD2Cl2 (125 MHz).  
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Figure A3.4. 1H NMR spectrum of mixture rac-7 in CD2Cl2 (500 MHz).  
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Figure A3.5. 1st expanded 1H NMR spectrum of mixture rac-7 in CD2Cl2 (500 MHz). 
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Figure A3.6. 2nd expanded 1H NMR spectrum of mixture rac-7 in CD2Cl2 (500 MHz). 
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Figure A3.7. 1H NMR spectrum of rac-8 in CD2Cl2 (500 MHz).  
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Figure A3.8. 13C NMR spectrum of rac-8 in CD2Cl2 (125 MHz). 
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Figure A3.9. HMBC spectrum of rac-8 in CD2Cl2. 
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Figure A3.10. Expanded partial HMBC spectrum of rac-8 in CD2Cl2. 
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Figure A3.11. NOESY spectrum of rac-8 in CD2Cl2. 
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Figure A3.12. 1H NMR spectrum of rac-9a in CD2Cl2 (500 MHz).  
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Figure A3.13. 1H NMR spectrum of 16 in CD2Cl2 (500 MHz).  
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Figure A3.14. 13C NMR spectrum of 16 in CD2Cl2 (125 MHz).  
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Table A3.1. Cartesian Coordinates of the Optimized Structures of 2, 11, 12, 14, I, II, VI, VII, 
VIII, TS1, TS2, TS3, and TS8. 
2 
        
         C 0.000000 1.058663 0.703548 
 
C 0.000000 1.058663 -0.703548 
C 0.000000 -0.133780 1.461354 
 
H 0.000000 2.010866 1.229771 
C 0.000000 -1.237588 0.625468 
 
H 0.000000 -0.134635 2.546586 
C 0.000000 -1.237588 -0.625468 
 
H 0.000000 -0.134635 -2.546586 
C 0.000000 -0.133780 -1.461354 
 
H 0.000000 2.010866 -1.229771 
         
         11 
        
         N 0.658688 1.187755 0.000049 
 
H 3.165422 0.531002 -0.882339 
C 1.288338 -0.005327 0.000047 
 
H 3.165529 0.533035 0.881006 
C -1.288338 -0.005326 -0.000049 
 
C -2.787534 0.003387 -0.000012 
N -0.658687 1.187756 -0.000019 
 
H -3.165445 0.531078 0.882245 
N -0.662806 -1.192306 -0.000014 
 
H -3.165417 -1.020549 -0.001030 
N 0.662804 -1.192306 0.000043 
 
H -3.165505 0.532960 -0.881101 
C 2.787534 0.003386 -0.000027 
 
H 3.165418 -1.020549 0.001063 
         
         12 
        
         C -3.672435 -0.689608 -0.088057 
 
H -4.615664 -1.227211 -0.135912 
C -2.490962 -1.379009 -0.029894 
 
H -2.516043 -2.462270 -0.046014 
C -1.222837 -0.711712 0.022938 
 
H -2.502943 2.494513 -0.072617 
C -1.214596 0.737777 0.019681 
 
H -4.603815 1.275673 -0.150426 
C -2.479304 1.411846 -0.042387 
 
H 4.603816 -1.275673 -0.150425 
C -3.665566 0.730075 -0.095512 
 
H 4.615664 1.227211 -0.135913 
C -0.011821 -1.438769 0.065144 
 
H 2.516043 2.462270 -0.046014 
C 0.011821 1.438769 0.065144 
 
C 0.052105 2.951698 0.135853 
C 1.222838 0.711712 0.022938 
 
H 0.828384 3.294387 0.826381 
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C 1.214596 -0.737778 0.019681 
 
H 0.265296 3.404334 -0.842267 
C 2.479305 -1.411846 -0.042386 
 
H -0.886189 3.375837 0.494261 
H 2.502944 -2.494512 -0.072617 
 
C -0.052106 -2.951698 0.135852 
C 3.665566 -0.730075 -0.095512 
 
H -0.828381 -3.294386 0.826386 
C 3.672435 0.689608 -0.088058 
 
H -0.265305 -3.404332 -0.842267 
C 2.490962 1.379009 -0.029894 
 
H 0.886189 -3.375840 0.494254 
         
         14 
        
         C 4.411359 -0.272021 0.297656 
 
H 2.119817 3.293972 1.007325 
C 3.513223 0.787468 0.238043 
 
H 2.208633 3.353772 -0.756839 
C 2.143151 0.553703 0.029430 
 
H 0.670448 3.704263 0.066566 
C 1.678685 -0.769449 -0.135655 
 
C -1.999451 0.003262 0.030364 
C 2.593252 -1.828375 -0.048738 
 
C -2.813003 0.958947 -0.589000 
C 3.946974 -1.584452 0.162694 
 
C -2.585793 -1.028732 0.774971 
H 5.468172 -0.079618 0.460336 
 
C -4.199640 0.877021 -0.465988 
H 3.871469 1.804660 0.359781 
 
H -2.349124 1.764398 -1.146241 
C 1.154061 1.628485 0.014916 
 
C -3.972560 -1.107310 0.883863 
C 0.245764 -0.985660 -0.427767 
 
H -1.954054 -1.761868 1.265382 
H 2.239016 -2.850649 -0.130738 
 
C -4.787444 -0.156406 0.264884 
H 4.640579 -2.418145 0.228354 
 
H -4.822153 1.624341 -0.950997 
N -0.120388 1.393439 0.008147 
 
H -4.416283 -1.909946 1.466992 
N -0.577165 0.108751 -0.051778 
 
H -5.868298 -0.219177 0.354791 
C -0.236833 -2.100297 -1.014413 
 
H -1.288514 -2.234016 -1.228625 
C 1.563366 3.076121 0.086364 
 
H 0.432489 -2.901150 -1.300412 
         
         I 
        
         C -4.366835 -0.272889 -0.274897 
 
H 0.337356 -3.002180 -0.053225 
C -3.492590 0.800592 -0.265228 
 
H 1.316818 -2.178609 1.132182 
C -2.111514 0.588503 -0.078586 
 
C -1.549992 3.102824 -0.096496 
C -1.613975 -0.731017 0.097063 
 
H -2.056656 3.324726 -1.043630 
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C -2.529574 -1.811544 0.090094 
 
H -2.238424 3.366024 0.715277 
C -3.880718 -1.581806 -0.098098 
 
H -0.659420 3.729179 -0.023630 
H -5.430106 -0.105607 -0.419967 
 
C 2.026524 0.016461 0.019463 
H -3.868093 1.809433 -0.399806 
 
C 2.836957 1.020102 0.583684 
C -1.147659 1.654204 -0.021709 
 
C 2.463422 -1.090498 -0.729671 
C -0.203503 -0.932221 0.269800 
 
C 4.206790 0.923302 0.383968 
H -2.166385 -2.825866 0.204135 
 
H 2.413357 1.831350 1.169151 
H -4.571390 -2.419871 -0.115239 
 
C 3.869508 -1.155983 -0.830061 
N 0.136335 1.428255 0.075347 
 
C 4.723821 -0.166102 -0.336508 
N 0.594198 0.152079 0.151545 
 
H 4.871767 1.677169 0.797648 
C 0.300638 -2.265597 0.751086 
 
H 4.325239 -1.994891 -1.362514 
H -0.373601 -2.635677 1.538777 
 
H 5.798004 -0.227497 -0.510828 
         
         II 
        
         C 3.361839 -0.698275 -1.153594 
 
H 2.306171 -2.490396 -0.583378 
C 2.294988 -1.404543 -0.590440 
 
H 2.306846 2.490174 -0.582738 
C 1.219743 -0.702266 -0.049487 
 
H 4.196446 1.240790 -1.588974 
C 1.219837 0.702209 -0.049466 
 
H -4.196300 -1.241045 -1.589089 
C 2.295343 1.404322 -0.590110 
 
H -4.196170 1.240958 -1.589403 
C 3.362043 0.697915 -1.153369 
 
H -2.306388 2.490256 -0.583264 
C -0.000028 -1.293439 0.623934 
 
C -0.000016 -2.795105 0.840507 
C 0.000073 1.293468 0.623934 
 
H -0.000187 -3.334817 -0.112300 
C -1.219786 0.702184 -0.049532 
 
H 0.884123 -3.096053 1.409898 
C -1.219808 -0.702267 -0.049435 
 
H -0.883982 -3.096068 1.410169 
C -2.295228 -1.404461 -0.590145 
 
C -0.000013 2.795236 0.839957 
H -2.306682 -2.490314 -0.582797 
 
H 0.000128 3.334477 -0.113097 
C -3.361974 -0.698111 -1.153407 
 
H -0.884148 3.096365 1.409258 
C -3.361899 0.698066 -1.153567 
 
H 0.883930 3.096524 1.409496 
C -2.295088 1.404414 -0.590391 
 
N 0.000075 0.610802 2.052985 
H 4.196030 -1.241245 -1.589486 
 
N -0.000072 -0.610186 2.053211 
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VI 
        
         C -4.399150 -1.363393 -0.469632 
 
H 2.502314 -0.837417 1.894386 
C -3.441133 -1.913541 0.381244 
 
C 3.847176 -1.281405 -1.714593 
C -2.097321 -1.536601 0.290397 
 
H 1.771530 -1.275058 -2.311171 
C -1.675371 -0.582201 -0.691484 
 
C 4.744844 -1.222299 -0.648607 
C -2.678679 -0.013738 -1.525790 
 
H 4.947542 -1.024890 1.491089 
C -4.002809 -0.405552 -1.415179 
 
H 4.211213 -1.420263 -2.729125 
H -5.439552 -1.663452 -0.391800 
 
H 5.813488 -1.299952 -0.827409 
H -3.744170 -2.634508 1.134114 
 
C 0.846486 2.253722 0.740857 
C -1.077727 -2.028998 1.206558 
 
C 0.833628 3.271285 1.668317 
C -0.302081 -0.240556 -0.775238 
 
C 0.107232 2.210322 -0.422617 
H -4.743955 0.038980 -2.074798 
 
C -0.032617 4.350353 1.423046 
N 0.183142 -1.746991 1.086620 
 
H 1.457635 3.250302 2.558806 
N 0.587294 -0.924830 0.062482 
 
C -0.739191 3.310056 -0.653020 
C -1.433916 -2.924457 2.364156 
 
C -0.809440 4.363421 0.263178 
H -2.145523 -2.435018 3.040358 
 
H -0.094807 5.169962 2.135390 
H -1.901009 -3.854476 2.016569 
 
H -1.338897 3.343344 -1.561482 
H -0.529412 -3.174496 2.921742 
 
H -1.473582 5.200814 0.065979 
C 1.991898 -1.007581 -0.184493 
 
C 0.184599 1.038829 -1.407145 
C 2.890069 -0.959073 0.889686 
 
H 1.215246 0.938703 -1.755058 
C 2.473610 -1.186281 -1.487666 
 
H -0.415494 1.274228 -2.289780 
C 4.256890 -1.068648 0.653205 
 
H -2.407609 0.723962 -2.272611 
         
         VII 
        
         C -4.576084 -0.394838 -0.611979 
 
H 2.033044 -0.744093 1.809091 
C -3.752915 -1.210513 0.158551 
 
C 3.819943 -1.628701 -1.515887 
C -2.360536 -1.026601 0.160864 
 
H 1.828022 -1.721870 -2.355894 
C -1.791135 -0.009132 -0.632266 
 
C 4.574052 -1.414769 -0.361209 
C -2.630256 0.813372 -1.387523 
 
H 4.510972 -0.938207 1.741771 
C -4.012625 0.621642 -1.384694 
 
H 4.311095 -1.893740 -2.448416 
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H -5.651922 -0.547095 -0.605736 
 
H 5.656643 -1.503999 -0.391832 
H -4.190755 -1.999789 0.761701 
 
C 0.078566 1.394479 0.424783 
C -1.457073 -1.878330 0.939417 
 
C 0.008226 1.860542 1.731178 
C -0.289968 0.215138 -0.514016 
 
C 0.602169 2.156703 -0.615351 
H -4.647009 1.272765 -1.979912 
 
C 0.504278 3.155124 1.946843 
N -0.180436 -1.899075 0.727609 
 
H -0.405118 1.275843 2.548533 
N 0.347370 -1.095353 -0.259335 
 
C 1.084980 3.443084 -0.418103 
C -1.980809 -2.835800 1.978335 
 
C 1.026687 3.927218 0.897934 
H -2.561597 -2.317285 2.751855 
 
H 0.480677 3.576322 2.948853 
H -2.638493 -3.595047 1.534310 
 
H 1.493042 4.054108 -1.219297 
H -1.139302 -3.346896 2.450838 
 
H 1.395184 4.926838 1.114579 
C 1.784327 -1.184314 -0.278795 
 
C 0.388886 1.078052 -1.663464 
C 2.541274 -0.980190 0.880416 
 
H 1.308406 0.635481 -2.050915 
C 2.428505 -1.523817 -1.472801 
 
H -0.258494 1.315577 -2.512460 
C 3.929964 -1.097732 0.837165 
 
H -2.215661 1.628393 -1.971375 
         
         VIII 
        
         C 3.197695 2.616198 -0.130894 
 
H -3.754344 1.165378 1.208448 
C 1.865995 3.144717 -0.337755 
 
C -3.728199 -2.127944 -0.836916 
C 0.781201 2.339833 -0.122324 
 
H -1.667197 -1.651278 -1.268090 
C 0.943278 0.976775 0.334116 
 
C -4.902638 -1.719468 -0.203407 
C 2.313542 0.438657 0.752307 
 
H -5.825273 -0.199802 1.019283 
C 3.428880 1.377642 0.348059 
 
H -3.714602 -3.039911 -1.427583 
H 4.042898 3.261939 -0.360482 
 
H -5.805262 -2.318054 -0.287270 
H 1.747198 4.169879 -0.669692 
 
C 2.455449 -1.014223 0.280440 
C -0.608712 2.751250 -0.296701 
 
C 3.613431 -1.549551 -0.285683 
C -0.136770 0.156386 0.444067 
 
C 1.332353 -1.841294 0.452321 
H 4.447832 1.046494 0.527950 
 
C 3.665210 -2.895223 -0.659575 
N -1.624231 1.947171 -0.184495 
 
H 4.478192 -0.915368 -0.452848 
N -1.405014 0.628934 0.120032 
 
C 1.386090 -3.183834 0.074974 
C -0.940600 4.177440 -0.641022 
 
C 2.554064 -3.716497 -0.475273 
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H -0.551623 4.864307 0.120934 
 
H 4.573506 -3.296526 -1.101515 
H -0.480336 4.462179 -1.595672 
 
H 0.510501 -3.815533 0.209393 
H -2.022581 4.300347 -0.718303 
 
H 2.589704 -4.762603 -0.767429 
C -2.577292 -0.180190 0.019209 
 
C 0.077137 -1.220115 1.035406 
C -3.756781 0.238158 0.646154 
 
H -0.781991 -1.877897 0.907586 
C -2.569291 -1.356862 -0.740072 
 
H 2.324718 0.371744 1.862102 
C -4.913221 -0.529596 0.529238 
 
H 0.208457 -1.091585 2.124406 
         
         TS1 
        
         C -4.609661 -0.089678 -0.041643 
 
H 1.148405 -2.430970 0.036955 
C -3.669966 0.921442 -0.033311 
 
H -0.281549 -2.946984 0.971889 
C -2.290305 0.607765 -0.007252 
 
C -1.549392 3.071264 -0.007934 
C -1.882505 -0.750406 0.008909 
 
H -2.113293 3.356240 -0.904378 
C -2.863953 -1.770317 0.000748 
 
H -2.145887 3.366239 0.863842 
C -4.204455 -1.441981 -0.024101 
 
H -0.610078 3.626696 0.006051 
H -5.668132 0.153815 -0.061502 
 
C 2.553161 -0.152163 0.006849 
H -3.986847 1.959043 -0.046410 
 
C 2.980671 1.152448 0.043042 
C -1.249246 1.595617 0.005721 
 
C 3.120440 -1.308246 -0.042937 
C -0.469170 -1.022871 0.036198 
 
C 4.386722 1.200539 0.015587 
H -2.558274 -2.810687 0.014910 
 
H 2.350208 2.031091 0.083768 
H -4.954659 -2.227547 -0.030199 
 
C 4.530758 -1.240776 -0.071042 
N 0.023042 1.266710 0.030167 
 
C 5.146670 0.019851 -0.040688 
N 0.400334 -0.032128 0.045249 
 
H 4.883065 2.168141 0.038380 
C 0.055685 -2.432837 0.063219 
 
H 5.152140 -2.136677 -0.114192 
H -0.324384 -3.000195 -0.794873 
 
H 6.232928 0.091820 -0.060343 
         
         TS2 
        
         C 2.898836 0.704697 -1.828732 
 
H 1.418491 -3.303474 1.393131 
C 2.148072 1.404715 -0.901746 
 
H -0.244868 -3.087460 1.970188 
C 1.384431 0.707542 0.059406 
 
C 0.450027 2.838847 1.165316 
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C 1.384423 -0.707537 0.059543 
 
H 1.418534 3.303739 1.392477 
C 2.148056 -1.404906 -0.901473 
 
H 0.087539 3.270620 0.226961 
C 2.898828 -0.705078 -1.828595 
 
H -0.244818 3.087852 1.969605 
H 3.491560 1.242669 -2.563412 
 
C -3.578865 0.701960 -1.164673 
H 2.150685 2.490057 -0.907038 
 
C -2.535447 1.446483 -0.574736 
C 0.582214 1.340690 1.076495 
 
C -1.562070 0.636399 -0.016557 
C 0.582196 -1.340479 1.076753 
 
C -1.562073 -0.636386 -0.016427 
H 2.150656 -2.490249 -0.906551 
 
C -2.535454 -1.446580 -0.574438 
H 3.491546 -1.243200 -2.563170 
 
C -3.578868 -0.702175 -1.164528 
N 0.188442 0.662144 2.169970 
 
H -4.407835 1.231948 -1.628709 
N 0.188434 -0.661718 2.170097 
 
H -2.537538 2.533136 -0.576211 
C 0.449993 -2.838618 1.165862 
 
H -2.537550 -2.533234 -0.575689 
H 0.087518 -3.270569 0.227584 
 
H -4.407841 -1.232254 -1.628455 
         
         TS3 
        
         C -3.466985 0.700253 -1.009464 
 
H -2.369819 2.487539 -0.536172 
C -2.358323 1.401776 -0.544310 
 
H -2.369820 -2.487539 -0.536170 
C -1.222036 0.706194 -0.110284 
 
H -4.336356 -1.242937 -1.370631 
C -1.222037 -0.706194 -0.110285 
 
H 4.336356 1.242936 -1.370631 
C -2.358324 -1.401776 -0.544309 
 
H 4.336355 -1.242937 -1.370632 
C -3.466986 -0.700253 -1.009463 
 
H 2.369819 -2.487539 -0.536171 
C 0.000000 1.327411 0.454881 
 
C 0.000000 2.818426 0.702998 
C 0.000000 -1.327411 0.454881 
 
H 0.000002 3.380327 -0.238499 
C 1.222037 -0.706194 -0.110284 
 
H -0.883413 3.111054 1.277315 
C 1.222037 0.706194 -0.110283 
 
H 0.883411 3.111053 1.277319 
C 2.358324 1.401776 -0.544309 
 
C 0.000000 -2.818426 0.702997 
H 2.369821 2.487539 -0.536170 
 
H -0.000008 -3.380326 -0.238500 
C 3.466986 0.700252 -1.009463 
 
H 0.883417 -3.111055 1.277310 
C 3.466986 -0.700253 -1.009463 
 
H -0.883408 -3.111053 1.277323 
C 2.358323 -1.401776 -0.544309 
 
N -0.000001 -0.592425 2.074125 
H -4.336355 1.242937 -1.370632 
 
N -0.000001 0.592424 2.074125 
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         TS8 
        
         C 4.508189 -0.243863 0.056127 
 
C 1.764839 3.123144 0.719554 
C 3.658886 0.823741 0.279179 
 
H 2.305533 3.107782 1.673244 
C 2.268072 0.673038 0.095757 
 
H 2.431664 3.560867 -0.032560 
C 1.739811 -0.574171 -0.326215 
 
H 0.885793 3.760491 0.827384 
C 2.629618 -1.653793 -0.541907 
 
C -1.921324 0.310286 -0.139860 
C 3.988106 -1.488026 -0.350183 
 
C -2.565303 1.400700 -0.747175 
H 5.578293 -0.125802 0.199077 
 
C -2.559493 -0.742247 0.521606 
H 4.058601 1.779645 0.600060 
 
C -3.952992 1.444627 -0.711483 
C 1.328095 1.738706 0.320244 
 
H -1.994896 2.188063 -1.231220 
C 0.314965 -0.705094 -0.511744 
 
C -3.965186 -0.637939 0.527165 
H 2.244996 -2.622558 -0.834828 
 
C -4.656526 0.419132 -0.064651 
H 4.659356 -2.326515 -0.510152 
 
H -4.482308 2.269261 -1.181615 
N 0.039900 1.564156 0.213220 
 
H -4.538756 -1.422484 1.021702 
N -0.450473 0.344720 -0.160057 
 
H -5.744156 0.454162 -0.030079 
C -0.293379 -1.949846 -1.012018 
 
O -1.492075 -3.003709 1.327392 
H 0.392827 -2.493974 -1.663159 
 
H -1.973653 -1.941358 1.060128 
H -0.599715 -2.587909 -0.114222 
 
H -0.901055 -2.810480 2.075186 
H -1.230172 -1.752032 -1.536604 
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Table A3.2. Cartesian Coordinates of the Hartree-Fock Stationary Points of rac-9a. 
C 2.20696 0.76325 -0.3341 
 
C 1.11612 3.31742 -0.46768 
C 0.82603 0.94612 -0.35276 
 
H 0.7082 4.30516 -0.50629 
C 0.27449 2.2133 -0.38958 
 
C 2.48478 3.14686 -0.47866 
C 2.74129 -0.61423 -0.1653 
 
H 3.12928 4.0015 -0.52877 
C 1.92432 -1.57456 0.43809 
 
C 3.0297 1.87896 -0.393 
C 0.49591 -1.21113 0.81193 
 
H 4.09302 1.7639 -0.34537 
C -0.03764 -0.30094 -0.32033 
 
C 4.02651 -0.96582 -0.55972 
N -1.45794 0.02697 -0.16176 
 
H 4.64618 -0.24916 -1.05983 
N -1.95829 1.32841 -0.19055 
 
C 4.51144 -2.23995 -0.33333 
C -1.19419 2.32991 -0.30283 
 
H 5.50379 -2.49675 -0.64628 
C -2.45495 -0.96249 -0.24275 
 
C 3.71119 -3.18123 0.28805 
H 0.1114 -0.82195 -1.26367 
 
H 4.0815 -4.17109 0.46669 
H -0.09384 -2.11601 0.84248 
 
C 2.42247 -2.84629 0.66332 
C 0.41677 -0.5287 2.18898 
 
H 1.7946 -3.58111 1.1292 
H 0.75732 -1.21188 2.95825 
 
C -2.18446 -2.22809 -0.75263 
H 1.03793 0.35618 2.21766 
 
H -1.21196 -2.47118 -1.12343 
H -0.60637 -0.24707 2.40557 
 
C -3.17561 -3.19447 -0.8074 
C -1.78047 4.33937 1.11752 
 
H -2.93794 -4.16064 -1.20754 
H -2.25432 5.31479 1.11156 
 
C -4.45338 -2.92204 -0.3661 
H -2.29545 3.71083 1.83356 
 
H -5.21803 -3.67112 -0.40973 
H -0.75544 4.45835 1.44599 
 
C -4.73074 -1.65756 0.13039 
C -1.85504 3.69097 -0.28521 
 
H -5.71875 -1.42265 0.4749 
H -2.8928 3.54707 -0.5516 
 
C -3.75204 -0.69026 0.19383 
H -1.40829 4.34049 -1.02783 
 
H -3.9733 0.28421 0.56633 
 
 
Table A3.3. Total Nuclear Spin-Spin Coupling J (Hz) of rac-9a. 
 
1 2 3 4 5 
1 0.000000D+00 
    2 0.853201D+02 0.000000D+00 
   3 0.142999D+02 0.668013D+02 0.000000D+00 
  4 0.554313D+02 0.282370D+01 0.644484D+01 0.000000D+00 
 5 0.156293D+02 -0.380570D+01 -0.638945D+01 0.178973D+02 0.000000D+00 
6 -0.804260D+00 -0.716853D+01 0.104092D+01 0.104709D+02 0.503339D+02 
7 -0.305024D+01 0.673358D+02 -0.150453D+01 -0.532962D+01 0.400108D+01 
8 0.701566D+01 -0.694195D+01 0.692185D+01 0.157938D+01 -0.474420D+00 
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9 0.408250D+02 -0.412005D+02 0.322391D+02 0.126638D+02 -0.190798D+02 
10 -0.986843D+02 0.100143D+03 -0.130296D+02 -0.308980D+02 0.474395D+02 
11 0.490428D+01 -0.231699D+01 0.296101D+01 0.143102D+01 -0.254627D+01 
12 0.637506D+01 -0.141815D+02 -0.153961D+01 0.142871D+01 -0.160335D+00 
13 0.423943D+00 0.682231D+01 -0.101184D+00 -0.693798D+00 -0.560225D+01 
14 0.282360D+01 0.979302D+00 -0.150963D+01 -0.895230D+01 0.253450D+01 
15 -0.261765D+00 -0.269791D+00 0.237411D+00 0.795186D+00 0.139135D+01 
16 0.113238D+00 0.173067D+00 0.507249D+00 0.100774D+01 0.164803D+01 
17 0.747255D+00 -0.535242D+00 -0.374905D-01 -0.195778D+01 0.107416D+02 
18 -0.190678D+02 0.193673D+02 -0.146322D+02 -0.581611D+01 0.913850D+01 
19 -0.206132D+01 0.203174D+01 -0.186687D+01 -0.637601D+00 0.917674D+00 
20 0.171554D+01 -0.182113D+01 0.124677D+01 0.624642D+00 -0.101528D+01 
21 0.239139D+01 -0.240588D+01 0.185255D+01 0.605559D+00 -0.108204D+01 
22 0.198123D+02 -0.181458D+02 0.176158D+02 0.590214D+01 -0.931939D+01 
23 -0.752692D+01 0.832443D+01 -0.165225D+01 -0.230595D+01 0.362438D+01 
24 -0.165698D+02 0.167397D+02 -0.117933D+02 -0.503533D+01 0.791419D+01 
25 0.578862D+01 0.455902D+01 0.651546D+02 0.202694D+01 -0.342355D+01 
26 -0.153647D+01 0.227506D+01 0.492892D+01 -0.126899D+01 0.151833D+01 
27 -0.762981D+01 0.461599D+01 0.161020D+02 0.133083D+00 0.484133D+01 
28 0.101663D+02 -0.306381D+01 -0.874444D+00 0.189787D+01 -0.205957D+01 
29 0.899149D+02 0.267524D+01 -0.148027D+02 0.400754D+01 -0.469432D+01 
30 -0.645239D+01 0.306551D+01 0.775118D+01 0.123350D+01 0.212871D+01 
31 0.158549D+02 -0.276263D+01 -0.595922D+01 0.227856D+02 0.628211D+02 
32 -0.459774D+01 0.212822D+01 0.297433D+01 0.206982D+02 -0.220301D+02 
33 -0.149313D+02 0.603722D+01 0.715030D+01 0.613232D+02 -0.577447D+02 
34 0.910055D+01 -0.256986D+01 -0.344535D+01 -0.201071D+02 0.244676D+02 
35 0.173626D+02 -0.574331D+01 -0.683916D+01 -0.577044D+02 0.617504D+02 
36 -0.795660D+01 0.248072D+01 0.308913D+01 0.248395D+02 -0.209318D+02 
37 -0.154339D+02 0.544868D+01 0.708886D+01 0.621307D+02 0.261983D+02 
38 0.926091D+01 -0.274185D+01 -0.350097D+01 -0.209217D+02 0.204700D+02 
39 -0.823889D+01 0.852772D+01 -0.636058D+01 -0.255571D+01 0.431011D+01 
40 0.342488D+01 -0.356780D+01 0.253395D+01 0.116367D+01 -0.158784D+01 
41 0.883836D+01 -0.916111D+01 0.680442D+01 0.276608D+01 -0.455652D+01 
42 -0.398713D+01 0.406984D+01 -0.302845D+01 -0.122776D+01 0.209467D+01 
43 -0.861259D+01 0.887474D+01 -0.662608D+01 -0.269750D+01 0.444170D+01 
44 0.366497D+01 -0.386882D+01 0.272227D+01 0.107587D+01 -0.197060D+01 
45 0.856156D+01 -0.872757D+01 0.660851D+01 0.266909D+01 -0.443716D+01 
46 -0.391713D+01 0.401133D+01 -0.299352D+01 -0.130182D+01 0.205138D+01 
47 -0.888130D+01 0.939722D+01 -0.683017D+01 -0.279915D+01 0.459061D+01 
48 0.324427D+01 -0.348181D+01 0.246017D+01 0.944801D+00 -0.180077D+01 
      
 
6 7 8 9 10 
6 0.000000D+00 
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7 0.699687D+02 0.000000D+00 
   8 0.110172D+01 0.217773D+02 0.000000D+00 
  9 -0.103909D+01 0.547412D+01 -0.689192D+01 0.000000D+00 
 10 0.264707D+01 -0.161983D+02 0.559465D+01 0.527854D+02 0.000000D+00 
11 -0.916054D+00 0.122732D+01 0.206367D+02 0.232449D+01 0.857413D+01 
12 -0.580408D+01 0.188006D+03 -0.256954D+01 -0.124327D+02 0.318521D+02 
13 0.173520D+03 -0.103763D+02 0.488645D+00 -0.137482D+01 0.324807D+01 
14 0.539581D+02 -0.499265D+01 -0.360865D-01 -0.347794D+01 0.894712D+01 
15 -0.793365D+01 0.962368D+01 -0.206526D+00 0.243476D+00 -0.798349D+00 
16 -0.902724D+01 0.258794D+01 -0.898960D-01 0.583563D-01 -0.161237D+00 
17 -0.101962D+02 0.297015D+01 -0.202531D+00 -0.848000D+00 0.240416D+01 
18 0.572513D+00 -0.410349D+01 0.149447D+01 0.912549D+01 -0.274972D+02 
19 0.161535D-01 -0.536096D+00 0.286721D+00 0.950063D+00 0.826882D+01 
20 -0.587346D-01 0.441693D+00 -0.690111D-01 -0.921088D+00 0.443057D+01 
21 -0.941146D-01 0.515981D+00 -0.172040D+00 -0.115983D+01 0.531027D+01 
22 -0.513274D+00 0.403777D+01 0.155433D+01 -0.478408D+01 0.915655D+02 
23 0.218716D+00 -0.162412D+01 0.294155D+00 0.481907D+01 -0.209977D+02 
24 0.370807D+00 -0.356713D+01 0.199745D+01 0.102310D+02 -0.266335D+02 
25 -0.337178D-01 0.411329D+01 -0.617877D+01 -0.409050D+02 0.103231D+03 
26 -0.311247D+00 0.299843D-01 0.204913D+01 0.159739D+02 -0.392980D+02 
27 0.560467D+00 -0.380462D+01 0.668897D+01 0.444435D+02 -0.106815D+03 
28 -0.630755D+00 0.211756D+01 -0.244182D+01 -0.180693D+02 0.480035D+02 
29 0.370504D+00 0.478513D+01 -0.624142D+01 -0.419410D+02 0.104084D+03 
30 -0.429508D+00 0.226692D+00 0.218950D+01 0.161161D+02 -0.424147D+02 
31 -0.103212D+02 0.764503D+01 -0.258411D+01 -0.189722D+02 0.475222D+02 
32 0.689638D+01 -0.387858D+01 0.880939D+00 0.758520D+01 -0.201752D+02 
33 0.116058D+02 -0.789707D+01 0.293923D+01 0.214550D+02 -0.536966D+02 
34 -0.559186D+01 0.366889D+01 -0.115262D+01 -0.911648D+01 0.235810D+02 
35 -0.910190D+01 0.829019D+01 -0.270820D+01 -0.205811D+02 0.515935D+02 
36 0.650624D+01 -0.376369D+01 0.105081D+01 0.824554D+01 -0.214500D+02 
37 0.973119D+01 -0.488635D+01 0.308134D+01 0.217044D+02 -0.542957D+02 
38 -0.192684D+01 0.352109D+01 -0.106868D+01 -0.889001D+01 0.233443D+02 
39 0.200692D+01 0.141257D+01 -0.106514D+01 0.369870D+01 -0.943779D+01 
40 0.241716D+00 0.123219D+00 0.702061D+00 -0.114688D+01 0.395222D+01 
41 -0.731897D+00 -0.122916D+00 0.204307D+01 -0.280216D+01 0.109625D+02 
42 0.338139D+00 0.539193D-03 0.182868D+00 0.125067D+01 -0.465530D+01 
43 0.856516D+00 0.196944D+00 -0.835245D+00 0.291414D+01 -0.104707D+02 
44 -0.462353D+00 -0.979631D-01 0.809789D-01 -0.109962D+01 0.431203D+01 
45 -0.728377D+00 -0.148787D+00 0.198620D+01 -0.266335D+01 0.104587D+02 
46 0.257207D+00 0.338007D+00 0.673262D-01 0.109809D+01 -0.470969D+01 
47 0.727584D+00 0.191579D+01 -0.170769D+01 0.497320D+01 -0.107818D+02 
48 -0.387628D+00 -0.566331D+00 0.908002D+00 -0.116320D+01 0.383635D+01 
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11 12 13 14 15 
11 0.000000D+00 
    12 0.196104D+01 0.000000D+00 
   13 -0.844874D-01 0.484993D+01 0.000000D+00 
  14 -0.660327D+00 0.583082D+01 -0.857473D+01 0.000000D+00 
 15 0.347765D-01 0.226073D+00 0.556904D+01 0.153823D+03 0.000000D+00 
16 -0.934459D-01 -0.143551D+01 0.143023D+02 0.155645D+03 -0.301534D+02 
17 0.169592D+00 -0.155795D+01 0.477094D+01 0.154597D+03 -0.303750D+02 
18 0.119390D+01 0.693220D+01 0.669947D+00 0.185675D+01 -0.238362D+00 
19 0.112932D+00 0.435142D+00 -0.158070D+00 0.168204D+00 -0.252069D+00 
20 -0.135302D+00 -0.995745D+00 -0.153676D+00 -0.154382D+00 -0.950355D-02 
21 -0.207986D+00 -0.116390D+01 -0.266400D+00 -0.214645D+00 -0.485049D-01 
22 -0.153908D+01 -0.747489D+01 -0.828317D+00 -0.195605D+01 0.178273D+00 
23 0.471140D+00 0.257973D+01 0.760342D-01 0.717272D+00 -0.335525D+00 
24 0.771277D+00 0.620167D+01 0.383917D+00 0.160647D+01 -0.478522D+00 
25 -0.490153D+01 -0.301497D+01 0.150544D+00 -0.415761D+00 -0.827788D-01 
26 0.188355D+01 0.490764D+00 -0.212070D+00 0.180814D+00 -0.315452D+00 
27 0.510283D+01 0.505823D+01 0.380954D-01 0.681567D+00 -0.665972D-01 
28 -0.233051D+01 -0.367565D+01 -0.552726D+00 -0.412280D+00 -0.266829D+00 
29 -0.475731D+01 -0.390313D+01 -0.568021D+00 -0.119446D+01 0.277798D-01 
30 0.209989D+01 0.607469D+00 -0.246753D+00 0.331206D+00 -0.250843D+00 
31 -0.220880D+01 -0.262907D+01 0.499658D+01 0.966064D+01 -0.969635D+00 
32 0.893391D+00 0.130191D+01 -0.229104D+01 -0.480535D+01 0.216278D+00 
33 0.246311D+01 0.294791D+01 -0.477047D+01 -0.908798D+01 0.857056D+00 
34 -0.126040D+01 -0.166864D+01 0.172686D+01 0.397611D+01 -0.698154D+00 
35 -0.240120D+01 -0.298593D+01 0.471115D+01 0.942597D+01 -0.927902D+00 
36 0.948784D+00 0.131302D+01 -0.268588D+01 -0.469293D+01 0.359356D+00 
37 0.259053D+01 0.268511D+01 -0.115893D+00 -0.817508D+01 0.684934D+00 
38 -0.109207D+01 -0.151634D+01 0.233744D+01 0.383245D+01 -0.119922D-01 
39 0.259961D+02 -0.518659D+00 0.529765D+00 0.877993D+00 -0.692805D-01 
40 0.211662D+02 0.898434D+00 0.643225D+00 -0.416529D+00 0.565934D-02 
41 0.705939D+02 0.665278D+00 -0.209896D+00 -0.100944D+01 0.893274D-01 
42 -0.228581D+02 -0.283100D+00 0.456224D+00 0.462288D+00 -0.170087D+00 
43 -0.667500D+02 -0.701990D+00 0.398378D+00 0.981632D+00 -0.113281D+00 
44 0.280767D+02 0.101797D+00 -0.193559D+00 -0.513253D+00 -0.124514D+00 
45 0.703708D+02 0.775680D+00 -0.422626D+00 -0.984163D+00 0.707920D-01 
46 -0.216259D+02 -0.740666D+00 0.507399D-01 0.448784D+00 -0.225072D+00 
47 0.241132D+02 -0.108799D+01 0.493611D+00 0.102501D+01 -0.105183D+00 
48 0.216557D+02 0.192080D+00 -0.353564D+00 -0.435180D+00 -0.930245D-01 
      
 
16 17 18 19 20 
16 0.000000D+00 
    17 -0.296909D+02 0.000000D+00 
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18 -0.475723D-01 0.463067D+00 0.000000D+00 
  19 -0.117678D+00 -0.467261D-01 0.150914D+03 0.000000D+00 
 20 0.234177D+00 0.408977D+00 0.157668D+03 -0.302788D+02 0.000000D+00 
21 0.391510D+00 0.145210D+00 0.153220D+03 -0.298929D+02 -0.302484D+02 
22 0.119811D+00 -0.395851D+00 0.601605D+02 -0.827348D+01 -0.100645D+02 
23 -0.206029D+00 0.166503D+00 -0.124984D+02 0.420368D+01 0.638756D+01 
24 -0.199889D+00 0.191964D+00 -0.138416D+02 0.469110D+01 0.155849D+02 
25 0.728824D-01 -0.281971D+00 0.200350D+02 0.197106D+01 -0.197084D+01 
26 0.331159D-02 -0.119706D+00 -0.870751D+01 -0.770522D+00 0.735824D+00 
27 0.147670D+00 0.318451D+00 -0.209318D+02 -0.225021D+01 0.192977D+01 
28 -0.114567D+00 -0.398566D+00 0.100229D+02 0.102562D+01 -0.132973D+01 
29 0.260869D+00 -0.472108D+00 0.199863D+02 0.204838D+01 -0.191613D+01 
30 0.604600D-01 -0.266872D+00 -0.917681D+01 -0.129037D+01 0.802977D+00 
31 -0.105574D+01 0.171243D+01 0.926148D+01 0.936860D+00 -0.106861D+01 
32 0.431536D+00 -0.119388D+01 -0.438233D+01 -0.668041D+00 0.352108D+00 
33 0.104927D+01 -0.158521D+01 -0.104767D+02 -0.114180D+01 0.113835D+01 
34 -0.729133D+00 0.347822D+00 0.497075D+01 0.397225D+00 -0.744141D+00 
35 -0.114818D+01 0.164928D+01 0.101059D+02 0.103102D+01 -0.116334D+01 
36 0.279524D+00 -0.116657D+01 -0.456242D+01 -0.641155D+00 0.336310D+00 
37 0.872059D+00 -0.188954D+01 -0.105644D+02 -0.114955D+01 0.115654D+01 
38 -0.729339D+00 0.630558D+00 0.499651D+01 0.433922D+00 -0.635887D+00 
39 0.101517D+00 0.173228D+00 -0.230348D+01 -0.371657D+00 0.214666D+00 
40 -0.122386D+00 -0.366405D-01 0.105229D+01 -0.632072D-01 -0.276635D+00 
41 -0.784059D-01 -0.736916D-01 0.250170D+01 0.298163D+00 -0.288160D+00 
42 -0.245159D+00 -0.643079D-01 -0.126083D+01 -0.363163D+00 -0.214588D-01 
43 -0.115478D-01 0.885083D-01 -0.245761D+01 -0.379006D+00 0.231041D+00 
44 -0.276338D+00 -0.226965D+00 0.110408D+01 0.276404D-02 -0.214959D+00 
45 -0.875450D-01 -0.350151D-01 0.242466D+01 0.307135D+00 -0.234775D+00 
46 -0.188524D+00 0.512215D-01 -0.122226D+01 -0.257975D+00 0.213498D+00 
47 0.186861D-01 0.216846D+00 -0.249926D+01 -0.376385D+00 0.289652D+00 
48 -0.810133D-01 0.363568D+00 0.111647D+01 0.166141D+00 0.451835D+00 
      
 
21 22 23 24 25 
21 0.000000D+00 
    22 -0.101863D+02 0.000000D+00 
   23 0.162771D+02 0.169876D+03 0.000000D+00 
  24 0.471921D+01 0.167946D+03 -0.314545D+02 0.000000D+00 
 25 -0.238076D+01 -0.196426D+02 0.820029D+01 0.174884D+02 0.000000D+00 
26 0.201257D+01 0.966149D+01 -0.425352D+01 -0.733912D+01 0.157202D+03 
27 0.273263D+01 0.213564D+02 -0.850489D+01 -0.181289D+02 0.939487D+02 
28 -0.123346D+01 -0.107503D+02 0.395765D+01 0.913636D+01 -0.788961D+01 
29 -0.252672D+01 -0.204548D+02 0.798378D+01 0.172566D+02 0.199838D+00 
30 0.106818D+01 0.956917D+01 -0.385537D+01 -0.847497D+01 0.475793D+01 
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31 -0.107594D+01 -0.944086D+01 0.363934D+01 0.805327D+01 -0.350653D+01 
32 0.516445D+00 0.457480D+01 -0.203047D+01 -0.406072D+01 0.138266D+01 
33 0.117877D+01 0.106843D+02 -0.422271D+01 -0.917302D+01 0.385763D+01 
34 -0.778586D+00 -0.536654D+01 0.176848D+01 0.442028D+01 -0.178468D+01 
35 -0.120094D+01 -0.103624D+02 0.399181D+01 0.881067D+01 -0.369521D+01 
36 0.483154D+00 0.471736D+01 -0.207510D+01 -0.418594D+01 0.142187D+01 
37 0.119929D+01 0.107800D+02 -0.424286D+01 -0.925888D+01 0.385664D+01 
38 -0.759454D+00 -0.534944D+01 0.196635D+01 0.438696D+01 -0.173451D+01 
39 0.243281D+00 0.239637D+01 -0.945514D+00 -0.159670D+01 0.861026D+01 
40 -0.275680D+00 -0.113942D+01 0.225637D+00 0.627811D+00 -0.361853D+01 
41 -0.356184D+00 -0.251078D+01 0.951145D+00 0.181066D+01 -0.929444D+01 
42 -0.268185D-01 0.119584D+01 -0.669487D+00 -0.106764D+01 0.410560D+01 
43 0.257601D+00 0.242922D+01 -0.985159D+00 -0.184101D+01 0.901379D+01 
44 -0.325980D+00 -0.117825D+01 0.345788D+00 0.634003D+00 -0.393046D+01 
45 -0.337851D+00 -0.242458D+01 0.978976D+00 0.170867D+01 -0.898942D+01 
46 -0.168815D-01 0.118933D+01 -0.373673D+00 -0.106351D+01 0.406093D+01 
47 0.268867D+00 0.246398D+01 -0.944177D+00 -0.189503D+01 0.937925D+01 
48 -0.179269D+00 -0.985078D+00 0.103423D+01 0.645008D+00 -0.349222D+01 
      
 
26 27 28 29 30 
26 0.000000D+00 
    27 -0.682129D+01 0.000000D+00 
   28 0.978095D+01 0.163872D+03 0.000000D+00 
  29 0.520501D+01 0.951142D+02 -0.889695D+01 0.000000D+00 
 30 0.130966D+01 -0.713058D+01 0.988199D+01 0.158502D+03 0.000000D+00 
31 0.160693D+01 0.476604D+01 -0.232453D+01 -0.574154D+01 0.240701D+01 
32 -0.977575D+00 -0.210856D+01 0.120929D+01 0.318621D+01 -0.552609D+00 
33 -0.191866D+01 -0.545239D+01 0.246126D+01 0.795599D+01 -0.277295D+01 
34 0.658676D+00 0.240225D+01 -0.138845D+01 -0.391601D+01 0.148083D+01 
35 0.169718D+01 0.517967D+01 -0.248702D+01 -0.777290D+01 0.258571D+01 
36 -0.114543D+01 -0.226456D+01 0.832107D+00 0.336107D+01 -0.137467D+01 
37 -0.192866D+01 -0.533125D+01 0.246280D+01 0.836281D+01 -0.279694D+01 
38 0.570540D+00 0.235893D+01 -0.157094D+01 -0.357686D+01 0.986761D+00 
39 -0.369960D+01 -0.911951D+01 0.408698D+01 0.864853D+01 -0.370761D+01 
40 0.144895D+01 0.374437D+01 -0.202711D+01 -0.363116D+01 0.170381D+01 
41 0.385773D+01 0.980699D+01 -0.453338D+01 -0.934039D+01 0.395775D+01 
42 -0.228882D+01 -0.444908D+01 0.197469D+01 0.418887D+01 -0.205341D+01 
43 -0.388269D+01 -0.955588D+01 0.432880D+01 0.906174D+01 -0.394929D+01 
44 0.154520D+01 0.405376D+01 -0.228488D+01 -0.399165D+01 0.160985D+01 
45 0.375385D+01 0.948933D+01 -0.437755D+01 -0.903069D+01 0.380265D+01 
46 -0.202137D+01 -0.438112D+01 0.187343D+01 0.408990D+01 -0.220282D+01 
47 -0.395716D+01 -0.994540D+01 0.444636D+01 0.945973D+01 -0.404715D+01 
48 0.194617D+01 0.365748D+01 -0.201093D+01 -0.362094D+01 0.138413D+01 
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31 32 33 34 35 
31 0.000000D+00 
    32 0.131498D+03 0.000000D+00 
   33 0.299736D+02 0.192125D+02 0.000000D+00 
  34 0.200108D+02 -0.281998D+01 0.134378D+03 0.000000D+00 
 35 0.604134D+02 -0.196256D+02 0.272252D+02 0.197813D+02 0.000000D+00 
36 -0.201501D+02 0.126590D+02 0.201386D+02 -0.339065D+01 0.133105D+03 
37 -0.574325D+02 0.241172D+02 0.586770D+02 -0.193009D+02 0.282983D+02 
38 0.239438D+02 -0.128521D+02 -0.188969D+02 0.123264D+02 0.197863D+02 
39 0.394820D+01 -0.179322D+01 -0.448136D+01 0.204951D+01 0.430608D+01 
40 -0.168204D+01 0.759743D+00 0.194568D+01 -0.107835D+01 -0.181109D+01 
41 -0.427018D+01 0.186847D+01 0.481859D+01 -0.232671D+01 -0.464978D+01 
42 0.194018D+01 -0.106859D+01 -0.222098D+01 0.974111D+00 0.213978D+01 
43 0.414511D+01 -0.190500D+01 -0.470501D+01 0.220020D+01 0.452218D+01 
44 -0.183749D+01 0.737264D+00 0.199825D+01 -0.114097D+01 -0.199370D+01 
45 -0.413170D+01 0.179442D+01 0.465290D+01 -0.225045D+01 -0.450080D+01 
46 0.194533D+01 -0.108933D+01 -0.227449D+01 0.946642D+00 0.212003D+01 
47 0.428790D+01 -0.195350D+01 -0.487044D+01 0.224097D+01 0.467368D+01 
48 -0.168389D+01 0.607701D+00 0.180189D+01 -0.110779D+01 -0.182219D+01 
      
 
36 37 38 39 40 
36 0.000000D+00 
    37 0.203216D+02 0.000000D+00 
   38 -0.324737D+01 0.133682D+03 0.000000D+00 
  39 -0.185959D+01 -0.462429D+01 0.211889D+01 0.000000D+00 
 40 0.851172D+00 0.211396D+01 -0.466257D+00 0.128518D+03 0.000000D+00 
41 0.196911D+01 0.499051D+01 -0.217840D+01 0.175865D+02 0.237931D+02 
42 -0.104368D+01 -0.226031D+01 0.127281D+01 0.264300D+02 -0.503083D+01 
43 -0.196891D+01 -0.485753D+01 0.218495D+01 0.727269D+02 -0.254755D+02 
44 0.794151D+00 0.207027D+01 -0.109797D+01 -0.255844D+02 0.149339D+02 
45 0.189194D+01 0.481402D+01 -0.215729D+01 -0.695358D+02 0.293435D+02 
46 -0.109185D+01 -0.234876D+01 0.931981D+00 0.289963D+02 -0.155080D+02 
47 -0.202869D+01 -0.502825D+01 0.223028D+01 0.749287D+02 -0.272220D+02 
48 0.830445D+00 0.187203D+01 -0.102304D+01 -0.288102D+02 0.169275D+02 
      
 
41 42 43 44 45 
41 0.000000D+00 
    42 0.126838D+03 0.000000D+00 
   43 0.130826D+02 0.258680D+02 0.000000D+00 
  44 0.268575D+02 -0.634390D+01 0.127882D+03 0.000000D+00 
 45 0.726286D+02 -0.247229D+02 0.112046D+02 0.271451D+02 0.000000D+00 
46 -0.246690D+02 0.155635D+02 0.260631D+02 -0.659593D+01 0.127525D+03 
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47 -0.715656D+02 0.300863D+02 0.739726D+02 -0.267091D+02 0.181295D+02 
48 0.313233D+02 -0.165923D+02 -0.263969D+02 0.159346D+02 0.254063D+02 
      
 
46 47 48 
  46 0.000000D+00 
    47 0.256107D+02 0.000000D+00 
   48 -0.475260D+01 0.133144D+03 0.000000D+00 
   
 
Table A3.4. Cartesian Coordinates of the Hartree-Fock Stationary Points of rac-9b. 
C 2.23216 0.75707 -0.42786 
 
H 4.03137 -4.13814 0.66281 
C 0.85975 0.9708 -0.33829 
 
C 2.46571 -2.71913 0.94127 
C 0.33338 2.24727 -0.36286 
 
H 1.90595 -3.37382 1.57551 
C 2.73745 -0.61824 -0.18306 
 
C -3.76885 -0.53303 0.10522 
C 1.97682 -1.45929 0.64465 
 
H -3.97231 0.41415 0.54997 
C 0.6204 -0.94524 1.14313 
 
C -4.78591 -1.43531 -0.11952 
C -0.00577 -0.25476 -0.11081 
 
H -5.78457 -1.17684 0.1738 
N -1.42412 0.09681 -0.01901 
 
C -4.53432 -2.66181 -0.7132 
N -1.8863 1.41514 0.07106 
 
H -5.32869 -3.35982 -0.88475 
C -1.10939 2.39903 -0.09592 
 
C -3.23967 -2.96315 -1.08151 
C -2.45545 -0.83491 -0.25854 
 
H -3.01728 -3.90176 -1.55028 
H 0.7975 -0.16119 1.87436 
 
C -2.20966 -2.06413 -0.86119 
H 0.13613 -0.91524 -0.9566 
 
H -1.224 -2.33835 -1.16716 
C 1.18493 3.32464 -0.58548 
 
C -0.24948 -2.01975 1.80827 
H 0.79652 4.32045 -0.62367 
 
H -1.21255 -1.60186 2.06502 
C 2.5404 3.11832 -0.73844 
 
H -0.41001 -2.87123 1.16158 
H 3.19192 3.95295 -0.90331 
 
H 0.22093 -2.36078 2.72391 
C 3.06837 1.84337 -0.63335 
 
C -1.41307 4.40095 1.42073 
H 4.12915 1.70248 -0.67741 
 
H -1.85476 5.38826 1.49793 
C 3.93641 -1.07044 -0.712 
 
H -1.82933 3.77613 2.20142 
H 4.49746 -0.43961 -1.37216 
 
H -0.34667 4.48867 1.58741 
C 4.4072 -2.33583 -0.41119 
 
C -1.72014 3.77634 0.03922 
H 5.33367 -2.67586 -0.82901 
 
H -2.78982 3.66414 -0.06882 
C 3.67441 -3.15634 0.42245 
 
H -1.37173 4.42515 -0.75509 
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Table A3.5. Total Nuclear Spin-Spin Coupling J (Hz) of rac-9b. 
 
1 2 3 4 5 
1 0.000000D+00 
    2 0.813947D+02 0.000000D+00 
   3 0.165516D+02 0.648508D+02 0.000000D+00 
  4 0.553559D+02 0.210383D+01 0.690854D+01 0.000000D+00 
 5 0.144759D+02 -0.366909D+01 -0.719958D+01 0.134437D+02 0.000000D+00 
6 0.155643D+00 -0.784429D+01 0.689118D+00 0.108690D+02 0.518446D+02 
7 -0.153124D+01 0.672640D+02 -0.170035D+01 -0.843788D+01 0.587909D+01 
8 0.613962D+01 -0.603145D+01 0.620754D+01 0.939212D+00 0.270666D+00 
9 0.400809D+02 -0.398766D+02 0.315549D+02 0.112852D+02 -0.175758D+02 
10 -0.955094D+02 0.954894D+02 -0.109253D+02 -0.277017D+02 0.438017D+02 
11 0.366579D+01 -0.159387D+01 0.201629D+01 0.942689D+00 -0.147664D+01 
12 0.426282D+01 0.481123D+01 -0.221678D+01 -0.150239D+02 0.590049D+01 
13 0.330450D+01 -0.119029D+02 -0.298120D+01 0.613560D+00 0.290431D+01 
14 0.317553D+01 0.732660D+01 0.628368D+02 0.114480D+01 -0.213388D+01 
15 -0.394121D+00 0.110100D+01 0.592219D+01 -0.909030D+00 0.980574D+00 
16 -0.463998D+01 0.133385D+01 0.185745D+02 0.117262D+01 0.334738D+01 
17 0.884245D+01 -0.159835D+01 -0.190350D+01 0.153325D+01 -0.146716D+01 
18 0.868256D+02 0.584676D+01 -0.171183D+02 0.349307D+01 -0.383610D+01 
19 -0.538804D+01 0.181517D+01 0.868577D+01 0.154020D+01 0.158957D+01 
20 0.142007D+02 -0.178843D+01 -0.646106D+01 0.228529D+02 0.647751D+02 
21 -0.375488D+01 0.172869D+01 0.319462D+01 0.207672D+02 -0.226507D+02 
22 -0.132038D+02 0.495638D+01 0.798563D+01 0.623260D+02 -0.598063D+02 
23 0.841972D+01 -0.215720D+01 -0.382504D+01 -0.207061D+02 0.253216D+02 
24 0.159337D+02 -0.475698D+01 -0.769581D+01 -0.589207D+02 0.640791D+02 
25 -0.741156D+01 0.208437D+01 0.344163D+01 0.254494D+02 -0.221054D+02 
26 -0.136350D+02 0.433464D+01 0.798855D+01 0.627467D+02 0.255847D+02 
27 0.859451D+01 -0.230080D+01 -0.384586D+01 -0.210127D+02 0.203931D+02 
28 -0.608082D+01 0.663955D+01 -0.458474D+01 -0.172519D+01 0.267037D+01 
29 0.204564D+01 -0.227661D+01 0.154819D+01 0.639051D+00 -0.108131D+01 
30 0.590059D+01 -0.602819D+01 0.451065D+01 0.166925D+01 -0.257642D+01 
31 -0.284758D+01 0.289204D+01 -0.215677D+01 -0.911530D+00 0.126811D+01 
32 -0.602479D+01 0.625174D+01 -0.457965D+01 -0.172244D+01 0.261497D+01 
33 0.256259D+01 -0.273679D+01 0.185963D+01 0.696166D+00 -0.117846D+01 
34 0.622396D+01 -0.650497D+01 0.473524D+01 0.177463D+01 -0.270524D+01 
35 -0.276309D+01 0.282603D+01 -0.209231D+01 -0.828371D+00 0.127232D+01 
36 -0.572476D+01 0.611983D+01 -0.435093D+01 -0.161554D+01 0.251072D+01 
37 0.254189D+01 -0.259307D+01 0.185382D+01 0.860771D+00 -0.949736D+00 
38 0.144385D-01 0.417403D+01 -0.357408D+00 0.101763D+01 -0.276790D+01 
39 -0.164451D+00 -0.523218D+00 0.101892D+00 0.110741D+01 0.886376D+01 
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40 -0.186192D+00 -0.526385D+00 0.528324D-01 0.229740D+00 0.171889D+01 
41 -0.201937D+00 0.163638D+00 0.102570D+00 0.139682D+00 0.109565D+01 
42 -0.182177D+02 0.181546D+02 -0.138669D+02 -0.524762D+01 0.840558D+01 
43 -0.182578D+01 0.171779D+01 -0.166712D+01 -0.533374D+00 0.768865D+00 
44 0.162352D+01 -0.168172D+01 0.117577D+01 0.586959D+00 -0.950866D+00 
45 0.229430D+01 -0.224813D+01 0.178614D+01 0.532146D+00 -0.973612D+00 
46 0.191817D+02 -0.171696D+02 0.169462D+02 0.538847D+01 -0.869834D+01 
47 -0.662874D+01 0.734187D+01 -0.850384D+00 -0.190036D+01 0.305005D+01 
48 -0.177148D+02 0.174969D+02 -0.126167D+02 -0.506205D+01 0.813641D+01 
      
 
6 7 8 9 10 
6 0.000000D+00 
    7 0.693095D+02 0.000000D+00 
   8 0.138700D+01 0.199164D+02 0.000000D+00 
  9 -0.333293D+01 0.427252D+01 -0.685355D+01 0.000000D+00 
 10 0.845282D+01 -0.133659D+02 0.430672D+01 0.520905D+02 0.000000D+00 
11 0.454552D+00 0.296312D+00 0.212379D+02 0.265004D+01 0.725470D+01 
12 0.176799D+03 -0.799900D+01 -0.482083D+00 -0.507664D+01 0.130097D+02 
13 -0.557871D+01 0.189589D+03 -0.234727D+01 -0.945206D+01 0.236168D+02 
14 -0.108999D+01 0.380466D+01 -0.528057D+01 -0.406181D+02 0.101161D+03 
15 0.846025D-01 0.224001D+00 0.177749D+01 0.158854D+02 -0.385453D+02 
16 0.196634D+01 -0.324233D+01 0.569031D+01 0.438887D+02 -0.103955D+03 
17 -0.136516D+01 0.181764D+01 -0.205122D+01 -0.178518D+02 0.468373D+02 
18 -0.760209D+00 0.400459D+01 -0.533443D+01 -0.412454D+02 0.100865D+03 
19 -0.657622D-02 0.438547D+00 0.190370D+01 0.159833D+02 -0.413825D+02 
20 -0.110105D+02 0.105381D+02 -0.171770D+01 -0.168525D+02 0.422231D+02 
21 0.708731D+01 -0.528209D+01 0.588428D+00 0.688625D+01 -0.182308D+02 
22 0.122293D+02 -0.106129D+02 0.201318D+01 0.195611D+02 -0.490411D+02 
23 -0.590365D+01 0.493128D+01 -0.916688D+00 -0.872809D+01 0.221607D+02 
24 -0.102811D+02 0.110055D+02 -0.183023D+01 -0.189416D+02 0.475199D+02 
25 0.684809D+01 -0.523560D+01 0.841420D+00 0.788242D+01 -0.201275D+02 
26 0.103416D+02 -0.838689D+01 0.219694D+01 0.198178D+02 -0.496555D+02 
27 -0.330306D+01 0.450784D+01 -0.752724D+00 -0.823668D+01 0.214988D+02 
28 -0.119787D+01 0.275893D+01 -0.223721D+01 0.375456D+01 -0.784496D+01 
29 0.588725D+00 -0.914758D+00 0.106463D+01 -0.688469D+00 0.272502D+01 
30 0.117149D+01 -0.864925D+00 0.246262D+01 -0.131603D+01 0.773131D+01 
31 -0.626442D+00 0.701933D+00 -0.135239D+00 0.565177D+00 -0.366551D+01 
32 -0.115620D+01 0.914946D+00 -0.134245D+01 0.165378D+01 -0.781556D+01 
33 0.474458D+00 -0.416508D+00 0.276992D+00 -0.558382D+00 0.319395D+01 
34 0.114306D+01 -0.772471D+00 0.257200D+01 -0.154652D+01 0.826778D+01 
35 -0.587828D+00 0.380028D+00 -0.312313D-01 0.666097D+00 -0.352595D+01 
36 -0.107217D+01 0.234784D+01 -0.158871D+01 0.242296D+01 -0.689809D+01 
37 0.424458D+00 -0.319818D+00 0.948465D+00 -0.666645D+00 0.302393D+01 
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38 0.605878D+02 -0.395958D+01 0.336440D+00 -0.843491D+00 0.205659D+01 
39 -0.976552D+01 0.264267D+01 -0.661189D-01 0.169258D+00 -0.398591D+00 
40 -0.918100D+01 0.184877D+01 -0.626075D-01 0.185579D+00 -0.631863D+00 
41 -0.978898D+01 0.988721D+01 -0.237029D+00 -0.817361D-01 0.960138D-01 
42 0.181106D+01 -0.338502D+01 0.126880D+01 0.888609D+01 -0.265921D+02 
43 0.148012D+00 -0.421994D+00 0.259846D+00 0.850353D+00 0.842185D+01 
44 -0.172392D+00 0.370912D+00 -0.205796D-01 -0.865791D+00 0.432614D+01 
45 -0.241979D+00 0.432389D+00 -0.176597D+00 -0.119020D+01 0.527288D+01 
46 -0.190307D+01 0.335219D+01 0.184902D+01 -0.456500D+01 0.905896D+02 
47 0.635547D+00 -0.119832D+01 0.182423D+00 0.445408D+01 -0.200194D+02 
48 0.160403D+01 -0.336503D+01 0.192870D+01 0.110305D+02 -0.278287D+02 
      
 
11 12 13 14 15 
11 0.000000D+00 
    12 -0.726866D+00 0.000000D+00 
   13 0.311918D+01 0.129217D+02 0.000000D+00 
  14 -0.374123D+01 -0.333539D+00 0.985698D-01 0.000000D+00 
 15 0.149918D+01 0.166536D+00 -0.849164D+00 0.156243D+03 0.000000D+00 
16 0.385375D+01 0.771485D+00 0.127942D+01 0.913556D+02 -0.567610D+01 
17 -0.180305D+01 -0.621530D+00 -0.171783D+01 -0.672119D+01 0.926067D+01 
18 -0.359537D+01 -0.167479D+01 -0.492599D+00 0.292683D+01 0.406517D+01 
19 0.172776D+01 0.332202D+00 -0.821935D+00 0.361791D+01 0.181998D+01 
20 -0.154866D+01 0.159092D+02 -0.973537D+00 -0.211178D+01 0.992534D+00 
21 0.657524D+00 -0.842944D+01 0.576799D+00 0.800340D+00 -0.701396D+00 
22 0.174911D+01 -0.153552D+02 0.112683D+01 0.233412D+01 -0.126810D+01 
23 -0.101919D+01 0.664743D+01 -0.754281D+00 -0.111780D+01 0.341675D+00 
24 -0.173766D+01 0.157057D+02 -0.115392D+01 -0.226227D+01 0.108550D+01 
25 0.748254D+00 -0.841283D+01 0.538943D+00 0.835695D+00 -0.837375D+00 
26 0.178729D+01 -0.133609D+02 0.104771D+01 0.227425D+01 -0.125603D+01 
27 -0.829037D+00 0.605869D+01 -0.608098D+00 -0.106605D+01 0.264571D+00 
28 0.243515D+02 0.105288D+01 -0.211107D+01 0.656484D+01 -0.280449D+01 
29 0.215311D+02 -0.462379D+00 0.606566D+00 -0.231197D+01 0.139076D+01 
30 0.702852D+02 -0.107246D+01 0.175024D+01 -0.632052D+01 0.265721D+01 
31 -0.215567D+02 0.318515D+00 -0.120167D+01 0.296235D+01 -0.148750D+01 
32 -0.666244D+02 0.979005D+00 -0.171254D+01 0.642012D+01 -0.280134D+01 
33 0.279886D+02 -0.739964D+00 0.582286D+00 -0.280234D+01 0.106096D+01 
34 0.705159D+02 -0.113001D+01 0.164269D+01 -0.666894D+01 0.277947D+01 
35 -0.226866D+02 0.250555D+00 -0.739119D+00 0.288880D+01 -0.168207D+01 
36 0.267022D+02 0.107267D+01 -0.173559D+01 0.608889D+01 -0.262880D+01 
37 0.211160D+02 -0.647407D+00 0.169785D+01 -0.267360D+01 0.990001D+00 
38 -0.363946D+00 -0.881341D+01 0.996638D+00 0.306781D+00 -0.108788D+00 
39 0.934411D+00 0.425600D+01 -0.617196D+00 -0.813150D-01 -0.245880D+00 
40 0.125460D+00 0.146974D+02 0.166079D+00 -0.106633D+00 -0.284647D+00 
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41 0.462553D+00 0.627977D+01 -0.168371D+01 0.286393D-01 -0.276053D+00 
42 0.928867D+00 0.263423D+01 0.496687D+01 0.192503D+02 -0.835699D+01 
43 0.594373D-01 0.171635D+00 0.174476D+00 0.172608D+01 -0.672099D+00 
44 -0.112392D+00 0.371353D-01 -0.786148D+00 -0.189186D+01 0.699607D+00 
45 -0.184137D+00 -0.356668D-01 -0.917834D+00 -0.229283D+01 0.194784D+01 
46 -0.133389D+01 -0.274967D+01 -0.537394D+01 -0.191666D+02 0.940070D+01 
47 0.318613D+00 0.858754D+00 0.159899D+01 0.731126D+01 -0.384599D+01 
48 0.724545D+00 0.246148D+01 0.500789D+01 0.187905D+02 -0.791752D+01 
      
 
16 17 18 19 20 
16 0.000000D+00 
    17 0.162654D+03 0.000000D+00 
   18 0.915419D+02 -0.749229D+01 0.000000D+00 
  19 -0.563808D+01 0.913718D+01 0.157613D+03 0.000000D+00 
 20 0.309878D+01 -0.163249D+01 -0.475235D+01 0.178472D+01 0.000000D+00 
21 -0.141256D+01 0.840691D+00 0.267178D+01 -0.277919D+00 0.131704D+03 
22 -0.370131D+01 0.172099D+01 0.659651D+01 -0.210018D+01 0.283018D+02 
23 0.163137D+01 -0.103814D+01 -0.338866D+01 0.110764D+01 0.205357D+02 
24 0.353647D+01 -0.178588D+01 -0.657315D+01 0.197474D+01 0.611966D+02 
25 -0.158046D+01 0.519258D+00 0.289636D+01 -0.109098D+01 -0.203570D+02 
26 -0.352253D+01 0.170236D+01 0.700276D+01 -0.211527D+01 -0.577218D+02 
27 0.158751D+01 -0.117731D+01 -0.303481D+01 0.678347D+00 0.241614D+02 
28 -0.690834D+01 0.308187D+01 0.657125D+01 -0.289495D+01 0.268823D+01 
29 0.236876D+01 -0.142443D+01 -0.237320D+01 0.847232D+00 -0.113206D+01 
30 0.661364D+01 -0.305876D+01 -0.628354D+01 0.271243D+01 -0.263184D+01 
31 -0.320336D+01 0.129118D+01 0.295823D+01 -0.163005D+01 0.131300D+01 
32 -0.675668D+01 0.304000D+01 0.638791D+01 -0.287309D+01 0.267275D+01 
33 0.284782D+01 -0.166755D+01 -0.282624D+01 0.109229D+01 -0.121595D+01 
34 0.697928D+01 -0.322926D+01 -0.663779D+01 0.287626D+01 -0.277653D+01 
35 -0.312587D+01 0.134065D+01 0.291275D+01 -0.148700D+01 0.130131D+01 
36 -0.639362D+01 0.280490D+01 0.604577D+01 -0.264060D+01 0.250638D+01 
37 0.274334D+01 -0.150378D+01 -0.265564D+01 0.121150D+01 -0.113168D+01 
38 -0.774789D-01 -0.795110D-01 -0.278145D-01 -0.110103D+00 0.156296D+01 
39 -0.493926D-01 -0.258766D+00 -0.243062D-02 -0.262157D+00 -0.482196D+00 
40 -0.661895D-01 -0.314141D+00 -0.213862D-01 -0.222520D+00 -0.698486D+00 
41 -0.746702D-01 -0.254282D+00 0.444823D-01 -0.262558D+00 -0.654806D+00 
42 -0.200577D+02 0.954275D+01 0.190623D+02 -0.876591D+01 0.821750D+01 
43 -0.198482D+01 0.874643D+00 0.178930D+01 -0.116249D+01 0.755677D+00 
44 0.183719D+01 -0.129585D+01 -0.181111D+01 0.752519D+00 -0.971845D+00 
45 0.263422D+01 -0.118584D+01 -0.240339D+01 0.104378D+01 -0.946179D+00 
46 0.207287D+02 -0.104043D+02 -0.197740D+02 0.928127D+01 -0.848929D+01 
47 -0.755201D+01 0.346135D+01 0.703494D+01 -0.343370D+01 0.294491D+01 
48 -0.194177D+02 0.973913D+01 0.184124D+02 -0.902553D+01 0.798331D+01 
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21 22 23 24 25 
21 0.000000D+00 
    22 0.197010D+02 0.000000D+00 
   23 -0.317744D+01 0.133761D+03 0.000000D+00 
  24 -0.199731D+02 0.269240D+02 0.201114D+02 0.000000D+00 
 25 0.128794D+02 0.204053D+02 -0.348323D+01 0.132897D+03 0.000000D+00 
26 0.241933D+02 0.591784D+02 -0.195661D+02 0.272038D+02 0.212436D+02 
27 -0.129271D+02 -0.192957D+02 0.124095D+02 0.199026D+02 -0.331248D+01 
28 -0.129272D+01 -0.313319D+01 0.153080D+01 0.303787D+01 -0.141455D+01 
29 0.340583D+00 0.122352D+01 -0.803005D+00 -0.126988D+01 0.507751D+00 
30 0.116797D+01 0.302682D+01 -0.157865D+01 -0.296836D+01 0.130384D+01 
31 -0.798018D+00 -0.160095D+01 0.596072D+00 0.148185D+01 -0.814908D+00 
32 -0.128264D+01 -0.311124D+01 0.153517D+01 0.302179D+01 -0.139121D+01 
33 0.450163D+00 0.134030D+01 -0.824688D+00 -0.136435D+01 0.521514D+00 
34 0.124873D+01 0.320684D+01 -0.165400D+01 -0.313049D+01 0.139073D+01 
35 -0.738183D+00 -0.152107D+01 0.657947D+00 0.148805D+01 -0.727861D+00 
36 -0.117406D+01 -0.291050D+01 0.140333D+01 0.283122D+01 -0.129289D+01 
37 0.567227D+00 0.140994D+01 -0.737064D+00 -0.127030D+01 0.621598D+00 
38 -0.588094D+00 -0.143298D+01 0.651319D+00 0.180224D+01 -0.890459D+00 
39 0.196363D+00 0.791055D+00 -0.738226D+00 -0.944678D+00 0.120664D+00 
40 0.622151D-01 0.628733D+00 -0.538790D+00 -0.679874D+00 0.314062D+00 
41 -0.451928D-01 0.542988D+00 -0.527602D+00 -0.610243D+00 0.260089D+00 
42 -0.390705D+01 -0.956191D+01 0.452707D+01 0.928780D+01 -0.420110D+01 
43 -0.581946D+00 -0.962424D+00 0.296708D+00 0.862539D+00 -0.568718D+00 
44 0.311113D+00 0.106720D+01 -0.681136D+00 -0.109659D+01 0.307797D+00 
45 0.457980D+00 0.106552D+01 -0.730394D+00 -0.109627D+01 0.440698D+00 
46 0.414118D+01 0.988430D+01 -0.496232D+01 -0.965608D+01 0.439538D+01 
47 -0.170918D+01 -0.353779D+01 0.145385D+01 0.335363D+01 -0.180313D+01 
48 -0.406563D+01 -0.936263D+01 0.448657D+01 0.905360D+01 -0.431353D+01 
      
 
26 27 28 29 30 
26 0.000000D+00 
    27 0.133695D+03 0.000000D+00 
   28 -0.318702D+01 0.146828D+01 0.000000D+00 
  29 0.124053D+01 -0.730302D+00 0.133764D+03 0.000000D+00 
 30 0.307933D+01 -0.144552D+01 0.185336D+02 0.251984D+02 0.000000D+00 
31 -0.162340D+01 0.594651D+00 0.255898D+02 -0.464557D+01 0.127674D+03 
32 -0.315958D+01 0.146192D+01 0.734190D+02 -0.261728D+02 0.118432D+02 
33 0.136201D+01 -0.797183D+00 -0.265234D+02 0.158435D+02 0.269131D+02 
34 0.326967D+01 -0.148536D+01 -0.710212D+02 0.311192D+02 0.720385D+02 
35 -0.151667D+01 0.824810D+00 0.298775D+02 -0.164862D+02 -0.244726D+02 
36 -0.294209D+01 0.138487D+01 0.748691D+02 -0.288246D+02 -0.694839D+02 
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37 0.152463D+01 -0.351043D+00 -0.272434D+02 0.169896D+02 0.293045D+02 
38 0.141756D+01 0.111140D+01 0.766116D+00 -0.383095D+00 -0.739348D+00 
39 0.153817D+01 -0.104321D+01 -0.247664D+00 0.497850D+00 0.570598D+00 
40 0.774843D+00 0.130763D+00 0.862839D-01 -0.210250D+00 -0.380475D-01 
41 0.808550D+00 0.171328D+00 -0.421202D+00 -0.140936D-01 0.405809D+00 
42 -0.966402D+01 0.453347D+01 -0.178273D+01 0.786354D+00 0.173482D+01 
43 -0.969925D+00 0.340355D+00 -0.275414D+00 0.114120D+00 0.211881D+00 
44 0.109063D+01 -0.578594D+00 0.189803D+00 0.341737D+00 -0.164335D+00 
45 0.109128D+01 -0.688817D+00 0.188914D+00 -0.162104D+00 -0.263917D+00 
46 0.999714D+01 -0.493921D+01 0.177587D+01 -0.670570D+00 -0.177064D+01 
47 -0.356409D+01 0.161766D+01 -0.595813D+00 0.952335D+00 0.649749D+00 
48 -0.947402D+01 0.446041D+01 -0.144640D+01 0.476535D+00 0.128521D+01 
      
 
31 32 33 34 35 
31 0.000000D+00 
    32 0.258196D+02 0.000000D+00 
   33 -0.649633D+01 0.128093D+03 0.000000D+00 
  34 -0.244137D+02 0.133728D+02 0.267384D+02 0.000000D+00 
 35 0.154822D+02 0.256515D+02 -0.629424D+01 0.127010D+03 0.000000D+00 
36 0.289905D+02 0.727117D+02 -0.256298D+02 0.180737D+02 0.264011D+02 
37 -0.155026D+02 -0.254301D+02 0.148903D+02 0.235408D+02 -0.485286D+01 
38 0.315378D+00 0.741989D+00 -0.399206D+00 -0.746022D+00 0.327127D+00 
39 -0.195323D+00 -0.429839D+00 -0.236392D-01 0.576956D+00 -0.305576D+00 
40 -0.265688D+00 0.918384D-01 -0.600773D-01 0.172783D+00 0.252740D+00 
41 -0.461252D+00 -0.434004D+00 -0.441418D-01 0.449389D+00 -0.428329D+00 
42 -0.899903D+00 -0.177966D+01 0.784153D+00 0.182103D+01 -0.917549D+00 
43 -0.214700D+00 -0.283385D+00 -0.433640D-01 0.202461D+00 -0.314871D+00 
44 0.125713D+00 0.148518D+00 -0.196850D+00 -0.210293D+00 -0.562165D-01 
45 -0.642490D-01 0.181581D+00 -0.290846D+00 -0.281608D+00 -0.736419D-01 
46 0.876207D+00 0.178522D+01 -0.874717D+00 -0.186699D+01 0.865033D+00 
47 -0.201123D+00 -0.656858D+00 0.194925D+00 0.619666D+00 -0.506158D+00 
48 -0.836811D+00 -0.142251D+01 0.448408D+00 0.140473D+01 -0.849658D+00 
      
 
36 37 38 39 40 
36 0.000000D+00 
    37 0.127522D+03 0.000000D+00 
   38 0.124073D+01 0.808368D-01 0.000000D+00 
  39 -0.223046D+00 0.241667D+00 0.157860D+03 0.000000D+00 
 40 0.546264D+00 0.996378D+00 0.157904D+03 -0.305444D+02 0.000000D+00 
41 -0.140598D+00 0.227814D+00 0.153278D+03 -0.308813D+02 -0.293509D+02 
42 -0.163117D+01 0.760453D+00 0.428339D+00 -0.903924D-01 -0.142280D+00 
43 -0.278649D+00 -0.997010D-01 0.361945D-02 -0.111183D+00 -0.232918D+00 
44 0.131653D+00 -0.230970D+00 -0.301723D-01 0.255691D+00 -0.905617D-01 
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45 0.170652D+00 -0.231394D+00 -0.705734D-01 0.174815D-01 -0.155483D+00 
46 0.175778D+01 -0.852207D+00 -0.487629D+00 0.101382D+00 0.588933D-01 
47 -0.625132D+00 0.778993D-01 0.128696D+00 -0.393489D-01 -0.235229D+00 
48 -0.114836D+01 0.433168D+00 0.397705D+00 -0.267487D+00 -0.336626D+00 
      
 
41 42 43 44 45 
41 0.000000D+00 
    42 -0.127842D-01 0.000000D+00 
   43 -0.174853D+00 0.151130D+03 0.000000D+00 
  44 0.149604D-01 0.157367D+03 -0.303452D+02 0.000000D+00 
 45 -0.651258D-01 0.153271D+03 -0.299869D+02 -0.301845D+02 0.000000D+00 
46 -0.582480D-01 0.599358D+02 -0.838052D+01 -0.100035D+02 -0.102002D+02 
47 -0.190357D+00 -0.121384D+02 0.425063D+01 0.626179D+01 0.162194D+02 
48 -0.225845D+00 -0.141530D+02 0.474729D+01 0.157000D+02 0.480761D+01 
      
 
46 47 48 
  46 0.000000D+00 
    47 0.169704D+03 0.000000D+00 
   48 0.168049D+03 -0.314031D+02 0.000000D+00 
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Chapter 5 
Two-Step Synthesis of the Reported Structure of 
Xylopyridine A, Precursor to New Fluorescent Probes 
 
 
 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with Dr. Mai N. Tran, a previous graduate student in 
the Chenoweth group at the University of Pennsylvania. 
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5.1 Introduction 
 
Figure 5.1. New route for the synthesis of the reported structure of xylopyridine A, (E/Z)-1 and 
applications of the derivatives. 
 
Recently, we synthesized the reported structure of the natural product xylopyridine A 
(E/Z)-1 in five steps from 4-cyanopyridine 2 (Fig. 5.1). To our surprise, the reported structure 
of xylopyridine A was inconsistent with all characterization data obtained for the originally 
proposed 2,2'-diazaxanthilidene structure (E-1).1 Despite this unexpected finding, we 
discovered that the 2,2'-diazaxanthilidene scaffold has fascinating potential for applications in 
structure-specific nucleic acid binding1 and in the development of photoactivatable 
fluorophores2 for live cell optical imaging applications (Fig. 5.1). Fluorescent dyes have been 
developed for many in vivo or in vitro labeling and tracking applications over the last 10 
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decades.3 For certain applications, small molecule organic dyes can be advantageous over 
biological fluorophores and quantum dots due to their low molecular weight and potential for 
live cell, tissue, and whole organism imaging without genetic manipulation even though toxicity 
can be a major issue.3,4 As a result, photostability and live cell imaging compatibility have 
become some of the most desirable properties of small-molecule fluorescent dyes for optical 
imaging applications in biology. Herein, we report a two-step synthesis of (E/Z)-1 using a 
commercially available pyridyne precursor 7 and 2-fluorobenzoic acid 3. We show that (E/Z)-1 
can be efficiently converted into two photoproducts 5 and 6 using a 
photoelectrocyclization/oxidation reaction. Furthermore, we show that photoproducts 5 and 6 
are photostable, cell-permeability, non-cytotoxic, and compatible with live cell imaging studies. 
 
5.2 Results and Discussion 
Scheme 5.1. Two-step synthesis of (E/Z)-1. 
 
In an effort to minimize the number of chemical steps and allow rapid access to (E/Z)-1, 
we envisioned the retrosynthesis outlined in Fig. 1. In the first step of the synthesis, 3,4-pyridyne 
precursor 7 was chosen to react with 2-fluorobenzoic acid 3. Pyridyne precursor 7 is 
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commercially available or can be prepared in a straightforward fashion.5 A pyridyne insertion 
reaction with 3 resulted in the desired azaxanthone 8 and its isomer 9. The resulting 
azaxanthone 8 underwent a tandem selenation/reductive coupling reaction to give (E/Z)-1. In 
our recently reported study on the structure of xylopyridine A, we developed a three-step 
synthesis of the key intermediate 3-azaxanthone 8 from 4-cyanopyridine 2.1 In our current one 
step protocol we produce not only our desired 3-azaxanthone 8 but also the 2-azaxanthone 
isomer 9. Azaxanthone isomer 9 is an important substructure that is embedded in several natural 
products such as SB236049, diaporphasine A-D, and 7-hydroxy-8-methoxy-3-methyl-10-oxo-
10H-chromeno[3,2-c]pyridine-9-carboxylic acid (Fig. 5.6).6 Among the several known synthesis 
of 2-azaxanthone 9,7 the three step synthesis from 4-fluoropyridine is one of the most efficient.7a 
Here, we describe a new directsynthesis of azaxanthone 8 and 9 by pyridyne insertion into 2-
fluorobenzoic acid 3. We conducted a thorough reaction optimization study in an effort to 
define conditions for the pyridyne insertion reaction (Table 5.2). Rather than 3, all alternative 2-
halobenzoic acids were examined for optimization but no other halogen substituents resulted in 
improved yields over the fluorine substituent, as expected based on the inverse element effect 
observed in SNAr chemistry (entry 1-7, Table 5.2). Common fluoride sources such as tetra-n-
butylammonium fluoride (TBAF) and CsF were tested for pyridyne insertion reaction, and CsF 
afforded the desired product 8 in relatively higher yield (entry 7-9, Table 5.2). Cs2CO3 as a basic 
additive for a deprotonation step made the total yield of 8 and 9 drop (entry 1, 2, 4, and 6, Table 
S1) even if the ratio of the two isomers was changed in some case (entry 4, Table 5.2). Most of 
the reaction conditions consistently gave 9 as a major product. Due to the required high reaction 
temperature (i.e., above 140 oC) for the completion of the reaction, o-Xylene and Ph2O 
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wereemployed as the solvents. At identical temperatures (140 oC), Ph2O resulted in higher 
yields than o-xylene (entries 10 and 11, Table 5.2). As a limiting reagent, 3 was chosen rather 
than 7 but the yield of 8 did not improve (entries 12-15, Table 5.2). Recently, the Daugulis 
group reported a new benzyne precursor that possesses a silylaryl halide scaffold and allows for 
the use of mild conditions to generate benzyne.8 Based on their studies, we prepared silylpyridyl 
bromide and performed the pyridine insertion reaction. However, no improvement in the yield 
of 8 was observed (Entries 16 and 17, Table 5.2). Rather than the insertion to benzoic acid, a 
reaction with methyl 2-hydroxybenzoate was also conducted but did not increase the yield of 8 
(entries 18-22, Table 5.2). The best yield of the desired product 8 was achieved by employing 
the reaction of 3 and 7 with CsF in Ph2O at 220 oC for 4 hours (entry 7, Table 5.2). 
 
Figure 5.2. A. Proposed mechanism of pyridine insertion reaction. B. Attempt to synthesize 8 via 
benzyne insertion reaction. 
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A plausible pyridyne insertion mechanism is described in Fig. 5.2A. The fluoride anion 
has a dual role in the first mechanistic step. First, after this anion deprotonation of the carboxylic 
group of benzoic acid 3 and generation of pyridine 11, Carboxylate 10 undergoes nucleophilic 
addition to pyridyne 11. The resulting p- or m-pyridinide anion on intermediate I is added to the 
ester carbon to form four-membered intermediate II. After rearrangement, a phenoxide anion 
on III attacks the carbon adjacent to the leaving group to form the ipso- carbon-bearing 
intermediate IV. To restore the aromaticity, elimination occurs to afford the desired 3- and 2-
azaxanthone 8 and 9. Larock et al. reported a benzyne insertion reaction to 2-fluorobenzoic acid 
to afford acridone.9 Furthermore, they successfully synthesized 4-azaxanthone from 2-
chloronicotinic acid in 22% yield. However, synthesis of 3-azaxanthone 8 has not been achieved  
 
Table 5.1. Optimization of Reductive Coupling Reaction of 8. 
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utilizing this method. We surveyed various fluoride sources (TBAF, KF/18-crown-6, and CsF), 
two different isonicotinic acids (12 and 13), common solvents (THF, CH3CN, toluene, and 
Ph2O), and various temperatures ranging from 60 oC to 220 oC. However, no azaxanthone 8 was 
observed (Fig. 5.2B). After optimization, our best set of reaction conditions for pyridyne 
insertion, the reaction of 3 and 7 with CsF in Ph2O at 220 oC within 4 hours, afforded the 
desired azaxanthone 8 in 12% yield and isomer 9 in 25% yield (Scheme 5.1). 
Next, wee focused the optimization of a single step reductive coupling reaction to 
conclude our 2-step approach. In our previous report, the two discrete synthetic steps involving 
thionation of azaxanthone 8 followed by copper reductive coupling yielded (E/Z)-1 in 73% over 
the two steps. We envisioned the possibility of a one-step homodimerization approach by 
utilizing Woollins’ reagent, the selenium analog of Lawesson’s reagent. The standard solvent 
often utilized for ketone-ketone homocoupling using Woollins’ reagent is toluene at a 
temperature of approximately 100 oC.10 A single example of a homo xanthone coupling has been 
reported using these standard conditions.10 However, the results of our solvent screen clearly 
indicated that toluene was not the best solvent for the azaxanthone coupling reaction. 
Interestingly, the reaction in Ph2O afforded a much higher yield of (E/Z)-1 than that in toluene 
or xylene at 100 or 140 oC (entries 1-6, Table 5.1). To investigate the effect of the reaction 
temperature, the reaction was conducted in Ph2O at 100, 140, and 170 oC (entries 3, 6, and 7, 
Table 5.1), and the best yield was obtained at 140 oC. In addition to the Woollins’ reaction, two 
known homo ketone reductive coupling conditions including McMurry coupling were tested. 
However, only a trace amount of the desired product was obtained from Zn/HCl reductive 
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coupling (entries 8 and 9, Table 5.1). The best yield of (E/Z)-1 was 88% utilizing our new 
Woollins’ reagent homodimerization approach in Ph2O at 140 oC for 12 hours. 
 
 
Figure 5.3. Photocyclization of (E/Z)-1 and X-ray crystal structure of 6 and (E)-1. Thermal 
ellipsoids are drawn at the 50% probability level. Chloroform was omitted for clarity of the 
structure of 6. 
 
After successfully developing a rapid 2-step synthetic approach to access (E/Z)-1, we 
focused on optimization of the photocyclization reaction of 1 in an effort to rapidly access our 
newly discovered class of fluorescent dyes. Applying Katz's condition reported in 1991 for 
stilbene photocyclization,11 a catalytic amount of iodine and excess methyloxirane were added to 
the solution of (E/Z)-1 upon exposure to a 365 nm UV light from a Rayonet photoreactor (Fig. 
5.3). The reaction successfully gave the two desired products in 74% yield with a 2:1 ratio of 5 
and 6. Based on a comparison of the x-ray structures of 1 and 6, the red shifts in the absorption 
spectra (i.e., 76 nm) and emission spectra (39 nm) of 6 were due to the larger conjugated system 
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and an increase in planarity within the scaffold, which allows for greater electron delocalization 
throughout the extended π-system. The crystal structure of 6 revealed that the dihedral angle 
(C13-C1-C15-C17 angle) of 44.2° is much greater than that of 31.4° for 11 (Fig. 5.3). However, 
on the opposite side, the dihedral angle (C3-C1-C15-C27 angle) of 4.9° is much less than that of 
31.4° for 1. Similar bathochromic shifts were also observed in 5. The higher rigidity also reduces 
non-radiative bond rotation and remarkably improves quantum yield (Fig. 5.4). Both 
photoproducts have higher quantum yields than most of the well-known fluorophores, such as 
quinine, DAPI, Hoechst, Cy3n, and Cy5.12,13 The photoconversion of (E/Z)-1 into 5 and 6 was 
conducted in one pot. However, this conversion was composed of two mechanistic steps 
including photocyclization of (E)-1 and (Z)-1 to intermediates 5Int and 6Int bearing 
dihydrophenanthrene (for 5Int) and dihydrobenzoisoquinoline (for 6Int) followed by air 
oxidation to afford 5 and 6. According to the relative ground-state free energy diagram obtained 
using the TD-B3LYP 6-31G(d) method on the center of Fig. 5.4, 5Int and 6Int (38.3 and 37.5 
kcal/mol) are highly unstable compared to (E/Z)-1, 5, and 6 (0.0, -0.6, -21.7, and -21.6 
kcal/mol). The instability of 5Int and 6Int may prevent isolation during the reaction. By 
comparing the HOMO and LUMO levels of each molecule, the HOMO-LUMO gap of cyclized 
intermediates 5Int and 6Int (2.50 and 2.54 eV) was much narrower than those of pre- cyclized 
forms (Z)-1 and (E)-1 (3.70 and 3.71 eV) or post-oxidized forms 5 and 6 (3.14 and 3.18 eV).  
 To predict the UV/vis spectra of non-isolable intermediates 5Int and 6Int, the same 
basis set [TD-B3LYP 6-31G(d)] was employed (middle-left, -right, and bottom, Fig. 5.4). This 
method successfully predicted the wavelength at maximum absorption for 5 and 6 (454 and 451 
nm from the experiment, 450 and 443 nm in theory) as well as (Z)-1 and (E)-1 (375 nm from  
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Figure 5.4 Overall photophysical properties and relative energy diagram of (E/Z)-1, 5, and 6. 
Frontier molecular orbitals of HOMO and LUMO of (E)-1 and (Z)-1 (upper-left corner) as 
well as 5 and 6 (upper-right corner) were depicted. Observed absorption and emission spectra 
of (E)-1 and (Z)-1 (middle-left corner) as well as 5 and 6 (middle-right corner) were shown. 
The height of each red marker represents the oscillator strength at each level of theory. Relative 
Gibbs free energy diagram describing each energy level of (E)-1, (Z)-1, 5Int, 6Int, 5, and 6 was 
depicted on the center. Photophysical property of each molecule was depicted in the bottom. a 
Maximum oscillator strength in the range between 300 and 800 nm. b Calculations were 
performed with TD-B3LYP method and 6-31G(d) basis set in chloroform. c Geometrically 
obtimized at DFT B3LYP/6-311G+(2d,p) level. d Ground state energy of two hydrogen atoms 
were added to the calculated energy of 5 and 6. 
 
the experiment, 385 and 384 nm in theory). Encouraged by these results, the predicted 
maximum absorption wavelengths of 5Int and 6Int were observed at 434 and 418 nm. These 
molecules were expected to have longer absorption wavelengths than 5 and 6 due to their 
smaller HOMO-LUMO gaps. This result may be explained by predicting the set of excitation 
transitions for each molecule. The transition of an electron from the HOMO to the LUMO of 
ground-state 5 or 6 (MO = 93 to 94, Figure A4.11) is predominant among the other transitions 
to higher excited states. However, a combination of two or three different transitions of 5Int or 
6Int including one major transition from HOMO to a higher excited state than LUMO (MO = 
94 to 96, Figure A4.11) affects the excitation energy and results in a higher energy and shorter 
wavelengths compared to the expected result. 
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Figure 5.5. A. Fluorescence images of live HeLa cells stained with 5 (upper panels) and 6 (lower 
panels). A 488/495 channel was used to observed 5 and 6 in live HeLa cells. Scale bar = 25 μm. 
B. Normalized plot of the average intensity of 5, 6, and Mitotracker Red FM over 100 laser 
pulses (300 ms/scan). The 444/525 channel was used to observe 5 and 6, and the 594/632 
channel was used to observe MitoTracker Red FM. C. Viabililty assays of HeLa cells incubated 
with 5 (5 μM), 6 (5 μM), and MitoTracker Red FM (1 μM) at 37 °C in a humidified atmosphere 
with 5% CO2 over 24 and 48 hours. 
 
 Based on confocal microscopy, both 5 and 6 were cell permeable and localized primarily 
in tubular networks in the cytoplasm of live HeLa cells (Fig. 5.5A). The 458/500 channel was 
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used to observe the two photoproducts 5 and 6. A high fluorescent contrast was still observed. 
To investigate the photostability of 5 and 6, time-lapse microscopy experiments using the 
444/495 channel were carried out. After 100 scans (300 ms/scan), only a slight decrease in the 
intensity (10 to 20%) was detected for both 5 and 6, indicating high resistance to 
photobleaching (Fig. 5.5B). In comparison, a similar experiment was performed using the 
594/632 channel to observe MitoTracker Red FM14, a commonly used commercially available 
mitochondrial stain. The dye was quite stable but only approximately 60% of the intensity 
remained at the end of the experiment. Cell viability assays in HeLa cells confirmed that both 5 
and 6 exhibited very low cytotoxicities. The percent viabilities were close to 90% after 48 hours 
(Fig. 5.5C).  These dyes provide a starting point for a new class of helicene-based fluorescent 
dye with low toxicity and many potential uses for live cell imaging. 
 
5.3 Conclusions 
In conclusion, the two-step synthesis of (E/Z)-1, which is the precursor for 
photoproducts 5 and 6, was successfully performed. Using CsF as a fluoride ion source and 
Ph2O as the solvent, the pyridyne insertion into 2-fluorobenzoic acid 3 was conducted at 220 oC 
for 4 hours, to afford both 3- and 2-azaxanthone (8 and 9). Employing the Woollin’s reductive 
coupling reaction of 8, the reported xylopyridine A structure (E/Z)-1 was obtained in good 
yield. Photocylization of (E/Z)-1 resulted in the two isomeric fluorescent molecules 5 and 6 
which were found to be non-cytotoxic, cell-permeable, and photostable with high quantum 
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yields and are well-suited as a new scaffold for the development of fluorescent live cell imaging 
probes. Further investigations into the versatility of diazaxanthilidene scaffolds as new chemical 
tools for imaging and sensing are ongoing in our laboratory. 
 
5.4 Experimental Section 
General information: 
Materials and spectroscopic methods.  
The reagents for the syntheses were purchased from Sigma Aldrich or Acros and used 
without further purification. The solvents were purchased from Fisher Scientific or Sigma 
Aldrich. The anhydrous solvents were purchased from Fisher Scientific and dried by passing 
through an alumina column in a solvent purification system. The silica gel (230-400 mesh) that 
was used for column chromatography was purchased from Silicycle. Thin layer chromatography 
plates (250 µm thickness) were purchased from Sorbent Technologies or Merck. Reverse-phase 
column chromatography was performed using a Teledyne Isco CombiFlash Rf system equipped 
with a RediSep Rf Gold C18 column. High-performance liquid chromatography (HPLC) was 
performed on a Jasco HPLC system using a Phenomenex column (Luna 5u C18(2) 100A; 250 x 
4.60 mm, 5 micron). The UV absorption spectra were recorded on a Jasco V-650 
spectrophotometer using a 1 cm path length quartz cuvette. The fluorescence emission spectra 
were recorded on a Horiba Jobin-Yvon FluoroLog using a 1 cm path length fluorescence quartz 
cuvette. The 1H NMR and 13C NMR spectra were recorded on either a Bruker DMX 500 (500 
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MHz) or a Bruker AVII 500 (500 MHz). High-resolution mass spectrometry was performed by 
Dr. Rakesh Kohli at the University of Pennsylvania using a Waters LCT Premier XE Mass 
Spectrometer (model KE 332). X-Ray chromatography was performed by Dr. Pattrick Carroll at 
the University of Pennsylvania using a Bruker APEX2-DUO CCD X-Ray Diffractometer. The 
photoreactions were carried out in a Rayonet Photochemical Reactor (model RPR-100). The 
quantum yield was determined using the serial dilution method with fluorescein (in NaOH 0.1 
M, Φ = 0.95) as a reference.12  
 
Cell imaging 
For live cell imaging, HeLa cells (purchased from ATCC) were used. The cells were 
cultured in a 60 mm culture dish or a 75 cm2 culture flask using Life Technologies Dulbecco's 
Modified Eagle Medium (DMEM) media with phenol red, 10% fetal bovine serum and 1% 
penicillin-streptomycin at 37 °C in a humidified atmosphere with 5% CO2. The cells were 
detached with 0.05% trypsin-EDTA and transferred to a 35 mm glass-bottom poly-D-lysine 
coated dish 2 days prior to imaging with approximately 2 mL of the previously mentioned 
media. Four microliters of a 1.5 mM solution of 5 and 6 in MiliQ water was mixed with 2 mL of 
new media and added to the cells after the old media was removed. After incubation for 12 
hours, the excess dyes were washed twice with DMEM without phenol red prior to imaging. The 
cells were maintained in 1 mL of non-phenol red DMEM during imaging. A Leica DMI 6000B 
inverted microscope equipped with a 100x oil immersion HCX PL APO (1.46 NA; correction 
collar), 63x oil immersion HCX PL APO CS (1.40-0.60 NA; variable iris), and 20x dry HC 
PLAN APO (0.70 NA) was used to record the images shown in Fig. 4. A Leica DM4000 
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spinning disk confocal microscope equipped with a 100x/1.4 NA oil immersion objective was 
used to obtain the images shown in Figs. S1-S3. All image processing was performed by using 
Fiji. 
 
 
Cytotoxicity studies 
In a 96-well plate, HeLa cells were plated at 5,000 cells/well in the previously mentioned 
culture media (50 μL/well) and incubated at 37 °C in a humidified atmosphere with 5% CO2. 
After 24 hours, the cells were treated with 5 and 6 (final concentration of 5 μM) as well as 
MitoTracker Red FM14 (final concentration 1 μM) and DMSO (vehicle control for 
MitoTracker). For wells treated with MitoTracker and DMSO, the DMSO concentration was 
maintained at 1%. Untreated cells were used as a vehicle control for 5 and 6. The final volumes 
were 100 μL/well. The cells were incubated at 37 °C in 5% CO2 for 24 or 48 hours. Alamar Blue 
(10 μL) was added 2 hours prior to the fluorescence measurement. Fluorescence was measured 
at an excitation wavelength of 560 nm and an emission wavelength of 590 nm. The vehicle 
control was taken as 100% cell viability. 
 
Computational details 
All theoretical calculations were performed using Gaussian09.15 The optimized 
structures of (E)-1 and (Z)-1 [B3LYP/6-311+G(2d,p)] were taken from our previous 
publication.1 All other structures (5Int, 6Int, 5, and 6) were optimized at the B3LYP method 
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with the 6-311+G(2d,p) basis sets. The TD-DFT calculations of (E)-1, (Z)-1, 5Int, 6Int, 5, and 
6 were performed at the B3LYP/6-31G(d) level in chloroform. 
 
Experimental procedures 
 
(E/Z)-3,3′-Diazaxanthylidene (1): A 4 mL vial was charged with 42 μmol of 8 (8.3 mg) from the 
stock solution of 8. 19 μmol of Woollins’ reagent (10.1 mg) and 840 uL of Ph2O was added to 
the vial inside the glovebox. Outside the glovebox, the resulting mixture was heated to 140 oC in 
a dark room. After 12 hours, the solution was cooled and purified using flash column 
chromatography (50% acetate/hexane to 100% acetone) to afford 1 (6.1 mg, 88%). The 
characterization data for 1 was reported in our previous publication.1 
 
The photolysis of 1 was performed using a modified version of a procedure reported by Katz et 
al.11 An oven-dried 25 mL vial was charged with a solution of (E)-1/(Z)-1 (96.0 mg, 265 μmol) 
in 20 mL of THF and 1 mL of methyloxirane. A very small amount of iodine (sub-
stoichiometric) was added to the solution before capping and irradiating the vial with 365 nm 
light in a Rayonet photoreactor for 26 h. The crude mixture was rotary evaporated to dryness on 
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Celite. Reverse-phase chromatography was used with acetonitrile and 0.1% TFA as the eluents 
to separate a mixture of protonated 5 and 6 from protonated 1. The protonated mixture of 5 and 
6 was transferred to a separatory funnel, treated with saturated sodium bicarbonate, and 
extracted with chloroform. Then, the mixture was separated on normal-phase silica gel using 
50% dichloromethane/ethyl acetate to afford 5 (48.0 mg, 50%) and 6 (23.0 mg, 24%). 
Basification and chloroform extraction of the protonated 1 solution provided 9.7 mg of pure 
recovered 1 (10 mg, 10%). 
For 5:  
1H NMR (500 MHz, CDCl3/CD2Cl2): δ (ppm) 8.65 (s, 2H), 8.21 (d, 2H, J = 5.3 Hz), 8.13 (d, 
2H, J = 7.8 Hz), 7.73 (d, 2H, J = 5.3 Hz), 7.62 (t, 2H, J = 8.0 Hz), 7.31 (dd, 2H, J = 8.0, 0.9 Hz).  
13C NMR (125 MHz, CDCl3): δ (ppm) 150.4, 149.0, 143.6, 141.3, 130.4, 128.8, 127.6, 121.4, 
119.8, 117.7, 117.5, 113.0.  
IR (neat): 3042, 2921, 1588, 1487, 1459, 1420, 1412, 1292, 781, 759 cm-1.  
HRMS (m/z): [M+H]+ calcd for C24H13N2O2+, 361.0972; found, 361.0975.  
Meting point 275-278 °C.  
Extinction coefficient (ε) = 4986 M-1.cm-1 (solvent: chloroform).  
Quantum yield (Φ) = 0.734 (solvent: chloroform, standard: fluorescein in NaOH 0.1 M). 
For 6:  
1H NMR (500 MHz, CDCl3): δ (ppm) 9.41 (s, 1H), 8.62 (s, 1H), 8.55 (s, 1H), 8.23-8.17 (m, 
2H), 7.90 (dd, 1H, J = 8.0, 1.5 Hz), 7.81 (d, 1H, J = 5.3 Hz), 7.63 (t, 1H, J = 8.0 Hz), 7.42-7.37 
(m, 1H), 7.32 (dd, 1H, J = 7.9, 1.0 Hz), 7.29 (dd, 1H, J = 8.3, 1.3 Hz), 7.05-7.00 (m, 1H).  
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13C NMR (125 MHz, CDCl3): δ (ppm) 152.9, 150.5, 149.2, 146.4, 143.6, 141.3, 140.0, 132.8, 
131.5, 129.0, 128.3, 127.9, 127.2, 125.8, 124.1, 123.4, 122.2, 120.1, 119.7, 119.0, 118.5, 118.4, 
117.0, 113.7.  
IR (neat): 2921, 1733, 1452, 1417, 1275, 1198, 813, 765, 605 cm-1.  
HRMS (m/z): [M+H]+ calcd for C24H13N2O2+, 361.0972; found, 361.0985.  
Meting point 280-283 °C.  
Extinction coefficient (ε) = 18085 M-1.cm-1 (solvent: chloroform).  
Quantum yield (Φ) = 0.796 (solvent: chloroform, standard: fluorescein in NaOH 0.1 M). 
 
4-(trimethylsilyl)pyridin-3-yl trifluoromethanesulfonate (7): 7 was prepared according to the 
literature procedure.5 
1H NMR (500 MHz, CDCl3): δ (ppm) 8.57 (s, 1H), 8.53 (d, 1H, J = 4.7 Hz), 7.44 (dd, 1H, J = 
4.7, 0.4 Hz), 0.37 (s, 9H). 
 
A 10 mL round-bottom flask was charged with 0.66 mmol of 3 (92.5 mg), 0.15 mmol of 7 (45.0 
mg), and 1.16 mmol of CsF (176 mg) in 2.0 mL of Ph2O and heated to 220 oC. After 12 hours, 
the solution was cooled and purified by flash column chromatography (100% hexane to 30% 
ethyl acetate/hexane) to afford 8 (3.5 mg, 12% yield) and 9 (7.3 mg, 25% yield). 
For 8: 
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The characterization data of 8 was reported in our previous publication.1 
For 9: 
The characterization data of 9 have been previously reported in the literature.16 
1H NMR (500 MHz, CDCl3): δ (ppm) 9.52 (s, 1H), 8.81 (d, 1H, J = 5.9 Hz), 8.35 (dd, 1H, J = 
7.9, 1.6 Hz), 7.78 (ddd, 1H, J = 8.6, 7.4, 1.6 Hz), 7.53 (d, 1H, J = 8.4 Hz), 7.45 (d, 1H, J = 7.4 
Hz), 7.39 (d, 1H, J = 5.9 Hz). 
 
3-bromo-4-(trimethylsilyl)pyridine (S1): S1 was prepared according to the literature 
procedure.17 
1H NMR (500 MHz, CDCl3): δ (ppm) 8.64 (d, 1H, J = 0.6 Hz), 8.46 (d, 1H, J = 4.7 Hz), 7.31 
(dd, 1H, J = 4.7, 0.6 Hz), 0.41 (s, 9H). 
 
 
Figure 5.6. Structures of the natural product bearing a 2-azaxanthone (9) moiety.6 S1, 7-
hydroxy-8-methoxy-3-methyl-10-oxo-10H-chromeno[3,2-c]pyridine-9-carboxylic acid. 
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Table 5.2. Optimization of the Pyridyne Insertion Reactiona. 
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Appendix 4 
NMR Spectra, Cell Images, Computational Results, and 
X-Ray Structure Data Relevant to Chapter 5 
 
 
 
 
 
 
This work was performed in collaboration with Dr. Mai N. Tran, a previous graduate student in 
the Chenoweth group at the University of Pennsylvania. 
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Figure A4.1. Time-lapse experiment for HeLa cells incubated with 5. Continuous irradiation was 
performed using the 444/495 channel for 30 seconds. Scale bar = 10 µm. 
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Figure A4.2. Time-lapse experiment for HeLa cells incubated with 6. Continuous irradiation was 
performed using the 444/495 channel for 30 seconds. Scale bar = 10 µm. 
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Figure A4.3. Time-lapse experiment for HeLa cells incubated with MitoTracker Red FM. 
Continuous irradiation was performed using the 594/632 channel for 30 seconds. Scale bar = 10 
µm. 
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Figure A4.4. 1H NMR spectrum of 5 in CD2Cl2/CDCl3 (500 MHz).  
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Figure A4.5. 13C NMR spectrum of 5 in CDCl3 (125 MHz). 
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Figure A4.6. 1H NMR spectrum of 6 in CDCl3 (500 MHz).  
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Figure A4.7. 13C NMR spectrum of 6 in CDCl3 (125 MHz). 
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Figure A4.8. 1H NMR spectrum of 7 in CDCl3 (500 MHz). 
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Figure A4.9. 1H NMR spectrum of 9 in CDCl3 (500 MHz).  
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Figure A4.10. 1H NMR spectrum of S1 in CDCl3 (500 MHz).  
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Table A4.1. Summary of Structure Determination of 3. 
 
Empirical formula  C25H13N2O2Cl3 
Formula weight  479.72 
Temperature  143(1) K 
Wavelength  0.71073 Å  
Crystal system  monoclinic 
Space group  C2/c       
Cell constants:   
a  26.245(5) Å  
b  10.808(2) Å  
c  28.103(5) Å  
b 91.015(10)° 
Volume 7970(3) Å 3 
Z 16 
Density (calculated) 1.599 Mg/m3 
Absorption coefficient 0.489 mm-1 
F(000) 3904 
Crystal size 0.45 x 0.22 x 0.01 mm3 
Theta range for data collection 1.45 to 25.48° 
Index ranges -29 ≤ h ≤ 31, -12 ≤ k ≤ 13, -33 ≤ l ≤ 33 
Reflections collected 73138 
Independent reflections 7329 [R(int) = 0.0464] 
Completeness to theta = 25.48° 99.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6513 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7329 / 0 / 578 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0456, wR2 = 0.1040 
R indices (all data) R1 = 0.0636, wR2 = 0.1130 
Largest diff. peak and hole 0.522 and -0.466 e.Å -3 
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DFT Calculations 
Figure A4.11. Calculated transition molecular orbitals of (Z)-1, (E)-1, 5Int, 6Int, 5, and 6 
contributing to each excitation. 
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Table A4.2. Coordinates of the B3LYP/6-311+G(2d,p) Stationary Point for 5. 
C 0.69146 -0.10168 -0.02632 
 
H -0.15332 -2.55433 1.31247 
C 1.38958 1.15148 0.14600 
 
C -2.10264 -3.41451 1.24516 
C 0.71296 2.39796 0.13805 
 
H -1.80141 -4.32064 1.75964 
C 1.43872 3.57226 0.40029 
 
C -3.79263 -2.21015 0.31311 
H 0.93175 4.52636 0.42356 
 
H -4.84209 -2.11424 0.05304 
C 3.47481 2.30827 0.67130 
 
C -2.92674 -1.15288 0.03721 
H 4.53374 2.24942 0.88604 
 
O -3.48412 -0.02521 -0.49580 
C 2.77498 1.14808 0.41583 
 
C -2.77495 1.14799 -0.41603 
O 3.48432 -0.02503 0.49520 
 
C -3.47484 2.30819 -0.67131 
C 2.92683 -1.15280 -0.03742 
 
H -4.53375 2.24935 -0.88617 
C 3.79267 -2.21014 -0.31324 
 
C -1.43883 3.57226 -0.40008 
H 4.84216 -2.11426 -0.05327 
 
H -0.93196 4.52640 -0.42322 
C 2.10258 -3.41468 -1.24486 
 
C -0.71300 2.39796 -0.13797 
H 1.80135 -4.32094 -1.75910 
 
C -1.38958 1.15145 -0.14611 
C 1.17478 -2.42148 -0.98724 
 
C 2.79384 3.52564 0.66103 
H 0.15321 -2.55453 -1.31199 
 
H 3.33513 4.44047 0.86850 
C 1.56130 -1.25191 -0.31505 
 
C -2.79392 3.52556 -0.66084 
C -0.69142 -0.10168 0.02622 
 
H -3.33530 4.44038 -0.86816 
C -1.56124 -1.25189 0.31506 
 
N 3.39342 -3.33316 -0.89430 
C -1.17482 -2.42134 0.98751 
 
N -3.39347 -3.33304 0.89455 
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Table A4.3. Coordinates of the B3LYP/6-311+G(2d,p) Stationary Point for 6. 
C -0.70047 -0.06823 0.03724 
 
C 0.68171 -0.13888 -0.01830 
C -1.31193 1.22430 -0.14045 
 
C 1.49051 -1.33353 -0.30721 
C -0.57428 2.42839 -0.13275 
 
C 1.04025 -2.48176 -0.97653 
C -1.26735 3.62217 -0.40301 
 
H 0.01092 -2.56157 -1.29384 
H -0.73602 4.56610 -0.43292 
 
C 1.91403 -3.52163 -1.23832 
N -2.56494 3.68602 -0.65717 
 
H 1.56384 -4.41067 -1.75163 
C -3.26846 2.54672 -0.66440 
 
N 3.20857 -3.50838 -0.89203 
H -4.32868 2.60690 -0.88420 
 
C 3.66796 -2.40856 -0.31103 
C -2.68541 1.31919 -0.41817 
 
H 4.72168 -2.36829 -0.05363 
O -3.47792 0.20779 -0.51091 
 
C 2.85983 -1.30710 -0.03223 
C -3.00812 -0.96848 0.01669 
 
O 3.47762 -0.21159 0.50153 
C -3.96452 -1.94937 0.25770 
 
C 2.83301 0.99842 0.41862 
H -4.99269 -1.75078 -0.01628 
 
C 3.59618 2.12019 0.66647 
C -3.58751 -3.13451 0.86549 
 
H 4.65074 2.00332 0.87907 
H -4.32883 -3.89919 1.06170 
 
C 2.98596 3.37454 0.65029 
C -2.26079 -3.32057 1.25597 
 
H 3.57928 4.25809 0.85045 
H -1.96724 -4.22349 1.77640 
 
C 1.63497 3.49650 0.39212 
C -1.31638 -2.34530 0.98889 
 
H 1.18023 4.47683 0.40839 
H -0.29726 -2.49678 1.31413 
 
C 0.84743 2.36141 0.13888 
C -1.64963 -1.15936 0.31288 
 
C 1.44983 1.07652 0.15144 
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Table A4.4. Coordinates of the B3LYP/6-311+G(2d,p) Stationary Point for Int5. 
C -0.72995 -0.10492 -0.00482 
 
C 2.05863 -3.40980 -1.33588 
C -1.40861 1.07942 -0.15682 
 
H 1.72930 -4.30243 -1.85715 
C -0.75884 2.42786 0.08836 
 
C 3.78961 -2.23789 -0.43709 
C -1.43281 3.55913 -0.63609 
 
H 4.84891 -2.15698 -0.21524 
H -0.86801 4.46222 -0.82966 
 
C 2.94322 -1.18855 -0.09898 
C -3.46764 2.24426 -0.76678 
 
O 3.51289 -0.07944 0.46393 
H -4.51799 2.18894 -1.02121 
 
C 2.81608 1.10348 0.40897 
C -2.81624 1.10305 -0.40895 
 
C 3.46721 2.24476 0.76709 
O -3.51278 -0.08005 -0.46422 
 
H 4.51753 2.18956 1.02168 
C -2.94299 -1.18902 0.09888 
 
C 1.43221 3.55935 0.63602 
C -3.78924 -2.23842 0.43712 
 
H 0.86730 4.46241 0.82937 
H -4.84857 -2.15762 0.21536 
 
C 0.75847 2.42798 -0.08848 
C -2.05811 -3.41002 1.33600 
 
C 1.40847 1.07965 0.15667 
H -1.72866 -4.30253 1.85739 
 
C -2.73130 3.46417 -0.96747 
C -1.14385 -2.41612 1.01858 
 
H -3.24145 4.29924 -1.43316 
H -0.11064 -2.53792 1.30804 
 
C 2.73065 3.46456 0.96768 
C -1.56622 -1.26928 0.33341 
 
H 3.24057 4.29969 1.43352 
C 0.73002 -0.10479 0.00467 
 
N -3.35833 -3.34578 1.03462 
C 1.56647 -1.26903 -0.33351 
 
N 3.35882 -3.34540 -1.03441 
C 1.14425 -2.41599 -1.01857 
 
H -0.95728 2.59223 1.17051 
H 0.11103 -2.53796 -1.30798 
 
H 0.95681 2.59245 -1.17064 
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Table A4.5. Coordinates of the B3LYP/6-311+G(2d,p) Stationary Point for Int6. 
C 0.74033 -0.07355 -0.00120 
 
C -1.50866 -1.33495 0.33106 
C 1.34663 1.14422 0.15476 
 
C -1.04136 -2.45592 1.02981 
C 0.64300 2.45989 -0.07624 
 
H -0.00500 -2.52942 1.32438 
C 1.28495 3.56723 0.72020 
 
C -1.91411 -3.48523 1.35068 
H 0.67622 4.41731 1.02208 
 
H -1.55018 -4.35756 1.88322 
N 2.52693 3.57423 1.03330 
 
N -3.21373 -3.48088 1.03952 
C 3.29926 2.45852 0.74262 
 
C -3.68812 -2.39908 0.42817 
H 4.35553 2.52743 0.96730 
 
H -4.74821 -2.36682 0.19787 
C 2.74517 1.26300 0.38996 
 
C -2.88570 -1.31713 0.08598 
O 3.52326 0.13577 0.43381 
 
O -3.49797 -0.23860 -0.49247 
C 3.02024 -1.02398 -0.09808 
 
C -2.85702 0.97511 -0.43030 
C 3.94778 -2.00978 -0.40697 
 
C -3.55810 2.08604 -0.79164 
H 4.99224 -1.82770 -0.18865 
 
H -4.60286 1.98130 -1.05359 
C 3.52124 -3.18450 -1.00819 
 
C -2.88153 3.34129 -0.98194 
H 4.24087 -3.95585 -1.25317 
 
H -3.42911 4.15310 -1.44609 
C 2.17482 -3.35067 -1.32271 
 
C -1.59145 3.49759 -0.64002 
H 1.83939 -4.24596 -1.83091 
 
H -1.06772 4.42788 -0.82165 
C 1.25601 -2.36651 -0.99064 
 
C -0.87150 2.39573 0.08311 
H 0.21981 -2.50612 -1.26061 
 
C -1.45214 1.01512 -0.16772 
C 1.64326 -1.19398 -0.32334 
 
H 0.86175 2.68880 -1.14171 
C -0.72077 -0.13849 -0.01118 
 
H -1.09078 2.54300 1.16393 
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Table A4.6. Excitation Energies and Oscillator Strengths of (Z)-1 Using the TD-B3LYP 
Method with 6-31G(d) Basis Sets in Chloroform. 
 
Excited State   1:      Singlet-B      3.2192 eV  385.14 nm  f=0.4432  <S**2>=0.000 
      94 -> 95         0.70248 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1182.79895077     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      3.8928 eV  318.50 nm  f=0.0044  <S**2>=0.000 
      93 -> 95         0.69759 
  
 Excited State   3:      Singlet-B      3.8946 eV  318.35 nm  f=0.0172  <S**2>=0.000 
      92 -> 95         0.70011 
  
 Excited State   4:      Singlet-B      4.2969 eV  288.54 nm  f=0.0013  <S**2>=0.000 
      87 -> 95         0.11755 
      89 -> 95         0.20426 
      91 -> 95         0.62454 
      94 -> 97        -0.17168 
  
 Excited State   5:      Singlet-A      4.3567 eV  284.58 nm  f=0.0061  <S**2>=0.000 
      88 -> 95         0.40095 
      90 -> 95         0.28697 
      94 -> 96         0.47759 
  
 Excited State   6:      Singlet-B      4.4062 eV  281.38 nm  f=0.0052  <S**2>=0.000 
      89 -> 95         0.25523 
      94 -> 97         0.64419 
  
 Excited State   7:      Singlet-A      4.4168 eV  280.71 nm  f=0.0004  <S**2>=0.000 
      88 -> 95        -0.31113 
      90 -> 95        -0.35253 
      94 -> 96         0.49476 
  
 Excited State   8:      Singlet-B      4.5063 eV  275.13 nm  f=0.0120  <S**2>=0.000 
      87 -> 95         0.19722 
      89 -> 95         0.50483 
      91 -> 95        -0.26876 
      94 -> 97        -0.19382 
      94 -> 98        -0.25609 
  
 Excited State   9:      Singlet-A      4.5573 eV  272.05 nm  f=0.1213  <S**2>=0.000 
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      88 -> 95        -0.45569 
      90 -> 95         0.49987 
      94 -> 99         0.12016 
  
 Excited State  10:      Singlet-B      4.6216 eV  268.27 nm  f=0.0093  <S**2>=0.000 
      87 -> 95         0.58151 
      91 -> 95        -0.10008 
      92 -> 97        -0.11386 
      94 -> 98         0.32774 
  
 Excited State  11:      Singlet-B      4.6708 eV  265.45 nm  f=0.0172  <S**2>=0.000 
      87 -> 95        -0.28357 
      89 -> 95         0.31781 
      94 -> 98         0.53066 
      94 ->100         0.10912 
  
 Excited State  12:      Singlet-A      4.7956 eV  258.54 nm  f=0.0011  <S**2>=0.000 
      86 -> 95         0.17339 
      94 -> 99         0.64561 
  
 Excited State  13:      Singlet-A      4.8336 eV  256.51 nm  f=0.0065  <S**2>=0.000 
      86 -> 95         0.60982 
      94 -> 99        -0.16710 
      94 ->101        -0.27298 
  
 Excited State  14:      Singlet-B      4.8708 eV  254.54 nm  f=0.1098  <S**2>=0.000 
      94 -> 98        -0.14394 
      94 ->100         0.65428 
  
 Excited State  15:      Singlet-A      5.0452 eV  245.75 nm  f=0.0195  <S**2>=0.000 
      86 -> 95         0.26494 
      92 -> 96        -0.21384 
      92 -> 99         0.13402 
      93 -> 97        -0.18267 
      93 -> 98        -0.14336 
      94 ->101         0.54042 
  
 Excited State  16:      Singlet-B      5.2482 eV  236.24 nm  f=0.0061  <S**2>=0.000 
      92 -> 97         0.23652 
      93 -> 96         0.62210 
      94 -> 98         0.10548 
  
 Excited State  17:      Singlet-A      5.3005 eV  233.91 nm  f=0.1437  <S**2>=0.000 
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      85 -> 95        -0.13720 
      92 -> 96         0.58854 
      94 ->101         0.19800 
      94 ->102        -0.18217 
  
 Excited State  18:      Singlet-A      5.3314 eV  232.56 nm  f=0.1948  <S**2>=0.000 
      88 -> 97        -0.17140 
      91 -> 96         0.12080 
      93 -> 97         0.46736 
      94 ->101         0.18683 
      94 ->102         0.36980 
  
 Excited State  19:      Singlet-B      5.3472 eV  231.87 nm  f=0.0062  <S**2>=0.000 
      91 -> 97         0.13337 
      92 -> 97         0.55918 
      93 -> 96        -0.27149 
      93 -> 99        -0.14789 
      94 ->100         0.12327 
  
 Excited State  20:      Singlet-A      5.4015 eV  229.53 nm  f=0.0262  <S**2>=0.000 
      92 -> 96         0.22133 
      93 -> 97        -0.38281 
      93 -> 98         0.15575 
      94 ->102         0.46859 
  
 Excited State  21:      Singlet-B      5.4658 eV  226.84 nm  f=0.0018  <S**2>=0.000 
      87 -> 97         0.16607 
      88 -> 96        -0.19109 
      88 -> 99         0.12860 
      88 ->101         0.11747 
      89 -> 97         0.25965 
      89 -> 98        -0.11342 
      90 -> 99         0.13893 
      91 -> 97         0.32776 
      91 -> 98        -0.12375 
      92 -> 97        -0.17767 
      92 -> 98        -0.26227 
      92 ->100         0.10002 
  
 Excited State  22:      Singlet-A      5.4889 eV  225.88 nm  f=0.0382  <S**2>=0.000 
      85 -> 95        -0.10874 
      88 -> 97         0.30029 
      88 -> 98        -0.13583 
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      89 -> 96        -0.13012 
      89 -> 99         0.10936 
      90 -> 97         0.26590 
      90 ->100         0.10449 
      91 -> 96        -0.15258 
      91 -> 99         0.14996 
      92 -> 99         0.11019 
      93 -> 97         0.20535 
      93 -> 98         0.28295 
      94 ->101         0.13224 
  
 Excited State  23:      Singlet-A      5.5625 eV  222.89 nm  f=0.0080  <S**2>=0.000 
      85 -> 95         0.18376 
      87 -> 96         0.10359 
      88 -> 98        -0.12510 
      89 -> 96         0.18638 
      90 -> 97        -0.13014 
      91 -> 96         0.36271 
      93 -> 98         0.41139 
      94 ->102        -0.18624 
  
 Excited State  24:      Singlet-B      5.5765 eV  222.33 nm  f=0.0000  <S**2>=0.000 
      87 -> 95        -0.10948 
      87 -> 98         0.10903 
      88 -> 96        -0.36101 
      90 -> 96        -0.27424 
      91 -> 97         0.10238 
      91 -> 98         0.12591 
      92 -> 98         0.41004 
      93 -> 99         0.11252 
  
 Excited State  25:      Singlet-A      5.6064 eV  221.15 nm  f=0.1022  <S**2>=0.000 
      85 -> 95         0.32986 
      87 -> 96        -0.24154 
      88 -> 95        -0.10497 
      88 -> 98         0.19448 
      89 -> 96        -0.20766 
      90 -> 98         0.14251 
      91 -> 96        -0.18194 
      92 -> 99        -0.22450 
      93 -> 98         0.19101 
      93 ->100         0.10580 
      94 ->101         0.10075 
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      94 ->102        -0.13977 
  
 Excited State  26:      Singlet-B      5.6137 eV  220.86 nm  f=0.0210  <S**2>=0.000 
      92 -> 97         0.21246 
      92 ->100         0.31285 
      93 -> 99         0.53469 
  
 Excited State  27:      Singlet-A      5.6273 eV  220.33 nm  f=0.0825  <S**2>=0.000 
      85 -> 95         0.43694 
      87 -> 96        -0.13143 
      88 -> 97         0.13490 
      90 -> 97         0.12537 
      90 -> 98        -0.10945 
      91 -> 96         0.24025 
      92 -> 96         0.14167 
      93 -> 97         0.12639 
      93 -> 98        -0.31876 
  
 Excited State  28:      Singlet-B      5.6749 eV  218.48 nm  f=0.0029  <S**2>=0.000 
      87 -> 97         0.10559 
      87 -> 98        -0.12883 
      88 -> 96         0.20747 
      88 ->101         0.11003 
      89 -> 97         0.12473 
      89 -> 98        -0.17232 
      90 -> 96         0.20941 
      90 -> 99         0.11809 
      91 -> 98        -0.18927 
      92 -> 98         0.45711 
  
 Excited State  29:      Singlet-A      5.7092 eV  217.17 nm  f=0.0257  <S**2>=0.000 
      85 -> 95         0.16936 
      88 -> 98         0.12899 
      89 -> 99        -0.11211 
      90 ->100        -0.11246 
      92 -> 99         0.43292 
      93 -> 98         0.17738 
      93 ->100        -0.38305 
  
 Excited State  30:      Singlet-B      5.7689 eV  214.92 nm  f=0.1010  <S**2>=0.000 
      89 -> 98         0.16540 
      90 -> 96        -0.13309 
      91 -> 97        -0.13921 
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      92 -> 98         0.10668 
      92 ->100         0.50715 
      93 -> 99        -0.34537 
      93 ->101        -0.12081 
  
 Excited State  31:      Singlet-A      5.7913 eV  214.09 nm  f=0.2651  <S**2>=0.000 
      89 -> 96        -0.22786 
      92 -> 99         0.36484 
      93 ->100         0.49857 
  
 Excited State  32:      Singlet-B      5.8301 eV  212.66 nm  f=0.0088  <S**2>=0.000 
      86 -> 96        -0.14758 
      87 -> 97        -0.22269 
      87 -> 98         0.16735 
      88 -> 96        -0.11444 
      89 -> 97        -0.20995 
      90 -> 96         0.29349 
      91 -> 97         0.37709 
      92 ->100         0.21932 
      93 ->101        -0.11528 
  
 Excited State  33:      Singlet-A      5.8656 eV  211.37 nm  f=0.0000  <S**2>=0.000 
      85 -> 95         0.14648 
      87 ->101        -0.10566 
      88 -> 98         0.11998 
      89 -> 96         0.40720 
      89 ->101         0.10645 
      90 -> 98        -0.28449 
      91 -> 96        -0.28803 
      91 -> 99         0.11148 
      93 ->100         0.21674 
  
 Excited State  34:      Singlet-B      5.9778 eV  207.41 nm  f=0.0137  <S**2>=0.000 
      89 -> 97         0.10867 
      91 ->100        -0.17249 
      92 ->100         0.18769 
      93 ->101         0.60465 
  
 Excited State  35:      Singlet-B      5.9971 eV  206.74 nm  f=0.0367  <S**2>=0.000 
      88 -> 96         0.39734 
      89 -> 98        -0.10259 
      90 -> 96        -0.36278 
      91 -> 97         0.25307 
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      91 -> 98         0.23614 
      93 -> 99         0.10141 
      93 ->101        -0.11835 
      94 ->103        -0.13494 
  
 Excited State  36:      Singlet-A      6.0339 eV  205.48 nm  f=0.0001  <S**2>=0.000 
      86 ->100         0.12119 
      87 -> 96         0.11914 
      88 -> 98        -0.12730 
      88 ->100        -0.10321 
      90 -> 98         0.11084 
      90 ->100         0.21997 
      91 -> 96        -0.14328 
      92 -> 99         0.11959 
      92 ->101         0.47344 
      92 ->102         0.24805 
  
 Excited State  37:      Singlet-A      6.0690 eV  204.29 nm  f=0.0007  <S**2>=0.000 
      86 -> 97         0.17990 
      88 -> 97         0.23105 
      88 -> 98         0.15030 
      89 -> 96        -0.13007 
      89 -> 99        -0.12372 
      90 -> 97        -0.25501 
      91 -> 96         0.12281 
      91 -> 99         0.18291 
      92 -> 99        -0.10414 
      92 ->101         0.39653 
      92 ->102        -0.17022 
  
 Excited State  38:      Singlet-B      6.1010 eV  203.22 nm  f=0.0028  <S**2>=0.000 
      87 -> 97        -0.22446 
      89 -> 97         0.44284 
      90 -> 96         0.20183 
      91 -> 98         0.32157 
      91 ->100         0.13330 
      93 ->102         0.22264 
  
 Excited State  39:      Singlet-B      6.1314 eV  202.21 nm  f=0.0134  <S**2>=0.000 
      86 -> 96        -0.25234 
      87 -> 97        -0.23213 
      88 -> 96        -0.10926 
      89 -> 98        -0.26033 
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      90 -> 96        -0.20802 
      91 -> 97        -0.21009 
      91 -> 98        -0.22984 
      91 ->100         0.10886 
      93 ->102         0.33057 
      94 ->103        -0.11557 
  
 Excited State  40:      Singlet-A      6.1579 eV  201.34 nm  f=0.2250  <S**2>=0.000 
      86 -> 97         0.18152 
      87 -> 96        -0.27365 
      88 -> 98         0.13322 
      89 -> 96         0.25639 
      90 -> 97         0.33961 
      90 -> 98         0.26637 
      91 -> 96         0.17965 
      92 ->101         0.12919 
      92 ->102         0.13684 
  
 Excited State  41:      Singlet-B      6.1676 eV  201.03 nm  f=0.0130  <S**2>=0.000 
      84 -> 95         0.47753 
      94 ->103         0.48074 
  
 Excited State  42:      Singlet-A      6.1718 eV  200.89 nm  f=0.0133  <S**2>=0.000 
      86 -> 97         0.12226 
      86 -> 98         0.12270 
      87 -> 96         0.31757 
      87 -> 99         0.11777 
      88 -> 97        -0.18417 
      88 -> 98         0.14847 
      89 -> 96        -0.15018 
      89 -> 99        -0.17718 
      90 -> 97         0.37989 
      90 -> 98        -0.13694 
      92 -> 99        -0.10586 
      92 ->101         0.12545 
  
 Excited State  43:      Singlet-A      6.2098 eV  199.66 nm  f=0.0528  <S**2>=0.000 
      87 -> 96         0.37555 
      88 -> 97         0.43628 
      88 -> 98         0.26691 
      89 -> 96         0.10563 
      90 -> 98         0.15062 
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 Excited State  44:      Singlet-B      6.2415 eV  198.65 nm  f=0.0505  <S**2>=0.000 
      86 -> 96         0.16289 
      87 -> 97         0.26608 
      87 -> 98         0.26557 
      87 ->100         0.15095 
      89 ->100        -0.14181 
      90 -> 99        -0.11248 
      91 ->100        -0.23441 
      93 ->102         0.37517 
      94 ->103         0.12871 
  
 Excited State  45:      Singlet-B      6.2690 eV  197.77 nm  f=0.0862  <S**2>=0.000 
      86 -> 96        -0.14955 
      87 -> 97         0.24342 
      87 -> 98         0.18956 
      87 ->100        -0.13545 
      88 -> 96         0.18999 
      88 -> 99        -0.21005 
      89 -> 98         0.29611 
      90 -> 99         0.11000 
      91 -> 97         0.11327 
      91 -> 98        -0.18455 
      91 ->100         0.26213 
      93 ->101         0.11365 
      93 ->102         0.11994 
  
 Excited State  46:      Singlet-A      6.2699 eV  197.75 nm  f=0.0517  <S**2>=0.000 
      86 -> 97         0.35390 
      86 ->100        -0.12918 
      89 -> 96        -0.14058 
      90 -> 98        -0.12350 
      91 -> 99         0.18862 
      92 ->101        -0.11624 
      92 ->102         0.49293 
  
 Excited State  47:      Singlet-B      6.2868 eV  197.21 nm  f=0.1963  <S**2>=0.000 
      82 -> 95         0.10258 
      84 -> 95         0.25747 
      86 -> 96         0.34616 
      87 -> 97        -0.19568 
      87 -> 98        -0.20217 
      89 -> 98         0.15425 
      91 -> 97         0.11471 
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      91 -> 98        -0.29349 
      91 ->100        -0.15521 
      93 ->102         0.15628 
      94 ->103        -0.13568 
  
 Excited State  48:      Singlet-B      6.3060 eV  196.61 nm  f=0.0827  <S**2>=0.000 
      86 -> 96         0.35732 
      89 -> 97        -0.24192 
      89 -> 98        -0.14002 
      90 -> 99         0.21872 
      91 -> 98         0.16591 
      91 ->100         0.39011 
      93 ->101         0.11223 
      93 ->102         0.12629 
  
 Excited State  49:      Singlet-A      6.3067 eV  196.59 nm  f=0.0025  <S**2>=0.000 
      86 -> 97        -0.29110 
      88 -> 97        -0.13480 
      88 -> 98         0.12685 
      90 -> 98         0.19991 
      91 -> 99         0.55512 
  
 Excited State  50:      Singlet-B      6.3665 eV  194.74 nm  f=0.0523  <S**2>=0.000 
      82 -> 95         0.24290 
      84 -> 95         0.29672 
      86 -> 96        -0.12964 
      86 -> 99         0.10324 
      87 -> 97         0.17491 
      88 -> 96        -0.10041 
      88 -> 99         0.12318 
      90 -> 96         0.10332 
      90 -> 99         0.25263 
      91 -> 97        -0.13751 
      91 -> 98         0.18130 
      91 ->100        -0.16359 
      94 ->103        -0.25385 
  
 Excited State  51:      Singlet-A      6.3681 eV  194.70 nm  f=0.1710  <S**2>=0.000 
      83 -> 95         0.30020 
      87 -> 99        -0.13269 
      88 -> 98         0.30337 
      89 -> 99         0.19601 
      89 ->101        -0.12032 
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      90 -> 98        -0.19273 
      90 ->100         0.33419 
      91 -> 96         0.13751 
  
 Excited State  52:      Singlet-A      6.4185 eV  193.17 nm  f=0.0344  <S**2>=0.000 
      83 -> 95         0.43611 
      86 -> 97        -0.21824 
      88 -> 98        -0.10865 
      88 ->100        -0.13749 
      89 -> 99        -0.37580 
      92 ->102         0.13060 
  
 Excited State  53:      Singlet-B      6.4302 eV  192.81 nm  f=0.0855  <S**2>=0.000 
      82 -> 95        -0.14953 
      87 -> 97        -0.18598 
      87 -> 98         0.11308 
      88 -> 99         0.43380 
      89 -> 98         0.31790 
      89 ->100        -0.20188 
      90 -> 99         0.22161 
  
 Excited State  54:      Singlet-B      6.4460 eV  192.34 nm  f=0.0190  <S**2>=0.000 
      82 -> 95         0.16657 
      86 -> 96         0.20813 
      87 -> 97        -0.13302 
      87 -> 98         0.37545 
      87 ->100        -0.20671 
      88 -> 99         0.14359 
      89 ->100         0.38841 
  
 Excited State  55:      Singlet-A      6.4569 eV  192.02 nm  f=0.0309  <S**2>=0.000 
      83 -> 95         0.37524 
      86 -> 98         0.14188 
      87 -> 99         0.33790 
      88 ->100         0.10993 
      89 -> 99         0.20376 
      89 ->101         0.14574 
      90 -> 98         0.23909 
      91 ->101         0.16219 
  
 Excited State  56:      Singlet-B      6.4608 eV  191.90 nm  f=0.0296  <S**2>=0.000 
      82 -> 95        -0.11219 
      87 ->100        -0.18175 
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      88 -> 99        -0.24615 
      88 ->101         0.10609 
      89 -> 98        -0.10999 
      89 ->100        -0.23518 
      90 -> 99         0.42174 
      91 ->100        -0.25741 
  
 Excited State  57:      Singlet-A      6.4838 eV  191.22 nm  f=0.0633  <S**2>=0.000 
      83 -> 95         0.10681 
      87 -> 99        -0.21406 
      88 ->100         0.58471 
      90 ->100         0.11695 
      91 ->101        -0.23197 
  
 Excited State  58:      Singlet-B      6.5023 eV  190.68 nm  f=0.0310  <S**2>=0.000 
      82 -> 95         0.16695 
      86 -> 99         0.30584 
      87 -> 98         0.21488 
      87 ->100         0.22802 
      89 -> 97         0.18026 
      89 -> 98        -0.11348 
      89 ->100        -0.21940 
      90 ->101        -0.15713 
      93 ->102        -0.30326 
  
 Excited State  59:      Singlet-A      6.5181 eV  190.21 nm  f=0.0345  <S**2>=0.000 
      83 -> 95        -0.16550 
      86 -> 98        -0.11867 
      86 ->100        -0.24272 
      87 -> 99         0.28506 
      88 -> 98         0.14949 
      88 ->100         0.14816 
      89 -> 99        -0.25187 
      90 ->100         0.32199 
      91 ->101         0.23350 
  
 Excited State  60:      Singlet-B      6.5469 eV  189.38 nm  f=0.0961  <S**2>=0.000 
      82 -> 95        -0.22521 
      87 ->100         0.46377 
      88 -> 99        -0.20947 
      89 -> 98         0.10182 
      89 ->100         0.32370 
      90 -> 99         0.15197 
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      90 ->102         0.10612 
  
 Excited State  61:      Singlet-A      6.5754 eV  188.56 nm  f=0.0142  <S**2>=0.000 
      86 -> 97        -0.12075 
      86 -> 98         0.43182 
      87 -> 99        -0.30244 
      89 -> 99        -0.10120 
      91 ->101         0.40758 
  
 Excited State  62:      Singlet-A      6.6342 eV  186.89 nm  f=0.0367  <S**2>=0.000 
      86 -> 97        -0.16824 
      87 -> 99         0.14041 
      87 ->101         0.31131 
      88 -> 98         0.18047 
      88 ->100         0.11514 
      89 ->101        -0.29159 
      90 -> 98        -0.18851 
      90 ->100        -0.31152 
      91 -> 99        -0.11469 
      91 ->102         0.12022 
      92 ->102         0.10812 
  
 Excited State  63:      Singlet-B      6.6587 eV  186.20 nm  f=0.0292  <S**2>=0.000 
      86 -> 99         0.37209 
      87 ->100        -0.14504 
      88 -> 99        -0.14007 
      88 ->101        -0.19927 
      89 -> 98         0.10818 
      89 ->100         0.10644 
      90 ->101         0.45100 
  
 Excited State  64:      Singlet-A      6.6979 eV  185.11 nm  f=0.1929  <S**2>=0.000 
      85 -> 97         0.17414 
      86 -> 98         0.37145 
      86 ->100        -0.36146 
      87 ->101        -0.11219 
      88 ->100        -0.11843 
      90 ->100         0.11702 
      91 ->101        -0.33825 
  
 Excited State  65:      Singlet-B      6.7080 eV  184.83 nm  f=0.0266  <S**2>=0.000 
      79 -> 95         0.11587 
      81 -> 95        -0.21444 
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      82 -> 95         0.43760 
      84 -> 95        -0.16048 
      85 -> 96         0.10013 
      86 -> 99        -0.14723 
      86 ->101        -0.11428 
      87 ->100         0.15903 
      88 ->101        -0.12778 
      90 ->101         0.15667 
      90 ->102         0.16567 
      94 ->103         0.19209 
  
 Excited State  66:      Singlet-B      6.7215 eV  184.46 nm  f=0.0021  <S**2>=0.000 
      87 -> 98         0.15149 
      88 -> 99        -0.17143 
      88 ->101         0.51622 
      89 -> 98         0.10234 
      90 -> 99        -0.15692 
      90 ->101         0.30660 
      90 ->102         0.11623 
  
 Excited State  67:      Singlet-A      6.7382 eV  184.00 nm  f=0.0081  <S**2>=0.000 
      86 -> 98        -0.14430 
      86 ->100        -0.27518 
      87 -> 99        -0.17560 
      87 ->101         0.21944 
      89 ->101         0.42223 
      89 ->102         0.12421 
      91 ->102         0.29014 
  
 Excited State  68:      Singlet-A      6.8249 eV  181.66 nm  f=0.0850  <S**2>=0.000 
      85 -> 97        -0.26748 
      87 ->101        -0.24941 
      87 ->102        -0.12757 
      89 ->101        -0.19394 
      91 ->102         0.51974 
  
 Excited State  69:      Singlet-B      6.8766 eV  180.30 nm  f=0.0532  <S**2>=0.000 
      81 -> 95         0.40666 
      85 -> 96        -0.19304 
      86 -> 99        -0.26823 
      88 ->101        -0.24434 
      89 ->100        -0.11949 
      90 ->101         0.15706 
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      90 ->102         0.20770 
      92 ->103         0.15867 
      93 ->102        -0.11294 
  
 Excited State  70:      Singlet-A      6.8895 eV  179.96 nm  f=0.1148  <S**2>=0.000 
      85 -> 98        -0.11564 
      86 -> 97         0.10265 
      86 -> 98         0.14957 
      86 ->100         0.22291 
      87 -> 99         0.10337 
      87 ->101         0.28509 
      87 ->102         0.18316 
      89 -> 99        -0.20570 
      89 ->102        -0.20199 
      91 ->102         0.20611 
      92 ->101        -0.10566 
      93 ->103         0.27417 
  
 Excited State  71:      Singlet-B      6.9560 eV  178.24 nm  f=0.0029  <S**2>=0.000 
      86 -> 99         0.20570 
      86 ->101         0.31688 
      88 ->102        -0.36890 
      90 ->102         0.38347 
      92 ->103        -0.20768 
  
 Excited State  72:      Singlet-B      6.9690 eV  177.91 nm  f=0.0012  <S**2>=0.000 
      81 -> 95         0.45399 
      82 -> 95         0.12780 
      85 -> 96         0.19711 
      86 -> 99         0.13247 
      86 ->102         0.12251 
      88 ->102         0.17266 
      92 ->103        -0.34305 
  
 Excited State  73:      Singlet-A      6.9886 eV  177.41 nm  f=0.0001  <S**2>=0.000 
      80 -> 95         0.14032 
      86 ->100         0.21212 
      87 ->101        -0.20878 
      89 ->102         0.53523 
      93 ->103         0.18052 
  
 Excited State  74:      Singlet-B      6.9996 eV  177.13 nm  f=0.0034  <S**2>=0.000 
      81 -> 95        -0.12654 
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      86 ->101         0.13576 
      88 ->101        -0.14110 
      88 ->102         0.50584 
      90 ->102         0.37513 
  
 Excited State  75:      Singlet-A      7.0200 eV  176.62 nm  f=0.1210  <S**2>=0.000 
      80 -> 95        -0.32608 
      85 -> 97        -0.11407 
      86 -> 97         0.10015 
      87 ->101         0.16676 
      87 ->102        -0.32142 
      89 ->102         0.17855 
      91 ->102        -0.11063 
      93 ->103         0.38464 
  
 Excited State  76:      Singlet-A      7.0442 eV  176.01 nm  f=0.0007  <S**2>=0.000 
      80 -> 95         0.45650 
      85 -> 98         0.15084 
      87 ->102        -0.37151 
      89 ->101         0.14750 
      89 ->102        -0.16399 
      93 ->103         0.18713 
  
 Excited State  77:      Singlet-B      7.0801 eV  175.12 nm  f=0.0275  <S**2>=0.000 
      85 -> 96         0.40228 
      86 ->101         0.35486 
      86 ->102         0.21727 
      90 ->102        -0.11723 
      92 ->103         0.33246 
  
 Excited State  78:      Singlet-A      7.1750 eV  172.80 nm  f=0.0788  <S**2>=0.000 
      80 -> 95         0.15618 
      85 -> 97        -0.34793 
      85 ->100        -0.10949 
      86 ->100        -0.18924 
      87 ->102         0.37233 
      89 -> 99         0.11135 
      92 ->101         0.10398 
      93 ->103         0.23414 
  
 Excited State  79:      Singlet-A      7.2123 eV  171.91 nm  f=0.2528  <S**2>=0.000 
      78 -> 95         0.12709 
      80 -> 95        -0.11625 
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      85 -> 97         0.37920 
      85 -> 98         0.16302 
      85 ->100        -0.23579 
      86 -> 98        -0.12623 
      87 ->101        -0.12306 
      89 ->102        -0.16814 
      90 ->100        -0.10878 
      93 ->103         0.29714 
  
 Excited State  80:      Singlet-B      7.2162 eV  171.81 nm  f=0.0922  <S**2>=0.000 
      79 -> 95        -0.27432 
      85 -> 96        -0.29141 
      85 -> 99        -0.12717 
      86 ->101         0.33638 
      86 ->102         0.19466 
      88 ->102         0.12779 
      90 ->102        -0.20304 
      92 ->103        -0.19041 
  
 Excited State  81:      Singlet-B      7.2327 eV  171.42 nm  f=0.0356  <S**2>=0.000 
      79 -> 95         0.46493 
      85 -> 96        -0.24763 
      86 ->102         0.38954 
  
 Excited State  82:      Singlet-A      7.2811 eV  170.28 nm  f=0.0493  <S**2>=0.000 
      78 -> 95         0.44445 
      80 -> 95         0.16303 
      85 -> 97         0.10468 
      86 -> 97         0.14707 
      87 ->101         0.16745 
      89 ->101        -0.17262 
      89 ->102         0.13671 
      90 -> 98         0.11528 
      92 ->102        -0.12134 
      93 ->103        -0.12288 
  
 Excited State  83:      Singlet-B      7.2911 eV  170.05 nm  f=0.0248  <S**2>=0.000 
      77 -> 95         0.54319 
      79 -> 95         0.17993 
      83 -> 96        -0.11151 
      85 -> 99        -0.15517 
      86 ->102        -0.15619 
      92 ->103        -0.16303 
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 Excited State  84:      Singlet-B      7.3098 eV  169.61 nm  f=0.2778  <S**2>=0.000 
      77 -> 95        -0.30804 
      79 -> 95         0.34994 
      86 ->101         0.23255 
      86 ->102        -0.32717 
      90 ->102        -0.10270 
      92 ->103        -0.15898 
  
 Excited State  85:      Singlet-A      7.3661 eV  168.32 nm  f=0.0637  <S**2>=0.000 
      76 -> 95        -0.14933 
      78 -> 95         0.20986 
      80 -> 95        -0.21903 
      85 -> 97        -0.12925 
      85 -> 98         0.41184 
      85 ->100         0.28066 
      94 ->104        -0.17162 
  
 Excited State  86:      Singlet-A      7.3926 eV  167.71 nm  f=0.0206  <S**2>=0.000 
      78 -> 95         0.21034 
      85 ->100         0.26064 
      94 ->104         0.58394 
  
 Excited State  87:      Singlet-B      7.4147 eV  167.21 nm  f=0.1140  <S**2>=0.000 
      77 -> 95         0.18396 
      85 -> 96        -0.11989 
      85 -> 99         0.44887 
      86 ->101         0.12214 
      86 ->102        -0.19235 
      87 ->103        -0.12282 
      91 ->103         0.16895 
      92 ->103         0.11218 
      94 ->103         0.11024 
      94 ->105         0.20662 
  
 Excited State  88:      Singlet-A      7.4335 eV  166.79 nm  f=0.0624  <S**2>=0.000 
      76 -> 95        -0.11946 
      78 -> 95        -0.35999 
      80 -> 95         0.12366 
      84 -> 96        -0.13966 
      85 -> 98         0.37697 
      86 -> 97         0.10472 
      87 ->101         0.10823 
413 
 
      89 ->101        -0.10114 
      94 ->104         0.23472 
  
 Excited State  89:      Singlet-A      7.4773 eV  165.81 nm  f=0.0026  <S**2>=0.000 
      76 -> 95         0.60748 
      83 -> 97         0.13818 
      84 -> 96        -0.11449 
      85 -> 98         0.20838 
  
 Excited State  90:      Singlet-B      7.4805 eV  165.74 nm  f=0.0410  <S**2>=0.000 
      85 -> 99        -0.21864 
      94 ->105         0.62445 
  
 Excited State  91:      Singlet-A      7.5476 eV  164.27 nm  f=0.0001  <S**2>=0.000 
      80 -> 95         0.10905 
      83 ->100        -0.13014 
      84 -> 96        -0.24547 
      85 -> 97         0.12873 
      85 -> 98        -0.13584 
      85 ->100         0.43595 
      86 -> 98        -0.10129 
      91 ->101         0.10019 
      93 ->103         0.16399 
      94 ->104        -0.18899 
  
 Excited State  92:      Singlet-B      7.5514 eV  164.19 nm  f=0.1197  <S**2>=0.000 
      85 -> 96         0.12409 
      85 -> 99         0.36169 
      86 -> 99        -0.11234 
      90 ->101         0.12324 
      91 ->103        -0.32535 
      92 ->103        -0.21197 
      94 ->105         0.15325 
  
 Excited State  93:      Singlet-B      7.6185 eV  162.74 nm  f=0.0129  <S**2>=0.000 
      83 -> 96        -0.13068 
      84 -> 97         0.26927 
      84 -> 98        -0.10039 
      85 -> 99         0.11830 
      85 ->101        -0.26126 
      86 ->102         0.10508 
      91 ->103         0.42637 
      92 ->103        -0.11114 
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 Excited State  94:      Singlet-B      7.6704 eV  161.64 nm  f=0.0613  <S**2>=0.000 
      77 -> 95        -0.13988 
      82 -> 97         0.15272 
      83 -> 96        -0.23565 
      83 -> 99         0.15044 
      84 -> 97         0.43368 
      84 -> 98         0.14708 
      85 ->101         0.22802 
      91 ->103        -0.13806 
  
 Excited State  95:      Singlet-A      7.7010 eV  161.00 nm  f=0.0176  <S**2>=0.000 
      76 -> 95        -0.19593 
      78 -> 95         0.13066 
      83 -> 97         0.39181 
      84 -> 96        -0.37947 
      84 -> 99         0.17653 
      85 ->100        -0.20492 
  
 Excited State  96:      Singlet-B      7.7488 eV  160.00 nm  f=0.0092  <S**2>=0.000 
      75 -> 95        -0.13039 
      82 ->100         0.10897 
      84 ->100         0.20012 
      85 ->101         0.44048 
      85 ->102        -0.11606 
      89 ->103         0.18425 
      91 ->103         0.32840 
  
 Excited State  97:      Singlet-A      7.7623 eV  159.73 nm  f=0.0415  <S**2>=0.000 
      83 -> 97         0.12193 
      88 ->103        -0.17996 
      90 ->103         0.61956 
  
 Excited State  98:      Singlet-B      7.8076 eV  158.80 nm  f=0.0043  <S**2>=0.000 
      83 -> 96        -0.12866 
      85 ->101        -0.14695 
      89 ->103         0.50560 
      94 ->106        -0.39586 
  
 Excited State  99:      Singlet-A      7.8201 eV  158.54 nm  f=0.0001  <S**2>=0.000 
      74 -> 95         0.14306 
      84 -> 96         0.16455 
      84 -> 99         0.15426 
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      88 ->103         0.59375 
      90 ->103         0.12365 
  
 Excited State 100:      Singlet-B      7.8405 eV  158.13 nm  f=0.0113  <S**2>=0.000 
      83 -> 96        -0.18746 
      84 -> 97        -0.15372 
      89 ->103         0.30095 
      94 ->106         0.53207 
 
 
Table A4.7. Excitation Energies and Oscillator Strengths of (E)-1 Using the TD-B3LYP 
Method with 6-31G(d) Basis Sets in Chloroform. 
 
Excited State   1:      Singlet-A      3.2255 eV  384.39 nm  f=0.4545  <S**2>=0.000 
      94 -> 95         0.70236 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1182.79889761     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      3.8889 eV  318.82 nm  f=0.0000  <S**2>=0.000 
      93 -> 95         0.69695 
  
 Excited State   3:      Singlet-A      3.9347 eV  315.10 nm  f=0.0222  <S**2>=0.000 
      92 -> 95         0.70048 
  
 Excited State   4:      Singlet-A      4.2221 eV  293.66 nm  f=0.0000  <S**2>=0.000 
      88 -> 95        -0.14342 
      91 -> 95         0.62071 
      94 -> 96         0.27200 
  
 Excited State   5:      Singlet-A      4.3171 eV  287.19 nm  f=0.0000  <S**2>=0.000 
      91 -> 95        -0.26201 
      94 -> 96         0.63897 
  
 Excited State   6:      Singlet-A      4.4032 eV  281.58 nm  f=0.0117  <S**2>=0.000 
      87 -> 95        -0.10724 
      88 -> 96         0.13012 
      89 -> 95         0.65705 
      94 -> 97        -0.11585 
  
 Excited State   7:      Singlet-A      4.4689 eV  277.44 nm  f=0.0000  <S**2>=0.000 
      88 -> 95         0.49166 
      89 -> 96         0.10745 
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      90 -> 95        -0.37067 
      91 -> 95         0.15874 
      94 -> 98         0.24987 
  
 Excited State   8:      Singlet-A      4.5254 eV  273.97 nm  f=0.0038  <S**2>=0.000 
      87 -> 95        -0.22929 
      94 -> 97         0.65462 
  
 Excited State   9:      Singlet-A      4.5323 eV  273.56 nm  f=0.0000  <S**2>=0.000 
      88 -> 95         0.44581 
      90 -> 95         0.39301 
      94 -> 98        -0.32795 
  
 Excited State  10:      Singlet-A      4.6411 eV  267.14 nm  f=0.1045  <S**2>=0.000 
      87 -> 95         0.63129 
      89 -> 95         0.15120 
      93 -> 96        -0.11180 
      94 -> 97         0.19466 
  
 Excited State  11:      Singlet-A      4.6454 eV  266.90 nm  f=0.0002  <S**2>=0.000 
      90 -> 95         0.42294 
      94 -> 98         0.55134 
  
 Excited State  12:      Singlet-A      4.8136 eV  257.57 nm  f=0.0000  <S**2>=0.000 
      85 -> 95        -0.10368 
      94 ->100         0.65805 
  
 Excited State  13:      Singlet-A      4.8687 eV  254.66 nm  f=0.1107  <S**2>=0.000 
      94 -> 99         0.66421 
      94 ->101         0.10013 
  
 Excited State  14:      Singlet-A      4.9349 eV  251.24 nm  f=0.0202  <S**2>=0.000 
      86 -> 95         0.57372 
      94 ->101         0.37318 
  
 Excited State  15:      Singlet-A      5.0577 eV  245.14 nm  f=0.0238  <S**2>=0.000 
      86 -> 95        -0.33964 
      92 -> 97        -0.20348 
      93 -> 96        -0.26498 
      93 ->100        -0.12076 
      94 ->101         0.47651 
  
 Excited State  16:      Singlet-A      5.2256 eV  237.26 nm  f=0.0000  <S**2>=0.000 
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      85 -> 95         0.10609 
      92 -> 96         0.64381 
      93 -> 97         0.15599 
  
 Excited State  17:      Singlet-A      5.2442 eV  236.42 nm  f=0.2365  <S**2>=0.000 
      86 -> 95        -0.14336 
      93 -> 96         0.61357 
      94 ->101         0.20613 
  
 Excited State  18:      Singlet-A      5.3375 eV  232.29 nm  f=0.0000  <S**2>=0.000 
      85 -> 95        -0.12193 
      88 -> 97         0.10092 
      89 -> 96         0.13422 
      91 -> 97        -0.10136 
      92 ->100         0.12021 
      93 -> 97         0.32008 
      94 ->102         0.52006 
  
 Excited State  19:      Singlet-A      5.4264 eV  228.48 nm  f=0.0609  <S**2>=0.000 
      88 -> 96        -0.17726 
      88 -> 98        -0.14859 
      89 -> 97        -0.26850 
      89 -> 99         0.13149 
      90 -> 96         0.10507 
      91 -> 96         0.35024 
      91 -> 98         0.17816 
      92 -> 97        -0.11294 
      93 -> 98        -0.33602 
  
 Excited State  20:      Singlet-A      5.4435 eV  227.76 nm  f=0.0000  <S**2>=0.000 
      87 -> 96        -0.13925 
      88 -> 97         0.11927 
      89 -> 96         0.13749 
      89 -> 98         0.12407 
      91 -> 97        -0.10874 
      92 -> 96        -0.17903 
      92 -> 98         0.12045 
      93 -> 97         0.42484 
      94 ->102        -0.37749 
  
 Excited State  21:      Singlet-A      5.4929 eV  225.72 nm  f=0.0044  <S**2>=0.000 
      88 -> 96        -0.12822 
      91 -> 96         0.20783 
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      92 -> 97        -0.37493 
      93 -> 96         0.10335 
      93 -> 98         0.48141 
      94 ->101        -0.12690 
  
 Excited State  22:      Singlet-A      5.5034 eV  225.28 nm  f=0.0000  <S**2>=0.000 
      88 -> 97         0.24289 
      89 -> 96         0.34344 
      89 -> 98         0.18275 
      90 -> 97        -0.10682 
      91 -> 97        -0.22575 
      91 -> 99         0.12713 
      93 -> 97        -0.33125 
      93 -> 99        -0.14927 
  
 Excited State  23:      Singlet-A      5.5199 eV  224.61 nm  f=0.0000  <S**2>=0.000 
      85 -> 95         0.59537 
      91 -> 97         0.16644 
      92 -> 96        -0.12282 
      92 ->100        -0.12755 
      93 -> 97         0.10919 
      94 ->102         0.14958 
  
 Excited State  24:      Singlet-A      5.5621 eV  222.91 nm  f=0.4174  <S**2>=0.000 
      86 -> 95        -0.10607 
      88 -> 96        -0.25428 
      88 -> 98         0.13028 
      89 -> 95         0.13144 
      89 -> 99        -0.14362 
      91 -> 96         0.27282 
      91 -> 98        -0.10013 
      92 -> 97         0.42227 
      93 -> 98         0.13365 
      94 ->101         0.16896 
  
 Excited State  25:      Singlet-A      5.5826 eV  222.09 nm  f=0.0847  <S**2>=0.000 
      88 -> 96        -0.16064 
      88 -> 98        -0.25575 
      89 -> 97        -0.16825 
      89 -> 99         0.16078 
      89 ->101         0.12560 
      91 -> 96        -0.26732 
      91 -> 98         0.10919 
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      92 -> 99         0.20969 
      93 -> 98         0.13038 
      93 ->100         0.33450 
      94 ->101         0.13712 
  
 Excited State  26:      Singlet-A      5.5923 eV  221.71 nm  f=0.0000  <S**2>=0.000 
      85 -> 95         0.14218 
      88 -> 95         0.12267 
      88 -> 99        -0.12290 
      89 -> 96        -0.25698 
      89 -> 98         0.23098 
      91 -> 99         0.14183 
      92 -> 98         0.47767 
      93 -> 97        -0.12738 
      93 -> 99        -0.15848 
  
 Excited State  27:      Singlet-A      5.6527 eV  219.34 nm  f=0.0000  <S**2>=0.000 
      87 -> 96        -0.14165 
      88 -> 99         0.13736 
      88 ->101         0.10988 
      89 -> 96         0.27033 
      89 -> 98        -0.24704 
      91 -> 99        -0.11354 
      92 -> 98         0.42483 
      93 -> 97        -0.13108 
      93 -> 99         0.20841 
      93 ->101         0.12175 
  
 Excited State  28:      Singlet-A      5.6566 eV  219.18 nm  f=0.1039  <S**2>=0.000 
      88 -> 98        -0.11671 
      89 -> 99         0.12714 
      90 -> 96        -0.15331 
      90 -> 98         0.15331 
      91 -> 98         0.33327 
      92 -> 97         0.24542 
      92 -> 99        -0.18151 
      93 -> 98         0.27014 
      93 ->100        -0.30378 
  
 Excited State  29:      Singlet-A      5.7423 eV  215.91 nm  f=0.0000  <S**2>=0.000 
      88 -> 99        -0.10498 
      89 -> 98         0.19132 
      90 -> 97        -0.12492 
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      91 -> 97         0.10083 
      91 -> 99         0.11470 
      92 ->100        -0.19623 
      93 -> 99         0.56874 
  
 Excited State  30:      Singlet-A      5.7542 eV  215.47 nm  f=0.0773  <S**2>=0.000 
      88 -> 96         0.27977 
      89 -> 97         0.11364 
      90 -> 96        -0.22086 
      91 -> 96         0.28114 
      91 -> 98         0.10270 
      92 -> 99         0.47889 
  
 Excited State  31:      Singlet-A      5.7985 eV  213.82 nm  f=0.0797  <S**2>=0.000 
      88 -> 96         0.12830 
      90 -> 96        -0.26644 
      90 ->100        -0.11027 
      91 -> 96         0.17032 
      92 -> 99        -0.35406 
      93 ->100         0.43563 
  
 Excited State  32:      Singlet-A      5.8166 eV  213.16 nm  f=0.0000  <S**2>=0.000 
      85 -> 95         0.12874 
      87 -> 98        -0.13454 
      91 ->101         0.12342 
      92 -> 98        -0.11331 
      92 ->100         0.58929 
      93 -> 99         0.10945 
  
 Excited State  33:      Singlet-A      5.8925 eV  210.41 nm  f=0.1229  <S**2>=0.000 
      88 -> 96         0.33098 
      88 -> 98        -0.26026 
      89 -> 99         0.11521 
      90 -> 96         0.38701 
      91 -> 96         0.16959 
      91 -> 98        -0.20472 
      92 -> 97         0.14536 
      92 -> 99        -0.11449 
  
 Excited State  34:      Singlet-A      5.8955 eV  210.30 nm  f=0.0003  <S**2>=0.000 
      86 -> 96         0.10841 
      87 -> 96         0.35440 
      87 -> 98        -0.27672 
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      87 ->100         0.12281 
      90 -> 97         0.20880 
      90 ->101         0.12345 
      91 -> 97        -0.30948 
      91 ->101         0.13985 
      93 -> 99         0.14866 
  
 Excited State  35:      Singlet-A      5.9699 eV  207.68 nm  f=0.0000  <S**2>=0.000 
      88 -> 99        -0.10415 
      89 -> 98         0.11229 
      91 -> 99        -0.24654 
      92 ->100        -0.11834 
      93 ->101         0.59518 
  
 Excited State  36:      Singlet-A      6.0314 eV  205.56 nm  f=0.0722  <S**2>=0.000 
      87 -> 97        -0.24807 
      88 -> 98         0.19098 
      90 -> 96         0.33302 
      90 ->100        -0.19608 
      91 -> 98         0.38795 
      93 ->100         0.16171 
      93 ->102        -0.15320 
  
 Excited State  37:      Singlet-A      6.0633 eV  204.48 nm  f=0.0000  <S**2>=0.000 
      86 -> 96         0.11911 
      89 -> 96         0.24878 
      89 -> 98         0.10794 
      90 -> 97         0.22509 
      91 -> 97         0.45067 
      91 -> 99        -0.10480 
      92 ->100        -0.11492 
      92 ->102         0.19355 
      93 ->101        -0.11237 
  
 Excited State  38:      Singlet-A      6.0755 eV  204.07 nm  f=0.0000  <S**2>=0.000 
      87 -> 96         0.39121 
      87 ->100        -0.20034 
      88 -> 97        -0.11216 
      89 -> 96         0.17628 
      90 -> 97        -0.24999 
      91 -> 97         0.16168 
      91 -> 99         0.29197 
      93 ->101         0.16046 
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 Excited State  39:      Singlet-A      6.0982 eV  203.31 nm  f=0.0292  <S**2>=0.000 
      86 -> 99         0.10182 
      90 ->100        -0.10262 
      91 -> 98        -0.14600 
      92 ->101         0.64326 
  
 Excited State  40:      Singlet-A      6.1598 eV  201.28 nm  f=0.0397  <S**2>=0.000 
      84 -> 95         0.10754 
      87 -> 97        -0.16423 
      90 -> 98        -0.38324 
      93 ->102         0.46477 
      94 ->103        -0.21996 
  
 Excited State  41:      Singlet-A      6.1868 eV  200.40 nm  f=0.0653  <S**2>=0.000 
      84 -> 95        -0.30347 
      87 -> 97         0.13482 
      89 -> 97         0.11541 
      90 -> 98        -0.18661 
      91 ->100         0.12600 
      93 ->102         0.15174 
      94 ->103         0.51242 
  
 Excited State  42:      Singlet-A      6.1946 eV  200.15 nm  f=0.0000  <S**2>=0.000 
      86 -> 96         0.13041 
      87 -> 96        -0.31458 
      87 -> 98        -0.17885 
      89 -> 98        -0.12039 
      90 -> 97         0.13368 
      90 -> 99         0.17140 
      91 -> 99         0.40279 
      92 ->102         0.23344 
      93 ->101         0.19773 
  
 Excited State  43:      Singlet-A      6.2353 eV  198.84 nm  f=0.1514  <S**2>=0.000 
      84 -> 95         0.13831 
      87 -> 99         0.16385 
      89 -> 97         0.11470 
      90 -> 98         0.18346 
      91 ->100         0.59865 
  
 Excited State  44:      Singlet-A      6.2433 eV  198.59 nm  f=0.0232  <S**2>=0.000 
      84 -> 95         0.11939 
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      88 -> 96        -0.29201 
      88 -> 98        -0.18588 
      89 -> 97         0.53200 
      91 ->100        -0.14789 
  
 Excited State  45:      Singlet-A      6.2588 eV  198.09 nm  f=0.0000  <S**2>=0.000 
      83 -> 95         0.10466 
      86 -> 96        -0.35666 
      87 -> 96         0.11756 
      88 -> 97         0.11892 
      90 -> 97        -0.14702 
      90 -> 99        -0.15578 
      92 ->102         0.48814 
  
 Excited State  46:      Singlet-A      6.2869 eV  197.21 nm  f=0.0000  <S**2>=0.000 
      86 -> 96         0.26429 
      88 -> 97         0.53529 
      89 -> 96        -0.24901 
      89 -> 98        -0.18163 
  
 Excited State  47:      Singlet-A      6.3106 eV  196.47 nm  f=0.1081  <S**2>=0.000 
      84 -> 95         0.33522 
      87 -> 97         0.41392 
      87 -> 99         0.10818 
      90 -> 98        -0.30335 
      90 ->100        -0.17198 
      93 ->102        -0.18480 
  
 Excited State  48:      Singlet-A      6.3162 eV  196.29 nm  f=0.0000  <S**2>=0.000 
      83 -> 95         0.22712 
      86 -> 96        -0.29706 
      87 -> 98         0.10294 
      87 ->100        -0.22128 
      88 -> 97         0.16218 
      90 -> 97         0.42406 
      90 -> 99        -0.11099 
      92 ->102        -0.17479 
  
 Excited State  49:      Singlet-A      6.3499 eV  195.25 nm  f=0.4399  <S**2>=0.000 
      86 ->101        -0.11982 
      87 -> 97         0.19689 
      87 ->101         0.10908 
      88 -> 96         0.12047 
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      88 -> 98         0.19895 
      88 ->100         0.10960 
      89 -> 99        -0.11318 
      90 -> 96         0.12029 
      90 -> 98         0.11938 
      90 ->100         0.35806 
      91 -> 98         0.20313 
      91 ->102        -0.26609 
      92 -> 99        -0.10599 
      92 ->101         0.12072 
      93 ->102         0.13055 
  
 Excited State  50:      Singlet-A      6.3629 eV  194.85 nm  f=0.0002  <S**2>=0.000 
      83 -> 95         0.35153 
      87 -> 98         0.29972 
      87 ->100         0.23915 
      90 -> 97        -0.11361 
      90 -> 99         0.24093 
      91 ->101         0.31903 
  
 Excited State  51:      Singlet-A      6.3867 eV  194.13 nm  f=0.0000  <S**2>=0.000 
      83 -> 95         0.48667 
      87 -> 98        -0.33318 
      88 -> 97        -0.10151 
      90 -> 97        -0.10315 
      91 -> 99        -0.19314 
      91 ->101        -0.20983 
  
 Excited State  52:      Singlet-A      6.4192 eV  193.15 nm  f=0.0244  <S**2>=0.000 
      82 -> 95         0.14272 
      84 -> 95         0.27952 
      87 -> 97        -0.31183 
      87 -> 99         0.10146 
      89 -> 99         0.15775 
      90 -> 98        -0.15224 
      90 ->100         0.38241 
      93 ->102        -0.17806 
      94 ->103         0.19556 
  
 Excited State  53:      Singlet-A      6.4340 eV  192.70 nm  f=0.0389  <S**2>=0.000 
      84 -> 95         0.14588 
      86 -> 97        -0.25672 
      88 -> 98         0.24137 
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      88 ->100         0.22461 
      89 -> 99         0.35192 
      90 ->100        -0.17181 
      91 ->100        -0.11101 
      93 ->102         0.24210 
      94 ->103         0.13191 
  
 Excited State  54:      Singlet-A      6.4421 eV  192.46 nm  f=0.0000  <S**2>=0.000 
      87 ->100        -0.17764 
      88 -> 99         0.48733 
      89 -> 98         0.27789 
      89 ->100        -0.14437 
      90 -> 99         0.19080 
      91 -> 99        -0.13495 
      92 ->102         0.15377 
  
 Excited State  55:      Singlet-A      6.4598 eV  191.93 nm  f=0.0127  <S**2>=0.000 
      84 -> 95        -0.18064 
      86 -> 97         0.36533 
      88 -> 98         0.26568 
      89 -> 99         0.40645 
      90 -> 98        -0.11787 
      91 ->102        -0.11823 
      93 ->102        -0.14462 
      94 ->103        -0.12151 
  
 Excited State  56:      Singlet-A      6.4650 eV  191.78 nm  f=0.0000  <S**2>=0.000 
      83 -> 95        -0.12884 
      86 -> 96        -0.17481 
      88 -> 99        -0.25904 
      89 -> 98        -0.22366 
      89 ->100        -0.30243 
      90 -> 99         0.43936 
  
 Excited State  57:      Singlet-A      6.4801 eV  191.33 nm  f=0.0000  <S**2>=0.000 
      86 -> 96        -0.10138 
      87 ->100        -0.22355 
      89 ->100         0.59891 
      90 -> 99         0.22944 
  
 Excited State  58:      Singlet-A      6.4903 eV  191.03 nm  f=0.0270  <S**2>=0.000 
      86 -> 97         0.15448 
      87 -> 99         0.42523 
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      88 -> 98        -0.10382 
      88 ->100         0.47810 
  
 Excited State  59:      Singlet-A      6.5594 eV  189.02 nm  f=0.0000  <S**2>=0.000 
      86 -> 98        -0.22207 
      86 ->100         0.14382 
      87 -> 98        -0.21365 
      88 ->101        -0.18470 
      89 -> 98        -0.17137 
      90 -> 99        -0.14224 
      90 ->101        -0.16873 
      91 ->101         0.46520 
  
 Excited State  60:      Singlet-A      6.5761 eV  188.54 nm  f=0.2850  <S**2>=0.000 
      82 -> 95        -0.11669 
      85 -> 96         0.11311 
      86 -> 97        -0.18574 
      87 -> 99         0.44533 
      88 ->100        -0.38673 
      91 ->100        -0.14629 
  
 Excited State  61:      Singlet-A      6.6328 eV  186.93 nm  f=0.0742  <S**2>=0.000 
      82 -> 95         0.33567 
      84 -> 95         0.13224 
      86 -> 97         0.32831 
      87 ->101         0.29464 
      88 ->100        -0.16600 
      89 ->101         0.19315 
      90 -> 98         0.16117 
      90 ->100        -0.13027 
  
 Excited State  62:      Singlet-A      6.6431 eV  186.64 nm  f=0.0000  <S**2>=0.000 
      83 -> 95         0.11364 
      86 -> 96         0.19361 
      86 -> 98        -0.33850 
      87 -> 98         0.18150 
      87 ->100        -0.28590 
      88 -> 99        -0.15067 
      90 ->101         0.35981 
  
 Excited State  63:      Singlet-A      6.6941 eV  185.21 nm  f=0.0252  <S**2>=0.000 
      85 -> 96         0.10716 
      86 -> 99        -0.13263 
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      87 ->101        -0.20779 
      88 -> 98         0.12099 
      88 ->102         0.11412 
      89 -> 99        -0.12981 
      89 ->101         0.48565 
      90 -> 98        -0.11513 
      91 ->102        -0.31600 
  
 Excited State  64:      Singlet-A      6.7004 eV  185.04 nm  f=0.0001  <S**2>=0.000 
      81 -> 95        -0.17204 
      86 -> 98         0.40307 
      86 ->100         0.19680 
      87 ->100        -0.15907 
      88 ->101        -0.22938 
      89 ->102        -0.10232 
      90 ->101         0.35420 
  
 Excited State  65:      Singlet-A      6.7495 eV  183.69 nm  f=0.1616  <S**2>=0.000 
      82 -> 95        -0.23947 
      85 -> 96        -0.19621 
      86 -> 99         0.10984 
      88 -> 98         0.13621 
      89 ->101         0.35915 
      90 ->100         0.10996 
      91 ->102         0.43649 
  
 Excited State  66:      Singlet-A      6.7532 eV  183.59 nm  f=0.0015  <S**2>=0.000 
      81 -> 95        -0.35441 
      86 ->100         0.30488 
      88 ->101         0.45383 
      89 -> 98         0.11480 
  
 Excited State  67:      Singlet-A      6.8040 eV  182.22 nm  f=0.0121  <S**2>=0.000 
      82 -> 95         0.31795 
      85 -> 96         0.23822 
      86 -> 97        -0.11409 
      86 -> 99         0.48054 
      87 ->101        -0.10161 
      89 ->101         0.10374 
      91 ->102         0.11317 
      94 ->103        -0.10214 
  
 Excited State  68:      Singlet-A      6.8065 eV  182.16 nm  f=0.0000  <S**2>=0.000 
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      80 -> 95        -0.16752 
      81 -> 95         0.51596 
      86 -> 98         0.11375 
      86 ->100         0.20435 
      87 ->102        -0.10854 
      88 ->101         0.25226 
  
 Excited State  69:      Singlet-A      6.8374 eV  181.33 nm  f=0.0228  <S**2>=0.000 
      82 -> 95        -0.25812 
      85 -> 96         0.24196 
      86 -> 99         0.12294 
      87 -> 99        -0.11702 
      87 ->101         0.45046 
      90 ->100        -0.10530 
      90 ->102         0.23810 
  
 Excited State  70:      Singlet-A      6.9109 eV  179.40 nm  f=0.0000  <S**2>=0.000 
      80 -> 95         0.11598 
      85 -> 97         0.15372 
      85 -> 99        -0.10603 
      86 -> 98        -0.18735 
      86 ->100         0.37207 
      87 ->100         0.17602 
      87 ->102        -0.20250 
      88 -> 99         0.10580 
      89 ->102        -0.28286 
      91 ->101        -0.13745 
      93 ->103        -0.20174 
  
 Excited State  71:      Singlet-A      6.9370 eV  178.73 nm  f=0.0854  <S**2>=0.000 
      82 -> 95        -0.18338 
      85 -> 96        -0.11857 
      86 -> 99         0.30410 
      88 ->102         0.45775 
      89 ->101        -0.14249 
      90 ->102        -0.10330 
      91 ->102        -0.13650 
      92 ->103        -0.19553 
      94 ->103         0.10298 
  
 Excited State  72:      Singlet-A      6.9453 eV  178.51 nm  f=0.0001  <S**2>=0.000 
      86 ->100         0.19611 
      87 ->102        -0.13839 
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      88 -> 99        -0.10400 
      88 ->101        -0.22551 
      89 ->102         0.58289 
      93 ->103        -0.10931 
  
 Excited State  73:      Singlet-A      6.9595 eV  178.15 nm  f=0.0795  <S**2>=0.000 
      85 ->100         0.12511 
      86 -> 97         0.12878 
      87 ->101        -0.13178 
      90 ->102         0.55088 
      92 ->103        -0.27508 
  
 Excited State  74:      Singlet-A      7.0036 eV  177.03 nm  f=0.0000  <S**2>=0.000 
      80 -> 95         0.16159 
      85 -> 97         0.26366 
      86 -> 96        -0.12475 
      87 ->102         0.50431 
      90 ->101         0.19316 
      92 ->102        -0.10426 
  
 Excited State  75:      Singlet-A      7.0125 eV  176.81 nm  f=0.0259  <S**2>=0.000 
      82 -> 95         0.11440 
      85 -> 98        -0.29294 
      86 -> 99        -0.15523 
      86 ->101        -0.24207 
      87 ->101         0.15086 
      88 ->102         0.38369 
      90 ->102         0.11805 
      92 ->103         0.28966 
  
 Excited State  76:      Singlet-A      7.0433 eV  176.03 nm  f=0.0000  <S**2>=0.000 
      80 -> 95         0.18484 
      85 -> 97         0.15299 
      86 -> 98        -0.12502 
      86 ->100        -0.14106 
      87 ->102        -0.31545 
      93 ->103         0.50771 
  
 Excited State  77:      Singlet-A      7.0498 eV  175.87 nm  f=0.5257  <S**2>=0.000 
      79 -> 95         0.22300 
      85 -> 96         0.45195 
      86 -> 99        -0.15205 
      88 ->102         0.19310 
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      90 ->100         0.12795 
      90 ->102        -0.18294 
      91 ->102         0.16300 
      92 ->103        -0.10711 
  
 Excited State  78:      Singlet-A      7.1055 eV  174.49 nm  f=0.0000  <S**2>=0.000 
      80 -> 95         0.49933 
      81 -> 95         0.11784 
      85 -> 97        -0.24938 
      85 -> 99         0.15871 
      86 ->100        -0.16146 
      90 ->101         0.12912 
      93 ->103        -0.21927 
  
 Excited State  79:      Singlet-A      7.1451 eV  173.52 nm  f=0.1486  <S**2>=0.000 
      79 -> 95         0.59639 
      85 -> 96        -0.17927 
      85 ->100         0.18774 
      90 ->102         0.10957 
  
 Excited State  80:      Singlet-A      7.1985 eV  172.24 nm  f=0.0373  <S**2>=0.000 
      77 -> 95        -0.11167 
      79 -> 95        -0.10506 
      85 -> 98         0.47213 
      85 ->100         0.18985 
      88 ->102         0.13992 
      92 ->103         0.35468 
  
 Excited State  81:      Singlet-A      7.2055 eV  172.07 nm  f=0.0000  <S**2>=0.000 
      78 -> 95         0.10088 
      85 -> 97         0.41131 
      85 -> 99         0.38528 
      86 ->100        -0.12861 
      87 ->102        -0.14104 
      91 ->103        -0.16039 
      93 ->103        -0.17051 
  
 Excited State  82:      Singlet-A      7.2514 eV  170.98 nm  f=0.3359  <S**2>=0.000 
      79 -> 95        -0.12246 
      85 -> 98        -0.25420 
      85 ->100         0.20122 
      85 ->102        -0.12650 
      86 ->101         0.54494 
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 Excited State  83:      Singlet-A      7.2882 eV  170.12 nm  f=0.0458  <S**2>=0.000 
      76 -> 95         0.17858 
      77 -> 95         0.38371 
      79 -> 95        -0.13664 
      83 -> 96        -0.13247 
      85 -> 98        -0.12561 
      85 ->100         0.36551 
      86 ->101        -0.15406 
      92 ->103         0.11282 
  
 Excited State  84:      Singlet-A      7.2919 eV  170.03 nm  f=0.0007  <S**2>=0.000 
      78 -> 95         0.42435 
      80 -> 95        -0.20026 
      84 -> 96         0.17638 
      85 -> 97        -0.16217 
      85 -> 99        -0.15427 
      86 ->102         0.25833 
      90 ->101         0.13809 
      93 ->103        -0.12541 
  
 Excited State  85:      Singlet-A      7.3212 eV  169.35 nm  f=0.0000  <S**2>=0.000 
      78 -> 95         0.48660 
      80 -> 95         0.10733 
      86 ->100         0.10621 
      86 ->102        -0.28416 
      90 ->101        -0.13057 
      93 ->103         0.11285 
      94 ->104        -0.15068 
  
 Excited State  86:      Singlet-A      7.3423 eV  168.86 nm  f=0.0000  <S**2>=0.000 
      80 -> 95         0.15702 
      85 -> 99         0.15463 
      86 -> 96         0.10553 
      86 ->102         0.52209 
      87 ->100        -0.10674 
      90 ->101        -0.15724 
      91 ->103         0.11061 
  
 Excited State  87:      Singlet-A      7.3896 eV  167.78 nm  f=0.0785  <S**2>=0.000 
      77 -> 95         0.24744 
      80 -> 95         0.11697 
      85 -> 99        -0.12776 
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      85 ->100        -0.21550 
      94 ->104         0.50543 
  
 Excited State  88:      Singlet-A      7.3900 eV  167.77 nm  f=0.1872  <S**2>=0.000 
      77 -> 95         0.38723 
      85 ->100        -0.33773 
      86 ->101         0.13963 
      94 ->104        -0.32679 
  
 Excited State  89:      Singlet-A      7.4952 eV  165.42 nm  f=0.0086  <S**2>=0.000 
      93 ->104         0.10877 
      94 ->105         0.66464 
  
 Excited State  90:      Singlet-A      7.5070 eV  165.16 nm  f=0.0000  <S**2>=0.000 
      80 -> 95        -0.10360 
      83 -> 99        -0.10010 
      84 -> 96         0.11216 
      85 -> 97        -0.21430 
      85 -> 99         0.33907 
      85 ->101        -0.10137 
      86 -> 98        -0.10609 
      90 ->103        -0.10687 
      91 ->101        -0.13316 
      91 ->103        -0.21281 
      93 ->103         0.19364 
      94 ->104         0.26368 
  
 Excited State  91:      Singlet-A      7.5183 eV  164.91 nm  f=0.0713  <S**2>=0.000 
      76 -> 95         0.46210 
      77 -> 95        -0.24614 
      79 -> 95         0.10050 
      85 -> 98        -0.13568 
      85 ->100        -0.20319 
      87 ->101        -0.13446 
      92 ->103         0.15008 
      94 ->105         0.11872 
  
 Excited State  92:      Singlet-A      7.5196 eV  164.88 nm  f=0.0001  <S**2>=0.000 
      84 -> 96         0.10649 
      85 ->101        -0.29167 
      91 ->103         0.55100 
  
 Excited State  93:      Singlet-A      7.6246 eV  162.61 nm  f=0.0563  <S**2>=0.000 
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      74 -> 95        -0.11061 
      76 -> 95         0.36859 
      82 -> 95         0.13677 
      82 -> 97         0.10029 
      83 -> 96        -0.16501 
      83 -> 98        -0.11277 
      84 -> 95        -0.13416 
      85 -> 96        -0.10655 
      85 -> 98         0.14785 
      86 -> 97        -0.12600 
      87 ->101         0.16239 
      87 ->103         0.12468 
      92 ->103        -0.23657 
      94 ->103        -0.13327 
  
 Excited State  94:      Singlet-A      7.6286 eV  162.53 nm  f=0.0000  <S**2>=0.000 
      85 -> 99         0.21778 
      85 ->101         0.52719 
      90 ->103         0.16742 
      91 ->103         0.26752 
  
 Excited State  95:      Singlet-A      7.6854 eV  161.32 nm  f=0.0420  <S**2>=0.000 
      76 -> 95         0.22828 
      77 -> 95         0.12323 
      83 -> 96         0.49907 
      83 -> 98         0.17680 
      84 -> 97        -0.22303 
      84 -> 99        -0.12074 
      85 ->102        -0.13627 
  
 Excited State  96:      Singlet-A      7.7033 eV  160.95 nm  f=0.0000  <S**2>=0.000 
      75 -> 95        -0.13126 
      78 -> 95        -0.16413 
      83 -> 97        -0.32327 
      84 -> 96         0.48354 
      85 -> 99        -0.11605 
  
 Excited State  97:      Singlet-A      7.7815 eV  159.33 nm  f=0.0000  <S**2>=0.000 
      85 ->101        -0.13191 
      90 ->103         0.48988 
      94 ->106        -0.43549 
  
 Excited State  98:      Singlet-A      7.8116 eV  158.72 nm  f=0.1502  <S**2>=0.000 
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      84 -> 97        -0.19361 
      85 ->102         0.25733 
      87 ->103         0.10828 
      89 ->103         0.57176 
  
 Excited State  99:      Singlet-A      7.8228 eV  158.49 nm  f=0.0001  <S**2>=0.000 
      85 ->101        -0.12200 
      88 ->103        -0.17031 
      90 ->103         0.39442 
      94 ->106         0.50310 
  
 Excited State 100:      Singlet-A      7.8525 eV  157.89 nm  f=0.0354  <S**2>=0.000 
      74 -> 95         0.11119 
      83 -> 96        -0.15080 
      84 -> 97        -0.11894 
      85 ->102        -0.33850 
      87 ->103         0.51771 
 
 
Table A4.8. Excitation Energies and Oscillator Strengths of 5Int Using the TD-B3LYP Method 
with 6-31G(d) Basis Sets in Chloroform. 
 
Excited State   1:      Singlet-A      2.1453 eV  577.94 nm  f=0.1147  <S**2>=0.000 
      94 -> 95         0.70768 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1182.77834307     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      2.5489 eV  486.42 nm  f=0.0107  <S**2>=0.000 
      93 -> 95         0.60410 
      94 -> 96         0.35631 
  
 Excited State   3:      Singlet-A      2.8565 eV  434.04 nm  f=0.3638  <S**2>=0.000 
      93 -> 95        -0.34094 
      94 -> 96         0.60214 
      94 -> 98        -0.10378 
  
 Excited State   4:      Singlet-A      3.3170 eV  373.78 nm  f=0.1240  <S**2>=0.000 
      93 -> 96         0.67344 
      94 -> 97         0.19233 
  
 Excited State   5:      Singlet-A      3.5266 eV  351.57 nm  f=0.0177  <S**2>=0.000 
      93 -> 96        -0.20030 
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      94 -> 97         0.66474 
  
 Excited State   6:      Singlet-A      3.7838 eV  327.67 nm  f=0.0995  <S**2>=0.000 
      91 -> 95        -0.22542 
      94 -> 98         0.64631 
  
 Excited State   7:      Singlet-A      3.9228 eV  316.06 nm  f=0.0145  <S**2>=0.000 
      92 -> 95         0.68962 
  
 Excited State   8:      Singlet-A      3.9915 eV  310.62 nm  f=0.0874  <S**2>=0.000 
      90 -> 95         0.10279 
      91 -> 95         0.64067 
      93 -> 97         0.14368 
      94 -> 98         0.20653 
  
 Excited State   9:      Singlet-A      4.1093 eV  301.72 nm  f=0.0002  <S**2>=0.000 
      87 -> 95        -0.16977 
      90 -> 95         0.46945 
      94 -> 98        -0.10850 
      94 -> 99        -0.45763 
  
 Excited State  10:      Singlet-A      4.1429 eV  299.27 nm  f=0.0506  <S**2>=0.000 
      88 -> 95         0.14010 
      93 -> 98        -0.11853 
      94 ->100         0.65584 
  
 Excited State  11:      Singlet-A      4.1620 eV  297.90 nm  f=0.0018  <S**2>=0.000 
      90 -> 95        -0.39310 
      93 -> 97         0.41703 
      94 -> 99        -0.37099 
  
 Excited State  12:      Singlet-A      4.1743 eV  297.02 nm  f=0.0074  <S**2>=0.000 
      89 -> 95         0.66033 
      90 -> 96         0.18194 
  
 Excited State  13:      Singlet-A      4.2382 eV  292.54 nm  f=0.1621  <S**2>=0.000 
      87 -> 95         0.15802 
      89 -> 96         0.10812 
      90 -> 95         0.25275 
      91 -> 95        -0.12631 
      93 -> 97         0.52907 
      94 -> 99         0.28476 
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 Excited State  14:      Singlet-A      4.3326 eV  286.17 nm  f=0.0009  <S**2>=0.000 
      88 -> 95         0.52503 
      93 -> 98        -0.38958 
      93 -> 99         0.10337 
      94 ->100        -0.20291 
  
 Excited State  15:      Singlet-A      4.4097 eV  281.17 nm  f=0.0039  <S**2>=0.000 
      88 -> 95         0.38355 
      91 -> 96         0.10759 
      93 -> 98         0.55086 
      94 ->101         0.15708 
  
 Excited State  16:      Singlet-A      4.4737 eV  277.14 nm  f=0.0023  <S**2>=0.000 
      87 -> 95         0.63469 
      89 -> 96         0.13361 
      94 -> 99        -0.21099 
  
 Excited State  17:      Singlet-A      4.6451 eV  266.91 nm  f=0.0112  <S**2>=0.000 
      89 -> 96         0.21575 
      90 -> 95        -0.11969 
      92 -> 96         0.58685 
      93 ->100        -0.24644 
  
 Excited State  18:      Singlet-A      4.6659 eV  265.72 nm  f=0.0038  <S**2>=0.000 
      89 -> 95        -0.17425 
      90 -> 96         0.30358 
      91 -> 96         0.54590 
      93 -> 98        -0.11683 
      94 ->101         0.16221 
  
 Excited State  19:      Singlet-A      4.7593 eV  260.51 nm  f=0.0137  <S**2>=0.000 
      87 -> 96         0.10543 
      89 -> 95        -0.13191 
      90 -> 96         0.54010 
      91 -> 96        -0.25255 
      93 -> 99        -0.13233 
      94 ->101        -0.20636 
  
 Excited State  20:      Singlet-A      4.7658 eV  260.16 nm  f=0.0003  <S**2>=0.000 
      87 -> 95        -0.12369 
      89 -> 96         0.55068 
      90 -> 95        -0.14537 
      90 -> 97        -0.10079 
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      92 -> 96        -0.10578 
      93 ->100         0.31661 
  
 Excited State  21:      Singlet-A      4.7825 eV  259.25 nm  f=0.0103  <S**2>=0.000 
      91 -> 96        -0.15205 
      93 -> 99        -0.37305 
      94 ->101         0.55303 
  
 Excited State  22:      Singlet-A      4.8180 eV  257.34 nm  f=0.1301  <S**2>=0.000 
      89 -> 96        -0.21681 
      92 -> 96         0.32291 
      93 ->100         0.55159 
  
 Excited State  23:      Singlet-A      4.9177 eV  252.12 nm  f=0.1210  <S**2>=0.000 
      88 -> 95        -0.14476 
      90 -> 96         0.15101 
      91 -> 96        -0.27427 
      93 -> 99         0.53165 
      94 ->101         0.23241 
  
 Excited State  24:      Singlet-A      5.1280 eV  241.78 nm  f=0.0075  <S**2>=0.000 
      88 -> 96         0.67432 
      91 -> 97         0.10308 
      92 -> 98        -0.11817 
  
 Excited State  25:      Singlet-A      5.2015 eV  238.36 nm  f=0.0070  <S**2>=0.000 
      87 -> 96         0.64768 
      91 -> 98        -0.13330 
      92 -> 97         0.14828 
  
 Excited State  26:      Singlet-A      5.3473 eV  231.86 nm  f=0.0085  <S**2>=0.000 
      83 -> 95         0.20517 
      85 -> 95         0.15008 
      86 -> 95         0.64942 
  
 Excited State  27:      Singlet-A      5.4294 eV  228.36 nm  f=0.0005  <S**2>=0.000 
      84 -> 95        -0.11949 
      89 -> 98         0.25075 
      89 -> 99         0.10187 
      90 -> 97         0.15686 
      90 -> 98         0.10122 
      90 ->100         0.11668 
      91 -> 97         0.23754 
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      93 ->101         0.49905 
  
 Excited State  28:      Singlet-A      5.4406 eV  227.89 nm  f=0.0097  <S**2>=0.000 
      87 -> 98         0.10314 
      89 -> 97         0.29541 
      89 ->100         0.17774 
      89 ->101        -0.11918 
      90 -> 98         0.37589 
      90 -> 99         0.13914 
      91 -> 98         0.13673 
      92 -> 97         0.30803 
      93 ->101        -0.17763 
  
 Excited State  29:      Singlet-A      5.4634 eV  226.94 nm  f=0.0005  <S**2>=0.000 
      84 -> 95         0.11863 
      89 -> 98         0.35427 
      89 -> 99         0.13156 
      90 -> 97         0.34039 
      90 ->100         0.15705 
      90 ->101        -0.10581 
      92 -> 98         0.18414 
      93 ->101        -0.33679 
  
 Excited State  30:      Singlet-A      5.5007 eV  225.40 nm  f=0.0128  <S**2>=0.000 
      83 -> 95         0.32837 
      85 -> 95         0.53717 
      86 -> 95        -0.22210 
      90 -> 98        -0.12740 
  
 Excited State  31:      Singlet-A      5.5619 eV  222.92 nm  f=0.0570  <S**2>=0.000 
      85 -> 95        -0.12638 
      87 -> 96        -0.14738 
      89 -> 97        -0.17761 
      90 -> 98        -0.17933 
      90 -> 99        -0.10341 
      92 -> 97         0.57911 
  
 Excited State  32:      Singlet-A      5.6407 eV  219.80 nm  f=0.1004  <S**2>=0.000 
      84 -> 95        -0.23604 
      88 -> 96        -0.10084 
      91 -> 97         0.49388 
      93 ->101        -0.22525 
      94 ->102         0.26888 
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 Excited State  33:      Singlet-A      5.6785 eV  218.34 nm  f=0.0432  <S**2>=0.000 
      84 -> 95         0.37243 
      89 -> 98        -0.15151 
      89 -> 99        -0.14079 
      90 -> 97         0.11969 
      90 ->100        -0.13639 
      91 -> 97         0.30974 
      94 ->102        -0.37074 
  
 Excited State  34:      Singlet-A      5.7164 eV  216.89 nm  f=0.1596  <S**2>=0.000 
      83 -> 95         0.56622 
      85 -> 95        -0.34778 
      88 -> 97         0.10481 
  
 Excited State  35:      Singlet-A      5.7568 eV  215.37 nm  f=0.0072  <S**2>=0.000 
      84 -> 95        -0.13385 
      89 -> 96         0.10674 
      89 -> 97         0.32732 
      89 -> 99        -0.15141 
      89 ->100        -0.18559 
      90 -> 96         0.11507 
      90 -> 97         0.36237 
      90 -> 99        -0.18926 
      90 ->100        -0.17265 
      91 -> 97        -0.13635 
      92 -> 98        -0.13273 
  
 Excited State  36:      Singlet-A      5.7598 eV  215.26 nm  f=0.0069  <S**2>=0.000 
      84 -> 95         0.12313 
      89 -> 96        -0.10751 
      89 -> 97         0.37646 
      89 -> 99         0.11008 
      89 ->100        -0.24282 
      90 -> 96         0.11455 
      90 -> 97        -0.31643 
      90 -> 99        -0.15390 
      90 ->100         0.18366 
      91 -> 97         0.12112 
      92 -> 98         0.12071 
  
 Excited State  37:      Singlet-A      5.8239 eV  212.89 nm  f=0.2356  <S**2>=0.000 
      84 -> 95         0.18528 
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      88 -> 96         0.11896 
      88 -> 98        -0.12680 
      89 -> 98        -0.11597 
      90 ->100        -0.14367 
      92 -> 98         0.44651 
      94 ->102         0.38803 
  
 Excited State  38:      Singlet-A      5.8830 eV  210.75 nm  f=0.0914  <S**2>=0.000 
      82 -> 95        -0.12133 
      84 -> 95        -0.37770 
      87 -> 97        -0.23812 
      89 -> 98        -0.12047 
      92 -> 98         0.40058 
      94 ->102        -0.25754 
      94 ->103         0.10806 
  
 Excited State  39:      Singlet-A      5.9161 eV  209.57 nm  f=0.0228  <S**2>=0.000 
      87 -> 98        -0.13938 
      88 ->100         0.10147 
      90 -> 98        -0.12540 
      91 -> 98         0.59818 
      92 ->100         0.13428 
  
 Excited State  40:      Singlet-A      5.9427 eV  208.63 nm  f=0.0239  <S**2>=0.000 
      82 -> 95         0.66212 
      94 ->102        -0.11691 
  
 Excited State  41:      Singlet-A      6.0984 eV  203.30 nm  f=0.0981  <S**2>=0.000 
      88 -> 97         0.62969 
      90 -> 98        -0.10413 
      92 ->100         0.14253 
      93 ->102         0.16953 
  
 Excited State  42:      Singlet-A      6.1020 eV  203.19 nm  f=0.0055  <S**2>=0.000 
      83 -> 96         0.10680 
      85 -> 96         0.11260 
      86 -> 96         0.46691 
      87 -> 97         0.35840 
      87 ->100        -0.10324 
      90 -> 97        -0.10562 
      91 ->100         0.18237 
      92 -> 99         0.10537 
      94 ->103         0.13498 
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 Excited State  43:      Singlet-A      6.1605 eV  201.26 nm  f=0.0012  <S**2>=0.000 
      88 -> 98        -0.13113 
      89 -> 98        -0.16540 
      90 -> 97         0.12458 
      91 -> 99         0.18733 
      91 ->100         0.21629 
      92 -> 99         0.53238 
      92 ->100         0.18277 
  
 Excited State  44:      Singlet-A      6.1621 eV  201.20 nm  f=0.0004  <S**2>=0.000 
      89 -> 97         0.14053 
      90 -> 98        -0.16560 
      91 -> 98        -0.10474 
      91 -> 99         0.31702 
      91 ->100        -0.16676 
      92 -> 99        -0.20368 
      92 ->100         0.47827 
  
 Excited State  45:      Singlet-A      6.2171 eV  199.42 nm  f=0.0011  <S**2>=0.000 
      85 -> 96        -0.16782 
      86 -> 96         0.31935 
      87 -> 97        -0.20479 
      88 -> 99         0.11628 
      89 -> 98        -0.28438 
      89 -> 99         0.15159 
      90 -> 97         0.17920 
      90 ->100         0.30428 
      92 -> 99        -0.10572 
  
 Excited State  46:      Singlet-A      6.2209 eV  199.30 nm  f=0.0077  <S**2>=0.000 
      87 -> 98        -0.15522 
      89 -> 97        -0.17080 
      89 ->100        -0.26511 
      90 -> 98         0.40492 
      90 -> 99        -0.24399 
      91 -> 99        -0.13527 
      92 ->100         0.23730 
  
 Excited State  47:      Singlet-A      6.2741 eV  197.61 nm  f=0.0317  <S**2>=0.000 
      81 -> 95        -0.17541 
      83 -> 96        -0.26750 
      86 -> 96        -0.15639 
442 
 
      87 -> 97         0.39329 
      89 -> 98        -0.27455 
      89 -> 99         0.14476 
      90 ->100         0.13257 
      91 ->100         0.16670 
      92 -> 99        -0.19441 
  
 Excited State  48:      Singlet-A      6.2926 eV  197.03 nm  f=0.0001  <S**2>=0.000 
      81 -> 95         0.16008 
      83 -> 96         0.26186 
      85 -> 96         0.49075 
      86 -> 96        -0.13421 
      89 -> 98        -0.17317 
      89 -> 99         0.11278 
      90 ->100         0.16970 
      91 ->100        -0.11888 
      94 ->103        -0.12020 
  
 Excited State  49:      Singlet-A      6.3074 eV  196.57 nm  f=0.1660  <S**2>=0.000 
      87 -> 98         0.21723 
      89 -> 97        -0.11052 
      89 ->100        -0.22698 
      90 -> 98         0.12747 
      90 -> 99        -0.13174 
      91 -> 98         0.10743 
      91 -> 99         0.51535 
      92 ->100        -0.19585 
  
 Excited State  50:      Singlet-A      6.3692 eV  194.66 nm  f=0.0160  <S**2>=0.000 
      87 -> 98        -0.33972 
      88 -> 98         0.17593 
      89 ->100         0.10012 
      92 ->100        -0.15953 
      93 ->102         0.46014 
      94 ->103        -0.11163 
      94 ->104        -0.12942 
  
 Excited State  51:      Singlet-A      6.3702 eV  194.63 nm  f=0.0176  <S**2>=0.000 
      83 -> 96        -0.12159 
      85 -> 96        -0.13180 
      86 -> 96         0.13056 
      87 -> 98         0.12938 
      88 -> 98         0.45343 
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      91 ->100        -0.17653 
      92 -> 99         0.16612 
      93 ->102        -0.17892 
      94 ->103        -0.28809 
  
 Excited State  52:      Singlet-A      6.4378 eV  192.59 nm  f=0.0476  <S**2>=0.000 
      83 -> 96         0.13966 
      86 -> 98         0.10334 
      87 -> 97        -0.11165 
      88 -> 98         0.17974 
      89 -> 99        -0.19366 
      91 ->100         0.47047 
      92 -> 99        -0.19495 
      94 ->103        -0.26910 
  
 Excited State  53:      Singlet-A      6.4447 eV  192.38 nm  f=0.0052  <S**2>=0.000 
      81 -> 95         0.21565 
      83 -> 96         0.26865 
      85 -> 96        -0.21407 
      86 -> 96        -0.14435 
      87 ->100         0.16357 
      88 -> 98         0.25191 
      89 -> 99         0.15791 
      90 ->100        -0.15688 
      94 ->103         0.36459 
  
 Excited State  54:      Singlet-A      6.4690 eV  191.66 nm  f=0.0766  <S**2>=0.000 
      84 -> 96         0.38935 
      87 -> 98         0.30143 
      88 -> 97        -0.15103 
      89 ->100         0.19524 
      90 -> 99        -0.29548 
      91 -> 98         0.10199 
      92 ->101        -0.12866 
      93 ->102         0.16598 
  
 Excited State  55:      Singlet-A      6.5038 eV  190.63 nm  f=0.0536  <S**2>=0.000 
      84 -> 96         0.30153 
      87 -> 98         0.15881 
      89 ->100        -0.32614 
      90 -> 99         0.42832 
      93 ->102         0.17140 
      94 ->104         0.17795 
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 Excited State  56:      Singlet-A      6.5131 eV  190.36 nm  f=0.0079  <S**2>=0.000 
      84 -> 96        -0.10131 
      89 ->100         0.11694 
      90 -> 99        -0.15985 
      93 ->102         0.18775 
      94 ->104         0.60972 
  
 Excited State  57:      Singlet-A      6.5431 eV  189.49 nm  f=0.1093  <S**2>=0.000 
      88 -> 98        -0.10277 
      89 -> 99         0.49701 
      90 ->100        -0.37841 
      91 ->100         0.10125 
      91 ->101         0.10967 
      94 ->103        -0.14727 
  
 Excited State  58:      Singlet-A      6.6021 eV  187.80 nm  f=0.0010  <S**2>=0.000 
      83 -> 96        -0.20852 
      85 -> 96         0.22826 
      87 -> 97        -0.12315 
      88 -> 98         0.20601 
      88 -> 99         0.50388 
      91 ->100         0.10866 
      94 ->103         0.20309 
  
 Excited State  59:      Singlet-A      6.6337 eV  186.90 nm  f=0.0237  <S**2>=0.000 
      82 -> 96        -0.13563 
      86 -> 97        -0.14872 
      87 -> 98         0.13315 
      87 -> 99        -0.31468 
      88 ->100         0.47475 
      92 ->101         0.24491 
  
 Excited State  60:      Singlet-A      6.6608 eV  186.14 nm  f=0.3788  <S**2>=0.000 
      78 -> 95         0.11984 
      80 -> 95         0.16442 
      82 -> 96        -0.14565 
      84 -> 96         0.35346 
      86 -> 97         0.11791 
      87 -> 98        -0.28622 
      88 -> 97         0.11856 
      91 -> 99         0.11405 
      92 ->100        -0.10486 
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      92 ->101        -0.10875 
      93 ->102        -0.26482 
      94 ->106        -0.19174 
  
 Excited State  61:      Singlet-A      6.6936 eV  185.23 nm  f=0.0927  <S**2>=0.000 
      81 -> 95         0.26763 
      83 -> 96        -0.32422 
      85 -> 96         0.11387 
      86 -> 96         0.10994 
      87 ->100         0.20378 
      88 -> 99        -0.25241 
      91 -> 97         0.10467 
      91 ->101         0.35597 
  
 Excited State  62:      Singlet-A      6.7075 eV  184.84 nm  f=0.0748  <S**2>=0.000 
      78 -> 95        -0.33113 
      80 -> 95        -0.16452 
      82 -> 96         0.45593 
      84 -> 96         0.21977 
      87 -> 99        -0.14015 
      92 ->101         0.18163 
  
 Excited State  63:      Singlet-A      6.7224 eV  184.43 nm  f=0.0447  <S**2>=0.000 
      81 -> 95         0.50121 
      83 -> 96        -0.22129 
      86 -> 96        -0.10504 
      87 ->100        -0.31360 
      91 ->101        -0.20551 
  
 Excited State  64:      Singlet-A      6.7629 eV  183.33 nm  f=0.0004  <S**2>=0.000 
      87 -> 99         0.54229 
      88 ->100         0.37099 
      94 ->106        -0.14414 
  
 Excited State  65:      Singlet-A      6.8024 eV  182.26 nm  f=0.0026  <S**2>=0.000 
      87 ->100        -0.18780 
      88 -> 99        -0.10306 
      93 ->104        -0.23016 
      94 ->105         0.61306 
  
 Excited State  66:      Singlet-A      6.8154 eV  181.92 nm  f=0.0109  <S**2>=0.000 
      78 -> 95        -0.17485 
      80 -> 95         0.60790 
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      81 -> 96         0.14219 
      82 -> 96         0.15865 
  
 Excited State  67:      Singlet-A      6.8555 eV  180.85 nm  f=0.0215  <S**2>=0.000 
      78 -> 95         0.20401 
      86 -> 97         0.20846 
      87 -> 99         0.11261 
      88 ->100        -0.17860 
      92 ->101         0.56132 
  
 Excited State  68:      Singlet-A      6.9101 eV  179.43 nm  f=0.0279  <S**2>=0.000 
      81 -> 95         0.16336 
      84 -> 95        -0.10068 
      87 ->100         0.44832 
      88 -> 98        -0.15264 
      88 -> 99         0.22418 
      91 ->101        -0.12307 
      93 ->104        -0.10632 
      94 ->103        -0.18375 
      94 ->105         0.17760 
  
 Excited State  69:      Singlet-A      6.9573 eV  178.21 nm  f=0.0265  <S**2>=0.000 
      78 -> 95         0.50708 
      82 -> 96         0.40370 
      86 -> 97        -0.15918 
      92 ->101        -0.10643 
  
 Excited State  70:      Singlet-A      6.9758 eV  177.73 nm  f=0.3676  <S**2>=0.000 
      79 -> 95         0.43616 
      86 -> 98         0.12470 
      87 ->100         0.10638 
      88 -> 99        -0.12084 
      90 ->101        -0.20038 
      91 ->101        -0.39054 
  
 Excited State  71:      Singlet-A      7.0322 eV  176.31 nm  f=0.0645  <S**2>=0.000 
      82 -> 96        -0.11258 
      85 -> 97         0.28461 
      86 -> 97        -0.14737 
      88 ->101         0.10295 
      89 ->101         0.25697 
      93 ->103         0.44129 
      94 ->106        -0.20275 
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 Excited State  72:      Singlet-A      7.0447 eV  176.00 nm  f=0.0008  <S**2>=0.000 
      77 -> 95         0.11268 
      79 -> 95         0.29533 
      90 ->101         0.58851 
  
 Excited State  73:      Singlet-A      7.0774 eV  175.18 nm  f=0.0173  <S**2>=0.000 
      89 ->101         0.61139 
      93 ->103        -0.23366 
  
 Excited State  74:      Singlet-A      7.1126 eV  174.32 nm  f=0.0585  <S**2>=0.000 
      77 -> 95        -0.12703 
      79 -> 95        -0.32807 
      86 -> 98         0.38017 
      88 -> 99        -0.10559 
      90 ->101         0.24992 
      91 ->101        -0.28624 
  
 Excited State  75:      Singlet-A      7.1392 eV  173.67 nm  f=0.0211  <S**2>=0.000 
      83 -> 97         0.17062 
      86 -> 97         0.26170 
      88 ->100         0.12408 
      88 ->101        -0.10567 
      93 ->103         0.34093 
      94 ->104         0.10485 
      94 ->106         0.42162 
  
 Excited State  76:      Singlet-A      7.1742 eV  172.82 nm  f=0.1152  <S**2>=0.000 
      80 -> 95         0.15145 
      83 -> 97         0.27019 
      85 -> 97         0.24123 
      86 -> 97         0.37512 
      88 ->101         0.14010 
      89 ->101        -0.10868 
      93 ->103        -0.16580 
      94 ->106        -0.25927 
  
 Excited State  77:      Singlet-A      7.1827 eV  172.61 nm  f=0.0114  <S**2>=0.000 
      74 -> 95         0.10462 
      77 -> 95         0.57911 
      79 -> 95        -0.11960 
      80 -> 96        -0.10992 
      83 -> 98         0.10672 
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      85 -> 98         0.12542 
      86 -> 98         0.12000 
      93 ->104         0.14803 
  
 Excited State  78:      Singlet-A      7.2214 eV  171.69 nm  f=0.0003  <S**2>=0.000 
      77 -> 95        -0.18628 
      84 -> 97         0.14036 
      86 -> 98        -0.10927 
      93 ->104         0.57531 
      94 ->105         0.22304 
      94 ->109         0.10771 
  
 Excited State  79:      Singlet-A      7.2401 eV  171.25 nm  f=0.0038  <S**2>=0.000 
      83 -> 97        -0.18965 
      85 -> 97        -0.35452 
      86 -> 97         0.22280 
      88 ->101         0.45542 
      93 ->103         0.17467 
  
 Excited State  80:      Singlet-A      7.3094 eV  169.62 nm  f=0.0358  <S**2>=0.000 
      74 -> 95        -0.11474 
      77 -> 95        -0.15657 
      80 -> 96        -0.16024 
      83 -> 98         0.22888 
      84 -> 97         0.17882 
      85 -> 98         0.32838 
      85 -> 99        -0.10445 
      86 -> 98         0.11953 
      87 ->101         0.36544 
      93 ->104        -0.10630 
  
 Excited State  81:      Singlet-A      7.3521 eV  168.64 nm  f=0.0013  <S**2>=0.000 
      84 -> 97         0.29723 
      86 -> 98        -0.26597 
      87 ->101        -0.14749 
      91 ->101        -0.10993 
      93 ->106         0.22032 
      94 ->108         0.34777 
      94 ->109        -0.21906 
  
 Excited State  82:      Singlet-A      7.3702 eV  168.22 nm  f=0.0548  <S**2>=0.000 
      83 -> 97         0.14969 
      86 -> 97        -0.11285 
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      88 ->101         0.26095 
      93 ->103        -0.11672 
      93 ->105        -0.15498 
      94 ->106         0.16990 
      94 ->107         0.52319 
  
 Excited State  83:      Singlet-A      7.3811 eV  167.98 nm  f=0.0375  <S**2>=0.000 
      81 -> 96         0.53460 
      85 -> 97         0.15693 
      88 ->101         0.23445 
      94 ->107        -0.24433 
  
 Excited State  84:      Singlet-A      7.4067 eV  167.40 nm  f=0.0091  <S**2>=0.000 
      74 -> 95         0.13717 
      75 -> 95         0.19214 
      77 -> 95         0.11259 
      80 -> 96         0.22538 
      83 -> 98        -0.19394 
      84 -> 97         0.11758 
      86 -> 98        -0.11780 
      86 -> 99         0.11173 
      87 ->101         0.46545 
      94 ->108        -0.14163 
  
 Excited State  85:      Singlet-A      7.4131 eV  167.25 nm  f=0.1253  <S**2>=0.000 
      79 -> 96        -0.11174 
      81 -> 96         0.33737 
      83 -> 97        -0.29949 
      86 -> 97         0.20414 
      88 ->101        -0.26982 
      93 ->105        -0.10691 
      94 ->107         0.26400 
  
 Excited State  86:      Singlet-A      7.4761 eV  165.84 nm  f=0.0000  <S**2>=0.000 
      75 -> 95         0.14958 
      80 -> 96         0.17523 
      84 -> 97        -0.18752 
      86 -> 98         0.19865 
      93 ->104         0.10833 
      94 ->108         0.49140 
  
 Excited State  87:      Singlet-A      7.4888 eV  165.56 nm  f=0.0403  <S**2>=0.000 
      76 -> 95         0.26031 
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      81 -> 96         0.17357 
      83 -> 97         0.39604 
      85 -> 97        -0.34176 
      88 ->101        -0.13361 
      93 ->103         0.10473 
      94 ->106        -0.10434 
      94 ->110         0.10267 
  
 Excited State  88:      Singlet-A      7.5161 eV  164.96 nm  f=0.0071  <S**2>=0.000 
      74 -> 95         0.29874 
      75 -> 95         0.22502 
      77 -> 95        -0.10346 
      80 -> 96         0.21584 
      82 -> 97        -0.13499 
      83 -> 98         0.23955 
      85 -> 98         0.24382 
      86 -> 99        -0.16313 
      87 ->101        -0.21007 
      94 ->108        -0.15557 
  
 Excited State  89:      Singlet-A      7.5508 eV  164.20 nm  f=0.0722  <S**2>=0.000 
      72 -> 95         0.13238 
      73 -> 95        -0.15403 
      76 -> 95         0.59276 
      83 -> 97        -0.11788 
      85 -> 97         0.16743 
  
 Excited State  90:      Singlet-A      7.5622 eV  163.95 nm  f=0.0264  <S**2>=0.000 
      84 -> 97         0.45675 
      85 -> 98        -0.37417 
      86 -> 98         0.23350 
      86 -> 99        -0.17971 
  
 Excited State  91:      Singlet-A      7.6068 eV  162.99 nm  f=0.0098  <S**2>=0.000 
      93 ->105         0.62127 
      94 ->106        -0.14660 
      94 ->107         0.22445 
  
 Excited State  92:      Singlet-A      7.6426 eV  162.23 nm  f=0.0002  <S**2>=0.000 
      74 -> 95         0.10000 
      75 -> 95         0.17780 
      80 -> 96        -0.12580 
      82 -> 97        -0.13000 
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      83 -> 98         0.39636 
      83 -> 99        -0.10473 
      85 -> 98        -0.23257 
      86 -> 98        -0.10822 
      86 -> 99         0.24617 
      93 ->106        -0.21097 
      94 ->108         0.12412 
      94 ->109         0.12043 
  
 Excited State  93:      Singlet-A      7.6550 eV  161.97 nm  f=0.1719  <S**2>=0.000 
      73 -> 95         0.10222 
      79 -> 96        -0.14454 
      84 -> 98        -0.32996 
      86 ->100         0.53118 
      93 ->105        -0.12147 
  
 Excited State  94:      Singlet-A      7.6609 eV  161.84 nm  f=0.0243  <S**2>=0.000 
      74 -> 95        -0.26138 
      75 -> 95         0.13345 
      77 -> 95         0.10218 
      78 -> 96        -0.22388 
      80 -> 96         0.20086 
      82 -> 97         0.34018 
      83 -> 98         0.16518 
      85 -> 98        -0.12076 
      86 -> 98         0.10057 
      86 -> 99         0.18685 
      93 ->106         0.17576 
      94 ->108        -0.12031 
  
 Excited State  95:      Singlet-A      7.6776 eV  161.49 nm  f=0.0168  <S**2>=0.000 
      73 -> 95         0.40060 
      76 -> 95         0.12818 
      77 -> 96         0.13916 
      79 -> 96        -0.13297 
      84 -> 98         0.22987 
      94 ->110        -0.36823 
      94 ->111        -0.14677 
  
 Excited State  96:      Singlet-A      7.6946 eV  161.13 nm  f=0.0013  <S**2>=0.000 
      74 -> 95         0.21306 
      75 -> 95         0.34582 
      78 -> 96         0.13059 
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      80 -> 96        -0.34087 
      82 -> 97         0.20136 
      83 -> 98        -0.15464 
      85 -> 99        -0.17940 
      93 ->106         0.17273 
      94 ->109        -0.10427 
  
 Excited State  97:      Singlet-A      7.7355 eV  160.28 nm  f=0.0021  <S**2>=0.000 
      74 -> 95         0.42460 
      75 -> 95        -0.35179 
      78 -> 96        -0.20137 
      82 -> 97         0.27447 
      85 -> 99        -0.14381 
  
 Excited State  98:      Singlet-A      7.7389 eV  160.21 nm  f=0.0020  <S**2>=0.000 
      86 -> 99         0.25274 
      93 ->104        -0.12668 
      93 ->106         0.26018 
      94 ->109         0.50899 
  
 Excited State  99:      Singlet-A      7.7486 eV  160.01 nm  f=0.0841  <S**2>=0.000 
      73 -> 95        -0.29551 
      77 -> 96        -0.10994 
      79 -> 96         0.32742 
      84 -> 98         0.22221 
      85 ->100         0.17726 
      86 ->100         0.24734 
      94 ->110        -0.31049 
  
 Excited State 100:      Singlet-A      7.7587 eV  159.80 nm  f=0.0092  <S**2>=0.000 
      72 -> 95        -0.14719 
      73 -> 95         0.10776 
      79 -> 96         0.27364 
      82 -> 98         0.10720 
      84 -> 98        -0.24209 
      85 ->100        -0.15809 
      91 ->102         0.40321 
      94 ->110        -0.23350 
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Table A4.9. Excitation Energies and Oscillator Strengths of 6Int Using the TD-B3LYP Method 
with 6-31G(d) Basis Sets in Chloroform. 
 
Excited State   1:      Singlet-A      2.1993 eV  563.75 nm  f=0.1155  <S**2>=0.000 
      94 -> 95         0.70758 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1182.77816052     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      2.5655 eV  483.28 nm  f=0.0305  <S**2>=0.000 
      93 -> 95         0.63472 
      94 -> 96        -0.29816 
  
 Excited State   3:      Singlet-A      2.9616 eV  418.64 nm  f=0.3870  <S**2>=0.000 
      93 -> 95         0.28351 
      94 -> 96         0.62939 
  
 Excited State   4:      Singlet-A      3.4035 eV  364.28 nm  f=0.1360  <S**2>=0.000 
      93 -> 96         0.68317 
      94 -> 97        -0.11709 
  
 Excited State   5:      Singlet-A      3.5915 eV  345.22 nm  f=0.0131  <S**2>=0.000 
      90 -> 95        -0.18823 
      92 -> 95         0.52969 
      93 -> 96        -0.14542 
      94 -> 97        -0.37233 
  
 Excited State   6:      Singlet-A      3.6598 eV  338.78 nm  f=0.0513  <S**2>=0.000 
      90 -> 95        -0.26644 
      92 -> 95         0.30584 
      94 -> 97         0.52930 
      94 -> 98         0.14060 
  
 Excited State   7:      Singlet-A      3.8192 eV  324.64 nm  f=0.0708  <S**2>=0.000 
      88 -> 95        -0.12652 
      90 -> 95         0.14218 
      91 -> 95        -0.16227 
      94 -> 97        -0.13305 
      94 -> 98         0.62860 
  
 Excited State   8:      Singlet-A      3.8573 eV  321.43 nm  f=0.0210  <S**2>=0.000 
      90 -> 95         0.57308 
      90 -> 96        -0.10680 
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      92 -> 95         0.31811 
      94 -> 97         0.14471 
  
 Excited State   9:      Singlet-A      3.9437 eV  314.39 nm  f=0.0904  <S**2>=0.000 
      91 -> 95         0.66120 
      94 -> 98         0.15814 
      94 -> 99         0.11033 
  
 Excited State  10:      Singlet-A      4.1535 eV  298.51 nm  f=0.0110  <S**2>=0.000 
      88 -> 95         0.11431 
      89 -> 95         0.55208 
      89 -> 96         0.13341 
      94 -> 99        -0.34111 
  
 Excited State  11:      Singlet-A      4.1622 eV  297.88 nm  f=0.0081  <S**2>=0.000 
      89 -> 95         0.33524 
      92 -> 96         0.10061 
      93 -> 97         0.13445 
      94 -> 99         0.56619 
  
 Excited State  12:      Singlet-A      4.2494 eV  291.77 nm  f=0.0663  <S**2>=0.000 
      88 -> 95         0.26522 
      89 -> 95        -0.11980 
      93 -> 97         0.55898 
      94 ->100         0.24310 
  
 Excited State  13:      Singlet-A      4.3183 eV  287.11 nm  f=0.0358  <S**2>=0.000 
      87 -> 95        -0.10433 
      92 -> 96        -0.16374 
      93 -> 97        -0.31688 
      93 -> 98        -0.21148 
      94 -> 99         0.12101 
      94 ->100         0.52435 
  
 Excited State  14:      Singlet-A      4.3638 eV  284.12 nm  f=0.0021  <S**2>=0.000 
      87 -> 95         0.31172 
      88 -> 95         0.10495 
      93 -> 98         0.54822 
      94 ->100         0.22874 
  
 Excited State  15:      Singlet-A      4.4216 eV  280.40 nm  f=0.0097  <S**2>=0.000 
      87 -> 95        -0.30057 
      88 -> 95         0.42076 
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      92 -> 96         0.33107 
      93 -> 97        -0.16126 
      93 -> 99        -0.11019 
      94 ->100        -0.12293 
      94 ->101        -0.13326 
  
 Excited State  16:      Singlet-A      4.4715 eV  277.28 nm  f=0.0540  <S**2>=0.000 
      87 -> 95         0.47282 
      88 -> 95         0.34146 
      93 -> 98        -0.29770 
      94 ->100        -0.16052 
  
 Excited State  17:      Singlet-A      4.5036 eV  275.30 nm  f=0.0144  <S**2>=0.000 
      87 -> 95         0.17898 
      88 -> 95        -0.19560 
      90 -> 96        -0.12116 
      92 -> 96         0.52806 
      93 -> 98        -0.20933 
      94 ->100         0.21068 
  
 Excited State  18:      Singlet-A      4.7114 eV  263.16 nm  f=0.0056  <S**2>=0.000 
      90 -> 96         0.43305 
      91 -> 96        -0.32182 
      92 -> 98         0.10262 
      93 -> 99        -0.34992 
  
 Excited State  19:      Singlet-A      4.7379 eV  261.69 nm  f=0.0174  <S**2>=0.000 
      89 -> 96         0.12449 
      90 -> 96         0.40947 
      91 -> 96         0.36743 
      92 -> 96         0.11470 
      92 -> 98         0.10323 
      93 -> 99         0.27147 
      93 ->100         0.18028 
  
 Excited State  20:      Singlet-A      4.7950 eV  258.57 nm  f=0.0252  <S**2>=0.000 
      89 -> 95        -0.12496 
      89 -> 96         0.38023 
      91 -> 96        -0.25464 
      93 -> 99         0.30086 
      94 ->101        -0.37896 
  
 Excited State  21:      Singlet-A      4.8124 eV  257.63 nm  f=0.0108  <S**2>=0.000 
456 
 
      89 -> 95        -0.13669 
      89 -> 96         0.48791 
      93 -> 99        -0.21688 
      94 ->101         0.36800 
  
 Excited State  22:      Singlet-A      4.8913 eV  253.48 nm  f=0.0773  <S**2>=0.000 
      91 -> 96         0.39118 
      93 -> 99        -0.28017 
      93 ->100        -0.26497 
      94 ->101        -0.37807 
  
 Excited State  23:      Singlet-A      4.9326 eV  251.35 nm  f=0.0804  <S**2>=0.000 
      90 -> 96        -0.17233 
      92 -> 96        -0.11627 
      92 -> 98         0.10187 
      93 -> 99        -0.21332 
      93 ->100         0.58312 
      94 ->101        -0.10920 
  
 Excited State  24:      Singlet-A      5.1474 eV  240.87 nm  f=0.0496  <S**2>=0.000 
      84 -> 95         0.10984 
      86 -> 95         0.67684 
  
 Excited State  25:      Singlet-A      5.1981 eV  238.52 nm  f=0.0010  <S**2>=0.000 
      88 -> 96         0.64909 
      90 -> 98        -0.12239 
      91 -> 97        -0.10976 
  
 Excited State  26:      Singlet-A      5.2455 eV  236.36 nm  f=0.0023  <S**2>=0.000 
      87 -> 96         0.64633 
      91 -> 97         0.13927 
      92 -> 98        -0.15219 
  
 Excited State  27:      Singlet-A      5.3703 eV  230.87 nm  f=0.0399  <S**2>=0.000 
      89 -> 97         0.13458 
      89 -> 98        -0.11964 
      89 -> 99         0.10039 
      90 -> 96        -0.15697 
      90 -> 97        -0.13790 
      90 -> 98        -0.23663 
      92 -> 97         0.48846 
      92 -> 98         0.16218 
      93 ->101         0.18981 
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 Excited State  28:      Singlet-A      5.4403 eV  227.90 nm  f=0.0428  <S**2>=0.000 
      89 -> 97         0.26225 
      89 -> 99         0.18689 
      90 -> 96         0.12080 
      90 -> 97         0.12480 
      90 -> 98         0.27387 
      92 -> 98        -0.33022 
      93 ->101         0.33962 
  
 Excited State  29:      Singlet-A      5.4578 eV  227.17 nm  f=0.0048  <S**2>=0.000 
      85 -> 95         0.13523 
      89 -> 97        -0.26904 
      89 -> 99        -0.15671 
      91 -> 97        -0.10037 
      92 -> 97        -0.16561 
      92 -> 98         0.14007 
      93 ->101         0.51651 
  
 Excited State  30:      Singlet-A      5.5560 eV  223.15 nm  f=0.0091  <S**2>=0.000 
      89 -> 97        -0.30932 
      89 -> 98         0.16013 
      89 -> 99        -0.21717 
      90 -> 97         0.15652 
      90 -> 98         0.11572 
      91 -> 97         0.10095 
      92 -> 97         0.41388 
      92 -> 98        -0.17667 
      92 -> 99        -0.12747 
  
 Excited State  31:      Singlet-A      5.6145 eV  220.83 nm  f=0.0136  <S**2>=0.000 
      84 -> 95        -0.36465 
      85 -> 95         0.51728 
      92 -> 98        -0.12937 
      94 ->102        -0.11561 
  
 Excited State  32:      Singlet-A      5.6616 eV  218.99 nm  f=0.0244  <S**2>=0.000 
      84 -> 95         0.42712 
      85 -> 95         0.11635 
      86 -> 96        -0.10945 
      91 -> 97        -0.26944 
      93 ->101        -0.12813 
      94 ->102        -0.40506 
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 Excited State  33:      Singlet-A      5.6664 eV  218.81 nm  f=0.0873  <S**2>=0.000 
      84 -> 95         0.12605 
      85 -> 95         0.23895 
      88 -> 96         0.15867 
      90 -> 97         0.20956 
      90 -> 98         0.18967 
      91 -> 97         0.40845 
      92 -> 98         0.26330 
      94 ->102        -0.15678 
  
 Excited State  34:      Singlet-A      5.7493 eV  215.65 nm  f=0.3662  <S**2>=0.000 
      87 -> 96        -0.20622 
      90 -> 97        -0.20543 
      90 -> 98        -0.13695 
      91 -> 97         0.33116 
      92 -> 98        -0.27843 
      93 ->100         0.11260 
      94 ->102        -0.32157 
  
 Excited State  35:      Singlet-A      5.8238 eV  212.89 nm  f=0.0359  <S**2>=0.000 
      84 -> 95        -0.26644 
      85 -> 95        -0.20977 
      89 -> 97        -0.10665 
      89 -> 99         0.13947 
      90 -> 97         0.38634 
      92 -> 99         0.25887 
      94 ->102        -0.25738 
  
 Excited State  36:      Singlet-A      5.8506 eV  211.92 nm  f=0.0117  <S**2>=0.000 
      84 -> 95         0.14963 
      85 -> 95         0.10560 
      88 -> 97         0.11286 
      89 -> 96        -0.12455 
      89 -> 97        -0.23528 
      89 -> 99         0.19482 
      91 -> 98         0.15829 
      92 -> 99         0.45395 
      92 ->100         0.10425 
      94 ->102         0.19040 
  
 Excited State  37:      Singlet-A      5.8914 eV  210.45 nm  f=0.0859  <S**2>=0.000 
      89 -> 99        -0.11683 
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      91 -> 98         0.64086 
  
 Excited State  38:      Singlet-A      5.9246 eV  209.27 nm  f=0.0325  <S**2>=0.000 
      84 -> 95         0.13301 
      85 -> 95         0.12482 
      86 -> 96         0.12660 
      89 -> 97         0.13293 
      89 -> 99        -0.12883 
      90 -> 97         0.40860 
      90 -> 98        -0.37408 
      92 -> 98        -0.15624 
      94 ->102         0.11466 
  
 Excited State  39:      Singlet-A      5.9633 eV  207.91 nm  f=0.0128  <S**2>=0.000 
      86 -> 96        -0.20349 
      89 -> 96        -0.11494 
      89 -> 97        -0.18003 
      89 -> 99         0.40069 
      89 ->100         0.14213 
      90 -> 98        -0.14013 
      90 -> 99        -0.11788 
      91 -> 98         0.11345 
      92 -> 99        -0.36104 
  
 Excited State  40:      Singlet-A      6.0089 eV  206.34 nm  f=0.0583  <S**2>=0.000 
      82 -> 95        -0.11515 
      83 -> 95         0.34287 
      86 -> 96         0.50335 
      88 -> 97        -0.11044 
      92 -> 99        -0.12060 
      92 ->100         0.15343 
  
 Excited State  41:      Singlet-A      6.0650 eV  204.43 nm  f=0.0530  <S**2>=0.000 
      81 -> 95         0.10667 
      83 -> 95         0.52835 
      84 -> 96        -0.11372 
      86 -> 96        -0.18688 
      88 -> 97         0.11401 
      89 -> 97         0.11175 
      89 -> 99        -0.12393 
      92 -> 99         0.11649 
      94 ->102         0.12213 
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 Excited State  42:      Singlet-A      6.1814 eV  200.58 nm  f=0.0281  <S**2>=0.000 
      86 -> 96        -0.13086 
      87 -> 97        -0.27493 
      88 -> 97        -0.14797 
      88 -> 98        -0.15732 
      89 -> 98        -0.24519 
      91 -> 99         0.20820 
      92 ->100         0.41584 
      93 ->102         0.10893 
  
 Excited State  43:      Singlet-A      6.2144 eV  199.51 nm  f=0.0134  <S**2>=0.000 
      87 -> 97        -0.13682 
      87 -> 98        -0.10837 
      89 -> 97         0.19940 
      89 -> 98         0.47092 
      91 -> 99        -0.19199 
      91 ->100         0.20176 
      92 ->100         0.28040 
  
 Excited State  44:      Singlet-A      6.2237 eV  199.21 nm  f=0.0174  <S**2>=0.000 
      82 -> 95        -0.13753 
      87 -> 97        -0.25602 
      88 -> 99        -0.10069 
      89 -> 98         0.25362 
      91 -> 99         0.43570 
      91 ->100        -0.21996 
      92 ->100        -0.17204 
      93 ->102         0.10590 
  
 Excited State  45:      Singlet-A      6.2654 eV  197.89 nm  f=0.0353  <S**2>=0.000 
      82 -> 95        -0.22944 
      87 -> 97         0.29590 
      88 -> 97         0.38113 
      88 -> 98        -0.23107 
      91 -> 99         0.15683 
      92 ->100         0.19239 
      93 ->102        -0.12433 
      94 ->103         0.12876 
  
 Excited State  46:      Singlet-A      6.2800 eV  197.43 nm  f=0.0836  <S**2>=0.000 
      82 -> 95        -0.29709 
      84 -> 96         0.10085 
      87 -> 97        -0.29744 
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      88 -> 97         0.10679 
      88 -> 98         0.10584 
      89 -> 98        -0.18706 
      91 -> 99        -0.17517 
      91 ->100         0.31211 
      92 ->100        -0.12950 
      93 ->102         0.18987 
      94 ->103         0.19005 
  
 Excited State  47:      Singlet-A      6.2911 eV  197.08 nm  f=0.0138  <S**2>=0.000 
      82 -> 95         0.25649 
      86 -> 96         0.14595 
      88 -> 97         0.31944 
      90 -> 98         0.10596 
      90 -> 99        -0.16199 
      91 ->100        -0.10309 
      92 ->101        -0.19714 
      93 ->102         0.36165 
  
 Excited State  48:      Singlet-A      6.3140 eV  196.36 nm  f=0.0008  <S**2>=0.000 
      82 -> 95         0.11512 
      87 -> 98        -0.10771 
      88 -> 98         0.10562 
      89 -> 98        -0.12397 
      90 -> 98        -0.16131 
      90 -> 99         0.58873 
  
 Excited State  49:      Singlet-A      6.3348 eV  195.72 nm  f=0.0034  <S**2>=0.000 
      87 -> 98        -0.32433 
      88 -> 97         0.20565 
      88 -> 98         0.34498 
      90 -> 99        -0.16640 
      90 ->100        -0.13338 
      91 ->100        -0.18604 
      92 ->100         0.15393 
      93 ->102        -0.19679 
  
 Excited State  50:      Singlet-A      6.3750 eV  194.49 nm  f=0.0322  <S**2>=0.000 
      82 -> 95         0.27185 
      86 -> 96         0.11591 
      88 -> 97         0.10789 
      88 -> 98         0.18603 
      91 -> 99         0.26886 
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      91 ->100         0.38102 
      93 ->102        -0.25782 
  
 Excited State  51:      Singlet-A      6.4386 eV  192.56 nm  f=0.0407  <S**2>=0.000 
      81 -> 95         0.20632 
      83 -> 96         0.11371 
      85 -> 96         0.15664 
      87 -> 97        -0.13993 
      87 -> 98        -0.12245 
      88 -> 98        -0.11586 
      90 -> 99         0.11783 
      90 ->100         0.31472 
      91 ->100        -0.12893 
      92 ->101        -0.18767 
      93 ->102        -0.15485 
      94 ->103         0.33264 
  
 Excited State  52:      Singlet-A      6.4622 eV  191.86 nm  f=0.0022  <S**2>=0.000 
      82 -> 95         0.14942 
      87 -> 98         0.21142 
      90 ->100        -0.34530 
      92 ->101         0.22085 
      94 ->103         0.41271 
  
 Excited State  53:      Singlet-A      6.4815 eV  191.29 nm  f=0.0993  <S**2>=0.000 
      82 -> 95        -0.10961 
      85 -> 95        -0.10453 
      85 -> 96         0.43183 
      87 -> 97        -0.17414 
      87 -> 98         0.21309 
      88 -> 97         0.11812 
      88 -> 98        -0.24426 
      92 ->101         0.15211 
      93 ->102        -0.16063 
      94 ->103        -0.19161 
  
 Excited State  54:      Singlet-A      6.4863 eV  191.15 nm  f=0.0193  <S**2>=0.000 
      81 -> 95        -0.23033 
      84 -> 96         0.16256 
      87 -> 98         0.35243 
      87 -> 99         0.19178 
      88 -> 98         0.20497 
      88 -> 99         0.10195 
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      88 ->100        -0.15310 
      91 ->100        -0.17761 
      92 ->100         0.11450 
      92 ->101        -0.24597 
  
 Excited State  55:      Singlet-A      6.5289 eV  189.90 nm  f=0.1505  <S**2>=0.000 
      82 -> 95         0.22008 
      84 -> 96         0.28434 
      85 -> 96        -0.26727 
      86 -> 97         0.10506 
      87 -> 97        -0.10515 
      88 -> 98        -0.13909 
      88 -> 99        -0.14583 
      91 -> 99        -0.12974 
      92 ->101         0.15636 
      93 ->102        -0.16184 
      94 ->104        -0.27007 
  
 Excited State  56:      Singlet-A      6.5843 eV  188.30 nm  f=0.0260  <S**2>=0.000 
      81 -> 95        -0.15401 
      84 -> 96         0.14975 
      87 ->100         0.10944 
      90 ->100         0.17003 
      92 ->101         0.22515 
      94 ->104         0.50958 
  
 Excited State  57:      Singlet-A      6.5934 eV  188.04 nm  f=0.0448  <S**2>=0.000 
      81 -> 95        -0.17214 
      84 -> 96        -0.13566 
      87 -> 99        -0.10591 
      88 -> 99         0.43319 
      90 ->100         0.21114 
      92 ->101         0.21119 
      94 ->104        -0.21877 
  
 Excited State  58:      Singlet-A      6.6145 eV  187.44 nm  f=0.1491  <S**2>=0.000 
      80 -> 95         0.11340 
      81 -> 95        -0.13164 
      84 -> 96        -0.27958 
      88 -> 98         0.15233 
      88 -> 99        -0.22355 
      89 -> 99        -0.11695 
      89 ->100         0.29844 
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      90 ->100         0.24492 
      91 ->101         0.20202 
  
 Excited State  59:      Singlet-A      6.6494 eV  186.46 nm  f=0.0554  <S**2>=0.000 
      84 -> 96         0.15387 
      87 -> 99        -0.10610 
      88 -> 99         0.17481 
      89 -> 99        -0.16917 
      89 ->100         0.57253 
      91 ->101        -0.18420 
  
 Excited State  60:      Singlet-A      6.6816 eV  185.56 nm  f=0.1895  <S**2>=0.000 
      84 -> 96         0.32966 
      85 -> 96         0.33460 
      86 -> 97        -0.16621 
      87 -> 97         0.15440 
      87 -> 99         0.12518 
      88 -> 99        -0.11028 
      91 ->101        -0.10040 
      93 ->102         0.13895 
      94 ->103         0.12202 
      94 ->104        -0.17849 
      94 ->106        -0.15175 
  
 Excited State  61:      Singlet-A      6.7159 eV  184.61 nm  f=0.0630  <S**2>=0.000 
      79 -> 95         0.13501 
      80 -> 95        -0.13705 
      81 -> 95         0.29969 
      87 -> 99         0.38018 
      87 ->100         0.11948 
      88 -> 99         0.20718 
      90 ->101        -0.18753 
      91 ->101         0.14401 
      92 ->101         0.13576 
      94 ->103        -0.11351 
  
 Excited State  62:      Singlet-A      6.7443 eV  183.83 nm  f=0.0487  <S**2>=0.000 
      79 -> 95        -0.12606 
      81 -> 95        -0.27055 
      84 -> 96        -0.13673 
      87 -> 98        -0.19893 
      87 -> 99         0.35667 
      87 ->100        -0.21709 
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      90 ->100        -0.20143 
      90 ->101        -0.15822 
      92 ->100        -0.13388 
  
 Excited State  63:      Singlet-A      6.8032 eV  182.24 nm  f=0.0525  <S**2>=0.000 
      86 -> 97         0.14056 
      87 -> 99         0.22971 
      87 ->100         0.18090 
      88 -> 99         0.14041 
      88 ->100         0.37975 
      90 -> 99         0.10210 
      90 ->101         0.32091 
      91 ->101        -0.22420 
      92 ->101        -0.13358 
  
 Excited State  64:      Singlet-A      6.8594 eV  180.75 nm  f=0.0388  <S**2>=0.000 
      78 -> 95        -0.22500 
      79 -> 95         0.37995 
      80 -> 95        -0.28883 
      81 -> 95        -0.11061 
      86 -> 97        -0.19638 
      87 ->100        -0.12270 
      88 ->100         0.14153 
      91 ->101         0.14755 
      94 ->105         0.18344 
  
 Excited State  65:      Singlet-A      6.8744 eV  180.36 nm  f=0.0479  <S**2>=0.000 
      79 -> 95        -0.30165 
      86 -> 97        -0.17103 
      87 ->100         0.10405 
      88 -> 99         0.17296 
      90 ->101         0.32532 
      91 ->101         0.36072 
      93 ->103        -0.10733 
      94 ->105         0.10151 
  
 Excited State  66:      Singlet-A      6.8938 eV  179.85 nm  f=0.0614  <S**2>=0.000 
      78 -> 95        -0.35537 
      79 -> 95         0.14480 
      80 -> 95         0.41827 
      81 -> 95         0.14099 
      83 -> 96        -0.12107 
      87 ->100        -0.12707 
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      90 ->101         0.12608 
      94 ->103        -0.10455 
      94 ->105        -0.10742 
  
 Excited State  67:      Singlet-A      6.9045 eV  179.57 nm  f=0.0018  <S**2>=0.000 
      79 -> 95        -0.12697 
      83 -> 96        -0.10773 
      86 -> 97        -0.13646 
      87 ->100        -0.30235 
      88 ->100         0.22354 
      91 ->101         0.12305 
      93 ->103         0.16021 
      93 ->104         0.16258 
      94 ->105        -0.29926 
      94 ->106         0.30805 
  
 Excited State  68:      Singlet-A      6.9324 eV  178.85 nm  f=0.0198  <S**2>=0.000 
      79 -> 95         0.14937 
      80 -> 95         0.13169 
      81 -> 95        -0.21791 
      83 -> 96         0.39733 
      86 -> 97        -0.17555 
      87 ->100         0.19090 
      91 ->101         0.14855 
      94 ->105        -0.30500 
  
 Excited State  69:      Singlet-A      6.9475 eV  178.46 nm  f=0.0126  <S**2>=0.000 
      78 -> 95         0.38345 
      79 -> 95         0.17105 
      80 -> 95         0.25739 
      86 -> 97        -0.10011 
      86 -> 98         0.16212 
      87 ->100        -0.16000 
      88 ->100         0.12259 
      91 ->101         0.16047 
      93 ->104        -0.10418 
      94 ->105         0.27515 
  
 Excited State  70:      Singlet-A      6.9783 eV  177.67 nm  f=0.1630  <S**2>=0.000 
      78 -> 95        -0.18205 
      83 -> 96        -0.11552 
      86 -> 97         0.14284 
      86 -> 98         0.43897 
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      88 ->100         0.13237 
      89 ->101        -0.10618 
      90 ->101        -0.25467 
      91 ->101         0.16403 
      92 ->101        -0.14459 
  
 Excited State  71:      Singlet-A      7.0089 eV  176.89 nm  f=0.0579  <S**2>=0.000 
      76 -> 95        -0.11649 
      77 -> 95        -0.20860 
      78 -> 95        -0.22379 
      79 -> 95        -0.21852 
      83 -> 96         0.34155 
      86 -> 97        -0.15934 
      88 ->100         0.21597 
      90 ->101        -0.14068 
      94 ->105         0.14592 
  
 Excited State  72:      Singlet-A      7.0324 eV  176.30 nm  f=0.0401  <S**2>=0.000 
      80 -> 95         0.10212 
      82 -> 96        -0.12278 
      83 -> 96        -0.10504 
      85 -> 97        -0.12076 
      86 -> 97        -0.17317 
      87 ->100         0.18261 
      88 ->100        -0.20142 
      89 ->101        -0.23655 
      93 ->103         0.29161 
      94 ->105         0.18669 
      94 ->106         0.27202 
  
 Excited State  73:      Singlet-A      7.0651 eV  175.49 nm  f=0.0148  <S**2>=0.000 
      86 -> 98         0.14018 
      89 ->101         0.61564 
      93 ->103         0.11106 
  
 Excited State  74:      Singlet-A      7.0798 eV  175.12 nm  f=0.0891  <S**2>=0.000 
      76 -> 95        -0.13153 
      77 -> 95         0.25164 
      78 -> 95        -0.13033 
      80 -> 95         0.11552 
      83 -> 96         0.18010 
      84 -> 97         0.12690 
      85 -> 97        -0.13563 
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      86 -> 97         0.30761 
      87 ->100        -0.15203 
      93 ->103         0.26308 
  
 Excited State  75:      Singlet-A      7.1171 eV  174.21 nm  f=0.0433  <S**2>=0.000 
      76 -> 95         0.15918 
      93 ->103         0.45802 
      93 ->104        -0.20896 
      94 ->104         0.13722 
      94 ->105        -0.10941 
      94 ->106        -0.33821 
  
 Excited State  76:      Singlet-A      7.1691 eV  172.94 nm  f=0.0633  <S**2>=0.000 
      76 -> 95         0.26557 
      77 -> 95        -0.27449 
      81 -> 96         0.10573 
      82 -> 96         0.41503 
      83 -> 96         0.16815 
      87 ->101         0.11592 
      88 ->100        -0.10137 
      90 ->101         0.11235 
      94 ->106         0.11706 
  
 Excited State  77:      Singlet-A      7.2114 eV  171.93 nm  f=0.0436  <S**2>=0.000 
      76 -> 95         0.49877 
      77 -> 95         0.11929 
      78 -> 96        -0.10305 
      79 -> 95        -0.19625 
      82 -> 96        -0.32778 
  
 Excited State  78:      Singlet-A      7.2411 eV  171.22 nm  f=0.0197  <S**2>=0.000 
      77 -> 95         0.40743 
      82 -> 96         0.17747 
      86 -> 97        -0.16058 
      86 -> 99         0.15053 
      86 ->100        -0.13505 
      91 ->101        -0.11423 
      93 ->104        -0.29379 
      94 ->106         0.12783 
  
 Excited State  79:      Singlet-A      7.2491 eV  171.03 nm  f=0.0205  <S**2>=0.000 
      77 -> 95         0.18468 
      82 -> 96         0.24139 
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      85 -> 97         0.18237 
      86 -> 98        -0.10143 
      87 ->101         0.10512 
      88 ->101         0.13439 
      93 ->103         0.10946 
      93 ->104         0.44385 
      94 ->105         0.18527 
      94 ->106        -0.13835 
  
 Excited State  80:      Singlet-A      7.2711 eV  170.52 nm  f=0.2062  <S**2>=0.000 
      76 -> 95        -0.19516 
      84 -> 98         0.17133 
      85 -> 97         0.23053 
      86 -> 98         0.31855 
      86 -> 99         0.13586 
      87 ->100        -0.11598 
      88 ->100        -0.13910 
      88 ->101        -0.19460 
      90 ->101         0.13447 
      91 ->101        -0.12590 
      92 ->101         0.12271 
      92 ->102        -0.12944 
      94 ->106        -0.12673 
  
 Excited State  81:      Singlet-A      7.3276 eV  169.20 nm  f=0.0043  <S**2>=0.000 
      81 -> 96        -0.11478 
      84 -> 97        -0.12779 
      84 -> 98        -0.12874 
      85 -> 97         0.24906 
      87 ->101         0.44475 
      88 ->101        -0.30657 
      93 ->104        -0.12716 
  
 Excited State  82:      Singlet-A      7.3629 eV  168.39 nm  f=0.0242  <S**2>=0.000 
      81 -> 96        -0.16640 
      86 -> 98         0.12297 
      86 -> 99         0.22884 
      87 ->101         0.26503 
      88 ->101         0.45441 
      94 ->107         0.11299 
  
 Excited State  83:      Singlet-A      7.4139 eV  167.23 nm  f=0.0142  <S**2>=0.000 
      81 -> 96         0.18114 
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      85 -> 97         0.19785 
      87 ->101        -0.20167 
      92 ->102        -0.11134 
      93 ->105        -0.27098 
      93 ->107         0.10125 
      94 ->107         0.42350 
      94 ->110        -0.13587 
  
 Excited State  84:      Singlet-A      7.4413 eV  166.62 nm  f=0.0271  <S**2>=0.000 
      74 -> 95        -0.10704 
      84 -> 97         0.27889 
      84 -> 98         0.21914 
      87 ->101         0.13082 
      90 ->102        -0.11584 
      92 ->102         0.41425 
      94 ->107         0.22376 
  
 Excited State  85:      Singlet-A      7.4643 eV  166.10 nm  f=0.1213  <S**2>=0.000 
      81 -> 96        -0.11328 
      84 -> 97        -0.22675 
      86 -> 99         0.17602 
      86 ->100         0.18073 
      87 ->101        -0.24591 
      90 ->102        -0.14156 
      92 ->102         0.39414 
      94 ->108        -0.12110 
  
 Excited State  86:      Singlet-A      7.4822 eV  165.71 nm  f=0.0044  <S**2>=0.000 
      74 -> 95         0.32184 
      81 -> 96         0.24764 
      84 -> 97         0.19398 
      85 -> 97         0.17436 
      86 -> 99         0.13633 
      92 ->102         0.10361 
      93 ->105        -0.11798 
      93 ->106        -0.13011 
      94 ->107        -0.28020 
      94 ->109         0.13316 
  
 Excited State  87:      Singlet-A      7.4923 eV  165.48 nm  f=0.0162  <S**2>=0.000 
      74 -> 95         0.45791 
      75 -> 95        -0.13939 
      78 -> 96         0.13738 
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      84 -> 97        -0.11203 
      84 -> 98        -0.10398 
      86 -> 99        -0.22197 
      92 ->102         0.12592 
      94 ->107         0.24208 
  
 Excited State  88:      Singlet-A      7.5222 eV  164.82 nm  f=0.0075  <S**2>=0.000 
      74 -> 95        -0.23741 
      80 -> 96        -0.12230 
      81 -> 96         0.41657 
      84 -> 97        -0.18318 
      84 -> 98        -0.13622 
      85 -> 98         0.10295 
      86 -> 99        -0.16465 
      88 ->101         0.11594 
      92 ->102         0.12709 
      94 ->107        -0.13329 
      94 ->108         0.13693 
  
 Excited State  89:      Singlet-A      7.5515 eV  164.18 nm  f=0.0229  <S**2>=0.000 
      81 -> 96        -0.11845 
      84 -> 97        -0.18903 
      84 -> 98         0.36355 
      85 -> 98        -0.23401 
      86 -> 99        -0.30523 
      86 ->100         0.10015 
      88 ->101         0.15489 
  
 Excited State  90:      Singlet-A      7.5582 eV  164.04 nm  f=0.0023  <S**2>=0.000 
      81 -> 96         0.13572 
      85 -> 97         0.12343 
      93 ->105         0.56166 
      93 ->106        -0.18785 
      94 ->107         0.14723 
      94 ->108        -0.10103 
      94 ->110        -0.10421 
  
 Excited State  91:      Singlet-A      7.5813 eV  163.54 nm  f=0.1167  <S**2>=0.000 
      78 -> 96         0.10453 
      84 -> 97         0.15029 
      84 ->100         0.11005 
      86 ->100         0.49577 
      90 ->102         0.16221 
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      91 ->102        -0.11009 
      94 ->109        -0.16427 
  
 Excited State  92:      Singlet-A      7.6108 eV  162.91 nm  f=0.0218  <S**2>=0.000 
      79 -> 96         0.12832 
      81 -> 96         0.12204 
      84 -> 97        -0.16880 
      85 -> 97        -0.19990 
      85 -> 98        -0.22579 
      86 -> 99         0.18115 
      86 ->100         0.14503 
      93 ->106         0.12169 
      94 ->108         0.36488 
  
 Excited State  93:      Singlet-A      7.6395 eV  162.29 nm  f=0.0108  <S**2>=0.000 
      75 -> 95         0.45596 
      79 -> 96         0.19870 
      80 -> 96        -0.10409 
      84 -> 97         0.11292 
      93 ->106         0.23553 
      94 ->108        -0.18827 
      94 ->110         0.13847 
  
 Excited State  94:      Singlet-A      7.6665 eV  161.72 nm  f=0.0134  <S**2>=0.000 
      79 -> 96        -0.12018 
      80 -> 96        -0.14242 
      85 -> 97         0.12008 
      85 -> 98         0.16295 
      90 ->102         0.15511 
      93 ->106         0.12225 
      94 ->108         0.20222 
      94 ->109         0.46907 
      94 ->110        -0.10148 
  
 Excited State  95:      Singlet-A      7.6686 eV  161.68 nm  f=0.0228  <S**2>=0.000 
      73 -> 95         0.16572 
      75 -> 95         0.16354 
      83 -> 97         0.10163 
      85 -> 97         0.17964 
      85 -> 98         0.26575 
      91 ->102         0.14271 
      94 ->108         0.35896 
      94 ->109        -0.28936 
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 Excited State  96:      Singlet-A      7.6872 eV  161.29 nm  f=0.0310  <S**2>=0.000 
      74 -> 95        -0.15547 
      75 -> 95        -0.15779 
      78 -> 96         0.11562 
      79 -> 96         0.39374 
      80 -> 96         0.34985 
      84 -> 98         0.10125 
      85 -> 98         0.18383 
      91 ->102         0.17465 
  
 Excited State  97:      Singlet-A      7.7128 eV  160.75 nm  f=0.0146  <S**2>=0.000 
      73 -> 95        -0.11638 
      75 -> 95         0.29254 
      78 -> 96         0.17384 
      79 -> 96        -0.13644 
      80 -> 96         0.33451 
      83 -> 97        -0.13207 
      84 -> 98        -0.14752 
      85 -> 98        -0.24533 
      91 ->102         0.14326 
      93 ->106        -0.12025 
      94 ->108         0.11479 
  
 Excited State  98:      Singlet-A      7.7252 eV  160.49 nm  f=0.0385  <S**2>=0.000 
      73 -> 95         0.15397 
      78 -> 96         0.10771 
      79 -> 96        -0.24680 
      80 -> 96         0.15587 
      83 -> 98        -0.10452 
      84 -> 98         0.11169 
      86 ->100         0.11313 
      90 ->102        -0.26770 
      92 ->102        -0.11257 
      93 ->106         0.34051 
  
 Excited State  99:      Singlet-A      7.7449 eV  160.09 nm  f=0.0037  <S**2>=0.000 
      73 -> 95         0.16790 
      74 -> 95        -0.10996 
      78 -> 96         0.28388 
      79 -> 96         0.18661 
      80 -> 96        -0.20103 
      83 -> 97         0.18180 
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      84 -> 99        -0.12695 
      84 ->100         0.10697 
      85 -> 98        -0.26182 
      85 -> 99         0.11878 
      90 ->102        -0.19801 
      94 ->108         0.11232 
  
 Excited State 100:      Singlet-A      7.7541 eV  159.90 nm  f=0.0246  <S**2>=0.000 
      73 -> 95         0.12927 
      78 -> 96         0.13429 
      79 -> 96        -0.15482 
      83 -> 97         0.13153 
      85 -> 98        -0.10729 
      85 -> 99         0.17392 
      90 ->102         0.33052 
      91 ->102         0.34183 
      93 ->106         0.17396 
      94 ->108        -0.14156 
      94 ->109        -0.11600 
 
 
Table A4.10. Excitation Energies and Oscillator Strengths of 5 Using the TD-B3LYP Method 
with 6-31G(d) Basis Set in Chloroform. 
 
Excited State   1:      Singlet-A      2.7546 eV  450.09 nm  f=0.3573  <S**2>=0.000 
      93 -> 94         0.70025 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1181.65767030     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      3.2425 eV  382.37 nm  f=0.0027  <S**2>=0.000 
      92 -> 94         0.68058 
      93 -> 95        -0.17125 
  
 Excited State   3:      Singlet-A      3.5452 eV  349.73 nm  f=0.1165  <S**2>=0.000 
      92 -> 94         0.15916 
      93 -> 95         0.63836 
      93 -> 96         0.20455 
  
 Excited State   4:      Singlet-A      3.7749 eV  328.44 nm  f=0.0068  <S**2>=0.000 
      93 -> 95        -0.17847 
      93 -> 96         0.66807 
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 Excited State   5:      Singlet-A      3.9781 eV  311.66 nm  f=0.0069  <S**2>=0.000 
      91 -> 94        -0.31547 
      93 -> 97         0.62586 
  
 Excited State   6:      Singlet-A      4.1174 eV  301.13 nm  f=0.0038  <S**2>=0.000 
      89 -> 94        -0.22362 
      91 -> 94         0.57558 
      93 -> 97         0.30609 
  
 Excited State   7:      Singlet-A      4.2110 eV  294.43 nm  f=0.0080  <S**2>=0.000 
      88 -> 94         0.55295 
      89 -> 94         0.11246 
      90 -> 94        -0.37844 
  
 Excited State   8:      Singlet-A      4.2146 eV  294.18 nm  f=0.0051  <S**2>=0.000 
      88 -> 94        -0.10339 
      89 -> 94         0.63092 
      91 -> 94         0.19891 
      92 -> 95         0.12020 
  
 Excited State   9:      Singlet-A      4.3605 eV  284.33 nm  f=0.1500  <S**2>=0.000 
      91 -> 94        -0.12233 
      92 -> 95         0.59150 
      92 -> 96         0.22933 
      93 -> 98        -0.23647 
  
 Excited State  10:      Singlet-A      4.3697 eV  283.73 nm  f=0.0403  <S**2>=0.000 
      88 -> 94         0.38105 
      90 -> 94         0.52671 
      93 -> 99        -0.17825 
      93 ->100        -0.11138 
  
 Excited State  11:      Singlet-A      4.4569 eV  278.19 nm  f=0.0578  <S**2>=0.000 
      90 -> 95         0.10356 
      92 -> 95         0.10364 
      92 -> 96         0.34458 
      93 -> 98         0.56851 
  
 Excited State  12:      Singlet-A      4.4828 eV  276.58 nm  f=0.1011  <S**2>=0.000 
      87 -> 94        -0.14611 
      90 -> 94         0.17825 
      93 -> 99         0.64136 
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 Excited State  13:      Singlet-A      4.6106 eV  268.91 nm  f=0.0284  <S**2>=0.000 
      87 -> 94         0.64847 
      92 -> 97        -0.18344 
      93 -> 99         0.16713 
  
 Excited State  14:      Singlet-A      4.6600 eV  266.06 nm  f=0.2166  <S**2>=0.000 
      86 -> 94         0.29973 
      92 -> 95        -0.26717 
      92 -> 96         0.49724 
      93 -> 98        -0.27679 
  
 Excited State  15:      Singlet-A      4.8562 eV  255.31 nm  f=0.0294  <S**2>=0.000 
      86 -> 94         0.61681 
      92 -> 95         0.15828 
      92 -> 96        -0.24172 
  
 Excited State  16:      Singlet-A      4.9621 eV  249.86 nm  f=0.4053  <S**2>=0.000 
      87 -> 94         0.17677 
      91 -> 95        -0.17187 
      92 -> 97         0.62864 
      93 -> 95         0.11575 
  
 Excited State  17:      Singlet-A      5.1495 eV  240.77 nm  f=0.0986  <S**2>=0.000 
      85 -> 94         0.63587 
      87 -> 95        -0.10786 
      92 -> 99         0.17186 
      93 ->101         0.14587 
  
 Excited State  18:      Singlet-A      5.1799 eV  239.36 nm  f=0.0538  <S**2>=0.000 
      91 -> 95         0.58735 
      92 -> 97         0.12650 
      92 -> 98         0.20234 
      93 ->100         0.28185 
  
 Excited State  19:      Singlet-A      5.2010 eV  238.38 nm  f=0.0005  <S**2>=0.000 
      84 -> 94         0.11706 
      91 -> 96         0.27164 
      92 -> 98        -0.39638 
      93 ->100         0.44373 
  
 Excited State  20:      Singlet-A      5.2427 eV  236.49 nm  f=0.0085  <S**2>=0.000 
      85 -> 94        -0.21900 
      87 -> 95        -0.12199 
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      90 -> 96        -0.13174 
      92 -> 99         0.61743 
  
 Excited State  21:      Singlet-A      5.2592 eV  235.75 nm  f=0.1237  <S**2>=0.000 
      86 -> 95        -0.11335 
      91 -> 95        -0.31957 
      92 -> 98         0.48309 
      93 ->100         0.33104 
  
 Excited State  22:      Singlet-A      5.3714 eV  230.82 nm  f=0.0018  <S**2>=0.000 
      88 -> 95         0.18689 
      88 -> 96         0.28312 
      88 -> 97        -0.20119 
      89 -> 95         0.20597 
      89 -> 96         0.29661 
      89 -> 97        -0.29372 
      90 -> 95        -0.10467 
      90 -> 96        -0.18401 
      90 -> 97         0.10402 
  
 Excited State  23:      Singlet-A      5.3748 eV  230.68 nm  f=0.0015  <S**2>=0.000 
      88 -> 95        -0.16529 
      88 -> 96        -0.24779 
      88 -> 97        -0.24782 
      89 -> 95         0.24034 
      89 -> 96         0.34191 
      89 -> 97         0.24322 
      90 -> 96         0.15221 
      90 -> 97         0.11981 
  
 Excited State  24:      Singlet-A      5.4189 eV  228.80 nm  f=0.2050  <S**2>=0.000 
      90 -> 95         0.58662 
      90 -> 96        -0.18967 
      92 -> 99        -0.19000 
      92 ->100        -0.17454 
  
 Excited State  25:      Singlet-A      5.4461 eV  227.66 nm  f=0.3284  <S**2>=0.000 
      84 -> 94         0.22491 
      91 -> 96         0.56117 
      92 -> 98         0.13077 
      93 ->100        -0.24141 
  
 Excited State  26:      Singlet-A      5.5400 eV  223.80 nm  f=0.0242  <S**2>=0.000 
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      87 -> 95         0.40801 
      88 -> 95         0.27219 
      88 -> 96         0.16715 
      90 -> 95         0.21901 
      90 -> 96         0.33115 
      92 -> 99         0.16275 
  
 Excited State  27:      Singlet-A      5.5918 eV  221.72 nm  f=0.0305  <S**2>=0.000 
      88 -> 97         0.25096 
      88 -> 98         0.17984 
      89 -> 95         0.54495 
      89 -> 99        -0.22486 
  
 Excited State  28:      Singlet-A      5.5966 eV  221.54 nm  f=0.0079  <S**2>=0.000 
      87 -> 95         0.18541 
      88 -> 95         0.12726 
      90 -> 95        -0.12854 
      91 -> 97         0.16012 
      93 ->101         0.58557 
  
 Excited State  29:      Singlet-A      5.6153 eV  220.80 nm  f=0.0157  <S**2>=0.000 
      87 -> 95        -0.17797 
      88 -> 95         0.47626 
      88 -> 99        -0.22231 
      89 -> 97         0.26208 
      89 -> 98         0.22994 
      93 ->101        -0.16043 
  
 Excited State  30:      Singlet-A      5.6620 eV  218.98 nm  f=0.0495  <S**2>=0.000 
      87 -> 95        -0.29791 
      88 -> 96         0.15604 
      90 -> 96         0.39382 
      91 -> 97         0.35476 
      91 -> 98        -0.10835 
      92 ->100        -0.21687 
  
 Excited State  31:      Singlet-A      5.6694 eV  218.69 nm  f=0.0679  <S**2>=0.000 
      84 -> 94         0.33728 
      88 -> 97         0.13129 
      88 -> 98         0.22358 
      89 -> 95        -0.25681 
      89 -> 96         0.33256 
      89 -> 99        -0.26380 
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      90 -> 98        -0.10907 
      91 -> 96        -0.12727 
  
 Excited State  32:      Singlet-A      5.7089 eV  217.18 nm  f=0.0067  <S**2>=0.000 
      87 -> 95         0.10985 
      88 -> 95        -0.31296 
      88 -> 96         0.39490 
      88 -> 99        -0.26247 
      89 -> 97         0.11469 
      89 -> 98         0.25837 
      90 -> 96        -0.17448 
      90 -> 99         0.12810 
  
 Excited State  33:      Singlet-A      5.7226 eV  216.66 nm  f=0.0851  <S**2>=0.000 
      84 -> 94         0.42738 
      86 -> 95        -0.13819 
      88 -> 98        -0.11599 
      89 -> 96        -0.25957 
      89 -> 99         0.15134 
      90 -> 97         0.30411 
      91 -> 96        -0.22096 
  
 Excited State  34:      Singlet-A      5.8057 eV  213.56 nm  f=0.1696  <S**2>=0.000 
      84 -> 94         0.17424 
      86 -> 95         0.54788 
      88 -> 97        -0.11072 
      89 -> 96        -0.11679 
      89 -> 99         0.11492 
      90 -> 97        -0.24683 
  
 Excited State  35:      Singlet-A      5.8103 eV  213.39 nm  f=0.0867  <S**2>=0.000 
      87 -> 95         0.19685 
      87 -> 96         0.12380 
      88 -> 96        -0.19416 
      90 -> 96        -0.23094 
      91 -> 97         0.50323 
      93 ->101        -0.22198 
  
 Excited State  36:      Singlet-A      5.9419 eV  208.66 nm  f=0.0381  <S**2>=0.000 
      87 -> 95         0.18088 
      87 -> 96         0.48577 
      91 -> 97        -0.13232 
      92 ->100        -0.42044 
480 
 
      93 ->102         0.12805 
  
 Excited State  37:      Singlet-A      6.0292 eV  205.64 nm  f=0.0136  <S**2>=0.000 
      83 -> 94        -0.10929 
      84 -> 94        -0.10516 
      85 -> 95         0.10882 
      86 -> 95         0.28240 
      86 -> 96        -0.19208 
      88 -> 97         0.19783 
      90 -> 97         0.47031 
      92 ->101         0.16842 
  
 Excited State  38:      Singlet-A      6.0902 eV  203.58 nm  f=0.1960  <S**2>=0.000 
      86 -> 97         0.20175 
      87 -> 95        -0.10608 
      87 -> 96         0.37474 
      89 -> 97        -0.18527 
      91 -> 98        -0.29667 
      92 ->100         0.34509 
      93 ->101         0.10708 
  
 Excited State  39:      Singlet-A      6.1002 eV  203.25 nm  f=0.0308  <S**2>=0.000 
      87 -> 96         0.18299 
      87 -> 99        -0.10237 
      89 -> 97         0.11561 
      90 -> 99        -0.16512 
      91 -> 98         0.55710 
      92 ->100         0.20569 
      93 ->101         0.10379 
  
 Excited State  40:      Singlet-A      6.1057 eV  203.06 nm  f=0.0206  <S**2>=0.000 
      83 -> 94         0.38806 
      85 -> 95         0.20229 
      86 -> 96        -0.28212 
      90 -> 98        -0.13918 
      91 -> 99         0.42151 
  
 Excited State  41:      Singlet-A      6.1651 eV  201.11 nm  f=0.0010  <S**2>=0.000 
      83 -> 94         0.21582 
      88 -> 97         0.40645 
      88 -> 98        -0.15563 
      89 -> 96         0.23592 
      89 -> 99         0.25958 
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      90 -> 97        -0.13684 
      90 -> 98         0.22889 
      91 -> 99        -0.19604 
  
 Excited State  42:      Singlet-A      6.1685 eV  200.99 nm  f=0.1162  <S**2>=0.000 
      83 -> 94         0.14888 
      88 -> 96         0.23401 
      88 -> 97        -0.11111 
      88 -> 99         0.26050 
      89 -> 97         0.40369 
      89 -> 98        -0.26706 
      91 -> 98        -0.19839 
      91 -> 99        -0.10908 
  
 Excited State  43:      Singlet-A      6.1687 eV  200.99 nm  f=0.0335  <S**2>=0.000 
      83 -> 94         0.40643 
      88 -> 97        -0.18945 
      88 -> 98         0.15799 
      88 -> 99        -0.10482 
      89 -> 96        -0.10542 
      89 -> 97        -0.16407 
      89 -> 98         0.10626 
      89 -> 99        -0.17383 
      90 -> 98         0.16877 
      91 -> 99        -0.32252 
  
 Excited State  44:      Singlet-A      6.1881 eV  200.36 nm  f=0.0073  <S**2>=0.000 
      83 -> 94        -0.14484 
      85 -> 95         0.50269 
      85 -> 96        -0.12984 
      86 -> 95        -0.11099 
      87 -> 97         0.13666 
      90 -> 97        -0.10468 
      91 -> 99        -0.14374 
      92 ->101         0.32464 
  
 Excited State  45:      Singlet-A      6.2813 eV  197.39 nm  f=0.0993  <S**2>=0.000 
      83 -> 94         0.10756 
      86 -> 96         0.35860 
      86 -> 99         0.11611 
      87 -> 97         0.48418 
      87 -> 98        -0.18757 
      88 -> 97         0.15001 
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 Excited State  46:      Singlet-A      6.3198 eV  196.18 nm  f=0.0052  <S**2>=0.000 
      82 -> 94         0.31038 
      88 -> 99         0.11773 
      90 -> 99         0.42426 
      93 ->102        -0.41543 
  
 Excited State  47:      Singlet-A      6.3621 eV  194.88 nm  f=0.0000  <S**2>=0.000 
      83 -> 94        -0.17318 
      84 -> 94         0.12634 
      85 -> 95         0.12849 
      85 -> 96         0.15436 
      86 -> 96        -0.31153 
      87 -> 97         0.35232 
      87 -> 98         0.13485 
      90 -> 98         0.23882 
      92 ->101        -0.27301 
  
 Excited State  48:      Singlet-A      6.3836 eV  194.22 nm  f=0.0026  <S**2>=0.000 
      82 -> 94        -0.28650 
      86 -> 97        -0.22555 
      89 -> 98        -0.13570 
      90 -> 99         0.42970 
      93 ->102         0.32612 
  
 Excited State  49:      Singlet-A      6.3900 eV  194.03 nm  f=0.0012  <S**2>=0.000 
      85 -> 96        -0.32183 
      87 -> 98        -0.14743 
      89 -> 99        -0.13310 
      90 -> 98         0.47907 
      91 -> 99         0.27103 
  
 Excited State  50:      Singlet-A      6.4188 eV  193.16 nm  f=0.0009  <S**2>=0.000 
      81 -> 94        -0.34181 
      82 -> 94         0.47312 
      86 -> 97        -0.13083 
      93 ->102         0.32903 
  
 Excited State  51:      Singlet-A      6.4515 eV  192.18 nm  f=0.4498  <S**2>=0.000 
      84 -> 97        -0.13593 
      85 -> 96         0.39431 
      86 -> 96         0.25770 
      86 -> 99        -0.15749 
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      87 -> 98         0.16383 
      88 -> 98         0.16153 
      90 -> 98         0.22782 
      91 -> 99         0.12644 
      91 ->100        -0.15281 
      92 ->101         0.11864 
  
 Excited State  52:      Singlet-A      6.4862 eV  191.15 nm  f=0.0033  <S**2>=0.000 
      85 -> 97         0.10212 
      88 -> 99         0.47024 
      89 -> 98         0.48352 
  
 Excited State  53:      Singlet-A      6.5020 eV  190.69 nm  f=0.0031  <S**2>=0.000 
      85 -> 96        -0.13126 
      87 -> 98        -0.16065 
      88 -> 98         0.50516 
      89 -> 99         0.42335 
  
 Excited State  54:      Singlet-A      6.5478 eV  189.35 nm  f=0.0385  <S**2>=0.000 
      85 -> 95        -0.26555 
      85 -> 96        -0.20662 
      87 -> 97         0.20706 
      87 -> 98         0.40818 
      88 -> 98         0.10337 
      91 ->100        -0.14532 
      92 ->101         0.31736 
  
 Excited State  55:      Singlet-A      6.5626 eV  188.93 nm  f=0.3350  <S**2>=0.000 
      81 -> 94        -0.22537 
      84 -> 95        -0.17891 
      85 -> 97        -0.16778 
      86 -> 97         0.48365 
      87 -> 96        -0.13287 
      87 -> 99        -0.16839 
      88 -> 99         0.11528 
      90 -> 99         0.17253 
  
 Excited State  56:      Singlet-A      6.5978 eV  187.92 nm  f=0.0105  <S**2>=0.000 
      81 -> 94        -0.18254 
      84 -> 95        -0.14289 
      84 -> 96        -0.13725 
      85 -> 97         0.19726 
      86 -> 97         0.15010 
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      86 -> 98        -0.27639 
      87 -> 99         0.48241 
  
 Excited State  57:      Singlet-A      6.6939 eV  185.22 nm  f=0.1474  <S**2>=0.000 
      81 -> 94        -0.21393 
      83 -> 95         0.11518 
      84 -> 95         0.60254 
      85 -> 97        -0.17455 
      87 -> 99         0.14060 
  
 Excited State  58:      Singlet-A      6.7210 eV  184.47 nm  f=0.0579  <S**2>=0.000 
      80 -> 94         0.14843 
      85 -> 95        -0.12569 
      85 -> 96         0.25847 
      86 -> 99         0.22941 
      91 ->100         0.50438 
      92 ->101         0.23035 
  
 Excited State  59:      Singlet-A      6.7393 eV  183.97 nm  f=0.0708  <S**2>=0.000 
      79 -> 94        -0.22153 
      81 -> 94         0.26541 
      82 -> 94         0.14634 
      83 -> 95         0.10255 
      84 -> 95         0.18150 
      85 -> 97         0.39664 
      86 -> 97         0.24573 
      86 -> 98        -0.12693 
      87 -> 99        -0.12082 
      93 ->102         0.13680 
  
 Excited State  60:      Singlet-A      6.7849 eV  182.74 nm  f=0.0098  <S**2>=0.000 
      79 -> 94        -0.16386 
      81 -> 94         0.22656 
      84 -> 96        -0.11838 
      85 -> 97        -0.10919 
      86 -> 98         0.46325 
      87 -> 99         0.33875 
      93 ->102         0.10192 
  
 Excited State  61:      Singlet-A      6.7926 eV  182.53 nm  f=0.0160  <S**2>=0.000 
      80 -> 94         0.54610 
      86 -> 99        -0.22427 
      87 -> 98        -0.28508 
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      91 ->100        -0.15975 
  
 Excited State  62:      Singlet-A      6.9008 eV  179.67 nm  f=0.0014  <S**2>=0.000 
      79 -> 94         0.44367 
      84 -> 96         0.14978 
      85 -> 97         0.34479 
      86 -> 98         0.31530 
  
 Excited State  63:      Singlet-A      6.9461 eV  178.49 nm  f=0.0016  <S**2>=0.000 
      79 -> 94        -0.33095 
      81 -> 94        -0.16044 
      84 -> 96         0.47074 
      85 -> 97         0.10384 
      90 ->100        -0.25801 
  
 Excited State  64:      Singlet-A      6.9519 eV  178.35 nm  f=0.1394  <S**2>=0.000 
      80 -> 94         0.28357 
      85 -> 95         0.11551 
      86 -> 99         0.51022 
      87 -> 98         0.10056 
      90 ->101        -0.13724 
      91 ->100        -0.18916 
      92 ->101        -0.11167 
      92 ->102         0.15227 
  
 Excited State  65:      Singlet-A      6.9897 eV  177.38 nm  f=0.0145  <S**2>=0.000 
      79 -> 94        -0.18619 
      81 -> 94        -0.14143 
      85 -> 97         0.11796 
      90 ->100         0.59784 
  
 Excited State  66:      Singlet-A      7.0214 eV  176.58 nm  f=0.0402  <S**2>=0.000 
      85 -> 99        -0.14781 
      89 ->100         0.62646 
      92 ->102         0.13064 
  
 Excited State  67:      Singlet-A      7.0798 eV  175.12 nm  f=0.0206  <S**2>=0.000 
      83 -> 95         0.29061 
      84 -> 96        -0.16293 
      85 -> 98        -0.14184 
      88 ->100         0.56653 
  
 Excited State  68:      Singlet-A      7.0860 eV  174.97 nm  f=0.0039  <S**2>=0.000 
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      80 -> 94         0.15124 
      85 -> 99         0.41852 
      89 ->100         0.24004 
      90 ->101        -0.16151 
      91 ->100         0.15078 
      92 ->102        -0.35093 
  
 Excited State  69:      Singlet-A      7.0934 eV  174.79 nm  f=0.0042  <S**2>=0.000 
      79 -> 94         0.10668 
      83 -> 95         0.55548 
      85 -> 98        -0.17480 
      88 ->100        -0.31250 
  
 Excited State  70:      Singlet-A      7.1193 eV  174.15 nm  f=0.0022  <S**2>=0.000 
      85 -> 99         0.12837 
      92 ->102         0.11336 
      92 ->103        -0.10806 
      93 ->104         0.65034 
  
 Excited State  71:      Singlet-A      7.1393 eV  173.67 nm  f=0.0066  <S**2>=0.000 
      78 -> 94        -0.16068 
      84 -> 97        -0.10846 
      85 -> 99         0.17868 
      86 -> 95         0.10259 
      86 -> 99        -0.15004 
      87 -> 98         0.14300 
      87 ->101        -0.16410 
      90 ->101         0.11387 
      91 ->100         0.14726 
      92 ->101        -0.11317 
      92 ->102         0.44920 
      93 ->104        -0.18867 
  
 Excited State  72:      Singlet-A      7.1501 eV  173.40 nm  f=0.0940  <S**2>=0.000 
      83 -> 95         0.20272 
      84 -> 99         0.10040 
      85 -> 98         0.57489 
      86 -> 98        -0.10935 
      87 ->100        -0.11884 
      93 ->103        -0.13595 
  
 Excited State  73:      Singlet-A      7.1609 eV  173.14 nm  f=0.0052  <S**2>=0.000 
      85 -> 98         0.11294 
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      92 ->104        -0.11352 
      93 ->103         0.67475 
  
 Excited State  74:      Singlet-A      7.1713 eV  172.89 nm  f=0.0000  <S**2>=0.000 
      78 -> 94         0.53538 
      83 -> 97        -0.13137 
      84 -> 97        -0.32660 
      86 ->100         0.11100 
  
 Excited State  75:      Singlet-A      7.1935 eV  172.36 nm  f=0.0163  <S**2>=0.000 
      78 -> 94         0.32927 
      82 -> 95        -0.11778 
      84 -> 97         0.37981 
      85 -> 99         0.32737 
      86 ->100        -0.13141 
      92 ->101         0.10020 
      92 ->102         0.19712 
  
 Excited State  76:      Singlet-A      7.2051 eV  172.08 nm  f=0.0498  <S**2>=0.000 
      79 -> 94         0.17620 
      81 -> 94         0.15107 
      83 -> 96         0.18516 
      84 -> 96         0.29718 
      85 -> 97        -0.16022 
      85 -> 98        -0.12381 
      87 -> 99         0.10202 
      87 ->100        -0.11619 
      90 ->100         0.14899 
      91 ->101         0.38620 
  
 Excited State  77:      Singlet-A      7.2369 eV  171.32 nm  f=0.0033  <S**2>=0.000 
      81 -> 95        -0.29218 
      82 -> 95         0.59746 
      84 -> 97         0.12862 
  
 Excited State  78:      Singlet-A      7.2613 eV  170.75 nm  f=0.0043  <S**2>=0.000 
      83 -> 96        -0.11416 
      84 -> 96        -0.10561 
      85 -> 98         0.18386 
      87 ->100         0.45718 
      91 ->101         0.45395 
  
 Excited State  79:      Singlet-A      7.3431 eV  168.85 nm  f=0.1522  <S**2>=0.000 
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      77 -> 94         0.10041 
      79 -> 94         0.10299 
      83 -> 96         0.26570 
      84 -> 99         0.15149 
      86 -> 98        -0.10688 
      87 ->100         0.46406 
      91 ->101        -0.30702 
  
 Excited State  80:      Singlet-A      7.4178 eV  167.14 nm  f=0.0085  <S**2>=0.000 
      80 -> 94        -0.10844 
      81 -> 95        -0.12996 
      82 -> 96        -0.10840 
      84 -> 97        -0.20196 
      84 -> 98        -0.12504 
      85 -> 99         0.28656 
      86 -> 99         0.11191 
      86 ->100         0.15388 
      87 -> 98        -0.12354 
      87 ->101         0.17303 
      90 ->101         0.36186 
      91 ->100        -0.15127 
      92 ->101         0.10137 
  
 Excited State  81:      Singlet-A      7.4373 eV  166.71 nm  f=0.0648  <S**2>=0.000 
      77 -> 94         0.33950 
      81 -> 94        -0.10500 
      83 -> 96         0.44649 
      84 -> 96        -0.21158 
      84 -> 99        -0.13918 
      91 ->101         0.11193 
  
 Excited State  82:      Singlet-A      7.4814 eV  165.72 nm  f=0.0684  <S**2>=0.000 
      78 -> 94        -0.14678 
      82 -> 96        -0.10245 
      83 -> 97        -0.19253 
      84 -> 97        -0.24677 
      84 -> 98         0.29990 
      85 ->100        -0.16891 
      86 ->100        -0.20061 
      87 -> 98        -0.11035 
      87 ->101         0.14646 
      90 ->101        -0.29954 
      92 ->102         0.11836 
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 Excited State  83:      Singlet-A      7.5555 eV  164.10 nm  f=0.0236  <S**2>=0.000 
      77 -> 94         0.57616 
      83 -> 96        -0.34728 
  
 Excited State  84:      Singlet-A      7.5954 eV  163.24 nm  f=0.0025  <S**2>=0.000 
      81 -> 95         0.24486 
      82 -> 95         0.12984 
      84 -> 98         0.11793 
      85 ->100        -0.10107 
      86 ->100         0.53676 
  
 Excited State  85:      Singlet-A      7.6091 eV  162.94 nm  f=0.0003  <S**2>=0.000 
      76 -> 94         0.54119 
      81 -> 96        -0.11487 
      82 -> 96         0.11807 
      83 -> 97         0.24908 
      84 -> 97        -0.11952 
      86 ->100         0.10529 
      90 ->101        -0.13189 
  
 Excited State  86:      Singlet-A      7.6271 eV  162.56 nm  f=0.0028  <S**2>=0.000 
      89 ->101        -0.22408 
      92 ->104        -0.17121 
      93 ->105         0.60676 
  
 Excited State  87:      Singlet-A      7.6461 eV  162.15 nm  f=0.0003  <S**2>=0.000 
      89 ->101         0.64359 
      93 ->105         0.22655 
  
 Excited State  88:      Singlet-A      7.6578 eV  161.91 nm  f=0.0002  <S**2>=0.000 
      76 -> 94        -0.11258 
      81 -> 95        -0.23275 
      82 -> 96         0.18779 
      84 -> 98        -0.21406 
      87 ->101         0.11782 
      88 ->101         0.49575 
      90 ->101        -0.21619 
  
 Excited State  89:      Singlet-A      7.6899 eV  161.23 nm  f=0.1497  <S**2>=0.000 
      75 -> 94         0.13510 
      80 -> 95        -0.10682 
      84 -> 99         0.57125 
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      86 ->101        -0.11188 
      89 ->101        -0.10432 
      91 ->102         0.17216 
  
 Excited State  90:      Singlet-A      7.6933 eV  161.16 nm  f=0.0012  <S**2>=0.000 
      76 -> 94        -0.39028 
      79 -> 96         0.12808 
      81 -> 95        -0.13863 
      81 -> 96        -0.13252 
      83 -> 97         0.41976 
      84 -> 98         0.11484 
      85 ->100        -0.12361 
      88 ->101        -0.18065 
  
 Excited State  91:      Singlet-A      7.6988 eV  161.04 nm  f=0.0088  <S**2>=0.000 
      81 -> 95        -0.29036 
      82 -> 95        -0.16349 
      82 -> 96        -0.12771 
      84 -> 98         0.17485 
      85 ->100         0.36944 
      86 ->100         0.17730 
      87 ->101        -0.27179 
      90 ->101        -0.19285 
  
 Excited State  92:      Singlet-A      7.7203 eV  160.60 nm  f=0.0002  <S**2>=0.000 
      81 -> 95        -0.13050 
      81 -> 96        -0.11289 
      82 -> 96         0.38532 
      83 -> 97        -0.23943 
      88 ->101        -0.27796 
      92 ->103         0.26416 
      93 ->106         0.22842 
  
 Excited State  93:      Singlet-A      7.7269 eV  160.46 nm  f=0.0026  <S**2>=0.000 
      81 -> 95         0.13266 
      82 -> 95         0.10007 
      84 -> 98         0.29097 
      87 ->101        -0.14550 
      88 ->101         0.32052 
      92 ->103         0.33688 
      93 ->106         0.23789 
  
 Excited State  94:      Singlet-A      7.7537 eV  159.90 nm  f=0.0174  <S**2>=0.000 
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      81 -> 96        -0.10484 
      82 -> 96         0.32578 
      83 -> 97        -0.10477 
      84 -> 98         0.31903 
      90 ->101         0.19329 
      92 ->103        -0.22709 
      93 ->106        -0.28231 
  
 Excited State  95:      Singlet-A      7.7669 eV  159.63 nm  f=0.0056  <S**2>=0.000 
      79 -> 95         0.10943 
      81 -> 95        -0.26196 
      81 -> 96         0.19135 
      82 -> 95        -0.16726 
      82 -> 96        -0.15200 
      84 -> 97         0.14223 
      84 -> 98         0.14164 
      85 -> 99        -0.12723 
      85 ->100        -0.18787 
      87 ->101         0.27408 
      90 ->101         0.14503 
      92 ->103         0.18290 
      93 ->106         0.13982 
  
 Excited State  96:      Singlet-A      7.7724 eV  159.52 nm  f=0.0096  <S**2>=0.000 
      73 -> 94         0.41922 
      75 -> 94         0.46204 
      84 -> 99        -0.14068 
      92 ->104        -0.10770 
  
 Excited State  97:      Singlet-A      7.8232 eV  158.48 nm  f=0.0038  <S**2>=0.000 
      80 -> 95         0.48992 
      92 ->104        -0.41769 
      93 ->105        -0.10541 
      93 ->107        -0.14371 
  
 Excited State  98:      Singlet-A      7.8428 eV  158.09 nm  f=0.0006  <S**2>=0.000 
      80 -> 95        -0.16308 
      92 ->103        -0.40462 
      92 ->104        -0.17674 
      93 ->106         0.48013 
  
 Excited State  99:      Singlet-A      7.8428 eV  158.09 nm  f=0.0020  <S**2>=0.000 
      73 -> 94         0.16110 
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      80 -> 95         0.39032 
      92 ->103        -0.17292 
      92 ->104         0.40896 
      93 ->105         0.16741 
      93 ->106         0.20385 
  
 Excited State 100:      Singlet-A      7.8697 eV  157.55 nm  f=0.0022  <S**2>=0.000 
      73 -> 94        -0.40044 
      75 -> 94         0.46200 
      80 -> 95         0.11634 
      82 -> 97         0.21955 
 
 
Table A4.11. Excitation Energies and Oscillator Strengths of 6 Using the TD-B3LYP Method 
with 6-31G(d) Basis Set in Chloroform. 
 
Excited State   1:      Singlet-A      2.7982 eV  443.08 nm  f=0.3748  <S**2>=0.000 
      93 -> 94         0.69958 
 This state for optimization and/or second-order correction. 
 Total Energy, E(TD-HF/TD-KS) =  -1181.65604131     
 Copying the excited state density for this state as the 1-particle RhoCI density. 
  
 Excited State   2:      Singlet-A      3.3212 eV  373.31 nm  f=0.0010  <S**2>=0.000 
      92 -> 94         0.64220 
      93 -> 95         0.28035 
  
 Excited State   3:      Singlet-A      3.5443 eV  349.81 nm  f=0.1493  <S**2>=0.000 
      92 -> 94        -0.27703 
      93 -> 95         0.61818 
      93 -> 96         0.13684 
  
 Excited State   4:      Singlet-A      3.8099 eV  325.42 nm  f=0.0098  <S**2>=0.000 
      93 -> 95        -0.11775 
      93 -> 96         0.68547 
  
 Excited State   5:      Singlet-A      3.9473 eV  314.10 nm  f=0.0045  <S**2>=0.000 
      91 -> 94         0.49919 
      93 -> 97         0.48404 
  
 Excited State   6:      Singlet-A      4.0195 eV  308.45 nm  f=0.0116  <S**2>=0.000 
      91 -> 94        -0.47189 
      93 -> 97         0.50341 
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 Excited State   7:      Singlet-A      4.2272 eV  293.30 nm  f=0.0015  <S**2>=0.000 
      88 -> 94        -0.39711 
      89 -> 94         0.52299 
      90 -> 94         0.11759 
      92 -> 95         0.12139 
  
 Excited State   8:      Singlet-A      4.2992 eV  288.39 nm  f=0.0026  <S**2>=0.000 
      88 -> 94         0.53051 
      89 -> 94         0.42937 
      89 -> 97        -0.10948 
  
 Excited State   9:      Singlet-A      4.3512 eV  284.95 nm  f=0.0933  <S**2>=0.000 
      87 -> 94         0.13714 
      88 -> 94         0.13282 
      90 -> 94         0.18504 
      92 -> 95         0.49430 
      92 -> 96         0.13294 
      93 -> 98        -0.37027 
  
 Excited State  10:      Singlet-A      4.4016 eV  281.68 nm  f=0.0736  <S**2>=0.000 
      90 -> 94         0.58142 
      92 -> 95        -0.29294 
      93 -> 98        -0.10121 
  
 Excited State  11:      Singlet-A      4.4574 eV  278.15 nm  f=0.1417  <S**2>=0.000 
      90 -> 94         0.24051 
      92 -> 95         0.24251 
      92 -> 96         0.24568 
      93 -> 98         0.52830 
  
 Excited State  12:      Singlet-A      4.5961 eV  269.76 nm  f=0.0318  <S**2>=0.000 
      90 -> 94         0.11895 
      91 -> 96         0.11890 
      92 -> 96        -0.14651 
      93 -> 99         0.63279 
  
 Excited State  13:      Singlet-A      4.6470 eV  266.80 nm  f=0.0501  <S**2>=0.000 
      86 -> 94        -0.16458 
      87 -> 94         0.49608 
      92 -> 96        -0.40087 
      93 -> 98         0.17385 
  
 Excited State  14:      Singlet-A      4.7002 eV  263.78 nm  f=0.0416  <S**2>=0.000 
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      86 -> 94         0.58956 
      87 -> 94         0.22711 
      92 -> 97         0.26710 
  
 Excited State  15:      Singlet-A      4.7986 eV  258.38 nm  f=0.0478  <S**2>=0.000 
      86 -> 94        -0.19454 
      87 -> 94         0.37476 
      92 -> 95        -0.23464 
      92 -> 96         0.43977 
      93 -> 99         0.15626 
  
 Excited State  16:      Singlet-A      4.8976 eV  253.15 nm  f=0.0099  <S**2>=0.000 
      88 -> 95         0.22708 
      89 -> 95         0.55930 
      91 -> 95         0.30766 
  
 Excited State  17:      Singlet-A      4.9773 eV  249.10 nm  f=0.3189  <S**2>=0.000 
      86 -> 94        -0.21408 
      87 -> 95         0.11991 
      89 -> 95         0.13909 
      91 -> 95        -0.23633 
      92 -> 97         0.57068 
  
 Excited State  18:      Singlet-A      5.0213 eV  246.92 nm  f=0.1157  <S**2>=0.000 
      86 -> 94        -0.11045 
      88 -> 95        -0.11244 
      89 -> 95        -0.25034 
      91 -> 95         0.56875 
      92 -> 97         0.21553 
  
 Excited State  19:      Singlet-A      5.1855 eV  239.10 nm  f=0.0086  <S**2>=0.000 
      84 -> 94         0.13012 
      85 -> 94        -0.29584 
      91 -> 96        -0.27644 
      93 ->100         0.51888 
  
 Excited State  20:      Singlet-A      5.2521 eV  236.07 nm  f=0.0054  <S**2>=0.000 
      91 -> 96        -0.17878 
      92 -> 98         0.63424 
      93 ->100        -0.18238 
  
 Excited State  21:      Singlet-A      5.2915 eV  234.31 nm  f=0.1119  <S**2>=0.000 
      85 -> 94         0.45998 
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      91 -> 96         0.16775 
      91 -> 97        -0.12025 
      92 -> 98         0.14556 
      92 -> 99         0.13628 
      93 ->100         0.33951 
      93 ->101        -0.17692 
  
 Excited State  22:      Singlet-A      5.3685 eV  230.95 nm  f=0.1195  <S**2>=0.000 
      85 -> 94         0.24558 
      88 -> 97         0.14861 
      89 -> 95        -0.13338 
      89 -> 96        -0.22999 
      89 -> 97         0.12009 
      90 -> 95         0.41858 
      90 -> 96        -0.17311 
      91 -> 96        -0.13220 
      91 -> 97         0.15553 
      92 -> 98        -0.10915 
      92 -> 99        -0.15580 
  
 Excited State  23:      Singlet-A      5.3906 eV  230.00 nm  f=0.0978  <S**2>=0.000 
      88 -> 95        -0.14769 
      88 -> 96        -0.19211 
      88 -> 97        -0.23167 
      88 -> 98        -0.12073 
      89 -> 96         0.30291 
      90 -> 95         0.41980 
      91 -> 96         0.12447 
      91 -> 97         0.13554 
      92 -> 98         0.11339 
  
 Excited State  24:      Singlet-A      5.4155 eV  228.94 nm  f=0.0141  <S**2>=0.000 
      88 -> 95        -0.19935 
      88 -> 96        -0.35602 
      88 -> 98        -0.13826 
      89 -> 96        -0.26828 
      89 -> 97         0.38166 
      90 -> 95        -0.13375 
      91 -> 97         0.10691 
  
 Excited State  25:      Singlet-A      5.4284 eV  228.40 nm  f=0.1052  <S**2>=0.000 
      85 -> 94        -0.22577 
      86 -> 95        -0.16513 
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      88 -> 97         0.12311 
      89 -> 96        -0.18801 
      90 -> 95         0.24366 
      92 -> 99         0.46181 
  
 Excited State  26:      Singlet-A      5.4905 eV  225.82 nm  f=0.3789  <S**2>=0.000 
      84 -> 94        -0.17544 
      85 -> 94        -0.16149 
      87 -> 95         0.11166 
      88 -> 97         0.10330 
      88 -> 98         0.11131 
      90 -> 96        -0.10535 
      91 -> 96         0.45972 
      91 -> 97         0.20487 
      92 -> 98         0.15000 
      92 -> 99        -0.21787 
      93 ->100         0.10854 
  
 Excited State  27:      Singlet-A      5.5337 eV  224.05 nm  f=0.1509  <S**2>=0.000 
      84 -> 94        -0.19510 
      86 -> 95         0.16908 
      87 -> 95         0.29341 
      88 -> 95        -0.22222 
      88 -> 96         0.10002 
      89 -> 95         0.11629 
      90 -> 96        -0.18306 
      91 -> 96        -0.15706 
      91 -> 97         0.26121 
      92 -> 99         0.25590 
      93 ->101        -0.12412 
  
 Excited State  28:      Singlet-A      5.5534 eV  223.26 nm  f=0.0309  <S**2>=0.000 
      84 -> 94        -0.13952 
      88 -> 95        -0.27470 
      90 -> 96        -0.20897 
      91 -> 97        -0.36109 
      92 ->100        -0.11593 
      93 ->101         0.39554 
  
 Excited State  29:      Singlet-A      5.5857 eV  221.97 nm  f=0.0286  <S**2>=0.000 
      84 -> 94        -0.11445 
      86 -> 95         0.19004 
      88 -> 95         0.45472 
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      88 -> 96        -0.18414 
      88 -> 97        -0.11640 
      89 -> 95        -0.17785 
      89 -> 96         0.12612 
      90 -> 96        -0.17447 
      92 -> 99         0.22716 
  
 Excited State  30:      Singlet-A      5.6211 eV  220.57 nm  f=0.1189  <S**2>=0.000 
      86 -> 95         0.44151 
      87 -> 95        -0.18951 
      88 -> 95        -0.10664 
      91 -> 96         0.10772 
      91 -> 97        -0.16060 
      92 ->100        -0.11216 
      93 ->101        -0.38152 
  
 Excited State  31:      Singlet-A      5.6685 eV  218.73 nm  f=0.1017  <S**2>=0.000 
      87 -> 95         0.45950 
      88 -> 98        -0.12640 
      90 -> 95         0.10604 
      90 -> 96         0.11062 
      90 -> 97         0.17108 
      91 -> 97        -0.27094 
      91 -> 98         0.12256 
      92 -> 99        -0.20290 
      93 ->101        -0.14750 
  
 Excited State  32:      Singlet-A      5.7142 eV  216.98 nm  f=0.0464  <S**2>=0.000 
      83 -> 94        -0.11178 
      84 -> 94         0.52122 
      87 -> 95         0.15759 
      90 -> 96        -0.15658 
      90 -> 97         0.23006 
      93 ->101         0.12849 
  
 Excited State  33:      Singlet-A      5.7816 eV  214.45 nm  f=0.0351  <S**2>=0.000 
      88 -> 94         0.12264 
      88 -> 96        -0.18179 
      88 -> 97        -0.15151 
      88 -> 98         0.45007 
      88 -> 99         0.16368 
      89 -> 96         0.11000 
      89 -> 97         0.11458 
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      89 -> 98        -0.23121 
      90 -> 98        -0.11493 
      91 -> 97        -0.10508 
      91 -> 98        -0.17937 
  
 Excited State  34:      Singlet-A      5.8192 eV  213.06 nm  f=0.0467  <S**2>=0.000 
      86 -> 95         0.25632 
      90 -> 96         0.48799 
      91 -> 97         0.15938 
      92 ->100        -0.25343 
      93 ->101         0.19997 
  
 Excited State  35:      Singlet-A      5.9251 eV  209.25 nm  f=0.0977  <S**2>=0.000 
      88 -> 98         0.16562 
      89 -> 98        -0.11097 
      91 -> 98         0.61843 
  
 Excited State  36:      Singlet-A      5.9496 eV  208.39 nm  f=0.0016  <S**2>=0.000 
      88 -> 96         0.24777 
      88 -> 97         0.22745 
      89 -> 96         0.37182 
      89 -> 97         0.46690 
  
 Excited State  37:      Singlet-A      5.9837 eV  207.20 nm  f=0.0745  <S**2>=0.000 
      83 -> 94         0.10399 
      84 -> 94        -0.10906 
      86 -> 95        -0.14214 
      86 -> 96        -0.10761 
      86 -> 98         0.10312 
      87 -> 95        -0.18566 
      90 -> 97         0.50699 
      92 ->100        -0.23103 
  
 Excited State  38:      Singlet-A      6.0246 eV  205.80 nm  f=0.0209  <S**2>=0.000 
      86 -> 95         0.18584 
      86 -> 96         0.20406 
      87 -> 95        -0.11200 
      87 -> 96         0.11650 
      87 -> 97        -0.12850 
      88 -> 97         0.10299 
      90 -> 97         0.22182 
      92 ->100         0.48597 
      93 ->102         0.11827 
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 Excited State  39:      Singlet-A      6.0708 eV  204.23 nm  f=0.0184  <S**2>=0.000 
      88 -> 96        -0.37256 
      88 -> 97         0.47839 
      89 -> 96         0.16954 
      89 -> 97        -0.17431 
      90 -> 97        -0.10714 
  
 Excited State  40:      Singlet-A      6.1190 eV  202.62 nm  f=0.0276  <S**2>=0.000 
      83 -> 94        -0.32236 
      85 -> 95         0.14696 
      86 -> 96         0.12275 
      87 -> 96         0.49052 
      88 -> 97        -0.14099 
      91 -> 99        -0.18966 
  
 Excited State  41:      Singlet-A      6.1444 eV  201.78 nm  f=0.1118  <S**2>=0.000 
      83 -> 94         0.30470 
      85 -> 95        -0.12824 
      86 -> 96         0.48503 
      87 -> 97         0.27797 
      92 ->100        -0.10437 
  
 Excited State  42:      Singlet-A      6.1942 eV  200.16 nm  f=0.0245  <S**2>=0.000 
      83 -> 94        -0.22442 
      85 -> 95         0.33672 
      86 -> 97        -0.13901 
      87 -> 96        -0.14111 
      87 -> 97         0.20848 
      91 -> 99         0.38069 
      92 ->101         0.23494 
  
 Excited State  43:      Singlet-A      6.2045 eV  199.83 nm  f=0.0031  <S**2>=0.000 
      83 -> 94         0.40245 
      84 -> 94         0.10235 
      85 -> 95         0.27468 
      86 -> 96        -0.17967 
      86 -> 97         0.26242 
      87 -> 96         0.23174 
      91 -> 99         0.13370 
      92 ->101         0.15824 
  
 Excited State  44:      Singlet-A      6.2285 eV  199.06 nm  f=0.0221  <S**2>=0.000 
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      85 -> 95        -0.29793 
      86 -> 96        -0.14517 
      86 -> 97         0.13076 
      86 -> 98         0.13086 
      87 -> 96         0.23260 
      87 -> 97         0.18262 
      90 -> 98         0.20081 
      90 -> 99        -0.12470 
      91 -> 99         0.31649 
      92 ->101        -0.24603 
  
 Excited State  45:      Singlet-A      6.3202 eV  196.17 nm  f=0.1105  <S**2>=0.000 
      83 -> 94        -0.15429 
      85 -> 95        -0.13092 
      86 -> 96         0.17022 
      86 -> 97         0.34006 
      87 -> 97        -0.25257 
      91 -> 99         0.19092 
      92 ->100        -0.14196 
      92 ->101         0.12377 
      93 ->102         0.32123 
  
 Excited State  46:      Singlet-A      6.3573 eV  195.03 nm  f=0.0982  <S**2>=0.000 
      82 -> 94         0.16237 
      86 -> 97        -0.19477 
      87 -> 97        -0.12149 
      89 -> 98        -0.18869 
      90 -> 98         0.46638 
      93 ->102         0.32174 
  
 Excited State  47:      Singlet-A      6.3780 eV  194.39 nm  f=0.0028  <S**2>=0.000 
      86 -> 97        -0.14033 
      88 -> 98         0.24742 
      89 -> 98         0.54792 
      89 -> 99        -0.17191 
      93 ->102         0.13015 
  
 Excited State  48:      Singlet-A      6.4003 eV  193.72 nm  f=0.0957  <S**2>=0.000 
      82 -> 94         0.23320 
      84 -> 95        -0.10745 
      85 -> 96         0.10973 
      86 -> 96        -0.14507 
      87 -> 97         0.15885 
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      90 -> 98        -0.33335 
      90 -> 99         0.25277 
      92 ->101        -0.18600 
      93 ->102         0.34066 
  
 Excited State  49:      Singlet-A      6.4127 eV  193.34 nm  f=0.0787  <S**2>=0.000 
      84 -> 95        -0.19406 
      86 -> 97         0.23928 
      87 -> 97         0.32300 
      87 -> 98        -0.23438 
      87 -> 99         0.14885 
      88 -> 98         0.11995 
      89 -> 98         0.13141 
      90 -> 98         0.12953 
      91 -> 99        -0.16486 
      91 ->100        -0.21512 
      92 ->101         0.12989 
  
 Excited State  50:      Singlet-A      6.4899 eV  191.04 nm  f=0.0247  <S**2>=0.000 
      85 -> 95        -0.13117 
      85 -> 96        -0.23569 
      86 -> 97         0.16935 
      86 -> 98         0.20742 
      87 -> 98        -0.10689 
      87 -> 99        -0.15643 
      89 -> 99        -0.15952 
      90 -> 99         0.32189 
      91 ->100         0.28933 
      92 ->101         0.17155 
  
 Excited State  51:      Singlet-A      6.5166 eV  190.26 nm  f=0.0842  <S**2>=0.000 
      82 -> 94         0.34787 
      84 -> 95         0.17361 
      84 -> 96        -0.16041 
      85 -> 96        -0.13618 
      86 -> 98         0.23469 
      87 -> 98        -0.23136 
      90 -> 99        -0.32094 
  
 Excited State  52:      Singlet-A      6.5470 eV  189.38 nm  f=0.0994  <S**2>=0.000 
      84 -> 95         0.32909 
      85 -> 95        -0.13365 
      85 -> 96        -0.11539 
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      85 -> 97         0.14070 
      86 -> 97        -0.11267 
      86 -> 98        -0.14412 
      87 -> 99         0.13566 
      89 -> 99         0.25261 
      90 -> 99         0.22866 
      91 ->100        -0.22206 
      92 ->101         0.16076 
  
 Excited State  53:      Singlet-A      6.5786 eV  188.47 nm  f=0.0427  <S**2>=0.000 
      84 -> 95        -0.14855 
      85 -> 97        -0.11151 
      86 -> 98         0.14068 
      88 -> 98         0.17334 
      89 -> 99         0.56374 
      91 ->100         0.15606 
  
 Excited State  54:      Singlet-A      6.6256 eV  187.13 nm  f=0.0134  <S**2>=0.000 
      82 -> 94         0.19852 
      84 -> 95        -0.15781 
      85 -> 96        -0.16560 
      87 -> 98         0.26539 
      88 -> 99         0.38710 
      89 -> 99         0.15997 
      90 -> 99        -0.14067 
      90 ->100         0.11802 
  
 Excited State  55:      Singlet-A      6.6472 eV  186.52 nm  f=0.1748  <S**2>=0.000 
      82 -> 94        -0.13778 
      84 -> 95         0.27728 
      85 -> 96         0.29094 
      86 -> 98        -0.11179 
      87 -> 98        -0.19273 
      88 -> 99         0.35038 
      89 -> 99         0.10176 
      90 -> 99        -0.10326 
      91 ->100         0.20254 
      93 ->102         0.11714 
  
 Excited State  56:      Singlet-A      6.6642 eV  186.04 nm  f=0.1509  <S**2>=0.000 
      82 -> 94        -0.12730 
      84 -> 96        -0.10388 
      85 -> 96        -0.19515 
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      85 -> 97        -0.10553 
      86 -> 98         0.18380 
      86 -> 99         0.10696 
      87 -> 98        -0.11744 
      87 -> 99         0.18012 
      88 -> 99         0.38710 
      90 -> 99         0.15282 
      90 ->100        -0.11507 
      91 ->100        -0.20732 
      92 ->101        -0.11821 
  
 Excited State  57:      Singlet-A      6.6698 eV  185.89 nm  f=0.0386  <S**2>=0.000 
      84 -> 95        -0.25373 
      84 -> 96        -0.11835 
      85 -> 95        -0.20913 
      85 -> 96         0.11916 
      86 -> 97        -0.17923 
      86 -> 98        -0.21287 
      86 -> 99         0.20331 
      87 -> 98        -0.15080 
      91 -> 99         0.10369 
      91 ->100         0.16058 
      92 ->101         0.27791 
  
 Excited State  58:      Singlet-A      6.6944 eV  185.21 nm  f=0.1465  <S**2>=0.000 
      79 -> 94        -0.21990 
      80 -> 94         0.28244 
      81 -> 94         0.28237 
      82 -> 94         0.21709 
      85 -> 95         0.10457 
      85 -> 96         0.13586 
      86 -> 96         0.11351 
      87 -> 97        -0.11653 
      87 -> 98        -0.14702 
      90 -> 99         0.16309 
      92 ->101        -0.12679 
      93 ->102        -0.19197 
  
 Excited State  59:      Singlet-A      6.7172 eV  184.58 nm  f=0.0470  <S**2>=0.000 
      81 -> 94         0.40798 
      82 -> 94        -0.10115 
      85 -> 96         0.10948 
      85 -> 97        -0.24419 
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      86 -> 98         0.19904 
      87 -> 98         0.28524 
      87 -> 99         0.22647 
      91 ->100         0.10382 
  
 Excited State  60:      Singlet-A      6.7305 eV  184.21 nm  f=0.1465  <S**2>=0.000 
      81 -> 94         0.42082 
      82 -> 94        -0.10463 
      84 -> 95        -0.13578 
      85 -> 96        -0.27670 
      86 -> 98        -0.17277 
      87 -> 98        -0.22420 
      87 -> 99        -0.21415 
      90 -> 99        -0.11347 
  
 Excited State  61:      Singlet-A      6.8467 eV  181.09 nm  f=0.0181  <S**2>=0.000 
      79 -> 94         0.15651 
      80 -> 94        -0.25906 
      81 -> 94         0.13339 
      84 -> 95        -0.10076 
      85 -> 96         0.17357 
      85 -> 97         0.46251 
      86 -> 98         0.21710 
      89 ->100         0.11622 
  
 Excited State  62:      Singlet-A      6.9137 eV  179.33 nm  f=0.0425  <S**2>=0.000 
      80 -> 94         0.17703 
      84 -> 96        -0.10233 
      86 -> 99         0.49819 
      87 -> 98         0.10764 
      87 -> 99        -0.26395 
      90 ->100        -0.14928 
      91 ->101         0.11445 
  
 Excited State  63:      Singlet-A      6.9345 eV  178.79 nm  f=0.0220  <S**2>=0.000 
      79 -> 94         0.20024 
      80 -> 94        -0.13767 
      82 -> 94         0.15793 
      84 -> 96         0.39673 
      85 -> 96        -0.10529 
      85 -> 97        -0.12415 
      86 -> 99         0.24058 
      89 ->100         0.28562 
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      90 ->100        -0.12815 
      91 ->100         0.10160 
  
 Excited State  64:      Singlet-A      6.9606 eV  178.12 nm  f=0.0210  <S**2>=0.000 
      80 -> 94         0.30651 
      82 -> 94        -0.13226 
      84 -> 96        -0.11203 
      85 -> 97         0.14309 
      87 -> 99         0.11898 
      89 ->100         0.45612 
      89 ->101        -0.10260 
      91 ->101        -0.19473 
  
 Excited State  65:      Singlet-A      6.9916 eV  177.33 nm  f=0.0233  <S**2>=0.000 
      79 -> 94         0.14464 
      83 -> 95        -0.12604 
      84 -> 96        -0.24522 
      85 -> 97        -0.15569 
      89 ->100         0.18363 
      90 ->100         0.47241 
      91 ->101         0.21748 
  
 Excited State  66:      Singlet-A      7.0223 eV  176.56 nm  f=0.0204  <S**2>=0.000 
      79 -> 94         0.43936 
      80 -> 94         0.23492 
      85 -> 97         0.11863 
      87 -> 99         0.17470 
      88 ->100        -0.13862 
      89 ->100        -0.27666 
      90 ->100         0.10830 
      91 ->100         0.11681 
      93 ->103         0.10032 
  
 Excited State  67:      Singlet-A      7.0416 eV  176.07 nm  f=0.0028  <S**2>=0.000 
      79 -> 94         0.15718 
      80 -> 94         0.10696 
      83 -> 95         0.12476 
      88 ->100         0.55707 
      93 ->103        -0.28161 
  
 Excited State  68:      Singlet-A      7.0565 eV  175.70 nm  f=0.0251  <S**2>=0.000 
      83 -> 95        -0.30341 
      84 -> 97        -0.10311 
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      88 ->100         0.28819 
      89 ->101        -0.12336 
      91 ->101        -0.25101 
      93 ->103         0.41699 
  
 Excited State  69:      Singlet-A      7.0574 eV  175.68 nm  f=0.0092  <S**2>=0.000 
      83 -> 95         0.35034 
      84 -> 96        -0.13509 
      84 -> 97         0.11322 
      88 ->100         0.12268 
      89 ->100         0.10049 
      90 ->100        -0.14476 
      91 ->101         0.23470 
      93 ->103         0.44647 
  
 Excited State  70:      Singlet-A      7.0695 eV  175.38 nm  f=0.0309  <S**2>=0.000 
      83 -> 95         0.41942 
      84 -> 95         0.11395 
      84 -> 96         0.18970 
      85 -> 98        -0.12149 
      86 -> 99         0.15831 
      89 ->100        -0.10056 
      90 ->100         0.30471 
      91 ->101        -0.22083 
  
 Excited State  71:      Singlet-A      7.1350 eV  173.77 nm  f=0.0114  <S**2>=0.000 
      79 -> 94         0.10435 
      80 -> 94        -0.10325 
      82 -> 94         0.12640 
      83 -> 95         0.10912 
      84 -> 96        -0.17580 
      85 -> 98         0.40483 
      85 -> 99         0.10885 
      86 -> 98        -0.10143 
      89 ->101        -0.20741 
      91 ->101        -0.27062 
      92 ->102        -0.10689 
  
 Excited State  72:      Singlet-A      7.1388 eV  173.68 nm  f=0.0281  <S**2>=0.000 
      84 -> 96        -0.18124 
      84 -> 97         0.39581 
      85 -> 98        -0.26848 
      85 -> 99         0.10672 
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      86 -> 99         0.10454 
      87 ->100         0.18010 
      90 ->101         0.11166 
      91 ->101        -0.18460 
      92 ->101        -0.12100 
  
 Excited State  73:      Singlet-A      7.1623 eV  173.11 nm  f=0.0008  <S**2>=0.000 
      78 -> 94         0.10872 
      82 -> 95        -0.13455 
      88 ->101        -0.13782 
      89 ->100        -0.10200 
      89 ->101        -0.42060 
      91 ->101         0.11997 
      92 ->102         0.44958 
  
 Excited State  74:      Singlet-A      7.1938 eV  172.35 nm  f=0.0246  <S**2>=0.000 
      78 -> 94         0.11414 
      84 -> 97        -0.10315 
      85 -> 98         0.22255 
      88 ->100         0.12921 
      88 ->101         0.13360 
      89 ->101         0.33270 
      90 ->101         0.10857 
      92 ->102         0.34949 
      93 ->104         0.20679 
  
 Excited State  75:      Singlet-A      7.2122 eV  171.91 nm  f=0.0032  <S**2>=0.000 
      77 -> 94         0.38794 
      78 -> 94         0.25569 
      80 -> 94         0.10473 
      83 -> 97        -0.12516 
      84 -> 97         0.10760 
      92 ->102        -0.23004 
      93 ->104         0.32813 
  
 Excited State  76:      Singlet-A      7.2245 eV  171.62 nm  f=0.0045  <S**2>=0.000 
      77 -> 94        -0.22595 
      78 -> 94        -0.27406 
      93 ->104         0.54834 
  
 Excited State  77:      Singlet-A      7.2494 eV  171.03 nm  f=0.0143  <S**2>=0.000 
      77 -> 94        -0.39906 
      78 -> 94         0.49035 
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      86 ->100         0.10081 
  
 Excited State  78:      Singlet-A      7.3187 eV  169.41 nm  f=0.0644  <S**2>=0.000 
      78 -> 94        -0.17444 
      79 -> 94        -0.19154 
      80 -> 94        -0.10722 
      82 -> 94        -0.10978 
      84 -> 97         0.14744 
      84 -> 98         0.15775 
      85 -> 97         0.10015 
      85 -> 98         0.29447 
      86 -> 99         0.10597 
      86 ->100         0.25559 
      87 -> 99         0.13846 
      89 ->101        -0.12578 
      91 ->100         0.10900 
      91 ->101         0.14519 
  
 Excited State  79:      Singlet-A      7.3417 eV  168.88 nm  f=0.1240  <S**2>=0.000 
      77 -> 94        -0.21200 
      80 -> 94         0.10480 
      84 -> 97         0.36367 
      85 -> 98         0.13638 
      85 -> 99        -0.24250 
      86 ->100        -0.21450 
      87 ->100        -0.29280 
      91 ->100        -0.11007 
  
 Excited State  80:      Singlet-A      7.3980 eV  167.59 nm  f=0.0690  <S**2>=0.000 
      83 -> 96         0.10113 
      84 -> 98        -0.25568 
      85 -> 98        -0.11611 
      86 ->100         0.40820 
      87 ->100        -0.21060 
      90 ->101         0.37121 
  
 Excited State  81:      Singlet-A      7.4149 eV  167.21 nm  f=0.0255  <S**2>=0.000 
      75 -> 94        -0.15547 
      76 -> 94        -0.15610 
      81 -> 97        -0.11001 
      83 -> 96         0.48876 
      84 -> 98         0.10600 
      85 -> 99        -0.16240 
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      86 ->100        -0.16848 
      87 ->100        -0.18113 
  
 Excited State  82:      Singlet-A      7.4498 eV  166.43 nm  f=0.0500  <S**2>=0.000 
      75 -> 94        -0.12218 
      76 -> 94        -0.14722 
      80 -> 94         0.10451 
      83 -> 96         0.21253 
      84 -> 96         0.11238 
      84 -> 97         0.11255 
      85 -> 98         0.11701 
      85 -> 99         0.11406 
      86 -> 98         0.10333 
      86 ->100         0.28865 
      86 ->101         0.14784 
      87 -> 99        -0.14666 
      87 ->100         0.16079 
      90 ->101        -0.23129 
      91 ->100        -0.11595 
  
 Excited State  83:      Singlet-A      7.4878 eV  165.58 nm  f=0.0819  <S**2>=0.000 
      79 -> 95        -0.13052 
      81 -> 95         0.10906 
      82 -> 95         0.43627 
      85 -> 99         0.36672 
      86 ->101         0.12405 
      87 ->100        -0.22462 
      91 ->102        -0.10170 
  
 Excited State  84:      Singlet-A      7.5199 eV  164.87 nm  f=0.0845  <S**2>=0.000 
      75 -> 94        -0.19298 
      79 -> 95        -0.13705 
      81 -> 95         0.10320 
      82 -> 95         0.29735 
      83 -> 97         0.11407 
      85 -> 99        -0.26551 
      87 ->100         0.31820 
      90 ->101         0.26695 
  
 Excited State  85:      Singlet-A      7.5332 eV  164.58 nm  f=0.0184  <S**2>=0.000 
      75 -> 94         0.11650 
      76 -> 94         0.11594 
      77 -> 94         0.10902 
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      82 -> 95         0.21000 
      84 -> 98         0.30822 
      84 -> 99        -0.16708 
      85 -> 99        -0.21928 
      86 ->100         0.18750 
      87 ->100        -0.19480 
      87 ->101         0.14405 
      90 ->101        -0.12535 
  
 Excited State  86:      Singlet-A      7.5601 eV  164.00 nm  f=0.0096  <S**2>=0.000 
      75 -> 94         0.33051 
      76 -> 94         0.41880 
      83 -> 96         0.29368 
      83 -> 97        -0.17140 
      87 ->100         0.10687 
      90 ->101         0.11198 
  
 Excited State  87:      Singlet-A      7.6336 eV  162.42 nm  f=0.0002  <S**2>=0.000 
      76 -> 94        -0.19158 
      81 -> 95         0.21096 
      81 -> 96         0.11424 
      83 -> 96        -0.12027 
      83 -> 97        -0.25296 
      84 -> 98         0.10350 
      88 ->101        -0.28356 
      90 ->101         0.12834 
      93 ->105         0.37904 
  
 Excited State  88:      Singlet-A      7.6340 eV  162.41 nm  f=0.0115  <S**2>=0.000 
      75 -> 94         0.19384 
      81 -> 96        -0.10463 
      83 -> 97         0.24538 
      84 -> 98        -0.16240 
      84 -> 99         0.21949 
      90 ->101        -0.12685 
      93 ->105         0.45986 
  
 Excited State  89:      Singlet-A      7.6527 eV  162.01 nm  f=0.0066  <S**2>=0.000 
      75 -> 94        -0.11663 
      81 -> 95         0.10477 
      83 -> 97        -0.12449 
      84 -> 98         0.10260 
      84 -> 99        -0.12994 
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      88 ->101         0.55608 
      89 ->101        -0.21015 
      93 ->105         0.21718 
  
 Excited State  90:      Singlet-A      7.6579 eV  161.90 nm  f=0.0149  <S**2>=0.000 
      75 -> 94         0.23189 
      76 -> 94        -0.16744 
      79 -> 95        -0.16801 
      80 -> 95         0.17537 
      81 -> 95         0.30557 
      83 -> 97        -0.10630 
      84 -> 99         0.18507 
      88 ->101         0.11890 
      90 ->101        -0.16916 
      91 ->102         0.14964 
      93 ->105        -0.22378 
  
 Excited State  91:      Singlet-A      7.6944 eV  161.14 nm  f=0.0912  <S**2>=0.000 
      79 -> 95         0.10788 
      84 -> 98         0.29763 
      84 -> 99         0.49604 
      87 ->101         0.12009 
      90 ->101         0.16813 
      91 ->102         0.11963 
  
 Excited State  92:      Singlet-A      7.6996 eV  161.03 nm  f=0.0040  <S**2>=0.000 
      81 -> 95         0.38625 
      81 -> 96        -0.11547 
      82 -> 95        -0.22911 
      82 -> 96         0.13403 
      83 -> 97         0.34667 
      84 -> 98         0.14222 
      86 ->101        -0.10034 
  
 Excited State  93:      Singlet-A      7.7228 eV  160.54 nm  f=0.0049  <S**2>=0.000 
      75 -> 94         0.36330 
      76 -> 94        -0.35165 
      83 -> 97         0.11059 
      84 -> 99        -0.21186 
      87 ->101         0.19710 
      90 ->101         0.13958 
  
 Excited State  94:      Singlet-A      7.7589 eV  159.80 nm  f=0.0037  <S**2>=0.000 
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      80 -> 95        -0.10457 
      84 -> 98         0.11251 
      85 ->100         0.28511 
      86 ->101         0.39901 
      87 ->101        -0.36239 
      91 ->102         0.17034 
  
 Excited State  95:      Singlet-A      7.8026 eV  158.90 nm  f=0.0075  <S**2>=0.000 
      78 -> 95         0.13170 
      79 -> 95        -0.29463 
      80 -> 95         0.33383 
      81 -> 95        -0.23963 
      82 -> 95        -0.13592 
      84 -> 98         0.10058 
      85 ->100         0.14113 
      87 ->101         0.11570 
      92 ->103         0.23187 
      92 ->104         0.15883 
  
 Excited State  96:      Singlet-A      7.8140 eV  158.67 nm  f=0.0069  <S**2>=0.000 
      79 -> 95         0.15508 
      80 -> 95        -0.14211 
      81 -> 95         0.13399 
      92 ->103         0.47638 
      92 ->104         0.32168 
      93 ->104         0.12626 
      93 ->107         0.12443 
  
 Excited State  97:      Singlet-A      7.8467 eV  158.01 nm  f=0.0654  <S**2>=0.000 
      81 -> 95         0.11569 
      85 ->100         0.26072 
      86 ->101         0.25611 
      87 ->101         0.40719 
      91 ->102        -0.22858 
  
 Excited State  98:      Singlet-A      7.8956 eV  157.03 nm  f=0.0173  <S**2>=0.000 
      74 -> 94         0.11229 
      75 -> 94         0.12287 
      79 -> 96        -0.12069 
      81 -> 96         0.16829 
      82 -> 96         0.39271 
      87 ->101        -0.12956 
      91 ->102        -0.35839 
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      93 ->106         0.10247 
  
 Excited State  99:      Singlet-A      7.9078 eV  156.79 nm  f=0.0069  <S**2>=0.000 
      73 -> 94         0.44190 
      74 -> 94        -0.42420 
      81 -> 97         0.10105 
  
 Excited State 100:      Singlet-A      7.9380 eV  156.19 nm  f=0.0107  <S**2>=0.000 
      79 -> 95         0.13147 
      80 -> 95         0.14729 
      91 ->102         0.16700 
      91 ->103        -0.13381 
      92 ->103         0.16754 
      92 ->104        -0.30324 
      93 ->106         0.41706 
      93 ->107         0.19349 
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Chapter 6 
Diazaxanthylidene-based Novel Molecular Tools for 
Nuclear Staining of Neuronal Subpopulations and 
Populations 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with Dr. J. Nicholas Betley and Elen Hernandez in the 
Betley group and Dr. Mai N. Tran, a previous graduate student in the Chenoweth group at the 
University of Pennsylvania. 
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6.1  Introduction 
Fluorescent microscopic imaging has been a critical tool capable of visualizing cells and 
tissues in both the biology and medical fields.1 Many fluorophores have been developed to meet 
requirements for various imaging experiments.2 In our previous reports, we have provided the 
synthesis of diazaxanthylidene derivatives and introduced their unique photophysical 
properties.3 N-methylated diazaxanthylidenes bearing a positive charge undergo tandem 
photocylization-oxidation reactions that makes original absorption and emission wavelength 
shifted to the red end of spectrum. Accompanying with high quantum yield, low toxicity, and 
specific sub-cellular localization of photoactivated diazaxanthylidenes, 
photocylization/oxidation mechanism is especially useful to enable intracellular 
photoconversion.  
Inspired by cell imaging data that demonstrated the staining potential of 
diazaxanthylidene derivatives to be used as fluorescent markers, we report post-
photocyclization/oxidation/methylation diazaxanthylidenes that can be used as nuclei-specific 
fluorescent probes for both live and fixed brain tissue imaging. Incubation of mouse brain tissue 
slices with these probes resulted in nuclear staining of neurons within the hippocampal region4 
as well as the Islands of Calleja (IC).5 Low toxicity was evaluated and shown through intracranial 
injections and live imaging. As a result of intracranial injections, potential retrograding 
properties were demonstrated. These fluorophores were evaluated for degradation and found to 
be stable after the incubation of fluorescent antibodies by using immunohistochemical 
protocols. 
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6.2  Results and Discussion 
 
Figure 6.1. Preparation and photophysical properties of NeuroX1-X3. (A) Synthesis of 
NeuroX1-X3. (B) Absorption and emission spectra of NeuroX1-X3. NeuroX1 (Abs lmax = 499 
nm, Em lmax = 592 nm, ε = 10437 M-1cm-1, Φ = 0.101) and NeuroX2 (Abs lmax = 521 nm, Em lmax 
= 602 nm, ε = 9240 M-1cm-1, Φ = 0.133) in water. NeuroX3 (Abs lmax = 493 nm, Em lmax = 572 
nm, ε = 6385 M-1cm-1, Φ = 0.217). 
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Due to the low isomerization barrier of (E)-1 to (Z)-1, as an isomeric form of (E)-1, 
four final photoproducts (NeuroX1-X3 and 8) were able to be prepared advantageously from 
only a single starting material during the two-step synthesis that proceeded via 
photocyclization/oxidation and N-methylation (Figure 6.1A). We applied Katz’s condition,6 
which has been often used for stilbenes photocyclization, to (E/Z)-1 which bears stilbene 
scaffold. With propylene oxide, as a scavenger, and a catalytic amount of iodine, the 
photocyclization of (E/Z)-1 gave 2:3 ratio of 2 and 3.3b To utilize the resulting photoproducts as 
water-soluble fluorescent probes in cells and tissues, 2 and 3 were methylated. Using 
dimethylsulfate, 2 provided only mono-N-methylated photoproduct, NeuroX1, and di-N-
methylated one, NeuroX2 in nearly 1:1 ratio. In the case of 3, the methylation reaction gave 
NeuroX3, a mixture of two regioisomers resulting from asymmetricity of 3, as well as 
dimethylated photoproduct 4. In comparing the ratio from the former case, interestingly, 
NeuroX3 is to around one of third to 4. The resulting photoproducts were purified in gradient 
elution with 0.1% trifluoroacetic acid in water and acetonitrile on high-performance liquid 
chromatography. We have found both mono- and di-N-methylated products to show large 
Stokes shifts (80-100 nm). All absorption and emission wavelengths of the methylated 
photoproducts fell into the same range in the visible light spectrum with the dimethylated 
compound slightly more red-shifted than the corresponding monomethylated derivatives. Water 
solubility is also a benefit for biological applications. 
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Figure 6.2. (A) Viability assays of HeLa cells incubated with NeuroX1-X3 (5 μM) at 37 °C in a 
humidified atmosphere with 5% CO2 over 24 and 48 hours. (B) A normalized plot of the average 
intensity of NeuroX1-X3 over 200 seconds of continuous irradiation. (C-N) Confocal images of 
live HeLa cells, formaldehyde-fixed HeLa cells, ethanol-fixed HeLa cells, and live Neuro-2a cells 
stained with NeuroX1-X3. A 488/600 channel was used to observe NeuroX1 and NeuroX3, 
while a 552/600 channel was used for NeuroX2, scale bar = 10 μm. (O-Z) Confocal time-lapse 
microscopy of division of live Neuro 2a cells stained with NeuroX1, scale bar = 10 µm. i, 
interphase; p, prophase; pm, prometaphase; m, metaphase; a, anaphase; t, telophase; c, 
cytokinesis. 
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Figure 6.3. (A) Red and box indicate region imaged. (B-D) Representative confocal imaging 
of overnight incubation of NeuroX1-X3 at 1.0 µM concentration located in the islands of Calleja 
(IC) imaged on confocal microscope with 20x objective, scale bar 100 µm. (B’-D’) with 63x 
objective, scale bar 50 µm. (E-G) in dentate gyrus (DG), scale bar = 100 µm. (E’-G’) with 63x 
objective, scale bar = 50 µm. (H) Representative confocal imaging of retrograde labeling of 
probes using intracranial bed nucleus stria terminalis (BST) injections, scale bar = 100 µm. (i) 
NeuroX1. (ii) NeuroX2. (iii) NeuroX3. (iv) RG Bead (v) SL1 Virus staining of neurons in 
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anterior olfactory nucleus (AON), BST, and paraventricular nucleus of thalamus (PVT). (I, J) 
Live tissue incubation of 1.0 µM of NeuroX1 in AON in IC, scale bar = 100 μm. (K-M) 
Expression of agouti-related peptide (AGRP) antibody (green) and NeuroX1-3 (red) in PVT of 
C57blk/6 mice, scale bar = 100 µm. NeuroX1 had minimal degradation after incubation with 
fluorescent antibody in the PVT. NeuroX2 degraded AGRP expression in the PVT. NeuroX3 
incubated after AGRP staining and had no degradation of either fluorescence. (N-Q) Tail vein 
injections of either fluorogold or NeuroX1-3 to paraventricular nucleus of the hypothalamus 
(PVH), scale bar = 100 µm. NeuroX1 expression in the PVH following tail vein injection of 1.5 
mM concentration. Minimal expression of NeuroX2 in the PVH using 2.0 mM. Staining of 
NeuroX3 in the PVH using 2.0 mM. (N’-Q’) Zoomed-in images from the red dashed box in N-
Q, scale bar = 10 µm. (R-W) NeuroX1 expression with DAPI Counterstaining in DG and IC, 
scale bar = 100 µm. 
 
Cell imaging experiments were performed using HeLa cells and neuro-2a cells. All 
methylated products were water-soluble, cell-permeable, and primarily localized in the nuclei, 
except for 4, which accumulated in vesicles within the cytoplasm of HeLa cells. To assess the 
photostability of NeuroX1-X3, timelapse experiments were performed with a 488/600 channel 
for the monomethylated derivatives NeuroX1 and NeuroX3, and a 552/600 channel for the 
dimethylated derivatives NeuroX2 (Figure 6.2A). After 200 seconds of continuous irradiation, 
around 80% or more of the average fluorescent intensity still remained, indicating high 
resistance to photobleaching. Viability assay showed low cytotoxicity for most methylated 
derivatives with more than 80% viability after 48 hours. Compound 4 had the lowest viability, 
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but more than 60% of the cells still survived after 48 hours. In formaldehyde-treated and 
ethanol-treated HeLa cells, all methylated photoproducts became much more selective nuclear 
stains (Figure 6.2B). Similar localization patterns were also seen in neuro-2a cell line. 
Furthermore, time-lapse experiment was performed for watching division of Neuro-2a cells 
(Figure 6.2O-2Z). On confocal microscope, the cells were incubated for 4 hours. A cell cycle 
from interphase to prophase and another cell cycle from prophase to cytokinesis were observed 
independently with no degradation or photobleaching. 
  To examine the toxicity of these derivatives in tissues, we implemented 
strategies for incubations conducting intracranial injections (Figure 6.3H). A C57blk/6 WT 
mouse was used for live imaging of the derivatives to observe the toxicity against live neurons. 
Coronal sections with a thickness of 200 µm were incubated with a probe and imaged for 
staining. As a representative, NeuroX1 was used in the incubation with live slices prior to 
intracranial injections. NeuroX1 was uptaken by live neurons within the anterior olfactory 
nucleus and IC (Figure 6.3I and 3J). These results demonstrate the low toxicity of these probes 
towards live cell imaging. There were no staining differences of the probes between live and 
fixed cells (Figure 6.2C-2N). As a result of low toxicity in live imaging, intracranial injections of 
each probe was performed in C57blk/6 WT mice. The target region for injection site was the 
bed nucleus stria terminalis (BST) for each probe. Probes stained live neurons within the bed 
nucleus stria terminalis post-surgery (Figure 6.3H). 
To determine the staining properties of these diazaxanthylidene derivatives, NeuroX1-
X3 (Figure 6.3B-3G’), we incubated coronal brain slices from a C57blk/6 WT mouse with a 
molecule overnight. A range of molarities were tested to determine the optimal concentration of 
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each probe. These derivatives demonstrated similar nuclear staining of neurons is several 
regions within fixed brain slices. NeuroX1 resulted in nuclear staining of neurons within IC (3B 
and 3B’) and dentate gyrus (DG) of the hippocampus (Figure 6.3E and 3E’). The staining for 
NeuroX1 was used at 1 µM as determined by the intensity (See Supplemental information). 
Both NeuroX2 and NeuroX3 stained neurons within the IC (Figure 6.3C, 3C’, 3D, and 3D’) 
and DG (Figure 6.3F, 3F’, 3G, and 3G’). The optimal concentration used for both these 
compounds was 2 µM. Expression of neuropeptide Y (NPY) neuron from transgenic mouse was 
not overlapped with nucleus (Red) co-stained with NeuroX1 (Figure 6.4). 
To directly examine whether these probes can be used with immunohistochemistry, 
fixed coronal slices were incubated with AGRP primary antibody and probes (Figure 6.3K-3M). 
NeuroX1 was incubated first overnight then applied AGRP antibody. Post- incubation of 
antibody resulted in minimal probe degradation (Figure 6.3K). NeuroX2 was incubated after 
AGRP antibody staining and resulted in antibody degradation (Figure 6.3L). NeuroX3 was 
incubated after AGRP antibody staining and resulted in no degradation of the probe (Figure 
6.3M). 
 To determine whether these probes have the potential to cross blood brain barrier, tail 
vein injections were performed (Figure 6.3N-3Q’). Using the tail vein protocol adapted from 
SWANSON (insert citation), each probe was diluted and injected into the tail vein of C57blk/6 
WT mice. Fluorogold was used as a control as it was previously shown to stain neurons located 
in the paraventricular hypothalamus (PVH) (Figure 6.3N and 3N’). Fluorogold resulted in an 
absence of neuron labeling within the PVH. NeuroX1 and NeuroX3 demonstrated minimal  
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Figure 6.4. Snapshots of reconstructed NPY neuron (green) with nucleus (Red) stained with 
NeuroX1 on confocal microscope with 100x objective, scale bar = 10 µm, each step 1.0 µm (total 
Z-stack size = 14.0 µm). 
 
staining located in the paraventricular hypothalamus (Figure 6.3O, 3O’, 3Q, and 3Q’). NeuroX2 
resulted in no staining of neurons with the PVH (Figure 6.3P and 3P’). 
To investigate potential retrograde labeling of these probes, intracranial injections to the 
BNST were performed for each probe. C57blk/6 WT mice were injected unilaterally with a 
probe to the BNST and recovered for two weeks. Mice were then perfused and coronal sections 
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were images for potential retrograde labeling. NeuroX1 resulted in minimal retrograde labeling 
in the anterior olfactory nucleus (AON) (top, Figure 6.3Hi). Injection site of the BNST 
demonstrated local staining of neurons as a result of each probe (middle, Figure 6.3Hi). 
Retrograde labeling of NeuroX1 was visible within the paraventricular thalamus (PVT) 
(bottom, Figure 6.3Hi). The concentration for NeuroX1 intracranial injection was 3 µM. As a 
result of minimal retrograde labeling, a higher concentration of probes was prepared for 
injections. NeuroX2 was injected at a concentration of 30 µM. As a result of a higher 
concentration, retrograde labeling in the AON and PVT was easily detectable (top and bottom, 
Figure 6.3ii). NeuroX3 was injected at a concentration of 30 µM and resulted in a higher 
retrograde labeling in AON in comparison to NeuroX1 and NeuroX2 (top, Figure 6.3iii). 
Retrograde labeling in the PVT was less than NeuroX2, but more visible than NeuroX1 
(bottom, Figure 6.3iii). Comparing retrograde tracing ability, retrograde (RG) beads were 
injected (Figure 6.3iv).7 The minimal expression was shown in the PVT and more visible in the 
BST and AON. When SL1 virus was employed for tracing, competitive expression was shown in 
the AON, BST, and PVT (Figure 6.3v). 
 
6.3  Conclusions 
We have generated a set of photocyclized diazaxanthylidene dyes which exist as 
trifluoroacetate salt form. Taken the advantage of isomerization of the starting material (E/Z)-1, 
we have synthesized the three fluorescent compounds NeuroX1-X3 from a single compound in 
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two steps. We have examined the fluorescent properties of these dyes as tools for staining several 
types of cell populations. According to the live and fixed cell imaging experiments, all three dyes 
were found to be competitive probes for the nucleus. Encouraged by these results, we have 
extended the research into the mice brain tissue imaging. Incubation of these molecules in brain 
tissue slices revealed nuclear staining of neurons in both the IC and DG. The IC are small 
clusters of granule cells placed in the olfactory tubercle and have been associated with dopamine 
1 and 3 receptors.5 DG is a cortical region located in the hippocampus related with pattern 
separation and environmental representation.4 The DG is consisted of glutamatergic and 
GABAergic granule cells. Both regions are associated with different functions and neuronal 
types, however, are selectively labeled by these fluorescent probes.  
  As an alternative to viral and dye labeling of neurons, these fluorescents probes 
can be used to stain specific neuronal populations through incubation. The unique uptaking of 
these derivatives allows for a clear visualization of a neuronal nucleus within different regions 
such as IC and DG. Low toxicity of these probes in incubation of live or fixed tissues allows for 
multiple implications of these novel tools. The stability of these probes demonstrated minimal 
to no photobleaching of the samples in cell and tissue imaging, especially overtime. Probes had 
little to no degradation after incubation of fluorescent antibodies. Overlaying all of these studies, 
NeuroX1-X3 as new nuclear staining dyes targeting to neuronal tissues, as well as either live or 
fixed cells, will enable research in neurobiology and chemical biology, which requires low toxic 
and slow photobleaching dyes.  
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6.4  Experimental Section 
General information 
Materials and spectroscopic methods 
Reagents for synthesis were purchased from Sigma Aldrich or Acros and used without 
further purification. Solvents were purchased from Fisher Scientific or Sigma Aldrich. 
Anhydrous solvents was purchased from Fisher Scientific and dried by passing through an 
alumina column of a solvent purification system. Silica gel (230-400 mesh) used for column 
chromatography was purchased from Silicycle. Thin layer chromatography plates (250 µm 
thickness) were purchased from Sorbent Technologies or Merck. Revered-phase column 
chromatography was done using a RediSep Rf Gold C18 column on a Teledyne Isco 
CombiFlash Rf system. High-performance liquid chromatography (HPLC) was performed on a 
Jasco HPLC system using a Phenomenex column (Luna 5u C18(2) 100A; 250 x 4.60 mm, 5 
micron). UV absorption spectra were obtained on a Jasco V-650 spectrophotometer using a 1 
cm path length quartz cuvette. Fluorescence emission spectra were taken on a Horiba Jobin-
Yvon FluoroLog using a 1 cm path length fluorescence quartz cuvette. 1H NMR and 13C NMR 
were recorded on either a Bruker DMX 500 (500 MHz) or a Bruker AVII 500 (500 MHz). 
High-resolution mass spectrometry was performed by Dr. Rakesh Kohli at the University of 
Pennsylvania using a Waters LCT Premier XE Mass Spectrometer (model KE 332). X-Ray 
chromatography was performed by Dr. Pattrick Carroll at the University of Pennsylvania using a 
Bruker APEX2-DUO CCD X-Ray Diffractometer. Photoreactions were carried out in a Rayonet 
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Photochemical Reactor (model RPR-100). Quantum yield was determined by serial dilution 
method using fluorescein (in NaOH 0.1 M, Φ = 0.95) as reference.8 
 
Cell imaging 
For live cell imaging, HeLa cells and neuro-2a cells (purchased from ATCC) were used. 
Cells were cultured in a 60 mm culture dish or a 75 cm2 culture flask using Life Technologies 
Dulbecco's Modified Eagle Medium (DMEM) media with phenol red, 10% Fetal Bovine Serum 
and 1% penicillin-streptomycin at 37 °C in a humidified atmosphere with 5% CO2. The cells 
were detached with 0.05% trypsin-EDTA and transferred to a 35 mm glass bottom poly-D-lysine 
coated dish 2 days before imaging with about 2 mL of the above-mentioned media. One 
microliter of a 5 mM solution of NeuroX1-X3, or 4 in MiliQ water was mixed with 2 mL new 
media and added to the cells after the old media was removed. After incubation (3 hours to 
overnight for NeuroX1-X3, and 4), the excess dyes were washed twice with non-phenol red 
DMEM before imaging. The cells were kept in 1 mL non-phenol red DMEM during imaging. A 
Leica DM4000 spinning disk confocal microscope equipped with a 100x/1.4 NA oil immersion 
objective was used in Figure 6.2C-2N. A Leica TCS SP8 confocal microscope equipped with a 
63x/1.4 NA oil immersion objective lens was used in Figure 6.2O-2Z. All image processing was 
done using Fiji. 
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Formaldehyde fixation 
After achieving the desired cell confluency (70-90%), media was removed and the cells 
were washed once with prewarmed PBS buffer and once with a prewarmed 4% formaldehyde 
solution. The cells were kept in 4% formaldehyde at room temperature for 20 minutes before the 
formaldehyde solution was removed and the dish was washed twice with PBS buffer. The sample 
can be kept in PBS buffer at 2-8 °C until needed. 
 
Ethanol fixation 
After achieving the desired cell confluency, media was removed and the cells were 
washed with PBS buffer, cold ethanol (- 20 °C), then kept in ethanol at - 20 °C. After 10 minutes, 
ethanol was removed and the dish was washed twice with PBS buffer and stored in PBS buffer at 
2-8 °C until needed. 
 
Cytotoxicity studies 
In a 96-well plate, HeLa cells were plated at 5,000 cells/well in culture media mentioned 
above (50 μL/well) and incubated at 37 °C in a humidified atmosphere with 5% CO2. After 24 
hours, cells were treated with NeuroX1-X3 and 4 (final concentration 5 μM), and MitoTracker 
Red FM24 (final concentration 1 μM), and DMSO (vehicle control for MitoTracker). For wells 
treated with MitoTracker and DMSO, DMSO concentration was kept at 1%. Untreated cells 
were used as vehicle control for NeuroX1-X3 and 4. Final volumes were 100 μL/well. Cells were 
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incubated at 37 °C in 5% CO2 for 24 or 48 hours. Alamar Blue (10 μL) was added 2 hours prior 
to fluorescence measurement. Fluorescence was measured at 560 nm excitation and 590 nm 
emission. Vehicle control was taken as 100% cell viability. 
 
Intracranial injections of derivatives 
Mice were anesthetized with 2% isoflurane and were placed into a stereotaxic apparatus 
(Stoelting Instruments). The skull was exposed through a small incision and a small hole was 
drilled for injection. Mice were injected with a probe unilaterally at the targeted brain region. A 
pulled glass pipette with 40–60-μm tip diameter was inserted into the brain and a unilateral 
injection (150 nl) of the probe was performed at coordinates around the BNST (bregma, +1.0 
mm; midline, -0.83 mm; dorsal surface, –4.25 mm). A micromanipulator was used to control the 
injection speed (10 nl min–1) and the pipette was withdrawn 2 minutes after injection of a probe. 
The incision was closed using sutures (Ethicon) and mice were returned to their home cage for a 
recovery period of two weeks. 
 
Live Tissue Imaging 
Mice were deeply anesthetized and killed by decapitation. Brains were dissected and 
immediately sectioned at 200µm using vibratome (Campden Instruments) submerged in a 95 % 
O2 / 5% CO2 bubbled ACSF bath. Coronal slices were incubated for 2 hours with a probe 
diluted in bubbled ACSF. Slices were mounted on glass slides using VECTASHIELD mounting 
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medium with DAPI, and cover-slipped for imaging. Tissue images were obtained using 
stereomicroscope (Leica). 
 
Immunohistochemistry 
Mice were deeply anesthetized and then killed by perfusion with phosphate buffered 
saline (PBS) followed by 4% paraformaldehyde in PBS. Brains were dissected and fixed 
overnight in 4% paraformaldehyde and transferred to PBS. Brain slices (100 μm) were cut by 
vibratome sectioning (Leica) and incubated overnight with a probe. Slices were mounted on 
glass slides using VECTASHIELD mounting medium with DAPI, and coverslipped for imaging. 
Tissue images were obtained using either a stereomicroscope (Leica) or deconvolution 
microscope (Leica). Neuronal images were collected using a confocal microscope (Leica). 
 
Statistical Analysis 
Values are reported as means and linear fitting was conducted using excel and 
SigmaPlot. Correlations and R values were obtained using SigmaPlot software. 
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Experimental procedures 
 
In a round bottom flask, 23b (6.6 mg, 0.018 mmol) was dissolved in toluene (7 mL). 
Dimethyl sulfate 1% v/v in toluene (0.55 mL, 0.058 mmol) was added and the reaction mixture 
was refluxed under argon. After 18 hours, the reaction mixture was allowed to cool down to 
room temperature. The reaction mixture was filtered. The red residue was washed with toluene 
and diethyl ether before being re-dissolved in methanol and dry-loaded to a reversed phase 
automated column using 0.1% TFA water and acetonitrile as eluents to obtain NeuroX13d (2.8 
mg, 0.0057 mmol, 31%), and NeuroX2 (4.1 mg, 0.0067 mmol, 36%), both as orange-red solides. 
The starting material 2 was also recovered after column chromatography (1.4 mg, 0.0038 mmol, 
21%). 
For NeuroX1: Characterization data of NeuroX1 have been published in our previous 
publication.3d  
For NeuroX2: 1H NMR (500 MHz, D2O): δ (ppm) 8.89 (d, 2H, J = 1.4 Hz), 8.32 (dd, 
2H, J = 6.6, 1.5 Hz), 8.23 (d, 2H, J = 6.6 Hz), 7.87 (d, 2H, J = 8.2 Hz), 7.75 (t, 2H, J = 8.1 Hz), 
7.27 (d, 2H, J = 7.9 Hz), 4.40 (s, 3H). 13C NMR (125 MHz, D2O): δ (ppm) 151.6, 148.8, 139.3, 
136.7, 134.9, 130.9, 129.9, 123.7, 119.5, 118.7, 118.3, 114.0, 48.2. IR (neat): 2924, 1682, 1207, 
1133, 801, 723 cm-1. HRMS (m/z): [M/2]+ calcd for C13H9NO+, 195.0679; found, 195.0687. 
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Meting point 200-203 °C. Extinction coefficient ε = 9240 M-1.cm-1 (solvent: water). Quantum 
yield Φ = 0.133 (solvent: water, standard: fluorescein in NaOH 0.1 M). 
 
In a round-bottom flask, compound 33b (8.2 mg, 0.023 mmol) was dissolved in toluene 
(8 mL) and a 1% (v/v) solution of dimethyl sulfate in toluene (0.6 mL, 0.068 mmol) was added. 
The reaction mixture was heat under reflux under argon for 20 hours before allowed to cool 
down to room temperature. Solvent was removed and the residue was washed with 15 mL 
diethyl ether and dried under vacuum. The residue was dissolved in methanol and dry-loaded in 
celite to a C18 column for a reverse phase chromatography using acetonitrile and 0.1% TFA 
water as eluents. A mixture of NeuroX3 (3.2 mg, 0.006 mmol, 26%) and pure 4 (10.4 mg, 0.016 
mmol, 70%) were obtained as orange-red solid. 
For NeuroX3: 1H NMR (500 MHz, D2O): δ (ppm) 9.53 (s, 1H Major), 9.34 (s, 1H 
Minor), 8.81 (s, 1H Minor), 8.72 (s, 1H Major), 8.67 (s, 1H Major), 8.54 (s, 1H Minor), 8.33 
(d, 1H Major, J = 6.3 Hz), 8.26 (d, 1H Minor, J = 6.6 Hz), 8.24-8.20 (m, 1H Major and 1H 
Minor), 8.18 (d, 1H Major, J = 8.2 Hz), 8.14 (d, 1H Minor, J = 8.3 Hz), 7.85-7.77 (m, 1H Major 
and 1H Minor), 7.69-7.64 (m, 1H Major and 1H Minor), 7.58 (d, 1H Major, J = 7.9 Hz), 7.55 
(d, 1H Minor, J = 8.1 Hz), 7.53-7.48 (m, 2H Major and 1H Minor), 7.45 (d, 1H Minor, J = 8.3 
Hz), 7.19-7.13 (m, 1H Major and 1H Minor), 4.57 (s, 3H Major), 4.36 (s, 3H Minor). HRMS 
(m/z): [M]+ calcd for C25H15N2O2+, 375.1128; found, 375.1127. Extinction coefficient ε = 6385 
533 
 
M-1.cm-1 (solvent: water). Quantum yield Φ = 0.217 (solvent: water, standard: fluorescein in 
NaOH 0.1 M). 
For 4: 1H NMR (500 MHz, D2O): δ (ppm) 9.64 (s, 1H), 8.78 (s, 1H), 8.68 (s, 1H), 
8.29 (dd, 1H, J = 6.7, 2.1 Hz), 8.21 (d, 1H, J = 6.7 Hz), 8.12 (d, 1H, J = 8.1 Hz), 7.79 (td, 1H, J = 
7.9, 2.1 Hz), 7.70 (t, 1H, J = 7.9 Hz), 7.56-7.50 (m, 2H), 7.46 (dd, 1H, J = 8.0, 2.1 Hz), 7.17 (t, 
1H, J = 7.7 Hz), 4.55 (s, 3H), 4.32 (s, 3H). IR (neat): 2925, 1682, 1204, 1127, 801, 722 cm -1. 
HRMS (m/z): [M/2]+ calcd for C16H9NO+, 195.0679; found, 195.0683. Meting point 194-197 
°C. Extinction coefficient ε = 13326 M-1.cm-1 (solvent: water). Quantum yield Φ = 0.343 
(solvent: water, standard: fluorescein in NaOH 0.1 M). 
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Appendix 5 
NMR Spectra, Cell Images, and HPLC Diagrams 
Relevant to Chapter 6 
 
 
 
 
 
 
 
This work was performed in collaboration with Dr. J. Nicholas Betley and Elen Hernandez in the 
Betley group and Dr. Mai N. Tran, a previous graduate student in the Chenoweth group at the 
University of Pennsylvania. 
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Figure A5.1. 1H NMR spectrum of NeuroX2 in D2O. 
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Figure A5.2. 13C NMR spectrum of NeuroX2 in D2O. 
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Figure A5.3. 1H NMR spectrum of NeuroX3 in D2O. 
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Figure A5.4. Expanded 1H NMR spectrum of NeuroX3 in D2O. 
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Figure A5.5. Expanded 1H NMR spectrum of NeuroX3 in D2O. 
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Figure A5.6. 1H NMR spectrum of 4 in D2O.  
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Figure A5.7. 13C NMR spectrum of 4 in D2O. 
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Figure A5.8. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated with 
NeuroX1. The fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure A5.9. Confocal microscopy images of EtOH-fixed HeLa cells incubated with NeuroX1. 
The fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
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Figure A5.10. Confocal microscopy images of live neuro-2a cells incubated with NeuroX1. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure A5.11. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated 
with NeuroX2. The fluorescence image was observed using the 552/600 channel. Scale bar = 10 
µm. 
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Figure A5.12. Confocal microscopy images of EtOH-fixed HeLa cells incubated with NeuroX2. 
The fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure A5.13. Confocal microscopy images of live neuro-2a cells incubated with NeuroX2. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
 
 
Figure A5.14. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated 
with NeuroX3. The fluorescence image was observed using the 488/600 channel. Scale bar = 10 
µm. 
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Figure A5.15. Confocal microscopy images of EtOH-fixed HeLa cells incubated with NeuroX3. 
The fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
 
 
Figure A5.16. Confocal microscopy images of live neuro-2a cells incubated with NeuroX3. The 
fluorescence image was observed using the 488/600 channel. Scale bar = 10 µm. 
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Figure A5.17. Confocal microscopy images of paraformaldehyde-fixed HeLa cells incubated 
with 4. The fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
 
 
Figure A5.18. Confocal microscopy images of EtOH-fixed HeLa cells incubated with 4. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
549 
 
 
 
Figure A5.19. Confocal microscopy images of live neuro-2a cells incubated with 4. The 
fluorescence image was observed using the 552/600 channel. Scale bar = 10 µm. 
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Figure A5.20. Timelapse experiment of HeLa cells incubated with NeuroX1. Continuous 
irradiation was perform using the 488/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure A5.21. Timelapse experiment of HeLa cells incubated with NeuroX2. Continuous 
irradiation was perform using the 552/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure A5.22. Timelapse experiment of HeLa cells incubated with NeuroX3. Continuous 
irradiation was perform using the 488/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure A5.23. Timelapse experiment of HeLa cells incubated with 4. Continuous irradiation was 
perform using the 552/600 channel for 200 seconds. Scale bar = 10 µm. 
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Figure A5.24. HPLC chromatogram of NeuroX2. Water containing 0.1% (v/v) trifluoroacetic 
acid and acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 20 
minutes. 
Time (min) % acetonitrile Time (min) % acetonitrile 
0.00 0.0 17.80 100.0 
1.00 0.0 18.00 0.0 
12.00 100.0 20.00 0.0 
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Figure A5.25. HPLC chromatogram of NeuroX3. Water containing 0.1% (v/v) trifluoroacetic 
acid and acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 20 
minutes. 
Time (min) % acetonitrile Time (min) % acetonitrile 
0.00 30.0 15.50 100.0 
1.00 30.0 18.80 100.0 
15.00 80.0 19.00 30.0 
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Figure A5.26. HPLC chromatogram of 4. Water containing 0.1% (v/v) trifluoroacetic acid and 
acetonitrile were used as eluents. Flow rate was 1 mL/min. Method time was 20 minutes. 
Time (min) % acetonitrile Time (min) % acetonitrile 
0.00 0.0 17.80 100.0 
1.00 0.0 18.00 0.0 
12.00 100.0 20.00 0.0 
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Chapter 7 
Synthesis of 9-Substituted Triptycene Building Blocks 
for Solid-Phase Diversification and Nucleic Acid 
Junction Targeting 
 
 
 
 
 
 
 
 
 
 
Adapted with permission from Yoon, I.;* Suh, S.-E.;* Barros, S. A.; Chenoweth, D. M. Org. Lett. 
2016, 18, 1096-1099 (* Equally contributed). Copyright 2016 American Chemical Society. 
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7.1  Introduction 
Nucleic acid junctions play important roles in many biological events. Three-way 
junctions (3WJs) have diverse architectures and are found in DNA and RNA, where they often 
serve as important structural elements.1 Several small molecules are known to bind to nucleic 
acid junctions. However, these molecules often lack specificity, leading to binding of various 
structures.2,3 Recently, we reported a new class of three-way junction stabilizers based on the 
triptycene scaffold.4 The unique shape and 3-fold symmetry of triptycene allows for binding to 
nucleic acid three-way junctions. We also reported triptycene derivatives that bind to a 
d(CAG)∙(CTG) trinucleotide repeat junction.5 
Efficient strategies for triptycene diversification are needed to accelerate the discovery of 
new nucleic acid junction binders with enhanced specificity and binding properties. Triptycene 
building blocks that are amenable to immobilization on a solid support would allow for rapid 
diversification and compound library construction (Scheme 7.1).6 To immobilize triptycene, we 
designed and synthesized a 9-substituted derivative that provides a point of attachment at the 
bridgehead, maintaining the C3 symmetry.7 Although triptycene has been extensively modified 
for use in materials chemistry applications,8 functionalization at the C9-position of triptycene 
has rarely been reported.9  
A carboxylic acid was chosen for functionalization at the C9 tertiary carbon of 
triptycene, due to its versatility of conversion into other functional groups, such as aldehyde, 
haloalkane, ester, and amide. The carboxyl group may also be removed via decarboxylation at a 
later stage. More importantly, the carboxyl group has been extensively employed for directed C-
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H bond functionalization reactions, which could prove valuable during future triptycene 
diversification efforts.10,11  
 
7.2  Results and Discussion 
Scheme 7.1. Strategy for Triptycene Solid-Phase Diversification and Retrosynthesis of Key 
Building Block A.a 
 
                     aFGI = functional group interconversion; ox. = oxidation; red. = reduction;  
              DA = Diels-Alder reaction 
Our synthetic plan (Scheme 7.1) relies on reduction of the nitro groups on precursor B 
to yield building block A. Further disconnection of the amide bond at the bridgehead position 
affords carboxylic acid C. A β-alanine ethyl ester was coupled to the carboxylic acid on C. O-
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directed nitration was envisioned to regioselectively build three nitro groups onto triptycene D. 
In addition to nitration, simultaneous oxidation of the alcohol of D to the desired bridgehead 
carboxylic acid was anticipated. Next, disconnection at C9 and C10 affords benzyne and 
anthracene E precursors, which could be assembled via a Diels-Alder reaction. Precursor E was 
prepared by reduction of aldehyde F. Early-stage functionalization of triptycene at C9 would 
provide an efficient route to a triptycene building block suitable for solid-phase immobilization 
and further diversification. 
 
Scheme 7.2. Approach Toward the Synthesis of 9-substituted Trifunctionalized Triptycene 6a-
6c and X-ray Crystal Structure of 5a 
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Commercially available anthracene-9-carbaldehyde 1 was employed as a starting 
material. Reduction of 1 using sodium borohydride afforded anthracen-9-ylmethanol 2 in 96% 
yield within one hour (Scheme 7.2). Prior to the addition of the Kobayashi benzyne precursor, 
the primary alcohol was protected with a MOM group to prevent electrophilic attack by 
benzyne. The Diels-Alder reaction between 3 and benzyne, which was generated in situ from 2-
(trimethylsilyl)phenyltrifluoromethanesulfonate and cesium fluoride, led to the efficient 
formation of triptycene 4 in high yield. 
Treatment of 4 with nitric acid resulted in nitration of the aromatic rings. During the 
nitration reaction the protecting group on the alcohol was simultaneously deprotected and 
oxidized to the carboxylic acid, providing 6a along with two other isomers 6b and 6c. The 
nitrated triptycene isomers proved inseparable by silica gel chromatography. Acid-catalyzed 
esterification of the crude mixture provided ester isomers 5a-5c, which were separated via silica 
gel chromatography. The structures of ester isomers 5a-5c were confirmed by two-dimensional 
NMR spectroscopy, HMBC and HSQC. Single crystals of 5a were grown in 
CHCl3/CH2Cl2/CH3OH, and the structure was determined by X-ray crystallography (Scheme 
7.2). Following separation of each isomer, saponification was performed to convert the ester to a 
carboxylic acid for coupling to an amine linker. Nitration on the alpha-carbon was not observed 
due to its higher electronegativity compared to that of beta-carbons.11  
To investigate the O-directing effect observed during nitration and to further reduce the 
number of undesired side products, compound 8, containing a carboxylic acid at the C9 
position, was prepared by deprotection of 4 followed by KMnO4 oxidation (Scheme 7.3). 
Compounds 4, 7, and 8 were treated with excess nitric acid at 80 °C for 24 h, and the crude 
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mixtures were analyzed by HPLC using 9,10-diphenylanthrancene as an internal standard. 
HPLC analysis demonstrated that nitration of 8 led to fewer side products compared to 
nitration of 4 and 7 (Figure A6.36-40 in Appendix 6). 
 
Scheme 7.3. Compositions of 6a-6c from the Nitration of Compounds 4, 7, and 8 
 
Interestingly, nitration of 7 produced little of desired products 6a-6c. The composition 
of 6a and 6c significantly changed compared to that from the nitration of 4 and 8, and the overall 
yield increased for the nitration of 8. Attempts were made to increase the proportion of 6a over 
that of the other isomers. The highest ratio of 6a to 6b achieved using this nitration method was 
0.33.12 The introduction of a carboxylic acid at the C9 position of triptycene significantly 
increased the ratio of 6a to 6b to 0.81. These observations are consistent with the carboxylic acid 
functioning as a directing group during the nitration reaction. 
Isomer 6a was chosen for further elaboration due to its three-fold symmetry, which is 
complementary to that of nucleic acid 3WJs. To extend the length of the linker at the 9-position, 
several standard reaction conditions for amide bond formation were examined. However, the 
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Table 8.1. Reaction Conditions for Amide Bond Formation at the Linker Position. 
 
amidation reaction proved recalcitrant and all attempted conditions resulted in unreacted 
starting material (Table 8.1, entries 2-4). The coupling of 9-triptycenecarboxylic acid derivatives 
with EDC has been previously reported.13 However, this method was not reproducible using 6a 
as the starting material (Table 8.1, entry 1). Our results suggested that the sterically hindered 
environment around the carboxylic acid prevents coupling of amines under standard conditions, 
possibly due in part to the bulky active ester intermediates. After a comprehensive literature 
search, we were inspired by Nicolaou’s use of methanesulfonyl chloride (MsCl) in the total 
synthesis of the CP molecules to overcome limitations of a difficult Arndt-Eistert homologation 
on sterically encumbered carboxylic acids.14 Triethylamine and MsCl were added to 6a followed 
by addition of β-alanine ethyl ester hydrochloride, which was pre-treated with triethylamine at 0 
°C. After warming to room temperature, 9 was synthesized in 48% yield (Table 8.1, entry 7). 
However, complete conversion of the starting material was not achieved under these conditions. 
To drive the reaction to completion, the base was changed to pyridine, which is less sterically 
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hindered and allows for access to the carboxylic acid near the bridge-head position. The solvent 
was also changed to dichloromethane due to solubility issues. These changes led to completion 
of the reaction within one hour after warming to room temperature and a substantial increase in 
the yield to 92% (Table 8.1, entry 5). A decrease in the equivalence of MsCl and pyridine 
decreased the yield to 61% (Table 8.1, entry 6). Among the various amide bond forming 
reaction conditions tested on triptycene 6a, only the mesylation route afforded the desired 
product in high yield. 
 
Scheme 7.4. Synthesis of SPPS Precursor 12 and Loading on 2-Chlorotrityl Chloride Resin. 
 
Pd/C-catalyzed hydrogenation of 9 led to reduction of the three nitro groups to afford 
triaminotriptycene 10. Next, the free amines were protected with Fmoc groups by treatment 
with Fmoc-chloride and pyridine. The linker ester group was hydrolyzed in the presence of 
sulfuric acid and water to produce acid 12. The free carboxylate of fully protected building block  
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Scheme 7.5. (a) Solid-Phase Peptide Synthesis of 9-substituted Triptycene on 2-Chlorotrityl 
Chloride Resin (b) Cleavage from the Resin to Generate Triptycene Derivatives 17-19. 
 
             *Deprotection required 12 h for triptycene 19. CT = 2-chlorotrityl  
        chloride resin. 
12 allowed for attachment to 2-chlorotrityl chloride resin, which is compatible with Fmoc 
deprotection chemistry (Scheme 7.4). After attachment to resin, the Fmoc groups were 
deprotected using 20% piperidine in dimethylformamide to generate the free amines. The 
corresponding Fmoc-protected amino acid was pre-activated with HATU and N,N-
diisopropylethylamine (DIPEA) and added to the deprotected triptycene on resin. (L)-
histidine, (L)-lysine, and (L)-asparagine  were selected for attachment to the triptycene arms. 
The deprotection and coupling steps were repeated until the desired sequence of amino acids 
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was achieved (Scheme 7.5a). Once the desired peptide was synthesized on solid phase, the 
triptycene derivatives were cleaved from the resin with simultaneous deprotection of the amino 
acid side chain protecting groups by treatment with a cleavage solution (9:1:1 trifluoroacetic 
acid (TFA) : 2,2,2-trifluoroethanol (TFE) : dichloromethane). Asparagine, which was coupled 
at the N-terminus, required longer cleavage times due to the slow deprotection rate of the trityl 
group close to the amino group (Scheme 7.5b).15 Each compound was purified by preparative 
reverse-phase HPLC and analyzed by analytical HPLC and MALDI-MS. 
 
 
Figure 7.1. (a) Graphical representation of the fluorescence-quenching 3WJ assay. (b) 
Dissociation constants of triptycenes 17-20. Note: Synthesis of triptycene 20 lacking a 
bridgehead substituent has been previously reported.5 
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Triptycenes 17-19 were evaluated for binding towards a d(CAG)∙(CTG) trinucleotide 
repeat junction using a previously developed fluorescence-quenching experiment.5 The binding 
of triptycenes 17-19 were compared to a previously reported triptycene that binds to the 
junction. The previously reported junction binder (20) is analogous to 17 but lacks the linker at 
the 9-position. A d(CAG)∙(CTG) repeat junction was labelled with a fluorophore (FAM) and a 
quencher (IowaBlk). This labelled 3WJ was pre-incubated with a 10 bp inhibitor (I10) strand 
that is complementary to the junction. Hybridization of the inhibitor strand to the junction 
results in an open form, leading to an increase in fluorescence (Figure 7.1a). Triptycenes 17-20 
were added to the pre-incubated fluorescent form. Binding of the triptycenes leads to 
displacement of I10 and reformation of the 3WJ, resulting in a decrease in fluorescence. The Kd 
value for triptycene 17 was determined to be 8.38 μM and exhibited a slight decrease in binding 
compared to that of triptycene 20 (i.e., Kd value of 1.76 μM). Triptycenes 18 and 19, containing 
di- or tripeptides substituents, exhibited enhanced binding affinity toward the junction 
compared to that of 20 with Kd values of 0.27 μM and 0.46 μM, respectively (Figure 7.1b). The 
presence of lysine appears to play an important role in binding to the junction and will be 
investigated in future studies. 
 
7.3  Conclusions 
In summary, we have developed a synthetic approach for preparing new 9-substituted 
triptycene building blocks. This approach enables solid-phase diversification of triptycene. 
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During the synthesis, O-directed nitration was observed from the MOM protected primary 
alcohol (4), primary alcohol (7), and carboxylic acid (8) at the C9 position of triptycene. These 
results indicated that the carboxylic group increased the ratio of nitration on beta-carbons 
toward the linker position, pointing to a possible carboxylic acid directing effect. In addition, a 
key amide bond formation was achieved on a sterically hindered and geometrically fixed tertiary 
carboxylic acid using a unique MsCl activation strategy. This may be regarded as a general 
strategy toward functionalization of extremely sterically encumbered tertiary carboxylic acids. 
For diversification of the new triptycene building block, three amino acids were utilized 
including histidine, lysine, and asparagine to produce trisubstituted peptide 17-19. The binding 
ability of the synthesized triptycene derivatives toward a d(CAG)∙(CTG) trinucleotide repeat 
junction was evaluated and triptycene 18 and 19 exhibited better binding affinity to the junction 
compared to that of a previously reported triptycene with no linker (20). This new synthetic 
strategy provides rapid and efficient access to triptycene building blocks, enabling high-
throughput diversification for rapid evaluation of potential junction binders and other medicinal 
chemistry targets.  
 
7.4  Experimental Section 
General information 
All commercial reagents and solvents were used as received. 9-
anthracenecarboxaldehyde, sodium borohydride, N,N-diisopropylethylamine, chloromethyl 
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methyl ether, beta-Alanine ethyl ester hydrochloride, Fmoc chloride, palladium on activated 
carbon, cesium fluoride, 2-(trimethylsilyl)phenyl trifluoromethanesulfonate, and nitric acid 
from Aldrich, 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium3-oxide  
hexafluorophosphate (HATU) from Oakwood Products, Inc., 2-chlorotrityl chloride resin from 
Advanced ChemTech, chloroform-d, methylene chloride-d2, dimethylsulfoxide-d6, and 
acetone-d6 from Cambridge Isotope Laboratories Inc. were purchased. HPLC-purified TNR 
DNA 3WJ oligo modified with a 5’-FAM and a 3’-IowaBlack (5’-(FAM)-
GCGGAGCAGCCCTTGGGCAGCACCTTGGTGCTGCTCCGC-(IowaBlk)-3’) and DNA 
inhibitor 10 (5’-GCTGCTCCGC-3’) were purchased from Integrated DNA Technologies 
(IDT). 
Flash column chromatography was performed using Silicycle silica gel (55−65 Å pore 
diameter). Thin-layer chromatography was performed on Sorbent Technologies silica plates 
(250 μm thickness). Proton nuclear magnetic resonance spectra (1H NMR) and Carbon nuclear 
magnetic resonance (13C NMR) spectra were recorded on a Bruker DMX 500. High-resolution 
mass spectrometry analysis was obtained by Dr. Rakesh Kohli at the University of Pennsylvania’s 
Mass Spectrometry Service Center on a Waters LC-TOF mass spectrometer (model LCT-XE 
Premier) using electrospray ionization. High-performance liquid chromatography (HPLC) 
chromatograms were recorded and triptycenes 17-19 was purified on JASCO HPLC (Easton, 
MD) equipped with a Phenomenx (Torrance, CA) column (Analytical: Luna 5µ C18(2) 100A; 
250 x 4.60 mm, 5 µm Semi-prep: 5µ C18(2) 100A; 250 x 10.00 mm, 5 µm) using aqueous (H2O 
+ 0.1% CF3CO2H) and organic (CH3CN) phases. Matrix-assisted laser desorption ionization 
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(MALDI) mass spectra were recorded on a Bruker Ultraflex III MALDI-TOF-TOF mass 
spectrometer (Billerica, MA) using α-cyano-4-hydroxycinnamic acid (CHCA). Fluorescence 
measurements were obtained on a Tecan M1000 plate reader (Mannedorf, Switzerland). 
 
Experimental procedures 
 
anthracen-9-ylmethanol (2): To 4.9 g (23.76 mmol) of anthracene-9-carbaldehyde (1) in THF 
(50 mL) was added 1.35g (35.64 mmol) of NaBH4. The mixture was stirred for 1 h at 25 ˚C. 
The mixture was poured into water (400 mL) resulting in a yellow precipitate. The yellow solid 
was filtered off, washed thoroughly with water, and dried. (4.7 g, 96 % isolated yield).16 
1H NMR (500 MHz, CDCl3) δ 8.46 (s, 1H), 8.40 (d, 2H, J = 8.8 Hz), 8.02 (d, 2H, J = 8.4 Hz), 
7.59-7.53 (m, 2H), 7.52-7.46 (m, 2H), 5.65 (s, 2H). 
 
9-((methoxymethoxy)methyl)anthracene (3): To 354 mg (1.7 mmol) of anthracen-9-
ylmethanol 2 in CH2Cl2 was added 1.76 mL (10.2 mmol) of N,N-diisopropylethylamine at 0 ˚C. 
After stirring for 30 min, 0.4 mL (5.1 mmol) of chloromethylmethyl ether was added to this 
solution at 0 ˚C. The mixture was stirred for 10 min, warmed to 25 ˚C, and stirred for 18 h. 
Saturated NH4Cl (aq) solution was added to the reaction. The organic layer was extracted from 
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the solution, dried with anhydrous sodium sulfate, concentrated in vacuo, and purified by 
column chromatography using ethyl acetate/hexanes (4%) as the eluent to give 391 mg of 3 
(391 mg, 91 % isolated yield). 
Physical Property: Pale yellow solid, m.p. = 80-81 ˚C. 
TLC: Rf = 0.52 (silica gel, 25% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) δ 8.53 (d, 2H, J = 8.8 Hz), 8.47 (s, 1H), 8.04 (d, 2H, J = 8.4 Hz), 
7.68-7.62 (m, 2H), 7.58-7.51 (m, 2H), 5.67 (s, 2H), 4.90 (s, 2H), 3.61 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 131.6, 131.3, 129.2, 128.7, 128.4, 126.4, 125.1, 124.4, 95.7, 61.1, 
55.8. 
IR (neat): 1733, 1446, 1265, 1147, 1093, 1061, 1029, 934, 914, 891, 731, 703, 640 cm-1. 
HRMS (ESI) calculated for C17H16NaO2+ [M+Na]+ 275.1043, found 275.1055. 
 
9-((methoxymethoxy)methyl)-9,10-dihydro-9,10-[1,2]benzenoanthracene (4): To a vial was 
added 384 mg (1.52 mmol) of 3, 907 mg (3.04 mmol) of 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate, 693 mg (4.56 mmol) of CsF, and 2.5 mL of acetonitrile at 25 ˚C. 
The solution was heated to 80 ˚C and stirred for 2 h under Argon gas. After the reaction was 
completed, Saturated NH4Cl (aq) solution and ethyl acetate were added to the reaction mixture. 
The organic layer was extracted from the solution, dried with anhydrous sodium sulfate, 
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concentrated in vacuo, and washed with hexanes. The crude mixture was then purified by 
column chromatography using dichloromethane (100%) as the eluent to give 4 (464 mg, 93 % 
isolated yield). 
Physical Property: Pale yellow solid, m.p. = 197-198 ˚C. 
TLC: Rf = 0.39 (silica gel, 25% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) δ 7.62-7.46 (m, 6H), 7.18-7.09 (m, 6H), 5.52 (s, 1H), 5.27 (s, 
2H), 5.22 (s, 2H), 3.80 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 146.7, 144.8, 125.3, 125.2, 123.6, 122.4, 98.3, 67.0, 56.8, 54.5, 
53.2. 
IR (neat): 1375, 1337, 1265, 1183, 1035, 951, 945, 824, 736, 647, 634 cm-1. 
HRMS (ESI) calculated for C23H20NaO2+ [M+Na]+ 351.1356, found 351.1356. 
 
methyl trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylate (5a-5c): To a round bottom 
flask was added 3.97 g (12.1 mmol) of 4 and 50 mL of concentrated nitric acid at 25 ˚C. The 
solution was heated to 80 ˚C and stirred for 24 h. After the reaction was complete, water was 
added to the solution. The solution was neutralized with K2CO3 and re-acidified with 1M HCl. 
Ethyl acetate was added to the solution and the organic layer was extracted from the solution. 
The combined organic solution was dried with anhydrous sodium sulfate, and concentrated in 
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vacuo. To the crude mixture was added 40 mg of H2SO4 and 100 mL of anhydrous methanol. 
The solution was stirred under reflux for 24 h. After the reaction was completed, the solution 
was cooled, extracted with ethyl acetate, dried with anhydrous sodium sulfate, and then 
concentrated in vacuo. The crude mixture of 5a-5c was then purified using column 
chromatography. The composition of each isomer was determined by HPLC analysis. 
methyl 2,7,15-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylate (5a): 
Physical Property: White solid, m.p. = 282-283 ˚C. 
TLC: Rf = 0.41 (silica gel, 50% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) δ 8.64 (d, 3H, J = 2.1 Hz), 8.08 (dd, 3H, J = 8.2, 2.2 Hz), 7.64 (d, 
3H, J = 8.2 Hz), 5.77 (s, 1H), 4.43 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ .167.9, 148.9, 146.3, 143.1, 124.9, 122.9, 120.1, 61.4, 53.8, 53.6. 
IR (neat): 2924, 1746, 1522, 1455, 1340, 1301, 1274, 1250, 1214, 1166, 1025, 903 cm-1. 
HRMS (ESI) calculated for C22H14N3O8+ [M+H]+, no peak matched the calculated exact mass. 
Hydrolysis of the ester to carboxylic acid 6a was required to obtain the HRMS. See next page for 
HRMS data on acid 6a. 
methyl (9s,10r)-2,6,15-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylate (5b):  
Physical Property: White Solid, m.p. = 163-164 ˚C. 
TLC: Rf = 0.73 (silica gel, 50% ethyl acetate/hexanes). 
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1H NMR (500 MHz, CDCl3) δ 8.63 (d, 2H, J = 2.0 Hz), 8.33 (d, 1H, J = 2.0 Hz), 8.04 (dd, 2H, J 
= 8.1, 2.0 Hz), 7.99 (dd, 1H, J = 8.5, 2.0 Hz), 7.89 (d, 1H , J = 8.5 Hz), 7.70 (d, 2H, J = 8.1 Hz), 
5.89 (s, 1H), 4.40 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ 168.1, 149.6, 147.9, 146.2, 144.4, 142.7, 125.4, 125.1, 122.9, 
122.1, 120.1, 119.4, 61.6, 53.5, 53.4. 
IR (neat): 2924, 1743, 1519, 1455, 1341, 1297, 1214, 1165, 1071, 1024, 892 cm-1. 
HRMS (ESI) calculated for C22H14N3O8+ [M+H]+, no peak matched the calculated exact mass. 
Hydrolysis of the ester to carboxylic acid 6b was required to obtain the HRMS. See next page for 
HRMS data on acid 6b. 
methyl (9r,10s)-2,6,14-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylate (5c):  
Physical Property: White Solid, m.p. = 161-162 ˚C. 
TLC: Rf = 0.81 (silica gel, 50% ethyl acetate/hexanes). 
1H NMR (500 MHz, CDCl3) δ 8.65 (d, 1H, J = 2.2 Hz), 8.33 (d, 2H, J = 2.3 Hz), 8.09 (dd, 1H, J 
= 8.2, 2.2 Hz), 8.05 (dd, 2H, J = 8.6, 2.3 Hz), 7.93 (d, 2H, J = 8.6 Hz), 7.67 (d, 1H, J = 8.2 Hz), 
5.80 (s, 1H), 4.37 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 168.1, 149.8, 147.4, 146.24, 146.21, 144.7, 142.3, 125.5, 124.9, 
122.9, 122.1, 120.3, 119.3, 61.9, 53.4, 53.3. 
IR (neat): 2924, 1744, 1598, 1458, 1438, 1342, 1254, 1165, 1023 cm-1. 
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HRMS (ESI) calculated for C22H14N3O8+ [M+H]+, no peak matched the calculated exact mass. 
Hydrolysis of the ester to carboxylic acid 6c was required to obtain the HRMS. See next page for 
HRMS data on acid 6c. 
 
General procedure for preparation of trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylic 
acid (6a-6c): To 1 eq of 5a (or 5b, 5c) dissolved in p-dioxane was added 3 eq of 1M NaOH (aq) 
and heated to 60 ˚C for 24 h. After the reaction was completed, the solution was neutralized and 
acidified with 1N HCl. Ethyl acetate was added to the solution and the organic layer was 
extracted from the solution. The combined organic layer was washed with NH4Cl (aq) and 
brine. The organic layer was dried with anhydrous sodium sulfate, and concentrated in vacuo to 
give 6a (or 6b, 6c) in quantitative yield. 
2,7,15-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylic acid (6a): 
Physical Property: Pale yellow solid, m.p. = 358-359 ˚C. 
TLC: Rf = 0.43 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, (CD3)2CO) δ 9.23 (s, 3H), 7.96 (dd, 3H, J = 8.1, 1.9 Hz), 7.74 (d, 3H, 8.1 
Hz), 6.21 (s, 1H). 
13C NMR (125 MHz, (CD3)2CO) δ 171.3, 151.3, 147.5, 146.1, 124.6, 121.8, 121.4, 63.7, 53.4. 
IR (neat): 2924, 1592, 1518, 1341, 1262, 1092, 1069, 1023, 903 cm-1. 
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HRMS (ESI) calculated for C21H10N3O8- [M-H]- 432.0473, found 432.0457. 
(9s,10r)-2,6,15-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylic acid (6b): 
Physical Property: Pale yellow solid, m.p. = 265-266 ˚C. 
TLC: Rf = 0.23 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, (CD3)2CO) δ 9.29 (d, 2H, J = 2.2 Hz), 8.54 (d, 1H, J = 8.3 Hz), 8.36 (d, 
1H, J = 2.2 Hz), 8.01 (dd, 2H, J = 8.1, 2.2 Hz), 7.88 (d, 1H, J = 8.1 Hz), 7.81 (d, 2H, J = 8.1 Hz), 
6.28 (s, 1H). 
13C NMR (125 MHz, (CD3)2CO) δ 171.2, 152.5, 151.7, 146.8, 146.0, 145.9, 145.5, 127.3, 124.6, 
121.8, 121.4, 121.1, 118.6, 63.7, 53.1. 
IR (neat): 2921, 1737, 1593, 1524, 1462, 1377, 1344, 1260, 1093 cm-1. 
HRMS (ESI) calculated for C21H10N3O8- [M-H]- 432.0473, found 432.0462. 
(9r,10s)-2,6,14-trinitro-9,10-[1,2]benzenoanthracene-9(10H)-carboxylic acid (6c): 
Physical Property: White solid, m.p. = 202-203 ˚C. 
TLC: Rf = 0.03 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, (CD3)2CO) δ 8.92 (s, 1H), 8.49 (s, 2H), 8.23 (d, 2H, J = 8.6 Hz), 8.15-
8.06 (m, 3H), 7.95 (d, 1H, 8.2 Hz), 6.47 (s, 1H). 
13C NMR (125 MHz, (CD3)2CO) δ 168.6, 151.1, 148.2, 146.2, 146.1, 145.7, 142.9, 125.8, 
125.53, 122.51, 121.7, 120.1, 119.5, 61.8, 52.5. 
IR (neat): 2927, 1720, 1598, 1518, 1458, 1418, 1341, 1260, 1179, 1090, 902 cm-1. 
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HRMS (ESI) calculated for C21H10N3O8- [M-H]- 432.0473, found 432.0466. 
 
9,10-[1,2]benzenoanthracen-9(10H)-ylmethanol (7): To a vial was added 1.95 g (5.94 mmol) 
of 4, 70 mL of 1M HCl, and 100 mL of THF. The solution was stirred at 25 ˚C. After 1 h, ethyl 
acetate was added to the solution. The organic layer was extracted from the solution, dried with 
anhydrous sodium sulfate, and concentrated in vacuo to give 7 (1.68 g, 99 % isolated yield). 
Physical Property: Pale yellow solid.17 
TLC: Rf = 0.31 (silica gel, 25% ethyl acetate/hexanes). 
1H NMR (500 MHz, (CD3)2CO) δ 7.65-7.44 (m, 6H), 7.04-6.97 (m, 6H), 5.58 (s, 1H), 5.30 (d, 
2H, J = 3.6 Hz), 4.60 (t, 1H, J = 3.6 Hz). 
13C NMR (125 MHz, (CD3)2CO) δ 147.2, 145.6, 124.71, 124.66, 123.3, 122.9, 60.0, 54.2, 54.0. 
IR (neat): 3308, 2962, 2918, 1579, 1458, 1261, 1071, 1035, 798, 740, 648, 629, 611, 481 cm-1. 
HRMS (ESI) calculated for C21H17O+ [M+H]+ 285.1274, found 285.1288. 
 
9,10-[1,2]benzenoanthracene-9(10H)-carboxylic acid (8): To a vial, 31.9 mg (0.11 mmol) of 7 
was dissolved in acetone and heated to 50 ˚C. 88.6 mg (0.56 mmol) of KMnO4 was added to the 
578 
 
solution. Whenever the solution turned to black or brown, an additional 88.6 mg (0.56 mmol) 
of KMnO4 was added to the solution. After 3 days, sodium sulfite solution (aq) was added to the 
crude mixture and then extracted with ethyl acetate. The combined organic layer was dried with 
anhydrous sodium sulfate, and concentrated in vacuo to yield 8 (22.4 mg, 67 % isolated yield). 
Physical Property: Pale yellow solid.18 
TLC: Rf = 0.28 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, (CD3)2CO) δ 8.09-8.01 (m, 3H), 7.46-7.42 (m, 3H), 7.02-6.97 (m, 6H), 
5.57 (s, 1H) 
13C NMR (125 MHz, (CD3)2CO) δ 172.3, 146.4, 144.6, 125.1, 124.6, 124.6, 123.2, 62.4, 54.2. 
IR (neat): 2925, 1712, 1458, 1448, 1386, 1261, 1213, 1171, 1085, 1032, 867, 801, 748, 735, 703, 
685, 645, 624, 609, 478 cm-1. 
HRMS (ESI) calculated for C21H13O2- [M-H]- 297.0921, found 297.0914. 
 
ethyl 3-(2,7,15-tris((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-9,10-dihydro-9,10-
[1,2]benzenoanthracene-9-carboxamido)propanoate (11): To a vial was charged 180 mg 
(0.338 mmol) of 9, 3.6 mg (0.034 mmol) of Pd/C, 2 mL of MeOH under H2 gas. After 24 h 
stirring at 25 ˚C, the solution was filtered and concentrated in vacuo to yield crude of 10. To a 
round flask was added 10, 0.27 mL (3.38 mmol) of pyridine, and 30 mL of CH2Cl2. The solution 
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was cooled and stirred for 30 minutes at 0 ˚C. 612.1 mg (2.37 mmol) of Fmoc-Cl in 3 mL of 
CH2Cl2 was added to the solution. The crude mixture was warmed to 25 ˚C and stirred for 16 h. 
The solution was washed with saturated NH4Cl (aq), dried, and purified by column 
chromatography using ethyl acetate (100%) as the eluent to give 11 (310 mg, 83 % isolated 
yield). 
Physical Property: White solid, m.p. = 157-158.3 ˚C. 
TLC: Rf = 0.81 (silica gel, 50% ethyl acetate/hexanes). 
1H NMR (500 MHz, CD2Cl2) δ 7.98 (s, 3H), 7.78 (d, 6H, J = 7.5 Hz), 7.59 (d, 6H, J = 6.3 Hz), 
7.39 (t, 6H, J = 7.5 Hz), 7.32-7.20 (m, 12H), 7.15 (s, 3H), 6.75 (bs, 1H), 5.28 (s, 1H), 4.40 (d, 
6H, J = 6.7 Hz), 4.19 (t, 3H, J = 6.7 Hz), 4.06 (q, 2H, J = 7.1 Hz), 3.89 (q, 2H, J = 5.7 Hz), 2.80 
(t, 2H, J = 5.7 Hz), 1.11 (t, 3H, J = 7.1 Hz). 
13C NMR (125 MHz, CD2Cl2) δ 173.1, 168.8, 153.4, 144.3, 143.9, 141.4, 141.3, 135.2, 127.7, 
127.0, 125.0, 123.6, 119.9, 115.9, 66.7, 60.9, 60.5, 52.4, 47.1, 35.8, 34.1, 13.9. 
IR (neat): 1715, 1604, 1526, 1464, 1450, 1409, 1322, 1297, 1260, 1213, 1155, 1055, 985, 804, 
758, 737, 702, 621, 531, 501 cm-1. 
HRMS (ESI) calculated for C71H56N4NaO9+ [M+Na]+ 1131.3940, found 1131.3949. 
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3-(2,7,15-tris((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-9,10-dihydro-9,10-
[1,2]benzenoanthracene-9-carboxamido)propanoic acid (12): To a vial was charged 30.0 mg 
(0.027 mmol) of 11, 0.1 mL of H2SO4, 4 mL of 1,4-dioxane, and 2 mL of water. The solution was 
stirred at 80 ˚C. After 24 h, the solution was concentrated in vacuo and purified by column 
chromatography using ethyl acetate (100%) as the eluent to give 12 in quantitative yield. 
Physical Property: White solid, m.p. = 188-189 ˚C. 
TLC: Rf = 0.67 (silica gel, 100% ethyl acetate). 
1H NMR (500 MHz, (CD3)2SO) δ 9.83-9.53 (bs, 3H), 8.12-7.94 (bs, 4H), 7.87 (d, 6H, J = 7.5 
Hz), 7.71 (d, 6H, J = 7.5 Hz), 7.39 (t, 6H, J = 7.5 Hz), 7.30 (t, 6H, J = 7.5 Hz), 7.28-7.07 (m, 
6H), 5.36 (s, 1H), 4.39 (d, 6H, J = 6.8 Hz), 4.25 (t, 3H, J = 6.8 Hz), 3.78-3.68 (m, 2H), 2.78-
2.62 (m, 2H). 
IR (neat): 3324, 2924, 1719, 1604, 1536, 1464, 1299, 1216, 1052, 985 cm-1. 
HRMS (ESI) calculated for C69H51N4O9- [M-H]- 1079.3662, found 1079.3630. 
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General procedure for preparation of 17-19 (Solid-Phase Peptide Synthesis): To a SPPS 
reaction vessel was added 1 eq of 2-chlorotrityl chloride resin (100-200 mesh, substitution: 1.4 
mmol/g). The resin was stirred in dry CH2Cl2 for 30 min and the solvent was removed by 
vacuum. 1.2 eq of 12 dissolved in dimethylformamide:CH2Cl2 (1:5 volume ratio) and 5 eq of 
N,N-diisopropylethylamine (DIPEA) were added to the resin. After stirring for 10 min, an 
additional 1.5 eq of DIPEA was added to the resin and stirred overnight (12 hours) at 25 ˚C. 
HPLC grade methanol was added and stirred for 20 min to cap the remaining reactive functional 
group on the resin. The solution was removed by vacuum and the resin was washed with CH2Cl2 
(1 min, 3 times) and dimethylformamide (1 min, 3 times). 20 % (v/v) piperidine in 
dimethylformamide was added to the resin, stirred for 1 h, and then the solution was drained. 
The resin was washed with dimethylformamide (1 min, 3 times), CH2Cl2 (1 min, 3 times) and 
dimethylformamide (1 min, 3 times). 9.5 eq of corresponding Fmoc-protected amino acid 
(Fmoc-His(trt)-OH, Fmoc-Lys(boc)-OH, or Fmoc-Asn(trt)-OH) was pre-activated with 9 eq 
of HATU and 18 eq of DIPEA in dimethylformamide. The pre-activated solution was then 
added to the reaction vessel and stirred for ~12 hours overnight. The solution was removed by 
vacuum and the resin was washed with dimethylformamide (1 min, 3 times), CH2Cl2 (1 min, 3 
times) and dimethylformamide (1 min, 3 times). 20 % (v/v) piperidine in dimethylformamide 
was added to the resin, stirred for 1 h, and then the solution was drained. The process of washing 
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the resin and the amino acid coupling was repeated until the desired sequence of peptide was 
achieved. When the peptide coupling is completed, the resin was washed with 
dimethylformamide (1 min, 4 times), CH2Cl2 (1 min, 4 times). The desired product was cleaved 
from the resin by treating a mixture of trifluoroacetic acid(TFA), 2,2,2-trifluoroethanol(TFE), 
and CH2Cl2 (9:1:1 volume ratio) for 30 min twice. For compound 19, cleavage took 12 h. The 
cleavage solution was then collected and concentrated in vacuo. The crude mixture was 
dissolved in MilliQ water and purified by reverse-phase HPLC. Purified products (17-19) were 
analyzed by MALDI-MS and analytical reverse-phase HPLC for the purity. 
 
Fluorescence-quenching experiment 
 
Figure 7.2. Fluorescence-quenching assay for triptycenes 17 (A), 18 (B), 19 (C), and 20* (D) 
*Triptycene 20 is an analogue of triptycene 17 lacking a linker at the C9 position.5 
583 
 
Fluorescence-quenching experiments were conducted in 50 mM sodium phosphate 
buffer, pH 7.2. Inhibitor (I10) strand binding curves were obtained by adding 1 μL of increasing 
concentrations of I10 to 19 μL of 120 nM FQ-TNR 3WJ. Samples were incubated for 2 hours 
and ran in triplicate. Inhibitor strand displacement curves with tripycenes were obtained by 
incubating 14 μL of 120 nM FQ-TNR 3WJ with 1 μL of 150 μM I10 for 2 hours a room 
temperature. To this complex, 1 μL of increasing concentrations of triptycene was added and 
incubated for 2 hours. Fluoresence measurements were conducted in a 384-well plate and were 
recorded with an excitation at 495 nm and emission at 520 nm using 5 nm bandwidths. 
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Appendix 6 
NMR Spectra, HPLC Diagram, MALDI Spectra, and 
X-Ray Structure Data Relevant to Chapter 7 
 
 
 
 
 
 
 
 
 
Adapted with permission from Yoon, I.;* Suh, S.-E.;* Barros, S. A.; Chenoweth, D. M. Org. Lett. 
2016, 18, 1096-1099 (* Equally contributed). Copyright 2016 American Chemical Society. 
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Figure A6.1. 1H NMR spectrum of 2 in CDCl3 (500 MHz). 
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Figure A6.2. 1H NMR spectrum of 3 in CDCl3 (500 MHz). 
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Figure A6.3. 13C NMR spectrum of 3 in CDCl3 (125 MHz). 
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Figure A6.4. 1H NMR spectrum of 4 in CDCl3 (500 MHz). 
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Figure A6.5. 13C NMR spectrum of 4 in CDCl3 (125 MHz). 
 
592 
 
Figure A6.6. 1H NMR spectrum of 5a in CDCl3 (500 MHz). 
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Figure A6.7. 13C NMR spectrum of 5a in CDCl3 (125 MHz). 
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Figure A6.8. HSQC spectrum of 5a in CDCl3. 
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Figure A6.9. HMBC spectrum of 5a in CDCl3. 
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Figure A6.10. 1H NMR spectrum of 5b in CDCl3 (500 MHz). 
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Figure A6.11. 13C NMR spectrum of 5b in CDCl3 (125 MHz). 
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Figure A6.12. HSQC spectrum of 5b in CDCl3. 
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Figure A6.13. HMBC spectrum of 5b in CDCl3. 
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Figure A6.14. 1H NMR spectrum of 5c in CDCl3 (500 MHz). 
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Figure A6.15. 13C NMR spectrum of 5c in CDCl3 (125 MHz). 
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Figure A6.16. HSQC spectrum of 5c in CDCl3. 
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Figure A6.17. HMBC spectrum of 5c in CDCl3. 
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Figure A6.18. 1H NMR spectrum of 6a in (CD3)2CO (500 MHz). 
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Figure A6.19. 13C NMR spectrum of 6a in (CD3)2CO (125 MHz). 
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Figure A6.20. HMBC spectrum of 6a in (CD3)2CO. 
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Figure A6.21. Expanded HMBC spectrum of 6a in (CD3)2CO. 
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Figure A6.22. 1H NMR spectrum of 6b in (CD3)2CO (500 MHz). 
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Figure A6.23. 13C NMR spectrum of 6b in (CD3)2CO (125 MHz). 
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Figure A6.24. 1H NMR spectrum of 6c in (CD3)2CO (500 MHz). 
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Figure A6.25. 13C NMR spectrum of 6c in (CD3)2CO (125 MHz). 
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Figure A6.26. 1H NMR spectrum of 7 in (CD3)2CO (500 MHz). 
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Figure A6.27. 13C NMR spectrum of 7 in (CD3)2CO (125 MHz). 
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Figure A6.28. 1H NMR spectrum of 8 in (CD3)2CO (500 MHz).  
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Figure A6.29. 13C NMR spectrum of 8 in (CD3)2CO (125 MHz). 
 
616 
 
Figure A6.30. Carbonyl carbon peak (172.3 ppm) of 8 on 13C NMR spectrum between 210 and 
130 ppm in (CD3)2CO (125 MHz). 
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Figure A6.31. 1H NMR spectrum of 9 in (CD3)2CO (500 MHz). 
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Figure A6.32. 13C NMR spectrum of 9 in (CD3)2CO (125 MHz). 
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Figure A6.33. 1H NMR spectrum of 11 in CD2Cl2 (500 MHz). 
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Figure A6.34. 13C NMR spectrum of 11 in CD2Cl2 (125 MHz). 
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Figure A6.35. 1H NMR spectrum of 12 in (CD3)2SO (500 MHz). 
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HPLC analysis of compound 5a-5c 
After the nitration reaction of 4, 7, and 8 with nitric acid for 24 h at 80 ˚C, the crude 
mixture was cooled, neutralized with K2CO3, and re-acidified with 1M HCl. Ethyl acetate was 
added to the solution and the organic layer was extracted from the solution. The combined 
organic solution was dried with anhydrous sodium sulfate, and concentrated in vacuo. Crude 
mixtures were dissolved in acetonitrile. For quantitative analysis, 9,10-diphenylanthracene 
(internal standard) dissolved in acetonitrile was added to the crude mixture. All samples were 
then analyzed by reverse-phase HPLC. Solvent gradient method used is shown below. (A: 0.1 % 
CF3CO2H in MilliQ water, B: Methanol) 
 
Figure A6.36. Solvent gradient method for 4, 7, and 8. 
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Figure A6.37. Chromatogram of crude nitration mixture from compound 4. 
 
●: 6a, ▲: 6b, ★: 6c, and ■: 9,10-diphenylanthracene (internal standard) 
 
 
 
 
● 
▲ 
★ 
■ 
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Figure A6.38. Chromatogram of crude nitration mixture from compound 7. 
 
●: 6a, ▲: 6b, ★: 6c, and ■: 9,10-diphenylanthracene (internal standard) 
 
 
 
 
● ▲ ★ 
■ 
625 
 
Figure A6.39. Chromatogram of crude nitration mixture from compound 8. 
 
●: 6a, ▲: 6b, ★: 6c, and ■: 9,10-diphenylanthracene (internal standard) 
 
 
 
 
● 
▲ 
★ 
■ 
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Figure A6.40. Merged chromatogram of crude nitration mixtures from compound 4, 7, and 8. 
 
●: 6a, ▲: 6b, ★: 6c, and ■: 9,10-diphenylanthracene (internal standard) 
 
 
 
 
 
● 
▲ 
★ 
■ 
■ 
■ 
● ▲ ★ 
● ▲ 
★ 
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HPLC analysis of compound 12 and 17-19 
The purified samples were dissolved in acetonitrile (for compound 12) or in MilliQ 
water (for compounds 17-19) and then analyzed by reverse-phase HPLC to confirm the purity 
of samples. Two different gradients were used as shown below (top: compound 12, bottom: 
compound 17-19, A: 0.1 % CF3CO2H in MilliQ water, B: Acetonitrile). 
 
Figure A6.41. Solvent gradient method for 12. 
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Figure A6.42. Solvent gradient method for 17-19. 
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Figure A6.43. Chromatogram of analytical HPLC of compound 12. 
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Figure A6.44. Chromatogram of analytical HPLC of compound 17. 
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Figure A6.45. Chromatogram of analytical HPLC of compound 18. 
 
 
 
 
 
 
 
632 
 
Figure A6.46. Chromatogram of analytical HPLC of compound 19. 
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MALDI-MS analysis 
 
Calculated for C69H52N4NaO9+ [M+Na]+ 1103.363, found 1103.873.; C69H52KN4O9+ [M+K]+ 
1119.337, found 1119.863.; C69H51N4Na2O9+ [M-H+2Na]+ 1125.345, found 1125.873. 
Figure A6.47. MALDI-MS data of compound 12. 
 
 
Calculated for C42H44N13O6+ [M+H]+ 826.353, found 826.690.; C42H43N13NaO6+ [M+Na]+ 
848.335, found 848.679.; C42H42N13Na2O6+ [M-H+2Na]+ 870.317, found 870.670. 
Figure A6.48. MALDI-MS data of compound 17. 
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Calculated for C60H80N19O9+ [M+H]+ 1210.638, found 1211.290.; C60H79N19NaO9+ [M+Na]+ 
1232.620, found 1233.284.; C60H78N19Na2O9+ [M-H+2Na]+ 1254.602, found 1255.278. 
Figure A6.49. MALDI-MS data of compound 18. 
 
 
Calculated for C72H98N25O15+ [M+H]+ 1552.767, found 1553.231.; C72H97N25NaO15+ [M+Na]+ 
1574.749, found 1575.218.; C72H96N25Na2O15+ [M-H+2Na]+ 1596.731, found 1597.206. 
Figure A6.50. MALDI-MS data of compound 19. 
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Table A6.1. Crystal Data and Structure Refinement for 5c. 
 
Empirical formula  C47H29N6O16Cl9  
Formula weight  1252.81  
Temperature/K  100  
Crystal system  triclinic  
Space group  
P1
_
  
a  9.6450(4)Å   
b  11.5310(5)Å   
c  23.1800(9)Å   
α  92.059(2)°  
β  90.249(2)°  
γ  95.534(2)°  
Volume  2564.25(18)Å 3  
Z  2  
dcalc  1.623 g/cm3  
μ  0.569 mm-1  
F(000)  1268.0  
Crystal size, mm  0.28 × 0.14 × 0.03  
2θ range for data collection      3.55 - 50.764°  
Index ranges  -11 ≤ h ≤ 11, -13 ≤ k ≤ 13, 0 ≤ l ≤ 27  
Reflections collected  81802  
Independent reflections  9384[R(int) = 0.0693]  
Data/restraints/parameters  9384/0/706  
Goodness-of-fit on F2  1.036  
Final R indexes [I>=2σ (I)]  R1 = 0.0553, wR2 = 0.1464  
Final R indexes [all data]  R1 = 0.0644, wR2 = 0.1568  
Largest diff. peak/hole  1.25/-1.10 eÅ -3  
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Chapter 8 
Bridgehead-Substituted Triptycenes for Discovery of 
Nucleic Acid Junction Binders 
 
 
 
 
 
 
 
 
 
 
 
Adapted with permission from Barros, S. A.; Yoon, I.; Suh, S.-E.; Chenoweth, D. M. Org. Lett. 
2016, 18, 2423-2426. Copyright 2016 American Chemical Society. 
637 
 
8.1  Introduction 
Nucleic acid junctions are important structural intermediates in biology.1–3 Junctions are 
present in important biological processes including replication.4,5 These junctions also occur in 
viral genomes in addition to trinucleotide repeat expansions associated with numerous 
neurodegenerative diseases.6–12 These structures are also present in nanostructures and aptamer-
based sensors.13–20 The ability to selectively modulate a subset of nucleic acid structures using 
small molecules would allow for the chemical control of cellular processes as well as the 
reprogramming of cellular events.21–37 The ability to differentially stabilize predefined nucleic 
acid structures or to reprogram and bias the equilibrium distribution of an ensemble of 
structures in a precise manner could have a profound impact not only in biology but also in 
nucleic acid nanotechnology and materials applications. 
We previously demonstrated that triptycene-based molecules can bind to three-way 
junctions (3WJs).38 Additionally, we have shown that these molecules bind to d(CAG)·(CTG) 
repeats implicated in triplet repeat expansion diseases.39 The ability to synthesize libraries of 
triptycene derivatives on solid supports will accelerate efforts to identify biologically relevant 
nucleic acid junction binders and provide further insight into the molecular recognition 
properties of triptycenes toward diverse junction sequences and topologies. To facilitate solid-
phase immobilization, a point of attachment on triptycene is required. The bridgehead position 
provided a strategic location, as it is equidistant from the three amino groups that serve as sites 
of diversification (Figure 8.1a). We recently described a synthesis for bridgehead-substituted 
triptycene building blocks.40 Here, we report a modified, more efficient synthesis by utilizing a 
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combined Heck coupling/benzyne Diels-Alder strategy. The new triptycene building block was 
further diversified on solid phase with short di- and tri-peptides, and the final compounds were 
evaluated for binding to a d(CAG)·(CTG) repeat junction. We discovered new high-affinity 
lead compounds for this junction motif that will form the basis of further investigations.  
 
Figure 8.1. (a) Schematic of triptycene bound to a three-way junction and a key triptycene 
building block for diversification by solid-phase synthesis. (b) Improvement of the synthesis of 
triptycene intermediates in this work. 
 
8.2  Results and Discussion 
Similar to our previous route, our synthetic plan relied on the reduction of nitrated 
triptycene, a key intermediate, to install the three key amine functional groups that serve as 
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points of future diversification (Figure 8.1b). The synthetic strategy presented here provides a 
shorter synthesis with only four steps to the key intermediate compared to seven steps in our 
previous route. Additionally, this method significantly reduced total reaction times from 120 h 
to 37 h and showed an improvement in overall yield (Figure 8.1b). Moreover, the solubility of 
intermediates was improved. After extending the linker at the bridgehead via an amidation 
reaction in the previous route, the resulting product showed poor to moderate solubility in most 
organic solvents. However, the intermediates in this synthetic route have good solubility, 
allowing easier characterization and large-scale reactions. In addition, a new regioisomer 5c that 
has all three nitro groups facing away from the linker was isolated in this new synthetic route, 
whereas this regioisomer was not observed in the previous report. 
We initiated our synthesis with a Heck reaction between 9-bromoanthracene 1 and 
methyl acrylate in the presence of palladium(II) acetate, tri-o-tolylphosphine, and triethylamine 
in a sealed tube. The Heck reaction proceeded cleanly and resulted in the desired product 2 in 
84% yield (Scheme 8.1). Next, olefin 2 was reduced under mild conditions using palladium(II) 
acetate as the catalyst and potassium formate as the hydrogen source, producing 3 in 85% 
yield.41 The key Diels-Alder reaction with anthracene 3 and benzyne, generated in situ from 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate and cesium fluoride, proceeded smoothly to 
yield bridgehead-substituted triptycene 4 in 95% yield. Nitration of triptycene resulted in 
hydrolysis of the bridgehead ester and four major nitrated regioisomers that proved inseparable 
by standard chromatographic techniques. Esterification of the crude reaction greatly facilitated 
the separation of the regioisomeric mixture (5a-d) using standard silica gel column 
chromatography. The nitrated triptycene regioisomers were characterized by HMBC and 
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HSQC (Figure A7.9-12, 15-18, 21-24, 27, 28 in Appendix 7). A crystal of triptycene 5d was 
obtained in chloroform to confirm its structure by X-ray crystallography (Scheme 8.1). 
 
Scheme 8.1. Synthesis of Bridgehead-Substituted Triptycenes 5a-d. 
 
Next, isomer 5d was utilized in subsequent transformations that were described in the 
previous publication.40 Pd/C-catalyzed hydrogenation, Fmoc protection, and acid-catalyzed 
hydrolysis of the ester were performed to yield protected triptycene acid 7 in 78% yield over 
three steps. A key building block 7 was immobilized on 2-chlorotrityl chloride resin in 
preparation for solid-phase diversification (Scheme 8.2a). After addition of triptycene and 
washing of the resin, the Fmoc groups on triptycene were deprotected using piperidine in DMF 
(20% v/v) for 1 h. A decreased reaction time led to incomplete deprotection of all three Fmoc 
groups. After deprotection, the first amino acid was coupled onto the immobilized triptycene 
amino acids were continued until the final sequence was obtained. The final deprotection of the 
641 
 
Scheme 8.2. Solid-Phase Synthesis of Orthogonally Protected Building Block 7 and 
Fluorescence-Quenching Experiment of Triptycene-Peptides 
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using HATU and DIEA. Overnight couplings were required for complete reaction with all three 
hindered aniline nitrogens. Next, subsequent deprotections followed by coupling of the desired 
amino acid side chain protecting groups and cleavage from resin were performed simultaneously 
using 9:1:1 TFA/TFE/DCM. The resulting triptycene-peptides were purified by reverse phase 
HPLC and characterized prior to evaluation of the junction binding properties. In this 
manuscript, we focused our efforts on mono, di, and tri peptides to maximize diversity while 
maintaining minimal molecular weight. Longer peptides can certainly be produced although cell 
permeability will be a consideration as the size increases. 
Binding of the amino acid-substituted triptycenes was evaluated against a slipped-out 
d(CAG)·(CTG) repeat nucleic acid junction. Lysine and histidine containing triptycenes were 
synthesized due to their large presence in nucleic acid-protein interfacial interactions. Among 
the molecules previously tested, TripNL-(Lys)3 and TripNL-(His)3 exhibited the highest 
affinity towards the junction. Several dimeric and trimeric amino acid substituents were 
synthesized for comparison (Scheme 8.2b). A high-throughput assay in which the 3WJ was 
labelled with a fluorophore and a quencher was used to determine binding. The addition of a 10 
bp oligonucleotide strand that was complementary to the 5’ end of the junction (I10) opened 
the structure, resulting in a highly fluorescent state (TNR*-I10), as shown in Scheme 8.2c. 
Titration of junction-stabilizing molecules resulted in quenching of fluorescence due to 
displacement of the inhibitor strand and reformation of the junction (TNR*-Trip). To 
determine if increased flexibility of the amino acid may play an important role in binding, glycine 
was coupled directly to the triptycene core followed by lysine or histidine. Trip-(Gly-Lys)3 (8) 
exhibited increased potency compared to that of Trip-(Lys)3, with a Kd of 90 nM, indicating that 
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the increased flexibility may allow for better binding. This triptycene derivative demonstrates 
the highest binding affinity towards the TNR junction thus far. Interestingly, Trip-(Gly-His)3 
(9) did not exhibit improved binding compared to that of Trip-(His)3. Triptycenes substituted 
with three amino acids were also synthesized using lysine, histidine, and asparagine. Trip-(His-
Lys-His)3 (10), Trip-(His-Lys-Lys)3 (11), and Trip-(His-Lys-Asn)3 (12), which only differ in 
their final amino acid, exhibited Kd values of 0.20 μM, 0.17 μM, and 0.39 μM, respectively. It 
should be noted that most triptycene derivatives synthesized in this work showed improved 
binding affinity compared to the most potent triptycene derivative from the previous work, 
which exhibited a Kd value of 0.27 μM. We also compared the binding affinity of Trip-(His-Lys-
Asn)3 (12) to that of TripAM-(His-Lys-Asn)3, which have the same peptide sequence but an 
amide linker at the bridgehead. They exhibited similar binding affinities toward the junction. 
Triptycenes 8-12 were also characterized using a gel shift assay, where the inhibitor strand was 
incubated with unlabeled 3WJ (Figure 8.3). This change resulted in an electrophoretic shift that 
is consistent with a larger complex. Titration of triptycene with this complex resulted in 
reformation of the nucleic acid junction. 
 
8.3  Conclusions 
In summary, we have developed a shorter, more efficient synthetic strategy toward a 
bridgehead-substituted triptycene building block. This new synthetic route is improved in terms 
of solubility, enabling large-scale reactions. Moreover, this route provides an interesting new 
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regioisomer that was not observed through the previous route. A building block with an 
attachment point at the bridgehead provided rapid access to new triptycene peptide derivatives 
using solid-phase synthesis methods. The triptycene peptides were evaluated for nucleic acid 
junction binding to a triplet repeat expansion oligonucleotide using a fluorescence-based assay, 
which revealed the most potent binder to this junction to date. New triptycene building blocks 
that are amenable to solid-phase diversification provide a path for the discovery of new junction 
binders with superior properties. This new class of bridgehead-substituted triptycenes may allow 
for the generation of one-bead-one-compound combinatorial libraries for the rapid discovery of 
new junction binders using fluorescently labeled junctions. 42-44 Additionally, this new class of 
bridgehead-substituted triptycenes opens the door for the creation of pull-down probes to 
identify cellular targets in future studies.  
 
8.4  Experimental Section 
General information 
All commercial reagents and solvents were used as received. 9-bromoanthracene, 
potassium formate, nitric acid, Fmoc chloride, pyridine, and acetonitrile were purchased from 
Sigma-Aldrich (St. Louis, MO). Methyl acrylate, triethylamine (Et3N), tri-o-tolylphosphine, 
palladium(II) acetate, cesium fluoride, and Pd/C were purchased from Acros Organics. 
Methanol, dichloromethane (DCM), dimethylformamide (DMF) were purchased from Fisher 
Scientific (Waltham, MA). (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
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b]pyridinium3-oxide  hexafluorophosphate) (HATU) was purchased from Oakwood Products, 
Inc. (West Colombia, SC), 2-chlorotrityl chloride resin was purchased from Advanced 
ChemTech (Louisville, KY), diisopropylethylamine (DIEA), trifluoroacetic acid (TFA), and 
2,2,2-trifluoroethanol (TFE) were purchased from Alfa Aesar (Ward Hill, MA), and piperidine 
was purchased from American Bioanalytical (Natick, MA). Chloroform-d, methanol-d4, 
dimethylsulfoxide-d6 were purchased from Cambridge Isotope Laboratories (Tewksbury, MA). 
Thin-layer chromatography was done using Sorbent Technologies (Norcross, GA) silica plates 
(250 µm thickness). Flash chromatography was performed on a Teledyne Isco (Lincoln, NE) 
CombiFlash Rf system using RediSep Rf silica columns. 
TNR DNA 3WJ (5’-GCGGAGCAGCCCTTGGGCAGCACCTTGGTGCTGCTCCGC-3’) 
and DNA inhibitor 10 (5’-GCTGCTCCGC-3’) were purchased from Integrated DNA 
Technologies (IDT). HPLC-purified TNR DNA 3WJ oligo modified with a 5’-FAM and a 3’-
IowaBlack was purchased from IDT. 
 1H and 13C NMR were recorded on a Bruker UNI 500 NMR at 500 and 125 MHz, 
respectively. High resolution mass spectra were obtained at the University of Pennsylvania Mass 
Spectrometry Center on a Waters LC-TOF mass spectrometer (model LCT-XE Premier) using 
electrospray ionization in positive or negative mode, depending on the analyte. High-
performance liquid chromatography was performed on a JASCO HPLC (Easton, MD) 
equipped with a Phenomenx (Torrance, CA) column (Analytical: Luna 5µ C18(2) 100A; 250 x 
4.60 mm, 5 µm Semi-prep: 5µ C18(2) 100A; 250 x 10.00 mm, 5 µm) using aqueous (H2O + 
0.1% CF3CO2H) and organic (CH3CN) phases. Matrix-assisted laser desorption ionization 
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(MALDI) mass spectra were obtained on a Bruker Ultraflex III MALDI-TOF-TOF mass 
spectrometer (Billerica, MA) using α-cyano-4-hydroxycinnamic acid (CHCA). Fluorescence 
measurements were collected on a Tecan M1000 plate reader (Mannedorf, Switzerland). 
 
Experimental procedures 
 
methyl-3-(anthracen-9-yl)acrylate (2).45-47 A solution of 9-bromoanthracene (192 mg, 0.746 
mmol), methyl acrylate (642 mg, 7.46 mmol), Et3N (755 mg, 7.46 mmol), tri-o-tolylphosphine 
(25 mg, 0.082 mmol), and Pd(OAc)2 (8.37 mg, 0.0373 mmol) in DMF (7 mL) was heated at 
120 °C in a sealed tube for 5 h. Upon cooling, the mixture was filtered through Celite and 
washed with ethyl acetate. The filtrate was extracted with ethyl acetate and water several times. 
Combined organic layers were then dried over Na2SO4. The crude mixture was purified by 
column chromatography on silica gel (5% EtOAc/hexanes) to give 1 (164 mg, 84%). 1H NMR 
(500 MHz, CDCl3) δ 8.65 (d, 1H, J = 16.3 Hz), 8.45 (s, 1H), 8.25-8.23 (m, 2H), 8.03-8.01 (m, 
2H), 7.53-7.48 (m, 4H), 6.45 (d, 1H, J = 16.3 Hz), 3.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
167.0, 142.4, 131.4, 129.5, 129.4, 129.0, 128.4, 126.9, 126.5, 125.5, 125.3, 52.1; IR (neat) 3051, 
2949, 1719, 1635, 1435, 1265, 1170, 988, 886, 733; HRMS m/z calcd for C18H15O2+ [M+H]+ 
263.1067, observed 263.1074. 
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methyl 3-(anthracen-9-yl)propanoate (3).45-47 To a solution of 2 (102 mg, 0.389 mmol) in DMF 
(5 mL) was added potassium formate (654 mg, 7.78 mmol) and Pd(OAc)2 (4.4 mg, 0.02 mmol) 
and stirred at 60 °C for 4 h. After cooling, the mixture was filtered through Celite and washed 
with ethyl acetate. The filtrate was extracted with ethyl acetate and water. The combined organic 
layer was washed with water and brine, then dried over Na2SO4. The crude mixture was purified 
by column chromatography on silica gel (5% EtOAc/hexanes) to yield 3 (87.3 mg, 85%). 1H 
NMR (500 MHz, CDCl3) δ 8.38 (s, 1H), 8.28 (dd, 2H, J = 8.8, 0.6 Hz), 8.02 (dd, 2H, J = 8.4, 
0.5), 7.56-7.53 (m, 2H), 7.50-7.46 (m, 2H), 4.00-3.96 (m, 2H), 3.75 (s, 3H), 2.82-2.79 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 173.6, 132.4, 131.7, 129.6, 129.6, 126.5, 126.1, 125.1, 
124.0,  52.0, 35.2, 23.4; IR (neat) 3053, 2950, 1734, 1436, 1174, 885, 732; HRMS m/z calcd for 
C18H17O2+ [M+H]+ 265.1223, observed 265.1226. 
 
methyl 3-(9,10-[1,2]benzenoanthracen-9(10H)-yl)propanoate (4).48 To a solution of 3 (443 
mg, 1.68 mmol) in acetonitrile (2.8 mL) was added CsF (764 mg, 5.03 mmol) and 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate (1.0 g, 3.35 mmol) and stirred at 80 °C for 4 h. 
Upon cooling, saturated NH4Cl solution was added to the mixture and then extracted with 
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dichloromethane. The combined organic layer was washed with brine and dried over NasSO4. 
The crude mixture was purified by column chromatography on silica gel (5-10% 
EtOAc/hexanes) to yield 4 (542 mg, 95%). 1H NMR (500 MHz, CDCl3) δ 7.40-7.30 (m, 6H), 
7.04-6.95 (m, 6H), 5.34 (s, 1H), 3.85 (s, 3H), 3.36-3.31 (m, 2H), 3.21-3.15 (m, 2H); 13C NMR 
(125 MHz, CDCl3) δ 174.7, 147.0, 125.2, 125.1, 123.8, 122.1, 54.6, 53.4, 52.2, 30.7, 22.7; IR 
(neat) 2952, 1733, 1450, 1176, 628; HRMS m/z calcd for C24H20NaO2+ [M+Na]+ 363.1356, 
observed 363.1369. 
 
methyl 3-(trinitro-9,10-[1,2]benzenoanthracen-9(10H)-yl)propanoate (5a-5d). A solution of 4 
(424.5 mg, 1.25 mmol) in concentrated HNO3 (15 mL) was stirred at 75 °C overnight. The 
solution was cooled to room temperature, neutralized, and extracted with EtOAc. The organic 
layers were combined, washed with brine, and dried over Na2SO4. The crude mixture was then 
reesterified by stirring in methanol (50 mL) with catalytic H2SO4 under reflux overnight. The 
solution was concentrated under vacuum. Water was added and then basified by the addition of 
1M NaOH. The water was extracted with EtOAc immediately. The organic layer was washed 
with brine and dried over Na2SO4. The crude mixture was purified by column chromatography 
on silica gel (30% EtOAc/hexanes) to give 5a (110 mg, 19%), 5b (130 mg, 22%), 5c (37.2 mg, 
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6.3%), and 5d (88.3 mg, 15%). 5a 1H NMR (500 MHz, CDCl3) δ 8.32 (d, 2H, J = 1.3 Hz), 8.28 
(s, 1H), 8.01 (dd, 3H, J = 8.3, 2.2 Hz), 7.69 (d, 1H, J = 8.1 Hz), 7.62 (d, 2H, J = 8.4 Hz), 5.87 (s, 
1H), 3.91 (s, 3H), 3.52 (t, 2H, J = 7.4 Hz), 3.17 (t, 2H, J = 7.4 Hz); 13C NMR (125 MHz, 
CDCl3) δ 173.4, 151.3, 150.2, 146.2, 146.1, 145.8, 145.0, 125.2, 123.6, 122.5, 122.1, 119.4, 
118.3, 54.8, 53.3, 52.7, 30.2, 22.0; IR (neat) 2953, 1734, 1523, 1344, 1201, 738; HRMS m/z 
calcd for C24H18N3NaO8+ [M+Na]+ 498.0908, observed 498.0919; mp 143-146 °C; 5b 1H NMR 
(500 MHz, CDCl3) δ 8.32-8.27 (m, 3H), 8.04-7.97 (m, 3H), 7.69 (d, 2H, J = 8.1 Hz), 7.64 (d, 
1H, J = 8.4 Hz), 5.88 (s, 1H), 3.92 (s, 3H), 3.56 (t, 2H, J = 7.3 Hz), 3.20 (t, 2H, J = 7.3 Hz); 13C 
NMR (125 MHz, CDCl3) δ 173.4, 150.9, 150.5, 146.2, 145.8, 145.7, 145.3 125.2, 123.6, 122.4, 
122.1, 119.4, 118.1, 54.6, 53.4, 52.7, 30.2, 21.8; IR (neat) 3091, 2953, 2848, 1733, 1520, 1342, 
1201, 736; HRMS m/z calcd for C24H18N3NaO8+ [M+Na]+ 498.0908, observed 498.0919; mp 
139-142 °C; 5c 1H NMR (500 MHz, CDCl3) δ 8.32 (d, 3H, J = 2.2 Hz), 8.03 (dd, 3H, J = 8.4, 
2.2 Hz), 7.60 (d, 3H, J = 8.4 Hz), 5.79 (s, 1H), 3.92 (s, 3H), 3.48 (t, 2H, J = 7.6 Hz), 3.13 (t, 2H, 
J = 7.6 Hz); 13C NMR (125 MHz, CDCl3) δ 173.4, 149.9, 146.7, 146.4, 123.7, 122.2, 119.5, 55.2, 
53.6, 52.7, 30.5, 22.6; HRMS m/z calcd for C24H16N3O8- [M-H]- 474.0943, observed 474.0931; 
5d 1H NMR (500 MHz, CDCl3) δ 8.31 (d, 3H, J = 1.7 Hz), 8.04 (dd, 3H, J = 8.1, 1.8 Hz), 7.63 
(d, 3H, J = 8.1Hz), 5.78 (s, 1H), 3.96 (s, 3H), 3.57 (t, 2H, J = 7.3 Hz), 3.20 (t, 2H , J = 7.3 Hz); 
13C NMR (125 MHz, CDCl3) δ 173.4, 150.5, 146.4, 125.2, 122.5, 118.3, 54.6, 53.8, 52.9, 30.3, 
21.8; IR (neat) 3093, 2954, 2851, 1736, 1525, 1453, 1343, 1202, 1076, 903, 823; HRMS m/z 
calcd for C24H18N3NaO8+ [M+Na]+ 498.0908, observed [M+Na]+ 498.0910; mp 147-150 °C. 
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methyl 3-(2,7,15-triamino-9,10-[1,2]benzenoanthracen-9(10H)-yl)propanoate (6). To a 
solution of 5d (259 mg, 0.544 mmol) in methanol was added Pd/C (25 mg). The solution was 
purged with a H2 gas balloon and kept under H2 gas for 1 h. The mixture was filtered through 
Celite and washed with methanol. The filtrate was concentrated and purified by column 
chromatography on silica gel (5% MeOH/DCM) to give 6 (204 mg, 97%). 1H NMR (500 MHz, 
MeOD) δ 7.01 (d, 3H, J = 7.7 Hz), 6.79 (d, 3H, J = 1.7 Hz), 6.33 (dd, 3H, J = 7.7, 1.5 Hz), 4.98 
(s, 1H), 3.85 (s, 3H), 3.18-3.13 (m, 4H); 13C NMR (125 MHz, MeOD) δ 176.5, 144.6, 140.7, 
124.1, 112.6, 112.2, 54.2, 53.3, 52.5, 31.4, 23.8; IR (neat) 3354, 2951, 1724, 1605, 1473, 1326, 
1181, 582 HRMS m/z calcd for C24H24N3O2+ [M+H]+ 386.1863, observed 386.1848. 
 
3-(2,7,15-tris((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-9,10-[1,2]benzenoanthracen-
9(10H)-yl)propanoic acid (7). To a solution of 6 (116 mg, 0.301 mmol) in DCM (2.5 mL) was 
added excess pyridine. The solution was cooled to 0 °C, then added Fmoc chloride in DCM (2.5 
mL) slowly. The solution was allowed to warm to room temperature over time and stirred 
overnight. The mixture was extracted with DCM and acidic water. The organic layer was washed 
with brine and dried over MgSO4. The crude mixture was purified by column chromatography 
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on silica gel (30% EtOAc/hexanes). A solution of the ester (209 mg, 0.199 mmol) in dioxane (5 
mL), H2O (5 mL), and catalytic H2SO4 was stirred at 80 °C overnight. The reaction mixture was 
neutralized and concentrated under vacuum. Water was added to the mixture and was extracted 
with DCM. The organic layer was washed with brine and dried over Na2SO4. The crude mixture 
was purified by column chromatography on silica gel (50% EtOAc/hexanes) to yield 7 (165 mg, 
80%). 1H NMR (500 MHz, DMSO-d6) δ 12.44 (bs, 1H), 9.58 (s, 3H), 7.89 (d, 6H, J = 7.6 Hz), 
7.72 (d, 6H, J = 7.0 Hz), 7.50 (s, 3H), 7.40 (t, 6H, J = 7.4 Hz), 7.36-7.22 (m, 9H), 7.14 (bs, 3H), 
5.37 (s, 1H), 4.44 (d, 6H, J = 6.7 Hz), 4.28 (t, 3H, J = 6.7 Hz), 3.13-2.92 (m, 4H) ; 13C NMR 
(125 MHz, DMSO) δ 174.2, 153.4, 143.7, 141.3, 140.7, 135.7, 127.6, 127.1, 125.1, 123.2, 120.1, 
114.4, 113.5, 65.5, 52.2, 50.9, 46.6, 29.2, 22.2 IR (neat) 3375, 3325, 3075, 2950, 1709, 1605, 
1528, 1450, 1212, 738; HRMS m/z calcd for C69H52N3O8+ [M+H]+ 1038.3749, observed 
1038.3737; mp 169-171 °C. 
 
Solid Phase Synthesis: 
 All triptycenes were synthesized on 2-chlorotrityl chloride resin (100-200 mesh, 1.5 
mmol substitution/g). The resin was added to a dry glass reaction vessel and swollen by stirring 
in dichloromethane (DCM) for 30 min. After swelling, the DCM was removed by vacuum and 
Fmoc-Trip-OH (8d) was coupled to the resin. Fmoc-Trip-OH (1.5 equiv) in 1:5 DMF:DCM 
and DIEA (5equiv) were added and stirred for 5 min. DIEA (1.5 equiv) was added and the resin 
was stirred overnight. The solution was then drained by vacuum and the resin was washed 
thoroughly with DMF, then DCM, then DMF. The beads were deprotected by treatment with 
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20% piperidine in DMF for 1 h with stirring.  The deprotection solution was removed by 
vacuum and the resin was washed thoroughly with DMF, DCM, then DMF. The first Fmoc-
protected amino acid was then activated with HATU (9 equiv) in the presence of DIEA (18 
equiv) prior to addition to the reaction vessel and allowed to couple overnight. Subsequent 
deprotections and amino acid couplings were run as described above. Before cleavage from the 
resin, the terminal Fmoc was removed. The beads were thoroughly washed with DMF then 
DCM. Peptides were cleaved by addition of trifluoroacetic acid (TFA), 2,2,2-trifluoroethanol 
(TFE), and DCM (9:1:1). The cleavage solution was collected by vacuum and concentrated 
using a rotary evaporator. The crude residue was diluted in 1:1 (0.1% TFA/H2O:MeCN), 
purified by reverse-phase HPLC, and analyzed by MALDI-MS. 
 
Table 8.1. Calculated and Observed Triptycene Masses. 
 
 
Fluorescence Quenching Assay 
All experiments were conducted in 50 mM sodium phosphate buffer, pH 7.2. 
Fluorescence measurements were recorded with excitation at 495 nm and emission at 520 nm 
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using 5 nm bandwidths on a Tecan M1000 plate reader. Inhibitor strand displacement by 
triptycene curves were obtained by incubating 120 nM TNR DNA with 10 μM inhibitor 10 for 2 
h, followed by addition of increasing concentrations of triptycenes. Samples were incubated for 
2 h and measured in triplicate in a 384-well plate. 
 
Figure 8.2. Fluorescence-quenching experiment plots. Displacement of I10 from TNR 3WJ by 
Trip-(Gly-Lys)3 (a), Trip-(Gly-His)3 (b), Trip-(His-Lys-His)3 (c), Trip-(His-Lys-Lys)3 (d), 
Trip-(His-Lys-Asn)3 (e). An overlay of all plot is shown in (f). 
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Gel Shift Assay 
Gel shift experiments were conducted in 50 mM sodium phosphate buffer, pH 7.2. 
Triptycene titration gels were prepared by incubating TNR 3WJ (0.5 μM) with inhibitor strand 
10 (1.5 μM) for 2 h followed by titration of triptycenes and incubation at room temperature for 
2 h. Samples were loaded on a 20% non-denaturing polyacrylamide gel (19:1 monomer:bis) at 
50V in 1X TBR buffer at 4 °C for 10 h. Gels were imaged by staining with SYBR Gold for 15 min 
then visualized using a BioRad GelDoc XR+ imager. 
 
Figure 8.3. Gel shift assay in the presence of triptycenes. TNR 3WJ was incubated with I10 
followed by titration of triptycene derivatives, Gly-Lys (a), Gly-His (b), His-Lys-His (c), His-
Lys-Lys (d), or His-Lys-Asn (e). 
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Appendix 7 
NMR Spectra and X-Ray Structure Data 
Relevant to Chapter 8 
 
 
 
 
 
 
 
 
 
Adapted with permission from Barros, S. A.; Yoon, I.; Suh, S.-E.; Chenoweth, D. M. Org. Lett. 
2016, 18, 2423-2426. Copyright 2016 American Chemical Society. 
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Figure A7.1. 1H NMR spectrum of 2 in CDCl3 (500 MHz). 
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Figure A7.2. 13C NMR spectrum of 2 in CDCl3 (125 MHz). 
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Figure A7.3. 1H NMR spectrum of 3 in CDCl3 (500 MHz). 
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Figure A7.4. 13C NMR spectrum of 3 in CDCl3 (125 MHz). 
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Figure A7.5. 1H NMR spectrum of 4 in CDCl3 (500 MHz). 
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Figure A7.6. 13C NMR spectrum of 4 in CDCl3 (125 MHz). 
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Figure A7.7. 1H NMR spectrum of 5a in CDCl3 (500 MHz). 
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Figure A7.8. 13C NMR spectrum of 5a in CDCl3 (125 MHz). 
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Figure A7.9. HMBC spectrum of 5a in CDCl3. 
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Figure A7.10. Expanded HMBC spectrum of 5a in CDCl3. 
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Figure A7.11. HSQC spectrum of 5a in CDCl3. 
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Figure A7.12. Expanded HSQC spectrum of 5a in CDCl3. 
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Figure A7.13. 1H NMR spectrum of 5b in CDCl3 (500 MHz). 
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Figure A7.14. 13C NMR spectrum of 5b in CDCl3 (125 MHz). 
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Figure A7.15. HMBC spectrum of 5b in CDCl3. 
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Figure A7.16. Expanded HMBC spectrum of 5b in CDCl3. 
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Figure A7.17. HSQC spectrum of 5b in CDCl3. 
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Figure A7.18. Expanded HSQC spectrum of 5b in CDCl3. 
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Figure A7.19. 1H NMR spectrum of 5c in CDCl3 (500 MHz). 
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Figure A7.20. 13C NMR spectrum of 5c in CDCl3 (125 MHz). 
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Figure A7.21. HMBC spectrum of 5c in CDCl3. 
 
 
 
 
 
 
 
680 
 
Figure A7.22. Expanded HMBC spectrum of 5c in CDCl3. 
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Figure A7.23. HSQC spectrum of 5c in CDCl3. 
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Figure A7.24. Expanded HSQC spectrum of 5c in CDCl3. 
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Figure A7.25. 1H NMR spectrum of 5d in CDCl3 (500 MHz). 
 
684 
 
Figure A7.26. 13C NMR spectrum of 5d in CDCl3 (125 MHz). 
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Figure A7.27. HMBC spectrum of 5d in CDCl3. 
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Figure A7.28. Expanded HMBC spectrum of 5d in CDCl3. 
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Figure A7.29. 1H NMR spectrum of 6 in MeOD (500 MHz). 
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Figure A7.30. 13C NMR spectrum of 6 in MeOD (125 MHz). 
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Figure A7.31. 1H NMR spectrum of 7 in DMSO-d6 (500 MHz). 
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Figure A7.32. 13C NMR spectrum of 7 in DMSO-d6 (125 MHz). 
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Figure A7.33. HPLC Chromatograms of the crude solution of the triptycenes 8 and 9. 
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Figure A7.34. HPLC Chromatograms of the purified triptycenes 8 – 12. 
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Table A7.1. Crystal Data and Structure Refinement for 5d. 
Empirical formula  C25H18N3O8Cl3 
Formula weight  594.77 
Temperature  100(1) K 
Wavelength  0.71073 Å  
Crystal system  monoclinic 
Space group  C2/c       
Cell constants:   
a  29.8039(12) Å  
b  9.4923(4) Å  
c  22.1375(9) Å  
 120.796(2)° 
Volume 5379.8(4) Å 3 
Z 8  
Density (calculated) 1.469 Mg/m3 
Absorption coefficient 0.394 mm-1 
F(000) 2432 
Crystal size 0.25 x 0.12 x 0.10 mm3 
Theta range for data collection 1.59 to 25.40° 
Index ranges -35  h  32, -11  k  11, -26  l  26 
Reflections collected 39795 
Independent reflections 4911 [R(int) = 0.0251] 
Completeness to theta = 25.40° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.7055 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4911 / 0 / 345 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0335, wR2 = 0.0855 
R indices (all data) R1 = 0.0400, wR2 = 0.0897 
Largest diff. peak and hole              0.412 and -0.525 e.Å -3 
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Chapter 9 
Development of Novel Irreversible Multistage 
Photoconvertible Fluorophore 
 
 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with Joomyung V. Jun, a graduate student in the 
Chenoweth group at the University of Pennsylvania. 
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9.1  Introduction 
 
Figure 9.1. Irreversible photoconvertible fluorophores. Our previous double-stage (upper) and 
this multistage photoconvertible scaffolds (lower). 
 
Photoactivatable small molecules have been used as fluorescent probes for studying 
biological system. The mechanism for photoactivation of small molecules are various: 
photoisomerization, photouncaging, photodecomposition of azides, or photoclick reactions.1 
We recently reported the synthesis of mono-methylated diazaxanthilidene derivatives 1 and 2 
and their application for photoelectrocyclization-based live-cell imaging (Figure 9.1).2 The 
mechanism of these novel photoconvertible fluorophores is based on the photo-induced 6π 
cyclization. Changing the position of nitrogen atoms on pyridine rings, we developed different 
fluorescent localization pattern of mono-methylated diazaxanthilidenes in the cell. Here, on the 
basis of our previous result, we installed three photocyclizable sites on a single molecule to 
develop the multistaged photoelcetrocyclization-based fluorophore 5.  
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9.2  Results and Discussion 
Scheme 9.1. Synthesis of the First-Stage Compound 9. 
 
The synthesis of the thioketone 6 was reported by Kivala group in 2015 and we followed 
the literature procedures.3 Anthranilic acid, the starting material, underwent ester formation 
using thionyl chloride to afford methyl 2-aminobenzoate. Ullmann coupling with methyl 2-
iodobenzoate followed by iodination to prepare the trimethyl nitrilotrisiodobenzoate. After 
saponification and the subsequent intramolecular Friedel–Crafts reaction gave the iodinated 
heterotriangulene. The Negishi cross-coupling reaction of the the isodinated heterotriangulene 
with n-hexylzinc bromide gave 6. After thionation of 6, the thioketone (7 and 8) went through 
the Barton-Kellogg olefination of the thioketone 12 with 4-(diazo(phenyl)methyl)pyridine to 
prepare 9. Reduction of 9 with triphenylphosphine gave the desired product 5. Due to (E/Z) 
isomerization of 5, variable-temperature 1H-NMR spectroscopy was performed to confirm the 
structure of 5. Each multiplet peaks (δ 8.55-8.35, 8.20-8.10, and 6.80-6.70) of 5 at 25 oC was 
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observed as a single sharp peak at 67 oC, indicating fast exchange of (E, E), (E,Z), and (Z,Z) 
forms. 
 
Figure 9.2. Observed isomerization of 9 on variable-temperature NMR experiment. 
 
The compound 5 has three photocyclizable sites on a single molecule, thus, 5 was 
photocyclized in three discrete steps to the monocyclized product 10 and the dicyclized form 
11. The conversion of 5 to 10 and 10 to 11 was monitored by MALDI-MS analysis. According to 
the excitation and emission spectra of 5, 10, and 11 in the course of photocyclization, apparent 
redshift was shown (Figure 9.3).  
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Figure 9.3. Synthesis and multistage photoactivation of 5 and emission and excitation spectra of 
5, 10, and11. The dashed line represents excitation spectra and the solid line indicates emission 
spectra. 
 
9.3  Conclusions 
In conclusion, it has been demonstrated that the multistaged photoactivatable 
fluorophore 5 was synthesized and charcterized by NMR analysis. Photoconversion of 5 
afforded the single-cyclized and double-cyclized products 10 and 11. The excitation and 
emission spectra of 5, 10, and 11 have shown redshift. Mmore studies will be carried out to 
investigate its potential as a new tool for high-resolution optical imaging applications in addition 
to fluorescence lifetime imaging applications. 
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9.4  Experimental Section 
General information 
All commercial reagents and solvents were used without further purification. Flash 
column chromatography was done using Silicycle silica gel (55−65 Å pore diameter). Thin-layer 
chromatography was conducted on Sorbent Technologies silica plates (250 μm thickness). 
Proton nuclear magnetic resonance spectroscopy (1H NMR) and carbon nuclear magnetic 
resonance spectroscopy (13C NMR) spectra were obtained from a Bruker DMX 500 1H NMR. 
High performance liquid chromatography analysis was performed using a Jasco HPLC 
instrument equipped with a Phenomenex column (Luna 5u C18(2) 100A; 250 × 4.60 mm, 5 
μm). 
 
Experimental procedures 
 
2,6,10-trihexyl-4H-benzo[9,1]quinolizino[3,4,5,6,7-defg]acridine-4,8,12-trione (6): 6 was was 
prepared according to the literature procedure.3 
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1H NMR (500 MHz, CDCl3) δ 8.66 (s, 6H), 2.90 (t, 6H, J = 7.7 Hz), 1.79 (quint, 6H, J = 7.5 
Hz) 1.46-1.31 (m, 18H), 0.91 (t, 9H, J = 7.0 Hz). 
 
(8Z,12Z)/(8Z,12E or 8E,12Z)/(8E,12E)-2,6,10-trihexyl-8,12-bis(phenyl(pyridin-4-
yl)methylene)-8,12-dihydro-4H-benzo[9,1]quinolizino[3,4,5,6,7-defg]acridin-4-one (9): A vial 
was charged with 10 μmol of 6 (5.8 mg), 50 μmol of Lawesson’s reagent (26.6 mg) in 1.0 mL of 
anhydrous toluene and was heated under reflux. After 24 hours, the solution was cooled down 
and passed through silica gel packed filter. Blue or purple-colored fractions were collected, dried 
in vacuo, and used for the next step without further purification. A solution of 0.1 mmol (19.5 
mg) of 4-(diazo(phenyl)methyl)pyridine in 1.0 mL of toluene was added to the crude mixture 
and the corresponding reaction mixture was stirred at 24 oC. After 12 hours, 0.1 mmol (33.3 mg) 
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of triphenylphosphine (polymer-bound) was added to the solution and stirred under reflux for 
12 hours. The crude mixture was dried, redissolved in acetonitrile, and injected to HPLC for 
purification. 1.2 mg of 9 was isolated (14 % over three steps). 
1H NMR (500 MHz, CD3OD) δ 8.73-8.47 (m, 4h), 8.27-8.07 (m, 2H), 7.92-7.64 (m, 4H), 7.60-
7.28 (m, 12H), 6.96-6.78 (m, 2H), 2.62-2.28 (m, 4H), 2.11-1.81 (m, 2H), 1.39-0.64 (m, 33H). 
13C NMR (126 MHz, CD3OD) δ 177.5, 160.2, 143.3, 142.7, 139.9, 138.6, 138.2, 136.7, 134.6, 
134.1, 131.2, 130.9, 130.4, 130.4, 130.3, 130.0, 129.83, 129.76, 129.68, 129.60, 129.5, 129.2, 
129.1, 128.6, 128.2, 128.0, 127.7, 127.58, 127.56, 127.39, 127.36, 127.0, 126.8, 126.39, 126.35, 
126.33, 122.90, 122.85, 122.7, 121.4, 121.3, 119.9, 119.63, 34.60, 34.4, 34.2, 31.34, 31.30, 31.2, 
31.0, 30.7, 28.5, 22.3, 22.23, 22.17, 13.04, 13.00. 
Physical Property: Brown semi-solid. 
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Figure A8.1. 1H NMR spectrum of 6 in CDCl3 (500 MHz).  
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Figure A8.2. 1H NMR spectrum of 9 in CD3OD (500 MHz).  
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Figure A8.3. 13C NMR spectrum of 9 in CD3OD (125 MHz).  
 
